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Carbon-hydrogen bonds are ubiquitous in nature. The development of 
transformations for selective and functional group tolerant methods for the direct 
functionalization of C–H bonds is an important challenge in organic chemistry. Recent 
work in our group has shown that Pd(OAc)2 in conjunction with PhI(OAc)2 serves as an 
efficient catalyst for ligand-directed palladium-catalyzed C–H activation/acetoxylation 
reactions. These reactions are believed to proceed via a PdII/IV catalytic cycle.  
In order to expand the scope of these oxygenation reactions we sought to explore 
whether high and predictable levels of site selectivity could be achieved for the 
functionalization of meta-substituted arenes. These substrates consist of two different C–
H bonds that could undergo chelate-directed functionalization. In general, our results 
show that the palladium-catalyzed C–H activation/acetoxylation of meta-substituted 
arenes occurs preferentially at the less congested position.  
Additionally, we desired to install other functionalities such as halogen and aryl 
groups in the final products using electrophilic halogenating and arylating reagents as 
terminal oxidants. A detailed exploration of palladium-catalyzed chelate-directed 
chlorination, bromination, and iodination of arenes using N-halosuccinimides as terminal 
oxidants has been conducted. These halogenation reactions often lead to products 
complementary to those obtained by traditional electrophilic aromatic substitution 
reactions. Additionally, we have shown that diaryl iodonium salts can be used as oxidants 
for site selective C–H activation/arylation reactions in the presence of Pd(OAc)2 as the 
catalyst. Preliminary results suggest that the mechanism of this reaction involves a 
PdII/PdIV catalytic cycle, which is of interest because nearly all palladium mediated C–C 
bond forming reactions proceed via a Pd0/PdII cycle.  
 xii 
Finally, we have applied the insights gained from the aforementioned oxidation 
reactions towards the functionalization of PdII intermediates generated through 
organometallic transformations different from C-H activation. In this regard, a 
methodology for the oxidative halogenation of PdII-alkyl complexes generated via olefin 
insertion into Pd-aryl bonds to form 1,2-arylhalogenated products has been developed. 
Interestingly, the isomeric 1,1-arylhalogenated products could also be obtained in high 
selectivity just by tuning the reaction conditions. 
In all, this thesis describes a variety of site selective palladium-catalyzed 
oxidative functionalization reactions. These include palladium-catalyzed chelate-directed 
C–H activation/C–X (X = C, O, Cl, Br, I) bond formation and the palladium-catalyzed 
difunctionalization of olefins. The PdII/IV catalytic cycle proposed for many of these 
transformations has allowed for bond formations (e.g., carbon-halogen) that previously 
proved challenging via traditional Pd0/II catalytic cycles. The generality, high selectivity, 
and functional group tolerance of these reactions make them attractive for the 
















The development of site selective, chemoselective and functional group tolerant 
methods for the direct conversion of C–H bonds to more versatile C–X (X = O, C, N, F, 
Cl, Br, I) bonds remains an important challenge in contemporary chemistry (Scheme 1, 
path a). 1-7 Such an approach would preclude the need for pre-functionalized starting 
materials (3) (Scheme 1, path b) that are often not readily accessible for the assembly of 
complex molecules.  
 
Scheme 1: Strategies for Constructing Diverse C-X Bonds 
R H R X R FG
path a path b




New methodologies for the direct functionalization of C–H bonds have the 
potential to dramatically change retrosynthetic strategies for the synthesis of complex 
molecules. Additionally, they might expedite the process of structure activity relationship 
(SAR, studies of change in activity of a drug based on small structural modifications) in 
the pharmaceutical industry by allowing for late stage derivatization of biologically 
active molecules. For example, indeno-quinoline-6-carboxamide (4) is a cytotoxic 




























Current methods of synthesizing analogues of 4 with different X groups require at 
least four steps starting from functionalized reactants 5 and 6 (Scheme 3). 8,9 The 
proposed direct C–H bond functionalization strategy (Scheme 1, pathway a) could 
significantly shorten the synthesis by allowing the installation of the X groups at an 
advanced intermediate 10 (Scheme 4). Importantly, it would eliminate the need to start 
with the X functionality in the reactant 5. 
 























































While an attractive strategy, there are several challenges that need to be 
considered to develop methodologies for the direct functionalization of C–H bonds. First, 
there is a significant kinetic barrier associated with the homolytic or heterolytic cleavage 
of C–H bonds (Challenge 1). 1,2,5,10 The splitting of C–H bonds can occur in two 
different ways to generate radicals, or carbanions (Scheme 5). The difficulty of splitting 
C–H bonds homolytically (Scheme 5, path a) can be thought of in terms of their large 
bond dissociation energies (90-110 kcal mol-1). The unfavorable heterolytic cleavage 
(Scheme 5, path b) of C–H bonds is exemplified by the high pKa values of the conjugate 
acids of unstabilized carbanions (pKa ~ 40-50). These physical properties of C–H bonds 
can be attributed to (i) their nonpolar nature and (ii) their low energy HOMOs and high 
energy LUMOs. Both of these characteristics render the C–H bond inert towards 
reactions with most common electrophiles or nucleophiles. Hence, the traditional 
methods of functionalizing C–H bonds have relied on the use of highly reactive species 
such as super acids, carbenes, nitrenes, and free radicals. However, the low regio- and 
chemoselectivities of these transformations has limited their widespread applicability.5  
 
Scheme 5: Homolytic and Heterolytic Cleavage of C–H Bonds 
C H C H
path a





The second challenge entails achieving site selectivity in functionalization of 
structurally complex molecules that bear many different C–H bonds of comparable 
strengths and reactivity (Challenge 2). For example, most organic molecules contain 
both aromatic and alkyl C–H bonds, both of which have very similar bond dissociation 
energies and pKa’s. Hence, the selective functionalization of one over the other is often 
difficult.  
Finally, and perhaps the most important challenge in terms of synthetic utility, is 
the ability to install diverse functional groups in the final product (Challenge 3). As 
discussed above, one potential application of direct C–H bond functionalization is 
expediting SAR investigations of pharmaceuticals. However, for this to be realized, a 
method must be developed that has the ability to transform the C–H bond in advanced 
intermediates such as 10 (Scheme 4) to a variety of functionalities. 
Challenge 1 can be addressed by the use of transition metals. The binding of a C–
H bond to a transition metal leads to the formation of a σ complex 11 (Scheme 6).11 This 
metal/C–H interaction leads to weakening of the C–H bond due to (i) donation of electron 
density from the metal dπ orbital to the σ* orbital of the C–H bond and (ii) delocalization 
of the electrons in the bonding orbital of the C–H bond onto the metal. This weakening of 
the C–H bond renders it more susceptible to cleavage with concomitant formation of a 
M–C bond (as in 12, Scheme 6). The M–C bond thus generated is more reactive than the 
C–H bond and can subsequently be functionalized to afford the desired product 3.  
 
Scheme 6: Transition Metal Mediated C–H Bond Functionalization 
R H
C–H Activation





(1) (11) (12) (3)  
 
In order to take advantage of transition metal assisted activation of C–H bonds to 
selectively functionalize one of the many C–H bonds present in molecules (Challenge 2), 
researchers have employed a chelate-directed strategy (Scheme 7). 12-19 This approach 
involves the use of substrates 13 bearing appropriate coordinating moieties (L). As shown 
in Scheme 7, the binding of the metal to the ligand (L) directs the metal to activate the 
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proximal C–H bond to afford the cyclometallated complex 15.  Subsequent 
functionalization of 15 would occur selectively at the carbon bonded to the metal. This 
leads to the site selective installation of the desired functional group X proximal to the 
ligand (as in 16) with concomitant regeneration of the catalyst [M].  
 




















Judicious choice of the transition metal catalyst is critical to achieve a viable 
catalytic cycle that can realize Challenge 3, namely diverse functionalization of C–H 
bonds. The key features of the desired catalytic cycle that are dictated by the metal of 
choice are (i) the metal must have the ability to undergo facile cyclometallation of 13, (ii) 
the C–M bond in 15 must have the potential to be converted to diverse C–X bonds 
(Challenge 3), (iii) the metal species 14 that will undergo cyclometallation must be 
sufficiently stable towards oxidants (necessary for carbon-heteroatom bond formation 
since C–H to C–heteratom results in a net oxidation at the carbon atom) and (iv) the C–X 
bonds in the product (16) must be inert towards further activation by the metal catalyst.  
Several transition metals are known to effect cyclometallation of substrates 13. Of 
these metals however, only a few are amenable to the functionalization reaction shown in 
Scheme 7 for many reasons. First, most metals (e.g., Ru0, RhI, IrI) activate C–H bonds via 
an oxidative addition pathway, which results in an increase in oxidation state at the metal 
center upon cyclometallation (Scheme 8).5 As such, this process often requires metals in 
low oxidation states that are generally unstable under the oxidizing conditions necessary 
for carbon-heteroatom bond formation. Additionally, oxidative addition into the C–X (X 
= Cl, Br, I) bonds in the product is very facile at most low valent metal centers, which 


















On the other hand, some high oxidation state metal complexes (e.g., RhIII and IrIII)  
undergo C–H activation by an electrophilic mechanism (with no change of oxidation state 
at the metal center) instead of oxidative addition (Scheme 9).5 However, the resulting 
cyclometallated complexes 20 generated via ligand directed electrophilic C–H activation 
(Scheme 10) are usually resistant to further functionalization by either inner sphere or 
outer sphere oxidants (due to being coordinatively saturated and being stable toward 
ligand substitution).  
 

























In this regard, group 10 metals in the +2 or +4 oxidation states (PdII, PtII and PtIV) 
are the most suitable for the development of the desired diverse C–H bond 
functionalization reactions (Scheme 7) for several reasons: (i) PdII and PtIV are less 
susceptible to oxidation (by two electron oxidants) prior to cyclometallation, (ii) C–M 
bonds in the cyclometallated complexes generated by PdII-, PtII- and PtIV-mediated C–H 
activation, can be transformed into a variety of C–X (X = O, Cl, I) bonds and (iii) C–X 
bonds in the functionalized products are resistant to further activation by the metal 
catalyst. Pd (price/mole of PdCl2 = $5188) is significantly less expensive than Pt 
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(price/mole of PtCl2 = $17074); hence, PdII catalysts have attracted enormous attention 
for the desired C–H bond functionalization reactions. 
Indeed, over the past 40 years organic chemists have found that PdII complexes 
can undergo stoichiometric ligand-directed C–H activation to afford cyclopalladated 
complexes 21 (Scheme 11).20 Furthermore, 21 is now known to undergo reactions with a 
variety of electrophilic oxidants, which transform the C–Pd bond (in 21) into diverse C–
X (X = O, Cl, I) bonds (Scheme 11). The overall two-step process depicted in Scheme 11 
thus constitutes the desired site selective functionalization of a C–H bond adjacent to the 
ligand in the substrate (13), albeit with stoichiometric amounts of the metal.  
 






CL H+ CL X
C-H Activation Functionalization
(21)






Importantly, the key product-forming step in these reactions is proposed to 
involve C–X bond-forming reductive elimination from a transient PdIV intermediate 22 
(Scheme 12). The intermediacy of such PdIV species in these transformations is proposed 
to be critical in achieving bond constructions (e.g., C–H to C–Cl) that could not 
previously be realized.20 
 














Our group sought to exploit this unique stoichiometric cyclopalladation/oxidation 
sequence via PdIV intermediates (Scheme 11) for the development of palladium-catalyzed 
(Scheme 13) functionalization of C–H bonds. In particular, we wanted to explore and 
harness the mechanisms and reactivity available to PdIV complexes like 22 for the 
























 In 2004, our group reported the palladium-catalyzed ligand directed acetoxylation 
of both sp2 and sp3 C–H bonds using Pd(OAc)2 as the catalyst and PhI(OAc)2 as the 
oxidant (Scheme 14).21 Importantly, these reactions are believed to proceed via a PdII/IV 
catalytic cycle (Scheme 13) and do not require the exclusion of air or moisture. The 
oxidant  PhI(OAc)2 is the source of the acetate in the final product 20. 
 

























5 mol % Pd(OAc)2 
1-2 equiv PhI(OAc)2
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With these results in hand, we wanted to expand the scope of these oxygenation 
reactions. In this context, Chapter 2 details our studies towards the acetoxylation of meta 
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substituted arenes of general structure 24 (Scheme 15). These substrates contain two 
different C–H bonds (C–Ha and C–Hb) that could undergo chelate-directed 
functionalization to afford 25 and 26, respectively. Hence, we sought to explore whether 
high and predictable levels of site selectivity could be achieved for the functionalization 
of 24.22  
 



















Additionally, we desired to install other functionalities such as halogen and aryl 
groups in the final products using electrophilic halogenating and arylating reagents as 
terminal oxidants. Chapters 3 and 4 describe our efforts towards the development of Pd-
catalyzed carbon-carbon and carbon-halogen bond-forming reactions, respectively 
(Schemes 16 and 17). Interestingly, the PdII/IV reaction manifold for the C–C bond 
forming reactions allows for functional group tolerance and selectivities that are different 
from other widely used Pd0/II-catalyzed cross coupling strategies (Scheme 16). 23 
Furthermore, the halogenation reactions presented in Chapter 4 lead to products 
complementary to those obtained by traditional electrophilic aromatic substitution 
reactions (Scheme 17).24,25 
 






















(X = Cl, Br, I)
 
 
As discussed above, Chapters 2, 3 and 4 present our explorations of Pd-catalyzed 
ligand directed C–H activation/C–X (X = C, O, Cl, Br, I) bond-forming reactions. The 
key product-forming step in these reactions involves oxidative functionalization of the 
Pd–C bond of the cyclopalladated PdII complex 21 via PdIV intermediates (Scheme 13). 
Based on these results, we reasoned that other PdII σ alkyl or aryl intermediates (formed 
by organometallic transformations different from C–H activation) generated in the 
presence of strong oxidants might undergo functionalization to generate novel products. 
In particular, we envisioned that Pd-alkyl complexes 31 formed via olefin insertion into 
Pd-aryl bonds could be intercepted with oxidants to afford product 33 (Scheme 18). 
However, PdII-σ-alkyl species 31 is well known to undergo ß-hydride elimination under 
traditional Pd0/II catalysis to form alkenes such as 32.26 Nonetheless, we anticipated that 
under oxidative conditions, 31 could competitively react with the oxidant to afford the 
desired functionalized product 33.  
 






















In this regard, Chapter 5 details our efforts towards the oxidative halogenation of 
alkenes to form 1,2-arylhalogenated products 33 (Scheme 19). Interestingly, we also 
found that 1,1-arylhalogenated products 35 could also be obtained in high selectivity just 
by tuning the reaction conditions.27 
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In conclusion, this thesis describes a variety of site selective palladium-catalyzed 
oxidative functionalization reactions. These include palladium-catalyzed chelate-directed 
C–H activation/C–X (X = C, O, Cl, Br, I) bond formation and the palladium-catalyzed 
difunctionalization of olefins. The PdII/IV catalytic cycle proposed for many of these 
transformations has allowed for bond formations (e.g., carbon-halogen) that previously 
proved challenging via traditional Pd0/II catalytic cycles. The generality, high selectivity, 
and functional group tolerance of these reactions make them attractive for the 
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2.1 Background and Significance 
 
Palladium-catalyzed chelate-directed C–H activation/oxidation reactions have 
emerged as a powerful methodology for the direct conversion of C–H bonds to a variety 
of C–X (X = O,1-6 N,7-9 C,10-34 F,35 Cl, Br, I 2, 6, 36-43) bonds. Importantly, the chelate-
directed approach allows for the site selective functionalization of a C–H bond proximal 
to a directing group (L in Scheme 1).  
 




(1) (2)  
 
We and others have shown that this methodology is very general with respect to 
directing groups such as pyridines, oxime ethers, pyrazoles, isoxazolines, quinolines, 
tetrazoles, amides and azo linkages. Importantly, these chelating functionalities are 
widely prevalent in a variety of pharmaceutical candidates (Scheme 2).44-47 Hence, 
palladium-catalyzed ligand-directed oxidative functionalization reactions could 
potentially expedite the process of SAR studies by allowing for diverse functionalization 






































Our group has demonstrated that Pd(OAc)2 in conjunction with PhI(OAc)2 serves 
as an efficient catalyst for the ligand-directed acetoxylation of arene C–H bonds in 
substrates containing appropriate chelating groups. For example, the reaction of 2-
phenylpyridine (6) under our optimal acetoxylation conditions leads to the formation of 
the oxygenated product 7 in 52% isolated yield (Scheme 3).1, 2  
 













Notably, the two ortho C–H bonds (C–Ha) in 6 and most other substrates explored 
by our group are chemically equivalent. Hence, the oxygenation of either of the two C–
Ha bonds in these substrates affords the same product 7 (Scheme 3). In contrast, 
substrates of general structure 8 (Scheme 4), bearing a substituent meta to the directing 
group, contain two chemically inequivalent ortho C–H bonds: C–Ha and C–Hb (Scheme 
4). Palladium-catalyzed ligand-directed C–H activation/oxygenation of these substrates 
could potentially lead to two isomeric products A and B via acetoxylation of either C–Ha 
or C–Hb. We sought to explore the oxygenation of this important class of substrates in 
order to further expand the synthetic utility of the acetoxylation reactions developed by 
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our group. In particular, we wanted to study how the electronic and steric nature of the 
substituent R (Scheme 4) affected site selectivity of these transformations.48 
 


















The site selectivity of functionalization of meta-substituted arenes has been 
explored systematically for a number of other reactions in the literature (e.g., directed 
ortho-lithiation and ruthenium-catalyzed C–H activation/olefin coupling) that involve 
chelate-directed functionalization. Directed ortho-lithiation reactions involve ligand 
directed deprotonation of the ortho protons (C–Ha, Scheme 5) by a strong base like n-
BuLi to generate intermediate 10.49 Subsequent reaction of 10 with an electrophile (E+) 
affords the ortho functionalized product 11.  
 












(10) (11)  
 
The influence of meta substituents on site selectivity has been studied extensively 
for directed ortho-lithiation of substrates 8  (Scheme 6).4 In these reactions, selectivity is 
dictated by two factors: (i) the ability of the meta substituent to coordinate to the lithium 

























For example, reaction of substrates 12 (Scheme 7) and 14 (Scheme 8) bearing meta 
substituents such as OMe or F leads to isomer B (Scheme 6) as the major product with 
>20:1 selectivity via cooperation between the amide ligand and the OMe or F group.  
 

































The preference for isomer B (Scheme 6) with substrate 12 is attributed to the 
ortho directing effect of the amide and the increased acidity of the C–Ha because of the 
inductively electron withdrawing OMe group (Scheme 7). However for 14, both the dual 
chelation of the ligand and F to the Li atom and the increased acidity of the C-Ha proton 
are believed to be important in imparting the observed selectivity (Scheme 8).49, 50 In 
contrast, isomer A (Scheme 6) is the predominant product in the reaction of substrates 






















Such studies on site selectivity have also been conducted for ligand-directed 
ruthenium-catalyzed C–H activation/olefin coupling of a variety of meta-substituted aryl 
ketones (Scheme 10).51-57 In these reactions, dual chelation of the ligand and the R group 
to ruthenium directs C–C bond formation to the more sterically congested position when 
R is a coordinating meta substituent (e.g., F and OMe) (Scheme 10, entries 4 and 5). On 
the other hand, A is the major product with other substituents, R (e.g., CN, Me and CF3) 
that are either sterically hindered or have relatively poor ligand affinities for ruthenium in 
selectivities ranging from 2.7:1 (Scheme 10, entry 3) to >20:1 (Scheme 10, entries 1 and 
2).  
Scheme 10: Ruthenium-Catalyzed C–H Activation/Olefin Coupling 
O
R










Entry R Yield 19-A:19-B
1 82% only A




4 OMe 93% 1:8.3







In contrast to the reactions depicted in Schemes 7–10 above, investigations of site 
selectivity for functionalization of meta-substituted arenes in PdII-catalyzed C–H 
activation/C–heteroatom bond forming reactions were very sporadic and not very 
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extensive when we began our explorations.16, 58-61 However, several stoichiometric 
examples of palladium mediated C–H activation of meta-substituted arenes had been 
documented.  
For instance, Gutierrez and coworkers studied the reaction of a variety of meta-
substituted 2-phenylpyridine derivatives (20) with stoichiometric amounts of Li2PdCl4 in 
EtOH at room temperature (Scheme 11).62, 63 They demonstrated that cyclopalladation of 
20 proceeds via activation of the less sterically congested C–H bond regardless of the 
electronic and the steric nature of the meta substituent.  
 
















Less common are reports of cyclopalladation at the more sterically congested site. 
As shown in Scheme 12, the cyclopalladation of substrate 22 bearing the methylenedioxy 
meta substituent affords 22-B as the major product albeit with only modest selectivity 
(2:1).64 Additionally, the reaction of 23 with Pd(OAc)2 leads to complex 24 as the major 
product (Scheme 13).65  
 











































Although the stoichiometric examples in the literature suggest that 
cyclopalladation reactions most commonly proceed via activation of the less sterically 
hindered C–H bond (with the exception substrates 22 and 23), the relevance of these 
results to catalytic C–H activation/functionalization reactions was not clear. In particular, 
it is not known if the selectivity in stoichiometric reactions is a manifestation of kinetic or 
thermodynamic control. Hence, we sought to systematically explore the reactions of 
meta-substituted arenes in palladium-catalyzed C–H activation/acetoxylation reactions 
developed by our group. Importantly, the insights gained from this study could 
potentially be applied to other Pd-mediated carbon-heteroatom bond forming 
transformations. 
 
2.2 Results and Discussion 
 
We began our study with a variety of meta-substituted 2-(3-substituted phenyl) 
pyridine derivatives (25–31) (Table 2.1). We were pleased to find that the reaction of 
substrates 25–31 with 1.1 to 3.0 equiv of PhI(OAc)2 in the presence of 5 mol % Pd(OAc)2 
afforded the mono acetoxylated products in good yields (Table 2.1). Importantly, only 
trace amounts of diacetoxylation were observed in these transformations. The reaction is 
compatible with a variety of functional groups including ethers (Table 2.1, entries 6, 7), 
halides (Table 2.1, entry 4), and benzylic hydrogens (Table 2.1, entry 5). Additionally, 
these reactions proceeded in comparable times for substrates bearing electron rich (0.5 h 





Table 2.1: Acetoxylation of 2-Phenylpyridine Derivatives 
 
H HR R R








major product minor product
 
 





































aReaction Conditions: 5 mol% Pd(OAc)2, 1.1-3.0 equiv PhI(OAc)2, C6H6 or C6H6/Ac2O, 
100 oC. bSelectivities reported as >100:1 because only one product peak observed by GC.
 cSelectivities reported as >20:1 because other little peaks were observed by GC that might 






























 Both 1H NMR spectroscopy and gas chromatography (GC and GCMS) were 
employed to assess the site selectivity in these reactions. In most cases 1H NMR spectra 
and COSY analysis confirmed the structures of the major isomers. Authentic samples of 
the acetoxylated products were synthesized through an alternate route in cases for which 
the structure of the major isomer could not be assigned based on the 1H NMR spectra of 
the oxygenated compounds. The selectivities (A:B) reported in Table 2.1 were obtained 
by GC analysis of the crude reaction mixtures.  
In general, the major product (isomer A, Table 2.1) in these reactions resulted 
from C–H activation/oxygenation of the less sterically hindered C–H bond regardless of 
the electronic nature of the meta substituent, with >20:1 selectivity. These results are 
consistent with the site selectivities observed for the stoichiometric reactions of 2-phenyl 
pyridine derivatives mentioned in section 2.1.62 However, the site selectivities are 
somewhat attenuated for substrates 32 and 33 bearing relatively smaller cyano (14:1) and 
fluoro (6:1) groups as the meta substituents (Scheme 14).  
 
Scheme 14: Palladium-Catalyzed Acetoxylation of 32 and 33 
H HCN CN CN
HH 5 mol % Pd(OAc)2
3.0 equiv PhI(OAc)2







H HF F F
HH 5 mol % Pd(OAc)2
PhI(OAc)2








Notably, the observed site selectivity with substrates bearing coordinating meta 
substituents such as F (Scheme 14) and OMe (Table 2.1, entry 7), is complementary to 
that obtained in the directed ortho-lithiation49 and ruthenium-catalyzed C–H 
activation/olefin coupling reactions51 described in section 2.1. Furthermore, the 
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selectivity (14:1) observed with the small cyano group as the meta substituent (Scheme 
14) is significantly higher than that observed for the Ru-catalyzed reactions (2.7:1) 
(Scheme 10, entry 3). Finally, the result with substrate 33 (Scheme 14), which shows a 
modest preference for functionalization adjacent to H over F, is particularly remarkable, 
since these two atoms are sterically quite similar.66  
We next desired to explore the effect of the directing group on the reactivity and 
the site selectivity of C–H activation/oxygenation of meta-substituted arenes. Hence we 
studied the reaction of a series of meta-substituted 2-phenylpyrrolidinone derivatives 
(34–36) (Table 2.2). Unlike the phenylpyridine derivatives (25–31) (Table 2.1 and 
Scheme 14), the reactivity of these substrates was highly dependent on the electronics of 
the arene ring being functionalized. Under the optimal conditions (5 mol % Pd(OAc)2, 
1.1-3.0 equiv PhI(OAc)2, AcOH, 100 °C) the palladium-catalyzed acetoxylation of 
substrates (34–36) bearing electron rich arenes afforded the oxygenated products in good 













































aReaction Conditions: 5 mol% Pd(OAc)2, 1.1-3.0 equiv PhI(OAc)2,  AcOH/Ac2O, 
100 oC. bSelectivities determined by crude GC; >20:1 means that there were other little 
peaks observed by GC that might be the minor product but the ratio of the major 






























In contrast, the reaction of substrate 37 bearing an electron withdrawing fluorine 
substituent afforded low yield (45% based on GC conversion) with PhI(OAc)2 as the 
oxidant (Scheme 15). The modest yield of the oxygenated products was partly due to the 
low reactivity of the substrate since significant amounts of the starting material (55% 
based on GC conversion) remained at the end of the reaction. However, gratifyingly, the 
oxygenated products 37-A and 37-B could be obtained in excellent yield (88%) using a 
more reactive iodine(III) reagent (PhI(TFA)2) as the terminal oxidant (Scheme 15). 
Analogous to 37, the reaction of 38 bearing the CF3 substituted arene also led to higher 
yield (45%) of the acetoxylated product 38-A with PhI(TFA)2 (Scheme 15) than with 








































In these reactions the highly reactive PhI(TFA)2 oxidant might be accelerating the 
oxidative functionalization of the electron deficient cyclopalladated intermediates 
generated via C–H activation of 37 and 38, thereby facilitating catalytic turnover and 
leading to superior yields of the acetoxylated products. However, we were intrigued by 
the exclusive formation of the acetate products 37-A/37-B and 38-A despite the presence 
of two different carboxylate ions, OAc and OCOCF3 in the reaction mixture. None of the 
corresponding trifluoroacetate products were obtained from these reactions. There are 
atleast two possible rationales for the selective formation of acetate products in these 
reactions.67 One possibility is that upon oxidation of 39 to 40 (Scheme 16), the 
trifluoroacetate group in 40 might be displaced by the acetate from the AcOH solvent to 
afford a more stable PdIV intermediate 41. C–O bond forming reductive elimination from 
42 would then afford the acetate products (Scheme 16). Alternatively, at the PdIV 
intermediate 44, C–OAc reductive elimination is more facile than the C–TFA coupling 
(Scheme 17). At this time these two possibilities cannot be distinguished. 
 




































(43) (44) (42)  
 
While the reactivity of the phenylpyrrolidinone substrates was significantly 
influenced by the electronics of the arene moiety, site selectivity was relatively 
unaffected by the nature of the meta substituent. Analogous to the phenylpyridine 
derivatives, isomers 34-A–38-A were the major products in these reactions with a 
selectivity of >20:1 resulting from oxygenation of the less hindered C–H bond (Table 2 
and Scheme 15). The fluoro-substituted substrate 37 also underwent functionalization at 
the less sterically congested C–H bond, albeit with more modest selectivity (9:1) 
(Scheme 15). 
As mentioned above, functionalization of the less congested C–H bond occurs 
regardless of the nature of the meta substituents or the directing groups in Pd-catalyzed 
C–H activation/acetoxylation reactions. However, we wanted to further probe the system 
to see if we could override these steric effects and find a way to effect oxygenation of the 
more hindered C–H bond. We hypothesized that the lack of secondary directing effects 
by coordinating meta substituents such as OMe might be attributed to the formation of 
unfavorable 4,5-membered palladacyclic intermediates upon dual chelation assisted 
cyclopalladation (Scheme 18).  
 













Hence, we designed substrates 46 and 48 bearing the ketone moiety as the meta 
substituent. In these substrates, C–H activation via dual chelation of the pyridine and the 
carbonyl would afford favorable 5,5- or 5,6-membered palladacyclic intermediates 47 
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and 49 (Scheme 19). Importantly, ketones have been proposed to act as L type ligands for 
PdII in other Pd-catalyzed C–C bond forming reactions.68, 69  
 























As shown in Scheme 20, the reaction of substrates 46 and 48 under our optimal 
conditions afforded the acetoxylated products in good yields. However, the product was 
formed via acetoxylation of the C–H bond para to the ketone substituent in both cases, 
implicating a lack of secondary directing effects of the carbonyl moiety under our 
reaction conditions. 
 
Scheme 20: Palladium-Catalyzed Acetoxylation of 46 and 48 
H H
HH 5 mol % Pd(OAc)2
PhI(OAc)2










HH 5 mol % Pd(OAc)2
PhI(OAc)2













Based on the results described above, we surmised that the lack of dual chelation 
in the systems discussed above might arise due to the poor ligand abilities of the meta 
substituents for PdII. Hence, in an effort to bias toward functionalization at the more 
congested C–H bond, we next considered substrates 50–52 containing two strongly 
coordinating ligands (pyridine and oxime ether) meta to each other (Scheme 21). 
Notably, our group has previously shown that both oxime ethers and pyridines 
independently serve as effective directing groups in palladium-catalyzed C–H 
activation/acetoxylation reactions. Interestingly, however, the reaction of substrates 50–
52 still led to the ligand directed oxygenation of the less sterically hindered C–H bond 
affording products 50-A–52-A with >20:1 selectivity.  
 
Scheme 21: Palladium-Catalyzed Acetoxylation of 50–52 
Hb Hb
HaHa 5 mol % Pd(OAc)2
PhI(OAc)2












HaHa 5 mol % Pd(OAc)2
PhI(OAc)2


























Substrates 50–52 contain of three C–H bonds (C–Ha, C–Hb and C–Hc) that could 
potentially be functionalized via the ligand directed strategy (Scheme 16). The pyridine 
moiety could direct oxygenation of C–Ha in 50–51. The oxime ether and/or the pyridine 
could promote the functionalization of C-Hb in 50–52 and, finally, the oxime ether could 
independently direct acetoxylation of C-Hc in 50–52. However, the exclusive formation 
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of 50-A–52-A indicates that in substrates containing multiple chelating groups, the 
palladium-catalyzed C–H activation/functionalization is selectively directed by the most 
dominant ligand (e.g., pyridine in 50 and 51) at the less sterically hindered position.  
In a final effort to bias oxygenation to the more congested C–H bond, we 
investigated the reaction of substrates 53 and 23 (Scheme 22) that contain meta 
substituents for which secondary directing effects have been observed in stoichiometric 
cyclopalladation reactions (Schemes 12 and 13).64, 65  
 














As shown in Scheme 23 below, the reaction of 53 afforded a mixture of the 
acetoxylated products 53-A and 53-B in 29% yield. The low yield in this reaction is due 
to significant formation of the di-oxidized (67% based on GC conversion) products. 
However, consistent with the stoichiometric cyclpalladation reaction described in Scheme 
12 above, the major product from the reaction of 53 formed via oxygenation of the more 
sterically hindered C–H bond albeit with modest selectivity (53-A:53-B = 1:2).59 In this 
case, the cyclic nature of the -OCH2O- group might decrease the effective size of the 
meta substituent, hence allowing for oxygenation at the more congested position. 
Additionally, the conformational constraint of the five membered ether ring might render 
the lone pair of the oxygen more accessible for coordination to the palladium center.  
 
Scheme 23: Palladium-Catalyzed Acetoxylation of 53 
H H
HH 5 mol % Pd(OAc)2
PhI(OAc)2















We next subjected substrate 23 to our standard conditions for acetoxylation. 
However, as shown in Scheme 24, no oxygenated product was obtained from this 
reaction. We were surprised by this result because 23 is known to undergo stoichiometric 
cyclopalladation to afford complex 24 (Scheme 13). We reasoned that the two 
symmetrically disposed strongly coordinating pyridine ligands might be hindering the 
oxidative functionalization of the cyclopalladated complex 24 (generated upon C–H 
activation), hence preventing the formation of the acetoxylated product.  
 
Scheme 24: Palladium-Catalyzed Acetoxylation of 23 












In order to probe this hypothesis, we conducted the reaction of complex 24 with 
stoichiometric amounts of PhI(OAc)2.  As depicted in Scheme 25, this reaction did not 
afford the oxygenated product. These results indicate that the presence of two strongly 
coordinating pyridine ligands is necessary for selective dual chelation assisted 
cyclopalladation to occur with high selectivity in meta-substituted arenes (Scheme 13). 
However, in such cases, the oxidative functionalization of the cyclopalladated complex 
24 does not proceed. 
 
 









As discussed above, the palladium-catalyzed acetoxylation of meta-substituted 
arenes leads to the clean formation of the monoxygenated products via functionalization 
of the less sterically hindered C–H bond. However, the use of super stoichiometric 
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amounts of PhI(OAc)2 revealed that the dioxygenated products can form depending on 
the electronic nature of the arene being functionalized (Scheme 26). For example the 
reaction of substrate 31 containing an electron rich methoxy substituent, with 3.0 equiv of 
PhI(OAc)2 led to the formation of the diacetoxylated product 54 quantitatively (based on 
GC conversion). Under similar reaction conditions, substrate 29 bearing an electron 
neutral methyl substituent afforded only 64% of the diacetoxylated product 55. Finally, 
the reaction of substrate 26 containing an electron poor trifluoromethyl group led to only 
the monoacetoxylated product 26-A even with 3.0 equiv of the oxidant.  
 
Scheme 26: Reaction of 31, 29 and 26 with excess PhI(OAc)2 
H AcOOMe OMe
H
5 mol % Pd(OAc)2
3.0 equiv PhI(OAc)2




quantitative based on GC conversion
H AcOMe Me
H
5 mol % Pd(OAc)2
3.0 equiv PhI(OAc)2




64 % based on GC conversion
H CF3 CF3
H
5 mol % Pd(OAc)2
3.0 equiv PhI(OAc)2




quantitative based on GC conversion
 
 
These results suggest that the palladium-catalyzed C–H activation/acetoxylation 
of the more sterically hindered C–H bond is possible under our reaction conditions, but 
only after the formation of the monofunctionalized products. This along with the fact that 
the selectivity determining C–H activation step is not reversible and is rate determining 
for these reactions (found by other members of the group), we surmise that the 
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monooxygenated products obtained via preferential functionalization of the less sterically 




In summary, we have conducted the first comprehensive study of site selectivity 
for meta-substituted arenes in palladium-catalyzed ligand-directed C–H 
activation/functionalization reactions. In general, our results show that the palladium-
catalyzed C–H activation/acetoxylation of meta-substituted arenes occurs preferentially at 
the less congested position. The similar results observed for the 2-phenylpyridine and the 
phenylpyrrolidinone derivatives indicate that site selectivities reported herein might be 
general for a wide variety of directing groups. Additionally, as will be detailed in 
subsequent chapters (Chapters 3 and 4), the observed sensitivity to the steric 
environment of the arene ring for the acetoxylation reactions appears to be general for a 
wide variety of Pd-catalyzed C–H activation/functionalization reactions. Indeed, 
subsequent or concurrent to our work several reports have shown similar results for 
palladium-catalyzed oxidative functionalization of C–H bonds with pyridine, amide, 
oxime ether, and carboxylic acid directing groups. Furthermore, the modest selectivity for 
functionalization adjacent to H versus fluorine suggests that PdII-mediated C–H 
activation reactions might be very sensitive to slight steric perturbations in the system. 
Importantly, our results suggest that the site selectivities for palladium-catalyzed C–H 
activation/functionalization reactions might often be different and complementary to 
those obtained for directed ortho-lithiation or ruthenium-catalyzed C–H activation 
reactions. Finally, the predominant functionalization occurs adjacent to the more strongly 
coordinating ligand (e.g., pyridine) at the less sterically crowded C–H bond in substrates 
containing multiple chelating groups. This result is particularly exciting because it 
suggests the possible application of our methodology towards selective functionalization 
of the C–H bond proximal to the dominant directing group in complex biologically active 




2.4 Experimental Procedure 
 
General Procedures:  NMR spectra were obtained on a Varian Inova 500 
(499.90 MHz for 1H; 125.70 MHz for 13C) or a Varian Inova 400 (399.96 MHz for 1H; 
100.57 MHz for 13C; 376.34 MHz for 19F) spectrometer. 1H NMR chemical shifts are 
reported in parts per million (ppm) relative to TMS, with the residual solvent peak used 
as an internal reference.  Multiplicities are reported as follows: singlet (s), doublet (d), 
doublet of doublets (dd), doublet of doublets of doublets (ddd), doublet of triplets (dt), 
triplet (t), quartet (q), quintet (quin), multiplet (m), and broad resonance (br). IR spectra 
were obtained on a Perkin-Elmer “Spectrum BX” FT-IR spectrometer.  
 
Materials and Methods:  Pyridine substrate 31 was prepared by Suzuki cross-coupling 
of 3-methoxyphenyl boronic acid with 2-bromopyridine according to a literature 
procedure. Pyridine substrates 25–30, 32, 33, 46, 48, and 53 were prepared by Stille 
cross-coupling of 2-tributylpyridyltin with the corresponding aryl bromides. Substrates 
50–52 were synthesized by reaction of the corresponding ketones with methoxylamine 
hydrochloride using a known procedure for making oxime ethers. Amide substrates 34–
38 were prepared by palladium-catalyzed arylation of the corresponding lactam. 
Substrate 23 was prepared by coupling 2-lithiopyridine with N,N,N,N,-
tetraethylisopthalamide according to a literature procedure. The authentic compounds 
were prepared by Stille cross-coupling.  Cyclopalladated complex 24 was prepared 
according to a literature procedure. Pd(OAc)2 was obtained from Pressure Chemical and 
used as received, and PhI(OAc)2 and PhI(TFA)2 were obtained from Acros and used as 
received. Solvents were obtained from Fisher Chemical and used without further 
purification. Flash chromatography was performed on EM Science silica gel 60 (0.040–
0.063 mm particle size, 230–400 mesh) and thin layer chromatography was performed on 
Merck TLC plates pre-coated with silica gel 60 F254. Control reactions (in the absence of 








Substrate 25 (132 mg, 0.66 mmol, 1 equiv), PhI(OAc)2 (637 mg, 2.0 mmol, 3.0 equiv), 
and Pd(OAc)2 (7.38 mg, 0.03 mmol, 0.05 equiv) were combined in C6H6 (2.2 mL) and 
Ac2O (2.2 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was heated at 100ºC for 3 h. The solvent was removed under vacuum, and the 
resulting yellow solid was purified by chromatography on silica gel (Rf = 0.24 in 65% 
hexanes/35% ethyl acetate). The product 25-A was obtained as a pale yellow solid (101 
mg, 60% yield); mp = 98-99 °C. 1H NMR (d6-acetone): δ 8.75-8.73 (m, 1H), 8.71 (d, J = 
2.8 Hz, 1H), 8.33 (dd, J = 8.9, 2.8 Hz, 1H), 7.95-7.91 (m, 1H), 7.85-7.82 (m, 1H), 7.52 
(d, J = 8.9 Hz, 1H), 7.44-7.41 (m, 1H), 2.26 (s, 3H). 13C{1H} NMR (d6-acetone): δ 
168.98, 154.01, 153.93, 150.80, 146.74, 137.71, 135.14, 126.86, 126.03, 125.23, 124.56, 
124.17, 20.90. IR (thin film): 3098, 1760, 1591, 1531, 1353 cm-1. Anal. Calcd for 
C13H10N2O4: C, 60.47, H, 3.90, N, 10.85; Found: C, 60.34, H, 3.66, N, 10.53. Retention 





2-Bromo-6-nitrophenol (506 mg, 2.30 mmol, 1 equiv), Ac2O (4.6 mL) and pyridine (0.88 
mL) were combined in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was stirred for 12 h. The reaction mixture was diluted with CH2Cl2 (15 mL) and 
extracted with H2O (3 x 15 mL) and brine (1 x 15 mL). The combined organic layers 
were dried over MgSO4, filtered and concentrated under vacuum. The product, 1-bromo-
2-acetoxy-3-nitrobenzene was obtained as a yellow oil (559 mg, 93% yield). 
 
Under a nitrogen atmosphere, 1-bromo-2-acetoxy-3-nitrobenzene (559 mg, 2.1 mmol, 1 
equiv), and Pd(PPh3)4 (124 mg, 0.11 mmol, 0.05 equiv) and tributylpyridyltin (870 mg, 
2.4 mmol, 1.1 equiv) were combined in toluene (5 mL) in a 20 mL vial. The vial was 
sealed with a Teflon lined cap, and the reaction was heated at 110 ºC for 12 h. The 
 35 
reaction mixture was diluted with ethyl acetate, filtered through a pad of Celite, and 
washed with copious ethyl acetate. The washings were combined and concentrated under 
vacuum. The crude product was dissolved in ethyl acetate and extracted with 1M aqueous 
KF (4 x 30 mL). The combined organic layers were then extracted with brine (1 x 30 
mL), dried over MgSO4, filtered and concentrated. The resulting brown oil was purified 
by chromatography on silica gel (Rf = 0.25 in 65% hexanes/35% ethyl acetate). The 
product 25-B was obtained as a yellow solid (30.0 mg, 5% yield). 1H NMR (d6-acetone): 
δ 8.73-8.71 (m, 1H), 8.34 (td, J = 7.9, 1.5 Hz, 1H), 8.18 (dd, J = 8.1, 1.6 Hz, 1H), 7.94 
(td, J = 7.8, 1.7 Hz, 1H), 7.75 (d, J = 7.9 Hz, 1H), 7.67 (t, J = 8.1 Hz, 1H), 7.45-7.42 (m, 





Substrate 26 (208 mg, 0.93 mmol, 1 equiv), PhI(OAc)2 (450 mg, 1.40 mmol, 1.5 equiv), 
and Pd(OAc)2 (10.4 mg, 0.05 mmol, 0.05 equiv) were combined in C6H6 (3 mL) and 
Ac2O (3 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was heated at 100ºC for 45 min. The solvent was removed under vacuum, and 
the resulting orange oil was purified by chromatography on silica gel (Rf = 0.30 in 75% 
hexanes/25% ethyl acetate). The product 26-A was obtained as a pale yellow oil (211 mg, 
81% yield). 1H NMR (d6-acetone): δ 8.73-8.72 (m, 1H), 8.19 (s, 1H), 7.89 (td, J = 8.0, 
1.8 Hz, 1H), 7.84-7.79 (multiple peaks, 2H), 7.48 (d, J = 8.4 Hz, 1H), 7.42-7.38 (m, 1H), 
2.23 (s, 3H). 13C{1H} NMR (d6-acetone): δ 169.11, 154.36, 151.98, 150.58, 137.46, 
134.74, 128.61 (q, 3JC-F = 3.8 Hz), 128.51 (q, 2JC-F = 33 Hz), 127.10 (q, 3JC-F = 3.8 Hz), 
125.63, 124.89 (q, 1JC-F = 271 Hz), 124.39, 123.77, 20.74. IR (KBr): 1768, 1597 cm–1. 
Anal. Calcd for C14H10F3NO2: C, 59.79, H, 3.58, N, 4.98; Found: C, 60.14, H, 3.68, N, 






Substrate 27 (214 mg, 0.88 mmol, 1 equiv), PhI(OAc)2 (1094 mg, 3.40 mmol, 3.0 equiv), 
and Pd(OAc)2 (12.7 mg, 0.06 mmol, 0.05 equiv) were combined in C6H6 (3.6 mL) and 
Ac2O (3.6 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was heated at 100ºC for 1.5 h. The solvent was removed under vacuum, and the 
resulting orange oil was purified by chromatography on silica gel (Rf = 0.27 in 60% 
hexanes/50% ethyl acetate). The product 27-A was obtained as a pale yellow oil (171 mg, 
61% yield). 1H NMR (d6-acetone): δ 10.12 (s, 1H), 8.73 (d, J = 4.0 Hz, 1H), 8.39 (d, J = 
2.0 Hz, 1H),  8.02 (dd, J = 8.4, 2.0 Hz, 1H), 7.91 (td, J = 8.0, 2.0 Hz, 1H), 7.77 (dd, J = 
8.0, 0.8 Hz, 1H), 7.46 (d, J = 8.4 Hz, 1H), 7.39 (ddd, J = 8.0, 5.2, 1.2 Hz, 1H), 2.23 (s, 
3H). 13C{1H} NMR (d6-acetone): δ 191.99, 169.30, 155.14, 153.85, 150.72, 137.64, 
135.69, 134.89, 133.53, 130.91, 125.73, 124.54, 123.84, 21.03. HRMS electrospray 





Substrate 28 (206 mg, 0.88 mmol, 1 equiv), PhI(OAc)2 (312 mg, 0.97 mmol, 1.1 equiv), 
and Pd(OAc)2 (9.85 mg, 0.04 mmol, 0.05 equiv) were combined in C6H6 (2.8 mL) and 
Ac2O (2.8 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was heated at 100ºC for 1.5 h. The solvent was removed under vacuum, and the 
resulting orange oil was purified by chromatography on silica gel (Rf = 0.25 in 80% 
hexanes/20% ethyl acetate). The product 28-A was obtained as a pale yellow oil (213 mg, 
83% yield). 1H NMR (d6-acetone): δ 8.69 (ddd, J = 4.8, 1.8, 0.9, 1H), 7.99 (d, J = 2.5 Hz, 
1H), 7.89 (td, J = 7.5, 1.8 Hz, 1H), 7.73 (dt, J = 8.0, 1.0 Hz, 1H), 7.63 (dd, J = 8.6, 2.5 
Hz, 1H), 7.38 (ddd, J = 7.5, 4.8, 1.1 Hz, 1H), 7.19 (d, J = 8.6 Hz, 1H), 2.19 (s, 3H). 
13C{1H} NMR (d6-acetone): δ 169.45, 154.65, 150.69, 148.66, 137.58, 136.09, 134.20, 
133.21, 126.78, 124.50, 123.83, 119.53, 20.97. IR (KBr): 1764, 1585 cm-1. Anal. Calcd 
for C13H10BrNO2: C, 53.45, H, 3.45, N, 4.79; Found: C, 53.34, H, 3.51, N, 4.83. Only one 






Substrate 29 (214 mg, 1.26 mmol, 1 equiv), PhI(OAc)2 (448 mg, 1.39 mmol, 1.1 equiv), 
and Pd(OAc)2 (14.2 mg, 0.06 mmol, 0.05 equiv) were combined in C6H6 (8.2 mL) in a 20 
mL vial. The vial was sealed with a Teflon lined cap, and the reaction was heated at 
100ºC for 0.5 h. The solvent was removed under vacuum, and the resulting orange oil 
was purified by chromatography on silica gel (Rf = 0.32 in 70% hexanes/30% ethyl 
acetate). The product 29-A was obtained as a yellow oil (219 mg, 77% yield) as a 27:1 
(by GC) mixture of regioisomers. 1H NMR (d6-acetone): δ 8.68-8.66 (m,  1H), 7.83 (td, J 
= 7.5, 1.9, 1H), 7.65 (dd, J = 7.9, 1.0 Hz, 1H), 7.61 (d, J = 2.3 Hz, 1H), 7.31 (ddd, J = 
7.5, 4.8, 1.1 Hz, 1H), 7.25 (dd, J = 8.2, 2.3 Hz, 1H), 7.07 (d, J = 8.2 Hz, 1H), 2.39 (s, 
3H), 2.15 (s, 3H). 13C{1H} NMR (d6-acetone): δ 169.79, 156.48, 150.43, 147.28, 137.23, 
136.47, 133.71, 132.02, 130.90, 124.34, 124.26, 123.14, 21.01, 20.92. IR (thin film): 
2922, 1763, 1586 cm-1. Anal. Calcd for C14H13NO2: C, 73.99, H, 5.77, N, 6.16; Found: C, 





2-Bromo-6-methyphenolvii (500 mg, 2.70 mmol, 1 equiv), Ac2O (5.30 mL) and pyridine 
(1.11 mL) were combined in a 20 mL vial. The vial was sealed with a Teflon lined cap, 
and the reaction was stirred for 12 h. The reaction mixture was diluted with CH2Cl2 (15 
mL) and extracted with H2O (3 x 15 mL) and brine (1 x 15 mL). The combined organic 
layers were dried over MgSO4, filtered and concentrated under vacuum. The product, 1-
bromo-2-acetoxy-3-methylbenzene was obtained as a yellow oil (499 mg, 81% yield). 
 
Under a nitrogen atmosphere, 2-acetoxy-1-bromo-3-methylbenzene (500 mg, 2.18 mmol, 
1 equiv), and Pd(PPh3)4 (252 mg, 0.22 mmol, 0.10 equiv) were combined in toluene (11 
mL), and 2- tributylpyridyltin (883 mg, 2.40 mmol, 1.1 equiv) was then added. The 
reaction mixture was refluxed for 12 h, then diluted with ethyl acetate (30 mL), filtered 
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through a pad of silica gel and washed with copious ethyl acetate. The washings were 
combined, concentrated under vacuum, and, purified by column chromatography on 
silica gel (Rf = 0.20 in 75% hexanes/25% ethyl acetate). The product 29-B was obtained 
as a pale yellow solid (238 mg, 48% yield). 1H NMR (d6-acetone): δ 8.67-8.65 (m, 1H), 
7.85 (td, J = 7.5, 1.9 Hz, 1H), 7.63 (dt, J = 7.9, 1.0 Hz, 1H), 7.57 (d, J = 7.6 Hz, 1H), 
7.35-7.31 (multiple peaks, 2H), 7.27 (t, J = 7.5 Hz, 1H), 2.22 (s, 3H), 2.17 (s, 3H). 





Substrate 30 (214 mg, 1.30 mmol, 1 equiv), PhI(OAc)2 (448 mg, 1.40 mmol, 1.1 equiv), 
and Pd(OAc)2 (14.1 mg, 0.06 mmol, 0.05 equiv) were combined in C6H6 (8.2 mL) in a 20 
mL vial. The vial was sealed with a Teflon lined cap, and the reaction was heated at 100 
ºC for 0.5 h. The solvent was removed under vacuum, and the resulting orange oil was 
purified by chromatography on silica gel (Rf = 0.32 in 70% hexanes/30% ethyl acetate). 
The product 30-A was obtained as a yellow oil (219 mg, 77% yield). 1H NMR (d6-
acetone): δ 8.68-8.67 (m, 1H), 7.84 (td, J = 8.0, 1.8 Hz, 1H), 7.68 (d, J = 8.0 Hz, 1H), 
7.50-7.49 (m, 1H), 7.34-7.31 (m, 1H), 7.13-7.12 (m, 1H), 5.25 (s, 2H), 3.46 (s, 3H), 2.15 
(s, 3H). 13C{1H} NMR (d6-acetone): δ 169.94, 156.09, 156.02, 150.50, 143.74, 137.32, 
134.85, 125.37, 124.32, 123.37, 118.73, 118.16, 95.46, 56.17, 20.97. IR (thin film): 2956, 
1763, 1586 cm-1. HRMS electrospray (m/z): [M+ + Na] calcd for C15H15NO4, 296.0899; 
found, 296.0903. GC analysis (RESTEK Rtx®-5, FID detector): 100% integration. Only 





Substrate 31 (201 mg, 1.08 mmol, 1 equiv), PhI(OAc)2 (384 mg, 1.19 mmol, 1.1 equiv), 
and Pd(OAc)2 (12.1 mg, 0.05 mmol, 0.05 equiv) were combined in C6H6 (7 mL) in a 20 
mL vial. The vial was sealed with a Teflon lined cap, and the reaction was heated at 
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100ºC for 1.5 h. The solvent was removed under vacuum, and the resulting orange oil 
was purified by chromatography on silica gel (Rf = 0.27 in 60% hexanes/40% ethyl 
acetate). The product 31-A was obtained as a yellow oil (206 mg, 78% yield) as a 60:1 
(by GC) mixture of regioisomers. 1H NMR (d6-acetone): δ 8.69-8.67 (m, 1H), 7.84 (td, J 
= 7.6, 1.9 Hz, 1H), 7.68 (d, J = 8.0 Hz, 1H), 7.36 (d, J = 3.1 Hz, 1H), 7.31 (ddd, J = 7.5, 
4.8, 1.1 Hz, 1H), 7.12 (d, J = 8.8 Hz, 1H), 7.01 (dd, J = 8.8, 3.1 Hz, 1H), 3.85 (s, 3H), 
2.15 (s, 3H). 13C{1H} NMR (d6-acetone): δ 169.70, 158.11, 155.87, 150.17, 142.57, 
136.99, 134.45, 125.07, 124.05, 123.02, 115.69, 115.58, 55.73, 20.67. IR (thin film): 
2940, 1760, 1585 cm-1. Anal. Calcd for C14H13NO3: C, 69.12, H, 5.39, N, 5.76; Found: C, 





2-Bromo-6-methoxyphenolviii (500 mg, 2.46 mmol, 1 equiv), Ac2O (4.7 mL) and pyridine 
(4.7 mL) were combined in a 20 mL vial. The vial was sealed with a Teflon lined cap, 
and the reaction was stirred for 12 h. The reaction mixture was diluted with CH2Cl2 (15 
mL) and extracted with H2O (3 x 15 mL) and brine (1 x 15 mL). The combined organic 
layers were dried over MgSO4, filtered and concentrated under vacuum. The product, 1-
bromo-2-acetoxy-3-methoxybenzene was obtained as a yellow oil (542 mg, 90% yield). 
 
Under a nitrogen atmosphere, 1-bromo-2-acetoxy-3-methoxybenzene (542 mg, 2.21 
mmol, 1 equiv), and Pd(PPh3)4 (255 mg, 0.22 mmol, 0.10 equiv) were combined in 
toluene (11 mL), and 2- tributylpyridyltin (895 mg, 2.43 mmol, 1.1 equiv) was added. 
The reaction mixture was refluxed for 12 h, then diluted with ethyl acetate (30 mL), 
filtered through a pad of silica, and washed with copious ethyl acetate. The washings 
were combined, concentrated under vacuum, and purified by chromatography on silica 
gel (Rf = 0.25 in 65% hexanes/35% ethyl acetate). The product 31-B was obtained as a 
pale yellow solid (182 mg, 34% yield). 1H NMR (d6-benzene): δ 8.55 (d, J = 4.8 Hz, 1H), 
7.51 (d, J = 7.9 Hz, 1H), 7.44 (d, J = 7.9 Hz, 1H), 7.07 (t, J = 7.6 Hz, 1H), 7.01 (t, J = 7.9 
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Hz, 1H), 6.64-6.61 (m, 1H), 6.53 (d, J = 8.2, Hz, 1H), 3.28 (s, 3H), 1.91 (s, 3H). 





Substrate 32 (207 mg, 1.15 mmol, 1 equiv), PhI(OAc)2 (1110 mg, 3.45 mmol, 3.0 equiv), 
and Pd(OAc)2 (12.9 mg, 0.06 mmol, 0.05 equiv) were combined in C6H6 (3.7 mL) and 
Ac2O (3.7 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was heated at 100 ºC for 3.0 h. The solvent was removed under vacuum, and the 
resulting orange oil was purified by chromatography on silica gel (Rf = 0.32 in 60% 
hexanes/40% ethyl acetate). The product 32-A was obtained as a yellow oil (163 mg, 
60% yield). 1H NMR (d6-acetone): δ 8.72 (m, 1H), 8.21 (d, J = 1.6 Hz, 1H), 7.88 (td, J = 
6.8, 2.0 Hz, 2H), 7.77 (d, J = 6.8 Hz, 1H), 7.45 (d, J = 8.4 Hz, 1H), 7.39 (ddd, J = 7.6, 





Substrate 33 (207 mg, 1.20 mmol, 1 equiv), PhI(OAc)2  (462 mg, 1.4 mmol, 1.2 equiv), 
and Pd(OAc)2 (13.4 mg, 0.06 mmol, 0.05 equiv) were combined in C6H6 (7.7 mL) in a 20 
mL vial. The vial was sealed with a Teflon lined cap, and the reaction was heated at 
100ºC for 4 h. 1H NMR analysis of the crude reaction mixture showed a 6:1 mixture of 
regioisomers. The solvent was removed under vacuum, and the resulting orange oil was 
purified by chromatography on silica gel (Rf = 0.26 in 70% hexanes/30% ethyl acetate). 
The product 33-A was obtained as a pale yellow oil (163 mg, 59% yield) as a 6:1 (by 
NMR) mixture of regioisomers. 1H NMR (d6-acetone) (major isomer): δ 8.70-8.69 (m, 
1H), 7.88 (td, J = 7.6, 1.8 Hz, 1H), 7.73 (d, J = 8.0 Hz, 1H), 7.61-7.58 (m, 1H), 7.38-7.35 
(m, 1H), 7.26-7.23 (multiple peaks, 2H), 2.18 (s, 3H). 13C{1H} NMR (d6-acetone) (major 
isomer): δ 169.76, 161.18 (d, 1JCF = 241 Hz), 154.97, 150.66, 145.50, 137.56, 135.79 (d, 
3JCF = 8.34 Hz), 126.40 (d, 3JCF = 8.4 Hz), 124.40, 123.80, 117.66 (d, 2JCF = 24 Hz), 
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116.93 (d, 2JCF = 24 Hz), 20.94. 19F NMR (CDCl3): -116.27 to -116.32 (m), -128.33 to -
128.37 (m). IR (thin film): 1766, 1462 cm-1. Anal. Calcd for C13H10FNO2: C, 67.53, H, 





2-Bromo-4-fluorophenol (1.00 g, 5.20 mmol, 1 equiv), Ac2O (10.5 mL) and pyridine (2.0 
mL) were combined in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was stirred for 12 h. The reaction mixture was diluted with CH2Cl2 (30 mL) and 
extracted with H2O (3 x 30 mL) and brine (1 x 30 mL). The combined organic layers 
were dried over MgSO4, filtered and concentrated under vacuum. The product, 1-
acetoxy-2-bromo-4-fluorobenzene was obtained as a yellow oil (946 mg, 77% yield). 
 
Under a nitrogen atmosphere, 1-acetoxy-2-bromo-4-fluorobenzene (500 mg, 2.10 mmol, 
1 equiv), and Pd(PPh3)4 (248 mg, 0.21 mmol, 0.10 equiv) were combined in toluene (11 
mL), and 2- tributylpyridyltin (869 mg, 2.36 mmol, 1.1 equiv) was added. The reaction 
mixture was refluxed for 12 h, then diluted with ethyl acetate (30 mL), filtered through a 
pad of silica, and washed with copious ethyl acetate. The washings were combined, 
concentrated under vacuum, and purified by chromatography on silica gel (Rf = 0.24 in 
75% hexanes/25% ethyl acetate). The product (33-A) was obtained as pale yellow oil 
(248 mg, 50% yield). 1H NMR (d6-acetone): δ 8.70-8.68 (m, 1H), 7.89 (td, J = 8.0, 1.8 
Hz, 1H), 7.74 (d, J = 8.0 Hz, 1H), 7.60-7.57 (m, 1H), 7.39-7.36 (m, 1H), 7.26-7.24 







Substrate 34 (201 mg, 1.15 mmol, 1 equiv), PhI(OAc)2 (665 mg, 2.06 mmol, 1.8 equiv), 
and Pd(OAc)2 (12.8 mg, 0.06 mmol, 0.05 equiv) were combined in AcOH (13.5 mL) in a 
20 mL vial. The vial was sealed with a Teflon lined cap, and the reaction was heated at 
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100ºC for 12 h. The reaction mixture was filtered through a plug of glass wool and 
washed with copious ethyl acetate. The solvent was removed under vacuum, and the 
resulting black oil was purified by chromatography on silica gel (Rf = 0.22 in 20% 
hexanes/80% ethyl acetate). The product 34-A was obtained as a pale yellow oil (197 mg, 
74% yield). 1H NMR (d6-acetone): δ 7.18 (d, J = 2.0 Hz, 1H), 7.10 (dd, J = 8.3, 2.1 Hz, 
1H), 7.06 (d, J = 8.3 Hz, 1H), 3.72 (t, J = 7.0 Hz, 2H), 2.38 (t, J = 8.0 Hz, 2H), 2.31 (s, 
3H), 2.20 (s, 3H), 2.18-2.10 (multiple peaks, 2H). 13C{1H} NMR (d6-acetone): δ 173.97, 
169.25, 144.91, 136.61, 132.55, 128.77, 128.59, 124.16, 50.47, 31.58, 20.97, 20.79, 
20.02. IR (thin film): 2954, 1763, 1699, 1425 cm-1. HRMS electrospray (m/z): [M+ + Na] 
calcd for C13H15NO3, 256.0950; found, 256.0952. GC analysis (RESTEK Rtx®-5, FID 







Substrate 35 (202 mg, 1.05 mmol, 1 equiv), PhI(OAc)2 (510 mg, 1.58 mmol, 1.5 equiv), 
and Pd(OAc)2 (11.8 mg, 0.05 mmol, 0.05 equiv) were combined in AcOH (12.4 mL) in a 
20 mL vial. The vial was sealed with a Teflon lined cap, and the reaction was heated at 
100ºC for 3.0 h. The reaction mixture was filtered through a plug of glass wool and 
washed with copious ethyl acetate. The solvent was removed under vacuum, and the 
resulting orange oil was purified by chromatography on silica gel (Rf = 0.20 in 20% 
hexanes/80% ethyl acetate). The product 35-A was obtained as a pale brown solid (193 
mg, 73% yield); mp = 96.5-97.5ºC. 1H NMR (d6-acetone): δ 7.09 (d, J = 8.8 Hz, 1H), 
6.95 (d, J = 2.9 Hz, 1H), 6.86 (dd, J = 8.9, 3.0 Hz, 1H), 3.78 (s, 3H), 3.73 (t, J = 6.8 Hz, 
2H), 2.38 (t, J = 8.1 Hz, 2H), 2.19 (s, 3H), 2.17-2.09 (multiple peaks, 2H). 13C{1H} NMR 
(d6-acetone): δ 173.97, 169.48, 158,32, 140.64, 133.59, 124.99, 113.47, 113.29, 56.06, 
50.48, 31.61, 20.93, 20.02. IR (KBr): 2960, 1759, 1690, 1605 cm-1. Anal. Calcd for 
C13H15NO4: C, 62.64, H, 6.07, N, 5.62; Found: C, 62.46, H, 5.72, N, 5.59.  Only one 








Substrate 36 (202 mg, 0.91 mmol, 1 equiv), PhI(OAc)2 (530 mg, 1.64 mmol, 1.8 equiv), 
and Pd(OAc)2 (10.2 mg, 0.04 mmol, 0.05 equiv) were combined in AcOH (5.4 mL) and 
Ac2O (5.4 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was heated at 100ºC for 6.5 h. The reaction mixture was filtered through a plug 
of glass wool and washed with copious ethyl acetate. The solvent was removed under 
vacuum, and the resulting brown oil was purified by chromatography on silica gel (Rf = 
0.20 in 20% hexanes/80% ethyl acetate). The product 36-A was obtained as a light brown 
oil (179 mg, 70% yield). 1H NMR (d6-acetone): δ 7.10 (d, J = 8.9 Hz, 1H), 7.05 (d, J = 
2.9 Hz, 1H), 6.97 (dd, J = 8.9, 2.9 Hz, 1H), 5.18 (s, 2H), 3.73 (t, J = 6.8 Hz, 2H), 3.43 (s, 
3H), 2.39 (t, J = 8.1 Hz, 2H), 2.19 (s, 3H), 2.18-2.10 (multiple peaks, 2H). 13C{1H} NMR 
(d6-acetone): δ 173.99, 169.42, 155.95, 141.54, 133.58, 125.02, 115.84, 115.79, 99.51, 
56.19, 50.47, 31.58, 20.94, 20.02. IR (thin film): 2956, 1762, 1699, 1504 cm-1. HRMS 
electrospray (m/z): [M+ + Na] calcd for C14H17NO5, 302.1004; found, 302.1001. GC 
analysis (RESTEK Rtx®-5, FID detector): 99.4% integration. Only one isomer is 







Substrate 37 (205 mg, 1.14 mmol, 1 equiv), PhI(TFA)2 (1.08 g, 2.52 mmol, 2.2 equiv), 
and Pd(OAc)2 (12.8 mg, 0.05 mmol, 0.05 equiv) were combined in AcOH (7.0 mL) and 
Ac2O (7.0 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was heated at 100ºC for 3.5 h. GCMS analysis of the crude reaction mixture 
showed a 14:1 mixture of regioisomers. The reaction mixture was filtered through a plug 
of glass wool and washed with copious ethyl acetate. The solvent was removed under 
vacuum, and the resulting black oil was purified by chromatography on silica gel (Rf = 
0.26 in 20% hexanes/80% ethyl acetate). The product 37-A was obtained as a brown solid 
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(239 mg, 88% yield); mp = 49.9-52.0 ºC as a 20:1 (by GCMS) mixture of regioisomers. 
1H NMR (d6-acetone): δ 7.26-7.21 (multiple peaks, 2H), 7.11-7.06 (m, 1H), 3.78 (t, J = 
6.9 Hz, 2H), 2.41 (t, J = 7.7 Hz, 2H), 2.23 (s, 3H), 2.16 (quin, J = 7.7 Hz, 2H). 13C{1H} 
NMR (d6-acetone): δ 174.30, 169.23, 160.55 (d, 1JCF = 242 Hz), 143.08 (d, 4JCF = 3.0 
Hz), 134.19 (d, 3JCF = 11 Hz), 125.89 (d, 3JCF = 9.9 Hz), 114.69 (d, 2JCF = 25 Hz), 114.60 
(d, 2JCF = 23 Hz), 50.33, 31.51, 20.93, 19.96. 19F NMR (CDCl3): -114.96 to -115.01 (m). 
IR (thin film): 2984, 1766, 1702, 1503 cm-1. HRMS electrospray (m/z): [M+ + Na] calcd 
for C12H12FNO3, 260.0699; found, 260.0703. GC analysis (RESTEK Rtx®-5, FID 







The regioselectivity of this reaction could not be determined definitively from the 1H 
NMR spectrum of 37-A. As a result, 37-A was hydrolyzed to the phenol according to the 
following procedure in order to assess the regioselectivity.  Product 37-A (144 mg, 0.61 
mmol, 1 equiv) and K2CO3 (12.7 mg, 0.09 mmol, 0.15 equiv) were combined in MeOH 
(1.3 mL) in a 20 mL vial, and the reaction was stirred for 12 h. The reaction mixture was 
diluted with CH2Cl2 (15 mL) and extracted with H2O (3 x 15 mL) and brine (1 x 15 mL). 
The combined organic layers were dried over MgSO4, filtered and concentrated under 
vacuum. The product was obtained as a white solid (83 mg, 70% yield). 1H NMR (C6D6): 
δ 9.28 (s, 1H), 7.02 (dd, J = 8.9, 5.6 Hz, 1H), 6.67-6.63 (m, 1H), 6.33 (dd, J = 9.9, 2.9 








Substrate 38 (204 mg, 0.89 mmol, 1 equiv), PhI(TFA)2 (1913 mg, 4.40 mmol, 5.0 equiv), 
and Pd(OAc)2 (9.90 mg, 0.04 mmol, 0.05 equiv) were combined in AcOH (10.5 mL) in a 
20 mL vial. The vial was sealed with a Teflon lined cap, and the reaction was heated at 
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100ºC for 12 h. The reaction mixture was filtered through a plug of glass wool and 
washed with copious ethyl acetate. The solvent was removed under vacuum, and the 
resulting brown oil was purified by chromatography on silica gel (Rf = 0.29 in 30% 
hexanes/70% ethyl acetate). The product 38-A was obtained as a light brown oil (115 mg, 
45% yield). 1H NMR (d6-acetone): δ 7.81 (d, J = 2.0 Hz, 1H), 7.66 (dd, J = 8.4, 2.0 Hz, 
1H), 7.46 (d, J = 8.4 Hz, 1H), 3.84 (d, J = 6.8 Hz, 2H), 2.44 (t, J = 8.0 Hz, 2H), 2.28 (s, 
3H), 2.19 (quin, J = 7.6 Hz, 2H). 13C{1H} NMR (d6-acetone): δ 173.50, 167.78, 148.77, 
132.86, 127.49 (2JC-F = 32 Hz), 124.88, 124.58 (3JC-F = 12 Hz), 124.02 (3JC-F = 15 Hz), 





Substrate 46 (202 mg, 1.02 mmol, 1 equiv), PhI(OAc)2 (396 mg, 1.23 mmol, 1.2 equiv), 
and Pd(OAc)2 (11.5 mg, 0.05 mmol, 0.05 equiv) were combined in C6H6 (3.3 mL) and 
Ac2O (3.3 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was heated at 100 ºC for 0.5 h. The solvent was removed under vacuum, and the 
resulting orange oil was purified by chromatography on silica gel (Rf = 0.20 in 55% 
hexanes/45% ethyl acetate). The product 46-A was obtained as a yellow oil (213 mg, 
82% yield). 1H NMR (d6-acetone): δ 8.73-8.71 (m, 1H), 8.43 (d, J = 2.3 Hz, 1H), 8.07 
(dd, J = 8.4, 2.3 Hz, 1H), 7.89 (td, J = 7.5, 1.9 Hz, 1H), 7.74 (d, J = 8.0 Hz, 1H), 7.39-
7.35 (multiple peaks, 2H), 2.64 (s, 3H), 2.21 (s, 3H). 13C{1H} NMR (d6-acetone): δ 
196.99, 169.36, 155.47, 152.85, 150.63, 137.54, 136.16, 134.22, 132.01, 130.29, 124.99, 
124.50, 123.65, 26.85, 21.01. IR (thin film): 3005, 1766, 1684, 1587 cm-1. Anal. Calcd 
for C15H13NO3: C, 70.58, H, 5.13, N, 5.49; Found: C, 70.44, H, 5.17, N, 5.39. Only one 







Substrate 48 (207 mg, 0.98 mmol, 1 equiv), PhI(OAc)2 (473 mg, 1.47 mmol, 1.5 equiv), 
and Pd(OAc)2 (10.9 mg, 0.05 mmol, 0.05 equiv) were combined in C6H6 (3.2 mL) and 
Ac2O (3.2 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was heated at 100 ºC for 1.5 h. The solvent was removed under vacuum, and the 
resulting orange oil was purified by chromatography on silica gel (Rf = 0.32 in 70% 
hexanes/30% ethyl acetate). The product 48-A was obtained as a yellow oil (204 mg, 
77% yield). 1H NMR (d6-acetone): δ 8.68-8.66 (m, 1H), 7.84 (td, J = 8.0, 1.9 Hz, 1H), 
7.68-7.66 (multiple peaks, 2H), 7.34-7.29 (multiple peaks, 2H), 7.15 (d, J = 8.2 Hz, 1H), 
3.86 (s, 2H), 2.18 (s, 3H), 2.17 (s, 3H). 13C{1H} NMR (d6-acetone): δ 205.56, 169.70, 
156.22, 150.48, 148.19, 137.29, 134.00, 133.87, 132.84, 131.64, 124.45, 124.38, 123.25, 
49.94, 29.63, 21.01. IR (thin film): 3004, 1763, 1714, 1586 cm-1. HRMS electrospray 
(m/z): [M+ + Na] calcd for C16H15NO3, 292.0950; found, 292.0949. GC analysis 
(RESTEK Rtx®-5, FID detector): 100% integration. Only one isomer is observed by GC 






The regioselectivity of this reaction could not be determined definitively from the 1H 
NMR spectrum of 48-A. As a result, 48-A was hydrolyzed to the phenol according to the 
following procedure in order to assess the regioselectivity.  Product 48-A (100 mg, 0.37 
mmol, 1 equiv) and HCl (1ml) were combined in MeOH (2.0 mL) in a 20 mL vial, and 
the reaction was stirred for 8 h. The reaction mixture was diluted with CH2Cl2 (15 mL) 
and extracted with H2O (3 x 15 mL) and brine (1 x 15 mL). The combined organic layers 
were dried over MgSO4, filtered and concentrated under vacuum. The product was 
obtained as a orange oil (60.0 mg, 71% yield). 1H NMR (d6-acetone): δ 8.63-8.61 (m, 
1H), 8.17 (d, J = 8.3 Hz, 1H), 8.04-7.99 (m, 1H), 7.86 (d, J = 2.1 Hz, 1H), 7.44-7.40 (m, 







Substrate 50 (182 mg, 0.80 mmol, 1 equiv), PhI(OAc)2 (388 mg, 1.20 mmol, 1.5 equiv), 
and Pd(OAc)2 (8.99 mg, 0.04 mmol, 0.05 equiv) were combined in C6H6 (2.6 mL) and 
Ac2O (2.6 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was heated at 100ºC for 0.5 h. The solvent was removed under vacuum, and the 
resulting orange oil was purified by chromatography on silica gel (Rf = 0.20 in 75% 
hexanes/25% ethyl acetate). The product 50-A was obtained as a yellow oil (177 mg, 
77% yield) as a single isomer. 1H NMR (d6-acetone): δ 8.69 (ddd, J = 4.8, 1.8, 0.9 Hz, 
1H), 8.13 (d, J = 2.3 Hz, 1H), 7.88 (td, J = 7.9, 1.9 Hz, 1H), 7.79 (dd, J = 8.5, 2.3 Hz, 
1H), 7.71 (d, J = 7.9 Hz, 1H), 7.36 (ddd, J = 7.5, 4.8, 1.1 Hz, 1H), 7.23 (d, J = 8.5 Hz, 
1H), 3.96 (s, 3H), 2.26 (s, 3H), 2.18 (s, 3H). 13C{1H} NMR (CDCl3): δ 169.54, 155.93, 
153.95, 150.52, 149.93, 137.35, 135.34, 133.96, 129.22, 127.83, 124.57, 124.43, 123.39, 
62.25, 20.99, 12.42. IR (KBr): 2936, 1765, 1593 cm-1. Anal. Calcd for C16H16N2O3: C, 
67.59, H, 5.67, N, 9.85; Found: C, 67.39, H, 5.71, N, 9.75. Only one isomer is observed 






Substrate 51 (200 mg, 0.83 mmol, 1 equiv), PhI(OAc)2 (402 mg, 1.25 mmol, 1.5 equiv), 
and Pd(OAc)2 (9.32 mg, 0.04 mmol, 0.05 equiv) were combined in C6H6 (2.7 mL) and 
Ac2O (2.7 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was heated at 100ºC for 1.0 h. The solvent was removed under vacuum, and the 
resulting orange oil was purified by chromatography on silica gel (Rf = 0.24 in 60% 
hexanes/40% ethyl acetate). The product 51-A was obtained as a yellow oil (182 mg, 
74% yield) as a 2:1 mixture of oxime isomers.  1H NMR (CDCl3 with a few drops of 
C6D6) (major isomer): δ 8.50 (d, J = 4.8 Hz, 1H), 7.49 (td, J = 7.6, 1.8 Hz, 1H), 7.40 (d, J 
 48 
= 2.2 Hz, 1H), 7.33 (d, J = 7.9 Hz, 1H), 7.09 (dd, J = 8.2, 1.8 Hz, 1H), 7.02-6.99 (m, 1H), 
6.93 (d, 8.2 Hz, 1H), 3.70 (s, 3H), 3.34 (s, 2H), 1.95 (s, 3H), 1.59 (s, 3H). 13C{1H} NMR 
(CDCl3) (mixture of isomers): δ 169.90, 168.40, 155.15, 150.49, 150.43, 150.35, 149.21, 
146.76, 141.16, 137.36, 137.26, 129.15, 124.48, 124.22, 123.99, 122.92, 122.90, 109.91, 
106.98, 105.54, 103.48, 103.16, 41.13, 20.99, 20.53. IR (KBr): 2937, 1767, 1586 cm-1. 
Anal. Calcd for C17H18N2O3 (mixture of oxime isomers): C, 68.44, H, 6.08, N, 9.39; 
Found: C, 68.28, H, 6.26, N, 9.23. Retention time (GC): 10.9 min (major oxime) and 10.7 







Substrate 52 (200 mg, 0.908 mmol, 1 equiv), PhI(OAc)2 (351 mg, 1.09 mmol, 1.2 equiv), 
and Pd(OAc)2 (10.2 mg, 0.04 mmol, 0.05 equiv) were combined in AcOH (2.9 mL) and 
Ac2O (2.9 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was heated at 100ºC for 12 h. The solvent was removed under vacuum, and the 
resulting orange oil was purified by chromatography on silica gel (Rf = 0.20 in 90% 
hexanes/10% ethyl acetate). The product 52-A was obtained as a yellow oil (153 mg, 
61% yield).  1H NMR (CDCl3): δ 7.65 (d, J = 2.4 Hz, 1H), 7.61 (dd, J = 8.4, 2.4 Hz, 1H), 








Substrate 53 (150 mg, 0.75 mmol, 1 equiv), PhI(OAc)2 (291 mg, 0.90 mmol, 1.2 equiv), 
and Pd(OAc)2 (8.43 mg, 0.04 mmol, 0.05 equiv) were combined in C6H6 (4.9 mL) in a 20 
mL vial. The vial was sealed with a Teflon lined cap, and the reaction was heated at 100 
ºC for 10 h. The solvent was removed under vacuum, and the resulting orange oil was 
purified by chromatography on silica gel (Rf = 0.29 in 70% hexanes/30% ethyl acetate). 
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The product 53-B was obtained as a yellow oil (55.5 mg, 29% yield) as a 2:1 mixture of 
regioisomers. 1H NMR (d6-acetone) (major isomer): δ 8.64-8.62 (m, 1H), 7.82 (td, J = 
7.6, 1.9 Hz, 1H), 7.59 (dt, J = 8.0, 1.0 Hz, 1H), 7.32-7.27 (multiple peaks, 2H), 6.89 (d, J 
= 8.2 Hz, 1H), 6.11 (s, 2H), 2.21 (s, 3H). 13C{1H} NMR (d6-acetone) (mixture of 
isomers): δ 169.90, 168.39, 156.15, 150.43, 150.35, 149.21, 146.76, 144.05, 141.16, 
137.37, 137.27, 132.96, 129.16, 124.47, 124.22, 123.99, 122.93, 109.91, 106.98, 105.55, 
103.49, 103.16, 20.99, 20.52. IR(thin film): 2901, 1765, 1567 cm-1. HRMS electrospray 
(m/z): [M+ + Na] calcd for C14H11NO4, 280.0586; found, 280.0585. GC analysis 
(RESTEK Rtx®-5, FID detector): 65.8% integration (major isomer), 34.2% integration 







Bromosesamolix (500 mg, 2.30 mmol, 1 equiv), Ac2O (4.6 mL) and pyridine (0.88 mL) 
were combined in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was stirred for 12 h. The reaction mixture was diluted with CH2Cl2 (15 mL) and 
extracted with H2O (3 x 15 mL) and brine (1 x 15 mL). The combined organic layers 
were dried over MgSO4, filtered and concentrated under vacuum. The product, 1-
acetoxy-2-bromo-4,5-methylenedioxybenzene was obtained as a orange solid (594 mg, 
99% yield). 
 
Under a nitrogen atmosphere, 1-acetoxy-2-bromo-4,5-methylenedioxybenzene (501 mg, 
1.93 mmol, 1 equiv), and Pd(PPh3)4 (112 mg, 0.10 mmol, 0.05 equiv) were combined in 
toluene (10 mL), and 2- tributylpyridyltin (783 mg, 2.13 mmol, 1.1 equiv) was added. 
The reaction mixture diluted with ethyl acetate, filtered through a pad of Celite, and 
washed with copious ethyl acetate. The washings were combined and concentrated under 
vacuum. The crude product was dissolved in ethyl acetate (30 mL), extracted with 1M 
aqueous KF (4 x 30 mL). The combined organic layers were then extracted with brine (1 
x 30 mL), dried over MgSO4, filtered and concentrated. The resulting yellow oil was 
purified by chromatography on silica gel (Rf = 0.29 in 70% hexanes/30% ethyl acetate). 
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The product 53-A was obtained as a pale yellow solid (103 mg, 21% yield). 1H NMR (d6-
acetone): δ 8.65-8.62 (m, 1H), 7.82 (td, J = 8.0, 1.9 Hz, 1H), 7.64 (dt, J = 8.0, 1.1 Hz, 
1H), 7.31-7.26 (multiple peaks, 2H), 6.75 (s, 1H), 6.10 (s, 2H), 2.15 (s, 3H). Retention 






2-bromo-5,6-methylenedioxyphenolix, x (350 mg, 1.60 mmol, 1 equiv), Ac2O (3.2 mL) 
and pyridine (0.61 mL) were combined in a 20 mL vial. The vial was sealed with a 
Teflon lined cap, and the reaction was stirred for 12 h. The reaction mixture was diluted 
with CH2Cl2 (15 mL) and extracted with H2O (3 x 15 mL) and brine (1 x 15 mL). The 
combined organic layers were dried over MgSO4, filtered and concentrated under 
vacuum. The product, 1-acetoxy-6-bromo-2,3-methylenedioxybenzene was obtained as a 
orange solid (337 mg, 81% yield). 
 
Under a nitrogen atmosphere, 1-acetoxy-6-bromo-2,3-methylenedioxybenzene (337 mg, 
1.30 mmol, 1 equiv), and Pd(PPh3)4 (75.1 mg, 0.06 mmol, 0.05 equiv) were combined in 
toluene (10 mL), and 2- tributylpyridyltin (718 mg, 1.95 mmol, 1.5 equiv) was added. 
The reaction mixture diluted with ethyl acetate (30 mL), filtered through a pad of Celite, 
and washed with copious ethyl acetate. The washings were combined and concentrated 
under vacuum. The crude product was dissolved in ethyl acetate, extracted with 1M 
aqueous KF (4 x 30mL). The combined organic layers were then extracted with brine (1 x 
30 mL), dried over MgSO4, filtered and concentrated. The resulting yellow oil was 
purified by chromatography on silica gel (Rf = 0.29 in 70% hexanes/30% ethyl acetate). 
The product 53-B was obtained as a yellow oil (58.0 mg, 17% yield). 1H NMR (d6-
acetone): δ 8.63-8.62 (m, 1H), 7.84-7.61 (m, 1H), 7.59 (dt, J = 8.0, 1.1 Hz, 1H), 7.32-




Reaction with substrate 23:  Substrate 23 (20.0 mg, 0.07 mmol, 1 equiv), PhI(OAc)2 
(33.5 mg, 0.10 mmol, 1.5 equiv), and Pd(OAc)2 (0.78 mg, 0.003 mmol, 0.05 equiv) were 
combined in AcOH (0.45 mL), AcOH/Ac2O (0.23/0.23 mL), C6H6 (0.45 mL), C6H6/Ac2O 
(0.23/0.23 mL), CH2Cl2 (0.45 mL) or CH3CN (0.45 mL) in a 4 mL vial. The vial was 
sealed with a Teflon lined cap, and the reaction was heated at 100ºC for 12 h. The 
reaction was cooled to room temperature and analyzed by gas chromatography, which 
showed only starting material.  
 
Reaction with complex 24: Complex 24 (20.0 mg, 0.04 mmol, 1 equiv) and PhI(OAc)2 
(17.1 mg, 0.05 mmol, 1.2 equiv) were combined in AcOH (0.28 mL), AcOH/Ac2O 
(0.14/0.14 mL), C6H6 (0.28 mL), C6H6/Ac2O (0.14/0.14 mL), CH2Cl2 (0.28 mL) or 
CH3CN (0.28 mL) in a 4 mL vial. The vial was sealed with a Teflon lined cap, and the 
reaction was heated at 100ºC for 12 h. The reaction was cooled to room temperature and 
analyzed by 1H NMR spectroscopy and gas chromatography, which showed no formation 
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Palladium-Catalyzed C-H Activation/C-C Bond Formation 
 
 
3.1 Background and Significance 
 
Biaryl subunits are widely prevalent in pharmaceuticals and agrochemicals 
(Scheme 1).1 Additionally, they serve as integral components of semiconductors and 
liquid crystals. Hence, the formation of biaryl linkages is very important in synthetic 
organic chemistry, and as a result, a large number of metal-catalyzed reactions have been 
developed for this transformation.  
 























receptor antagonist  
 
 
Among these, Pd0/II-catalyzed cross-coupling reactions between organic halides 
(or triflates) and organometallic reagents (e.g., boronic acids, stannanes, silanes) have 




Scheme 2: Pd0/II Cross Coupling Reactions 
X [M]
cat. Pd0
(X = Cl, Br, I) (M = B, Si, Sn)  
 
However, these methods do have two significant disadvantages. These are: (i) the 
requirement for two functionalized starting materials that might not always be accessible 
in the context of complex molecule synthesis and (ii) the generation of undesired salt 
byproducts that necessitate tedious and expensive purification processes. Hence, 
significant research efforts have recently focused on the transition metal-catalyzed direct 
arylation of arene C–H bonds with organometallic reagents (or aryl halides) as a more 
attractive alternative (Scheme 3). This approach would employ more ubiquitous C–H 
bonds in lieu of one of the functionalized reactants and would lead to less byproduct 
formation, thus rendering the process more atom economical. However, one of the key 
challenges associated with this strategy is the achievement of site selective and 
chemoselective arylation of the desired C–H bond in a complex molecule. 
 
Scheme 3: Direct Arylation of Arenes 
H
[M]
(M = B, Si. Sn)
X




One approach to achieve site selectivity in direct arylation reactions has been the 
intramolecular coupling of a C–H bond with an appropriate arylating reagent. Several 
palladium-catalyzed transformations of this type have been reported.3,4 For example, 
Fagnou and coworkers have shown that 4 can be converted to 5 in the presence of 
catalytic Pd(OAc)2 (Scheme 4).3 However, these reactions are inherently limited by the 
requirement for the C–H bond and the aromatic coupling partner to be present in the 
same molecule.  
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1 mol % Pd(OAc)2
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A more general strategy employed for achieving site selective arylation of C–H 
bonds involves chelate-directed C–H activation/C–C bond formation. This approach 
allows for the selective installation of an aryl group proximal to the directing ligand (L) 
(Scheme 5).  
 
Scheme 5: Chelate Assisted Direct Arylation Reactions 
[M]
(M = B, Si. Sn)
X






Prior to our investigations in this field, there were several reports of ligand 
directed C–H activation/arylation reactions catalyzed by Ru and Rh complexes. For 
example, RhI-catalyzed ligand directed arylation of 2-phenylpyridine 8 was reported with 
aryl stannanes (Scheme 6).5 However, the use of toxic stannane 9 limits the practical 
applicability of this reaction. Additionally, Bedford and coworkers had demonstrated the 
ortho arylation of phenols using aryl bromides and a rhodium catalyst (Scheme 7).6 







Scheme 6: Rhodium-Catalyzed Pyridine Directed Arylation 
N
H
5 mol % RhCl(PPh3)3








Scheme 7: Rhodium-Catalyzed Phenol Directed Arylation 
5 mol % RhCl(PPh3)3
15 mol % ligand











 A ruthenium-catalyzed approach for ketone-directed arylation of arenes was 
developed using arylboronates. A variety of electronically diverse aromatic ketones and 
arylboronates were used in these transformations (Scheme 8).7,8 Subsequently, Oi 
reported a methodology for the ruthenium-catalyzed arylation of phenylpyridines with 
aryl bromides (Scheme 9).9,10 However, these transformations were not expanded to the 
use of other directing groups. 
 










(16) (17)  
 





  2.5 mol % RuCl2[(!
6-C6H6)]2
10 mol % PPh3 
NMP, 120 °C
(95%)
(18) (19) (20)  
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Finally, Miura demonstrated phenol and amide directed Pd0/II-catalyzed arylation 
reactions using aryl halides and triflates. As illustrated in Scheme 10, the palladium-
catalyzed reaction of 21 with phenyl iodide leads to the arylated product 23 in 76% 
isolated yield.11-13 Similarly, the arylated product 26 was obtained in 74% yield from the 
reaction of anilide 24 with PhOTf.14  
 
Scheme 10: Pd0/II-Catalyzed Direct Arylation Reactions 
I
  5 mol % Pd(OAc)2







  5 mol % Pd(OAc)2
30 mol % PPh3










While all the aforementioned examples demonstrated the feasibility of direct 
arylation reactions, they exhibit a limited scope of directing groups. More importantly, 
functionalities such as aryl halides are not tolerated in the methodologies described 
above. Hence the development of direct arylation reactions with a broad scope and 
functional group compatibility remains an area of current interest.  
Our group has demonstrated a general palladium-catalyzed ligand-directed 
acetoxylation of C–H bonds using PhI(OAc)2 as the terminal oxidant for substrates 
bearing a wide variety of directing groups.15-18 For example, the palladium-catalyzed 
reaction of 3-methyl-2-phenylpyridine 27 with PhI(OAc)2 in AcOH affords the 


















As shown in Scheme 12, the proposed mechanism of this reaction involves (i) 
ligand-directed C–H activation to afford 29, (ii) oxidation of 29 to the PdIV intermediate 
30 by PhI(OAc)2 and finally (iii) C–O bond forming reductive elimination from 30. 
Importantly, PhI(OAc)2 is believed to be the source of the acetate in the the PdIV 
intermediate 30 and hence in the final product.  
 










C-H Activation Reductive EliminationOxidation
PdII
PhI(OAc)2
(27) (29) (30) (28)  
 
Based on this mechanistic manifold, we reasoned that the use of diaryl iodonium 
salts [Ar–I–Ar]BF4, in place of PhI(OAc)2 might allow us to access the PdIV aryl 
intermediate 31 (Scheme 13). C–C reductive elimination from 31 would then afford the 
desired arylated product 32.19  
 










C-H Activation Reductive EliminationOxidation
PdII
Ar!IIII!Ar
(27) (29) (31) (32)  
 
Overall this process would allow for the palladium-catalyzed ligand-directed site 
selective arylation of C–H bonds in substrates containing appropriate chelating groups. 
Additionally, the proposed PdII/IV catalytic cycle for this reaction is highly unusual and 
mechanistically distinct from the Pd0/II-catalyzed C–C bond forming reactions. We were 
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excited about the implications of the PdII/IV manifold with respect to the synthetic utility 
of these direct arylation reactions. Based on the ambient reaction conditions and the 
stability of functional groups such as aromatic bromides to the PdII/IV-catalyzed 
acetoxylation reactions developed by our group, we envisioned that the proposed C–H 
activation/C–C bond forming transformation might exhibit a broad and complementary 
scope to traditional cross-coupling methodologies and to the other directed C–H arylation 
reactions described above. 
 
3.2 Synthetic Scope 
 
We began our studies with 3-methyl-2-phenylpyridine (27) as the substrate and 
[Ph–I–Ph]BF4 as the oxidant. After some optimization, my colleague Nick Deprez found 
that the palladium-catalyzed reaction of 27 with [Ph–I–Ph]BF4, in AcOH afforded the 
phenylated product 33 in 88% isolated yield (Scheme 14). Importantly, the C–H bond 
adjacent to the pyridine directing group was selectively phenylated in this system 
(Scheme 14). 
 
Scheme 14: Palladium-Catalyzed Direct Arylation of 27 








(27) (34) (33)  
 
In conjunction with Lopa Desai, we have shown that the palladium-catalyzed 
phenylation of a variety of other substrates could also be achieved. Varying the solvent 
(typically between AcOH, AcOH/Ac2O, C6H6 and toluene) and the equivalents of oxidant  
between 1.1 and 2.5 was necessary to obtain optimal conditions for each substrate. In 
addition, the use of NaHCO3 as an additive led to improved yields for the phenylation of 
certain amide substrates.  In these cases, the improved yields were attributed to the 
neutralization of the strong acid, HBF4 generated in these arylation reactions. Directing 
groups such as pyridines, amides, quinolines, and oxazolidinones could be effectively 
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used in these transformations (Table 3.1). Importantly, these ligands are widely prevalent 
in important biologically active molecules. Hence, this methodology could potentially be 
used to arylate C–H bonds proximal to chelating groups in late stages of the synthesis of 
pharmaceutical candidates.  
 








aReaction Conditions: 1 equiv of substrate, 1.1-2.5 equiv [Ph2I]BF4, 5 mol 
% Pd(OAc)2 in AcOH, AcOH/Ac2O, C6H6 or toluene, 100 C, 8 - 24 h. 



































This phenylation reaction is also tolerant of a number of common functional 
groups. For example, enolizable ketones (43), aromatic aldehydes (45) and benzylic 








Scheme 15: Functional Group Tolerance for Direct Phenylation 









































Furthermore, both electron rich (substrates 43 and 47, Scheme 15) and electron 
poor arenes can be effectively phenylated to afford products in good yields. Analogous to 
the acetoxylation reactions described in Chapter 2, substrates 43, 18, and 47 bearing 
meta-substituted arenes undergo phenylation at the less sterically congested C-H bond 
with >20:1 selectivity.18 Finally and most importantly, these reactions exhibit functional 
group tolerance complementary to traditional Pd0/II-catalyzed cross-coupling 
methodologies. For example, aromatic bromides in substrates 51 (which are reactive with 








Scheme 16: Tolerance of Aromatic Halides 























In order to further expand the synthetic utility of these transformations, we next 
desired to incorporate diverse aryl groups into the final products. We began these studies 
by investigating the reaction of 3-methyl-2-phenylpyridine 27 with a variety of mixed 
iodonium salts [Ph–I–Ar]BF4. In these reactions, one could obtain the phenylated product 
33 and/or the arylated product 32 via transfer of either the phenyl (Ph) or the aryl (Ar) 
group from the oxidant (Scheme 17). Hence we wanted to assess the effect of the 
electronic and steric nature of Ar on the ratio of 33 to 32. Importantly, the mixed oxidants 
[Ph–I–Ar]BF4 are easily accessible by the reaction of PhI(OAc)2 with ArB(OH)2 in the 
presence of BF3•Et2O (Scheme 18).  
 































We were pleased to find that the Pd(OAc)2-catalyzed reaction of 27 with the 
mixed iodine(III) reagents resulted in selective arylation of the C–H bond adjacent to the 
pyridine group (Table 3.2). A variety of functional groups including aromatic halides 
(Table 3.2, entries 1 and 2) and benzylic hydrogens (Table 3.2, entry 3.3) were well 
tolerated on the arene component (Table 3.2). However, the desired arylated products B 
were obtained only as mixtures with the analogous phenylated product A.  
 






















aReaction Conditions: 5 mol % Pd(OAc)2, 













 Notably, the electronic properties of the aryl group had a significant influence on 
the product distribution (Table 3.2). For example, the reaction of 27 with [Ph–I–(p-
CF3Ph)] led to B as the major product (Table 3.2, entry 5). In contrast, the use of [Ph–I–
(p-OMePh)], which contains an electron rich arene, afforded A and B in a ratio of 3:1 
favoring the phenylated product (Table 3.2, entry 4). Hence, electron deficient aryl 
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groups transfer with greater facility than electron rich arenes under our reaction 
conditions.  
In contrast, most Pd0/II cross-coupling reactions with [Ph–I–Ar]BF4 show high 
selectivity for the transfer of electron rich arenes.20 This is illustrated by the carbonylative 
Stille coupling of PhSnBu3 with [p-OMePh–I–Ph]BF4 shown in Scheme 19. Here, the 
electron rich methoxy substituted benzophenone 58 is the exclusive product (Scheme 
19).21  
 
Scheme 19: Electronic Effects of the Oxidant in Carbonylative Stille Coupling 













The steric properties of the oxidant also affected the product distribution in these 
direct arylation reactions. The yield of the arylated product decreased with increasing size 
of the Ar group. This is exemplified by the reaction of 27 with [Ph–I–(o-CH3Ph)] 
depicted in Scheme 20. In this system, the phenylated product 33 was formed 
preferentially over 60 with ~3:1 selectivity (Scheme 20).  
 
Scheme 20: Steric Effects of the Oxidant 















This steric effect was most striking when [Ph–I–mesityl]BF4 was employed as the 
oxidant. In this system, the phenylated product 33 was formed exclusively in 85% 
isolated yield.  None of the product 62 with the bulky mesityl group was observed in this 
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reaction (Scheme 21). Importantly, similar steric effects have been reported for Pd0/II-
catalyzed C–C bond forming reactions.20 
 
Scheme 21: Phenylation of 27 with [Ph–I–Mesityl]BF4 














We envisioned that, analogous to the reaction with [mesityl–I–Ph]BF4 (Scheme 
21), the use of [mesityl–I–Ar]BF4 might lead to the exclusive transfer of the smaller aryl 
groups (Scheme 22). Hence, this approach might allow for the formation of desired 
arylated products 32 in more synthetically useful selectivities than those obtained using 
[Ar–I–Ph]BF4.  
 
Scheme 22: Arylation of 27 with [Ar-I-Mesityl]BF4 











We were delighted to find that the use of [mesityl–I–Ar]BF4 under our standard 
reaction conditions exclusively effected transfer of the Ar group in good to excellent 
yields (Scheme 23).  The products 33, 60, and 64-68 were obtained with >20:1 selectivity 
regardless of the electronic nature of the aryl group. Furthermore, a variety of functional 
groups including aromatic halides (64 and 67) were well tolerated on the arene 
component. Additionally, the sterically hindered o-tolyl group was also incorporated in 
the final product (60) with high (>20:1) levels of selectivity. Interestingly, the reactions 
to form 33, 60, 64 and 66-68 showed complete consumption of 27 in 12 h at 100 °C. 
However, the reaction of 27 with the electron rich oxidant [mesityl–I–(p-OMePh)]BF4 to 
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form 65 required 120 °C to afford complete conversion. This effect of the oxidant 
electronics on the reaction rate suggests that oxidation by [Ar–I–mesityl]BF4 occurs at or 
before the rate-limiting step.  
 
Scheme 23: Scope of Arylation of 27 with [Ar-I-Mesityl]BF4 














(33, 85%) (64, 88%) (65, 81%)
(66, 84%) (67, 83%) (68, 87%)
(60, 70%)







3.3 Mechanistic Investigations 
 
Having explored the synthetic scope of these arylation reactions, we next turned 
our focus towards investigating the mechanism. As will be detailed below, we considered 
mechanisms involving Pd0/II and PdII/IV catalytic cycles. 
We first considered the most widely invoked mechanism for Pd0/II-catalytic cycles 
(mechanism 1, Scheme 24) using IIII reagents.20 This mechanism begins with oxidative 
addition of Pd0 (generated via in situ reduction of Pd(OAc)2) into the Ph–I bond of the 
oxidant to afford 69. Subsequent ligand directed C–H activation followed by C–C bond 
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forming reductive elimination could then release the product and regenerate the Pd0 
catalyst.  
 





















 We reasoned that if our arylation reactions proceeded via mechanism 1, then the 
use of conventional Pd0/II oxidants such as ArI in place of [Ar–I–Ar]BF4 should afford the 
arylated products. However, as shown in Scheme 25, the palladium-catalyzed reaction of 
27 with PhI or PhOTf as oxidants afforded <1% of the phenylated product 33. This result 
strongly suggests against mechanism 1 being operative under our catalytic conditions. 
 
Scheme 25: Reaction of 27 with PhI and PhOTf 
AcOH, 100 oCN N
PhH
5 mol % Pd(OAc)2
PhI or PhOTf
(27) (33, <1%)  
 
We next considered an alternative PdII/0 mechanism that commences with PdII 
mediated C–H activation to afford the cyclopalladated complex 29 (Scheme 26).20 
Transmetallation of the aryl group (Ar) from the iodine(III) reagent onto 29 with 
subsequent C–C reductive elimination leads to the arylated product 33. The first step of 
this mechanism, namely cyclopalladation, is well documented. In contrast, there is 
relatively little precedent for the transmetallation between a Pd-aryl species and [Ph–I–
Ph]BF4, although a report by Moriarty did suggest this mechanistic possibility in cross 
coupling reactions.22  
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It is well known that transmetallation of electron rich arenes to PdII intermediates 
is more facile than their electron poor counterparts. Hence, if mechanism 2 were 
operative for our arylation reactions, we would expect the selective transfer of the more 
electron rich aryl group. However, as discussed in section 3.2 above, the palladium-
catalyzed reaction of 27 with [m-CF3Ph–I–Ph]BF4 led to the preferential transfer of the 
electron poor trifluoromethyl substituted arene, suggesting against mechanism 2 (Table 2, 
entry 5). 
We next desired to probe the involvement of Pd nanoparticles or free radicals 
under our reaction conditions, as both of these have been proposed previously for Pd0/II 
catalyzed reactions. Importantly, a number of Heck reactions that were initially proposed 
to proceed via PdII/IV-catalytic cycles have now been shown to be catalyzed by palladium 
nanoparticles.23 In order to test for the participation of Pd nanoparticles in our reactions, 
27 was subjected to the standard reaction conditions in the presence of Hg. Notably, Hg 
is known to act as a potent poison for heterogeneous catalysis by forming an amalgam 
with Pd nanoparticles. However, as shown in Scheme 27, the arylation of 27 was 
unaffected by the presence of Hg, suggesting strongly against nanoparticle assisted 
catalysis. 
 
Scheme 27: Phenylation of 27 in the Presence of Hg 
5 mol % Pd(OAc)2
[Ph2I]BF4





GC yield  
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 In order to probe for the involvement of radicals, we conducted the reaction of 27 
with [Ph–I–Ph]BF4 in the presence of radical inhibitors. The data presented in Scheme 28 
suggests against any radical intermediates, as the reaction was unaffected by the presence 
of BHT (butylated hydroxytoluene), MEHQ (hydroquinone monomethyl ether) or 
galvinoxyl. 
 
Scheme 28: Phenylation of 27 in the Presence of Radical Inhibitors 
5 mol % Pd(OAc)2
[Ph2I]BF4






(Radical trap : BHT, MEHQ or galvinoxyl)
 
 
Finally, we wanted to directly investigate the viability of a PdII/IV catalytic 
manifold for the palladium-catalyzed ligand directed arylation reactions (Scheme 29). 
More specifically, we wanted to probe the intermediacy of (i) the cyclopalladated 
complex 29 and (ii) the proposed PdIV species 71.  
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In order to explore the former, we first examined the stoichiometric reaction of 72 
with [Ph–I–Ph]BF4. As shown in Scheme 30 below, this reaction led to the desired 
phenylated product 33, albeit in much lower yield (20%) than that obtained (88%) in the 
catalytic phenylation of 27 (Scheme 14). However, analysis of the crude reaction by 1H 
NMR spectroscopy and electrospray mass spectrometry revealed a complex mixture of 
additional high molecular weight organic products, and the MS data is consistent with the 
















While the origin of these products and the details of this reactivity are not known, 
we speculated that the highly reactive cationic palladium species 73 generated after initial 
C–C bond forming reductive elimination may be responsible for producing these 
polyphenylated products (Scheme 31). Notably, under the catalytic conditions, a large 
excess of substrate is present relative to catalyst, so such a reactive species is expected to 
be trapped rapidly in a productive manner.  
 





















Hence, we theorized that the addition of free ligand to the stoichiometric reaction 
might attenuate the reactivity of 73 and allow the stoichiometric arylation reaction  to 
proceed in higher yield without the formation of polyarylated side products. In order to 
probe this hypothesis, we investigated the stoichiometric reaction of 72 with [Ph–I–
Ph]BF4 in the presence of meta-methyl-2-phenylpyridine 18 (Scheme 32). Importantly, 
18 (which is electronically and structurally similar to 27) was used as the free ligand in 
place of 27 to allow us to quantify the yield of the arylation of 72 without complications 
from the arylation of the free ligand. Gratifyingly, these conditions led to the formation of 
the arylated product in 90% GC yield. This result supports the proposed oxidative 




















Furthermore, as depicted in Scheme 33, the cyclometallated complex 72 catalyzed 
the arylation reaction of 27 at rates comparable to that of Pd(OAc)2.. The phenylation 
reaction was complete in about 1.5 h using either 72 or Pd(OAc)2 as the catalyst at 90 °C. 
Taken together, the data in Schemes 32 and 33 suggest that the cyclopalladated complex 
72 is a kinetically competent intermediate for our direct arylation reactions.  
 

















Pd(OAc)2 as catalyst 
72 as catalyst 
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In order to gain further support for the proposed PdII/IV mechanism, we explored 
the reaction of palladacycle 72 with traditional Pd0/II oxidants in place of [Ph–I–Ph]BF4. 
While Canty has shown that [Ph–I–Ph]BF4 can oxidize PdII to PdIV (Scheme 34),24 there 
are no reports suggesting the accessibility of high oxidation state PdIV species with 
oxidants such as PhI and PhOTf.  
 











(74) (75) (76, 22%)




As shown in Scheme 35, the phenylated product 33 was not formed in the 
stoichiometric reaction of 72 with PhI or PhOTf. However, as mentioned above (Scheme 
31 and 33), 72 reacts with [Ph–I–Ph]BF4 to afford 33. These results lend further credence 
to the intermediacy of PdIV species in the catalytic oxidative arylation reactions.   
 









(72) (33, < 1%)  
 
Based on these preliminary mechanistic investigations, we surmise that the PdII/IV 
catalytic manifold depicted in Scheme 29 is operative for the palladium-catalyzed ligand 
directed C–H activation/arylation reactions. However, at this time we cannot exclude a 
mechanism involving direct electrophilic cleavage of the Pd-aryl bond in 29 by [Ph–I–
Ph]BF4 (Scheme 36). This alternative mechanism would constitute a PdII/II catalytic 



















3.4 Subsequent Examples 
 
There have been several publications on palladium-catalyzed ligand-directed C-H 
activation/arylation reactions to form biaryl linkages since our initial work in 2005. In 
particular there have been reports on carboxylic acid and anilide directed arylations of 
arenes that proceed via Pd0/II catalytic cycles with boronates or silanes as the arylating 
reagents.25, 26 However, the most interesting reactions in the context of our work are the 
arylations proposed to proceed via a PdII/IV catalytic manifold.27-32 Daugulis and 
coworkers reported a palladium-catalyzed ortho-diarylation of anilides using [Ph–I–
Ph]PF6 as the oxidant (Scheme 37). Notably, these reaction conditions are very similar to 
those reported by our group. However, only one substrate (77) was examined using 
Daugulis’ methodology.27  
 










(77) (78)  
 
Additionally, Daugulis and coworkers have demonstrated that these arylation 
reactions can proceed using aryl iodides instead of [Ph–I–Ph]PF6 as the arylating reagents 
in the presence of stoichiometric amounts of silver salts (Scheme 38).27 These reactions 
have been subsequently expanded to the use of other directing groups such as benzyl 
















(77) (78)  
 
A variety of electronically diverse substrates can be used in these reactions. 
Furthermore, a number of moderately electron poor and electron rich aryl iodides serve as 
effective arylating reagents. However, the use of aryl iodides containing strongly electron 
donating (4-iodoanisole)29 or electron withdrawing (p-trifluoromethyliodobenzene)28 
groups leads to diminished yields of the arylated products. Additionally, ortho-substituted 
aryl iodides are unreactive under these reaction conditions.32 As exemplified by the 
competition reaction depicted in Scheme 39 below, arylation of electron rich arenes is 
relatively faster than arylation of electron poor arenes.29 Interestingly, these 
transformations proceed faster with electron rich aryl iodides than with their electron 
poor counterparts.29 For example, the reaction of 79 with equimolar quantities of 84 and 
85 led to products 86 and 87 in a 2:1 ratio (Scheme 40). In contrast, as mentioned in 
section 3.2, the transfer of electron poor arenes was more facile in our arylation reactions.  
 
Scheme 39: Effects of Substrate Electronics in Phenylation of Anilide 
CF3CO2H, 120 
oC
































Scheme 40: Electronic Effects of the Iodoarene in Diphenylation of Anilide  
CF3CO2H, 120 
oC























Detailed mechanistic studies have not been performed for these transformations. 
However, the authors have speculated on two possible mechanisms for these arylations. 
The first (Scheme 41) involves a Pd0/II catalytic cycle while the second (Scheme 42) 
proceeds via a PdII/IV manifold.31  
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In order to distinguish between these mechanistic regimes, the reaction of 2-
naphthoic acid (94) with 3-iodotoluene (95) was conducted with either a Pd0 or a PdII 
catalyst in the absence of AgOAc (which is believed to be important for catalytic 
turnover).  As shown in Schemes 43 and 44, one turnover to the arylated product was 
observed with Pd(OAc)2 while no product was obtained with Pd0 sources such as 
Pd2(dba)3 and Pd(PtBu3)2. Based on these results along with the observed stability of aryl 
bromides and chlorides under the reaction conditions, the authors propose that the PdII/IV 
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reaction manifold is operative for their arylations. In particular, the authors suggest that 
the aryl iodide oxidizes the cyclopalladated complex (generated upon C–H activation) to 
a PdIV species. Furthermore, AgOAc is proposed to regenerate the Pd(OAc)2 catalyst via 
iodide exchange for an acetate at the PdII species formed upon reductive elimination.  
 
Scheme 43: Arylation of 2-Naphthoic Acid with a PdII Catalyst 
CH3CO2H
(ca. 1 turnover)







Scheme 44: Arylation of 2-Naphthoic Acid with Pd0 Catalysts 
 










As described above, Daugulis and coworkers have developed a methodology for 
the direct arylation of arenes. The key difference between these reactions and those 
developed by our group is the use of ArI instead of [Ar–I–Ar]BF4 as the arylating 
reagent. Analogous to our reactions, aromatic chlorides and bromides are stable under 
Daugulis’ reaction conditions. However, functional group tolerance is somewhat limited 
for these transformations due to the use of strongly acidic trifluoroacetic acid as the 
solvent in many cases. Additionally, as mentioned above, the scope of these reactions is 
subject to both electronic and steric limitations on the aryl iodide. This is in contrast to 
our reactions, in which both electron rich (p-OMePh) and electron poor (p-CF3Ph) as well 
as sterically hindered (o-tolyl) aryl groups can be efficiently incorporated into the final 
products. Finally, the key step leading to the arylated products is proposed to involve 
oxidation of the cyclometallated complex by the arylating reagent via a PdIV intermediate. 
While the oxidation of PdII to PdIV using [Ph–I–Ph]OTf  by Canty (Scheme 34) supports 
the feasibility of PdIV species in our reactions, there are no literature reports suggesting 
the accessibility of high oxidation state PdIV complexes using aryl iodides. Hence, a more 
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detailed mechanistic investigation with systematic exploration of different reaction 
variables is necessary in order to propose the PdII/IV catalytic cycle for arylation reactions 




In summary, we have shown that diaryl iodonium salts can be used as oxidants for 
site selective C–H activation/arylation reactions in the presence of Pd(OAc)2 as the 
catalyst. Preliminary results suggest that the mechanism of this reaction involve a 
PdII/PdIV catalytic cycle, which is of interest because nearly all palladium mediated C–C 
bond forming reactions proceed via a Pd0/PdII cycle.  
 
3.6 Experimental Procedure 
 
General Procedures:  NMR spectra were obtained on a Varian Inova 500 (499.90 MHz 
for 1H; 125.70 MHz for 13C) or a Varian Inova 400 (399.96 MHz for 1H; 100.57 MHz for 
13C) spectrometer. 1H NMR chemical shifts are reported in parts per million (ppm) 
relative to TMS, with the residual solvent peak used as an internal reference.  
Multiplicities are reported as follows: singlet (s), doublet (d), doublet of doublets (dd), 
doublet of triplets (dt), triplet (t), quartet (q), multiplet (m), and broad resonance (br). 
 
 
Materials and Methods:  Substrates 35, 37, 39, 41, 45, and 51 were obtained from 
commercial sources and used as received. Substrate 27 was prepared by Suzuki cross-
coupling of phenyl boronic acid and 2-bromo-3-methylpyridine according to a literature 
procedure.33 Pyridine substrates 18 and 43 were prepared by Stille cross-coupling of 2-
tributylpyridyltin with the corresponding aryl bromides.34 Amide substrates 47 and 49 
were prepared by palladium-catalyzed arylation of the corresponding lactam.35 Phenyl 
iodonium salts were prepared by the reaction of PhI(OAc)2 with ArB(OH)2 in the 
presence of BF3•Et2O (for [Ph2I]BF4, [Ph–I–p-FC6H4]BF4, [Ph–I–p-ClC6H4]BF4, [Ph–I–
o-CH3C6H5]BF4, [Ph–I–p-CH3C6H5]BF4)36 or trifluoromethanesulfonic acid (for [Ph–I–p-
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MeOC6H4]BF4 and [Ph–I–thienyl]BF4).37 Mesityl iodonium salts were prepared by the 
reaction of MesI(OAc)238 with ArB(OH)2 in the presence of BF3•Et2O (for [Mes–I–p-
FC6H4]BF4, [Mes–I–p-ClC6H4]BF4, [Mes–I–o-CH3C6H5]BF4, [Mes–I–p-CH3C6H5]BF4, 
[Mes–I–(1-naphthyl)]BF4, by reaction of PhI(OAc)2 with mesitylene in H2SO4,39 or by 
reaction of MesI(OAc)2 with anisole in CH2Cl2/trifluoroacetic acid.40 Pd(OAc)2 was 
obtained from Pressure Chemical and used as received and PhI(OAc)2 was obtained from 
Acros and used as received. Mercury (electrochemical grade, 99.9999%) was obtained 
from Aldrich and used as received. Solvents were obtained from Fisher Chemical and 
used without further purification. Flash chromatography was performed on EM Science 
silica gel 60 (0.040–0.063 mm particle size, 230–400 mesh) and thin layer 
chromatography was performed on Merck TLC plates pre-coated with silica gel 60 F254. 
Control reactions (in the absence of Pd catalyst) were run for each substrate, and 
generally showed no reaction under our standard conditions. In general, crude reaction 
mixtures were filtered through glass wool or Celite to remove insoluble materials that 
form at the end of the reaction before workup. 
 
I.  Experimental Procedures 
N
Ph  
Substrate 27 (200 mg, 1.18 mmol, 1 equiv), [Ph2I]BF4 (500 mg, 1.36 mmol, 1.15 equiv) 
and Pd(OAc)2 (13.2 mg, 0.059 mmol, 5 mol %) were combined in acetic acid (10 mL) in 
a 20 mL vial. The vial was sealed with a Teflon lined cap, and the reaction was stirred at 
100°C for 12 hours.  The reaction mixture was filtered through a plug of Celite and then 
concentrated under vacuum. The resulting crude oil was dissolved in CH2Cl2 and 
extracted with saturated aqueous NaHCO3 (2 x 30 mL) and brine (1 x 30 mL). The 
organic layer was dried over MgSO4, filtered, and concentrated to afford an orange oil, 
which was purified by chromatography on silica gel (Rf = 0.2 in 95% CH2Cl2/5% ethyl 
acetate).  The product 33 was obtained as a viscous yellow oil (255 mg, 88% yield); 1H 
NMR (d6-acetone): δ 8.47 (d, J = 4.8 Hz, 1H), 7.55-7.43 (multiple peaks, 3H), 7.40 (d, J 
= 7.5 Hz, 1H), 7.37-7.35 (m, 1H), 7.21-7.10 (multiple peaks, 6H), 1.75 (s, 3H).  13C{1H} 
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NMR (d6-acetone): δ 161.29, 148.19, 142.99, 142.40, 141.62, 139.03, 133.06, 131.80, 
131.32, 130.92, 130.04, 129.58, 128.98, 128.48, 124.00, 19.95.  Anal. Calcd for C18H15N: 





Substrate 35 (152 mg, 0.94 mmol, 1 equiv), [Ph2I]BF4 (521 mg, 1.41 mmol, 1.5 equiv), 
NaHCO3 (119 mg, 1.14 mmol, 1.5 equiv) and Pd(OAc)2 (11.9 mg, 0.053 mmol, 5 mol %) 
were combined in toluene (8 mL) in a 20 mL vial fitted with a Teflon lined cap, and the 
reaction was stirred at 100°C for 24 hours.  The reaction mixture was filtered through a 
plug of Celite and concentrated under vacuum to afford a yellow oil, which was purified 
by chromatography on silica gel (Rf = 0.1 in 50% ethyl acetate/50% hexanes).  The 
product 36 was obtained as an orange oil (170 mg, 75% yield). 1H NMR (CDCl3): δ 7.44-
7.35 (multiple peaks, 6H), 7.34-7.33 (m, 2H), 7.32 (t, J = 1.7 Hz, 1H), 3.21 (t, J = 7.0 Hz, 
2H), 2.43 (t, J = 8.1 Hz, 2H), 1.90-1.83 (m, 2H). 13C{1H} NMR (d6-acetone): δ 174.18, 
140.09, 140.03, 137.60, 130.95, 129.13, 128.78, 128.59, 128.44, 127.71, 127.59, 49.65, 
31.06, 18.99.  Anal. Calcd for C16H15NO: C, 80.98, H, 6.37, N, 5.90; Found: C, 80.67, H, 





Substrate 37 (150 mg, 0.92 mmol, 1 equiv), [Ph2I]BF4 (676 mg, 1.84 mmol, 2 equiv), 
Pd(OAc)2 (10.2 mg, 0.046 mmol, 5 mol %) and NaHCO3 (155 mg, 1.84 mmol, 2 equiv) 
were combined in benzene (8 mL) in a 20 mL vial. The vial was sealed with a Teflon 
lined cap and the reaction was heated at 100ºC for 12 hours. The reaction mixture was 
filtered through a plug of Celite and then evaporated to dryness. The resulting oil was 
dissolved in CH2Cl2 and extracted with saturated aqueous NaHCO3 (2 x 30 mL) and brine 
(1 x 30 mL). The organic layer was dried over MgSO4, filtered, and concentrated to 
afford an orange oil, which was purified by chromatography on silica gel (Rf = 0.23 in 
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97.5% CH2Cl2/2.5% ethyl acetate). The product 38 was obtained as a yellow solid (182 
mg, 83% yield); mp 107-109 ºC. 1H NMR (C6D6): δ 7.38 (dd, J = 7.8, 1.2 Hz, 1H), 7.32-
7.30 (m, 2H), 7.14-7.12 (m, 1H), 7.10-7.06 (multiple peaks, 3H), 7.05-6.99 (m, 2H) 3.24 
(dd, J = 8.6, 7.2 Hz, 2H), 2.55 (dd, J = 8.5, 7.2 Hz, 2H). 13C{1H} NMR (CDCl3): δ 
157.78, 139.62, 139.00, 135.08, 131.10, 128.89, 128.87, 128.58, 128.41, 128.25, 127.99, 
62.43, 47.13. Anal. Calcd for C15H13NO2: C, 75.30, H, 5.48, N, 5.85; Found: C, 75.50, H, 




Substrate 39 (200 mg, 0.97 mmol, 1 equiv), [Ph2I]BF4 (428 mg, 1.16 mmol, 1.2 equiv), 
and Pd(OAc)2 (10.9 mg, 0.054 mmol, 5 mol %) were combined in AcOH (8 mL) in a 20 
mL vial. The vial was sealed with a Teflon lined cap, and the reaction was heated at 
100ºC overnight. GC analysis at the completion of the reaction showed 19% starting 
material (39), 71% mono-arylated product (40) and 10% of the analogous diarylated 
product. The reaction mixture was filtered through a plug of Celite and then evaporated 
to dryness. The resulting oil was dissolved in CH2Cl2 and extracted with saturated 
aqueous NaHCO3 (2 x 30 mL) and brine (1 x 30 mL). The organic extracts were dried 
over MgSO4 and concentrated under vacuum to afford a yellow oil, which was purified 
by chromatography on silica gel (Rf = 0.22 in 94% hexanes/6% ethyl acetate). The 
product 40 was obtained as a pale yellow solid (157 mg, 58% yield); mp 134-138 ºC. 1H 
NMR (C6D6): δ 8.38 (d, J = 8.4 Hz, 1H), 8.14 (dd, J = 7.60, 1.45, 1H), 7.39-7.34 (m, 2H), 
7.31-7.28 (m, 2H), 7.26-7.16 (multiple peaks, 6H), 6.95-6.90 (m, 2H), 6.88-6.86 (m, 1H). 
13C{1H} NMR (CDCl3): δ 159.60, 147.94, 140.86, 140.46, 139.45, 134.43, 130.62, 
130.21, 129.52, 129.26, 129.06, 128.62, 128.04, 127.88, 127.59, 127.18, 126.60, 126.27, 
123.13. HRMS-electrospray (m/z): [M+ – H] calcd for C21H15N, 280.1126; found, 







Substrate 41 (150 mg, 0.93 mmol, 1 equiv), [Ph2I]BF4 (685 mg, 1.86 mmol, 2 equiv), and 
Pd(OAc)2 (10.4 mg, 0.047 mmol, 5 mol %) were combined in AcOH (5 mL) and Ac2O (5 
mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the reaction was 
heated at 100ºC overnight. GC analysis at the completion of the reaction showed 29% 
starting material (41) and 71% of the mono-arylated product (42). Notably, attempts to 
optimize the reaction conditions did not lead to further conversion with this substrate. 
The reaction mixture was evaporated to dryness, and the remaining solid residue was 
taken up in MeOH (20 mL) and filtered through a plug of Celite. The methanol was 
removed under vacuum and the solids were taken up in CH2Cl2 and extracted with 
saturated aqueous NaHCO3 (3 x 30 mL).  The organic extracts were concentrated under 
vacuum to afford a red oil, which was purified by chromatography on silica gel (Rf = 0.2 
in 70% hexanes/30% ethyl acetate). The product 42 was obtained as pale yellow solid 
(108 mg, 49% yield); mp 117-119 ºC. 1H NMR (d6-acetone): δ 7.52-7.14 (multiple peaks, 
8H), 4.23 (t, J = 7.2 Hz, 2H), 3.02 (t, J = 7.2 Hz, 2H), 1.50 (br s, 3H). 13C{1H} NMR (d6-
acetone): δ 141.58, 129.77, 128.16, 127.78, 126.02, 124.67,51.15, 22.89. (The 13C NMR 
peaks of 12a are broad and several are missing, presumably as a result of fluxional 
motion of the amide.)  Anal. Calcd for C16H15NO: C, 80.98, H, 6.37, N, 5.90; Found: C, 






Substrate 43 (150 mg, 0.76 mmol, 1 equiv), [Ph2I]BF4 (420 mg, 1.14 mmol, 1.5 equiv), 
and Pd(OAc)2 (8.5 mg, 0.038 mmol, 5 mol %) were combined in acetic acid (6 mL) in a 
20 mL vial. The vial was sealed with a Teflon lined cap and the reaction was heated at 
100ºC for 2 days. The reaction mixture was filtered through a plug of Celite and then 
evaporated to dryness. The resulting oil was dissolved in CH2Cl2 and extracted with 
saturated aqueous NaHCO3 (2 x 30 mL) and brine (1 x 30 mL). The organic layer was 
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dried over MgSO4, filtered, and concentrated to afford an orange oil, which was purified 
by chromatography on silica gel (Rf = 0.25 in 88% CH2Cl2/12% ethyl acetate). The 
product 44 was obtained as an orange/brown solid (189 mg, 91% yield); mp 77-78ºC. 1H 
NMR (acetone-d6): δ 8.59-8.57 (m, 1H), 8.07 (dd, J = 8.0, 1.9 Hz, 1H), 8.24 (d, J = 1.8 
Hz, 1H), 7.55 (d, J = 8.0, 1H), 7.50 (td, J =  7.7, 1.8 Hz, 1H), 7.26-7.25 (m, 3H), 7.21-
7.18 (m, 1H), 7.16-7.13 (m, 2H), 6.96-6.93 (m, 1H), 2.63 (s, 3H). 13C{1H} NMR 
(CDCl3): δ 197.80, 158.50, 149.81, 145.36, 140.37, 139.93, 136.43, 135.63, 131.12, 
129.64, 128.44, 128.18, 127.64, 125.49, 122.99, 26.96. HRMS-electrospray (m/z): [M+ + 
H] calcd for C19H15NO, 274.1232; found, 274.1233. Anal. Calcd for C19H15NO: C, 83.94, 
H, 5.53, N, 5.12; Found: C, 83.56, H, 5.45, N, 5.04. IR (KBr) 1683, 1586 cm-1. 
The regioselectivity of this reaction could not be definitively determined from the 
1H NMR spectrum of 44 due to overlapping aromatic resonances. As a result, a 
deuterated version of this product was prepared by reaction of 43 with [Mes–I–C6D5]BF4 
under analogous conditions to those described above. The 1H NMR data for the 
deuterated product (43-d5) was as follows: 1H NMR (d6-acetone): δ 8.69-8.67 (m, 1H), 
8.30 (d, J = 2.0 Hz, 1H), 8.17 (dd, J = 8.0, 2.0 Hz, 1H), 7.68 (d, J = 8 Hz, 1H), 7.63 (dt, J 
= 7.5, 1.5 Hz, 1H), 7.34-7.32 (m, 1H), 7.15-7.13 (m, 1H). 
 
N
Ph CHO  
Substrate 45 (200 mg, 1.09 mmol, 1 equiv), [Ph2I]BF4 (441 mg, 1.20 mmol, 1.1 equiv), 
and Pd(OAc)2 (12.2 mg, 0.054 mmol, 5 mol %) were combined in AcOH (9 mL) in a 20 
mL vial. The vial was sealed with a Teflon lined cap, and the reaction was heated at 
100ºC overnight. GC analysis at the completion of the reaction showed 11% starting 
material (45), 67% mono-arylated product (46) and 21% of the analogous diarylated 
product. The reaction mixture was filtered through a plug of Celite and evaporated to 
dryness. The resulting oil was dissolved in CH2Cl2 and extracted with saturated aqueous 
NaHCO3 (2 x 30 mL) and brine (1 x 30 mL). The organic extracts were dried over 
MgSO4 and concentrated under vacuum to afford a yellow oil, which was purified by 
chromatography on silica gel (Rf = 0.25 in 65% hexanes/35% ethyl acetate). The product 
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46 was obtained as pale yellow solid (142 mg, 51% yield); mp 90-94 ºC. 1H NMR 
(C6D6): δ 9.71 (s, 1H), 8.51-8.49 (m, 1H), 7.87 (d, J = 9.7 Hz, 1H), 7.74 (d, J = 1.5 Hz, 
1H), 7.61 (dd, J = 7.9, 1.5, 1H), 7.04-7.01 (m, 2H), 6.99-6.96 (multiple peaks, 3H), 6.74-
6.66 (m, 2H), 6.52-6.28 (m, 1H). 13C{1H} NMR (CDCl3): δ 191.60, 157.49, 149.32, 
144.64, 141.15, 139.63, 135.77, 135.11, 131.60, 131.08, 129.17, 128.14, 127.97, 127.01, 
124.97, 121.78. HRMS-electrospray (m/z): [M+ – H] calcd for C18H13NO, 258.0919; 




Substrate 18 (150 mg, 0.89 mmol, 1 equiv), [Ph2I]BF4 (489 mg, 1.33 mmol, 1.5 equiv), 
and Pd(OAc)2 (9.9 mg, 0.044 mmol, 5 mol %) were combined in acetic acid (4 mL) and 
acetic anhydride (4 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap and 
the reaction was heated at 100ºC for 12 hours. The reaction mixture was filtered through 
a plug of Celite and then evaporated to dryness. The resulting oil was dissolved in 
CH2Cl2 and extracted with saturated aqueous NaHCO3 (2 x 30 mL) and brine (1 x 30 
mL). The organic layer was dried over MgSO4, filtered, and concentrated to afford a 
yellow oil, which was purified by chromatography on silica gel (Rf = 0.24 in 97.5% 
CH2Cl2/2.5% ethyl acetate). The product 20 was obtained as a brown solid (156 mg, 74% 
yield); mp 80-84 ºC . 1H NMR (C6D6): δ 8.58 (d, J = 4.8 Hz, 1H), 7.79 (s, 1H), 7.27 (d, J 
= 7.8 Hz, 1H), 7.22-7.20 (m, 2H), 7.04-6.95 (multiple peaks, 4H), 6.83-6.79 (m, 2H), 
6.77-6.75 (m, 1H), 2.17 (s, 3H). 13C{1H} NMR (CDCl3): δ 158.88, 148.94, 140.85, 
138.76, 137.36, 136.92, 134.68, 130.66, 130.03, 129.28, 128.86, 127.59, 126.08, 125.04, 
120.84, 20.66. HRMS-electrospray (m/z): [M+ + H] calcd for C18H15N, 246.1283; found, 








Substrate 47 (180 mg, 0.94 mmol, 1 equiv), [Ph2I]BF4 (692 mg, 1.88 mmol, 2 equiv), 
Pd(OAc)2 (10.5 mg, 0.047 mmol, 5 mol %) and NaHCO3 (158 mg, 1.88 mmol, 2 equiv) 
were combined in toluene (8 mL) in a 20 mL vial. The vial was sealed with a Teflon 
lined cap and the reaction was heated at 100ºC for 12 hours. The reaction mixture was 
evaporated to dryness, and the residue was redissolved in CH2Cl2 and filtered through a 
plug of Celite. The solution was concentrated to afford a yellow oil, which was purified 
by chromatography on silica gel (Rf = 0.25 in 70% ethyl acetate/30% hexanes). The 
product 48 was obtained as a yellow solid (211 mg, 84% yield); mp 61-64 ºC. 1H NMR 
(C6D6): δ 7.41-7.39 (m, 2H), 7.18-7.16 (m, 1H), 7.14-7.05 (multiple peaks, 4H), 6.73 (dd, 
J = 8.5, 2.6 Hz, 1H), 3.30 (s, 3H), 2.78 (t, J = 6.9 Hz, 2H), 2.03 (t, J = 8.0 Hz, 2H), 1.19-
1.12 (m, 2H). 13C{H} NMR (CDCl3): δ 175.15, 159.10, 138.41, 136.62, 131.46, 131.09, 
127.92, 127.89, 126.74, 113.70, 112.89, 54.95, 49.66, 30.74, 18.46. HRMS-electrospray 
(m/z): [M+ + Na] calcd for C17H17NO2, 290.1157; found, 290.1167. IR (KBr) 1687, 1609 
cm–1. 
The regioselectivity of this reaction could not be definitively determined from the 
1H NMR spectrum of 48 due to overlapping aromatic resonances. As a result, a 
deuterated version of this product was prepared by reaction of 47 with [Mes–I–C6D5]BF4 
under analogous conditions to those described above. The 1H NMR data for the 
deuterated product (48-d5) was as follows: 1H NMR (d6-acetone): δ 7.31 (d, J = 8.5 Hz, 
1H), 6.98 (dd, J = 8.5, 2.6 Hz, 1H), 6.92 (d, J = 2.6 Hz, 1H), 3.84 (s, 3H), 3.26 (t, J = 6.9 







Substrate 49 (180 mg, 0.75 mmol, 1 equiv), [Ph2I]BF4 (689 mg, 1.87 mmol, 2.5 equiv), 
and Pd(OAc)2 (8.4 mg, 0.038 mmol, 5 mol %) were combined in toluene (6.25 mL) in a 
20 mL vial. The vial was sealed with a Teflon lined cap and the reaction was heated at 
100ºC for 12 hours. The reaction mixture was filtered through a plug of Celite and then 
evaporated to dryness. The resulting oil was dissolved in methylene chloride and 
extracted with saturated aqueous NaHCO3 (2 x 30 mL) and brine (1 x 30 mL). The 
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organic layer was dried over MgSO4, filtered, and concentrated to afford an orange oil, 
which was purified by chromatography on silica gel (Rf = 0.23 in 96% CH2Cl2/4% ethyl 
acetate). The product 50 was obtained as an orange-brown solid (180 mg, 78% yield); mp 
116-118 ºC. 1H NMR (C6D6): δ 7.52 (s, 1H), 7.23 (d, J = 7.3 Hz, 2H), 7.13-7.06 (multiple 
peaks, 4H), 6.79 (d, J = 8.1 Hz, 1H), 2.59 (t, J = 6.8 Hz, 2H), 1.93 (t, J = 8.0 Hz, 2H), 
1.13-1.06 (m, 2H). 13C{1H} NMR (CDCl3): δ 175.39, 138.49, 137.84, 137.38, 131.89, 
131.26, 130.90, 128.39, 127.93, 127.75, 121.44, 49.77, 30.85, 18.79. Anal. Calcd for 
C16H14BrNO: C, 60.78, H, 4.46, N, 4.43; Found: C, 61.08, H, 4.66, N, 4.19. IR (KBr) 








Substrate 51 (250 mg, 1.47 mmol, 1 equiv), [Ph2I]BF4 (1.08 g, 2.95 mmol, 2 equiv), and 
Pd(OAc)2 (16.5 mg, 0.074 mmol, 5 mol %) were combined in benzene (12 mL) in a 20 
mL vial. The vial was sealed with a Teflon lined cap and the reaction was heated at 
100ºC for 12 hours. The reaction mixture was filtered through a plug of Celite and then 
evaporated to dryness. The resulting oil was dissolved in CH2Cl2 and extracted with 
saturated aqueous NaHCO3 (2 x 30 mL) and brine (1 x 30 mL). The organic layer was 
dried over MgSO4, filtered, and concentrated to afford an orange oil, which was purified 
by chromatography on silica gel (Rf = 0.28 in 55% diethyl ether/45% hexanes). The 
product 52 was obtained as an orange-brown solid (240 mg, 67% yield); mp 125-126 ºC. 
1H NMR (C6D6): δ 9.02 (s, 1H), 7.10-7.05 (multiple peaks, 3H), 6.97-6.95 (m, 2H), 6.91 
(dd, J = 8.2, 2.2 Hz, 1H), 6.75 (d, J = 8.2 Hz, 1H), 6.64 (s, 1H), 1.25 (s, 3H). 13C{1H} 
NMR (CDCl3): δ 167.96, 136.65, 135.27, 133.40, 130.55, 130.19, 128.82, 128.66, 
127.88, 123.94, 121.24, 24.04. Anal. Calcd for C14H12ClNO: C, 68.44, H, 4.92, N, 5.70; 
Found: C, 68.38, H, 4.99, N, 5.47. IR (KBr) 3224, 3026, 1648, 1532 cm–1. 
 
 The regioselectivity of this reaction could not be definitively assigned from the 1H 
NMR spectrum of 52 due to overlapping aromatic resonances. As a result, a deuterated 
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version of this product was prepared by reaction of 51 with [Mes–I–C6D5]BF4 under 
analogous conditions to those described above. The 1H NMR data for the deuterated 
product (52-d5) was as follows: 1H NMR (C6D6): δ 9.02 (br. s, 1H), 6.92 (dd, J = 8.2, 2.1 




Substrate 27 (150 mg, 0.89 mmol, 1 equiv), [Mes–I–p-CH3C6H5]BF4 (489 mg, 1.15 
mmol, 1.3 equiv) and Pd(OAc)2 (10 mg, 0.044 mmol, 5 mol %) were combined in acetic 
acid (8 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the reaction 
was stirred at 100°C for 12 hours.  The reaction mixture was filtered through a plug of 
glass wool and concentrated under vacuum. The resulting oil was dissolved in CH2Cl2 
and extracted with saturated aqueous NaHCO3 (1 x 30 mL). The organic layer was dried 
over MgSO4, filtered, and concentrated to afford an orange oil, which was purified by 
chromatography on silica gel (Rf = 0.25 in 80% hexanes/20% ethyl acetate). The product 
60 was obtained as a white solid (165 mg, 72% yield); mp 73-77 ºC.  1H NMR (d6-
acetone): δ 8.30 (d, J = 3.6 Hz, 1H), 7.48-7.44 (multiple peaks, 2H), 7.39-7.36 (multiple 
peaks, 2H), 7.32-7.30 (m, 1H), 7.10-7.03 (multiple peaks, 3H), 6.96-6.92 (multiple peaks, 
2H), 2.16 (s, 3H), 1.95 (s, 3H). 13C{1H} NMR (d6-acetone): δ 160.12, 147.01, 141.58 
(br), 141.42, 137.95, 136.67 (br), 131.97, 131.13, 130.67, 130.63, 128.35, 127.81, 125.53, 
122.81, 20.74, 19.34. (Several of the 13C NMR peaks of 1h are broad and three are 
missing  – this is believed to be the result of fluxional motion about the aryl-aryl bonds.) 
Anal. Calcd for C18H14FN: C, 87.99, H, 6.61, N, 5.40; Found: C, 88.09, H, 6.51, N, 5.24. 





Substrate 27 (153 mg, 0.91 mmol, 1 equiv), [Mes–I–p-FC6H5]BF4 (446 mg, 1.04 mmol, 
1.15 equiv) and Pd(OAc)2 (10.1 mg, 0.043 mmol, 5 mol %) were combined in acetic acid 
(8 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the reaction was 
stirred at 100°C for 12 hours.  The reaction mixture was filtered through a plug of glass 
wool and concentrated under vacuum. The resulting oil was dissolved in CH2Cl2 and 
extracted with saturated aqueous NaHCO3 (1 x 30 mL). The organic layer was dried over 
MgSO4, filtered, and concentrated to afford an orange oil, which was purified by 
chromatography on silica gel (Rf = 0.3 in 75% hexanes/25% ethyl acetate).  The product 
64 was obtained as a yellow solid (210 mg, 88% yield); mp 135-137 ºC. 1H NMR (d6-
acetone): δ 8.43 (d, J = 4.0 Hz, 1H), 7.57-7.32 (multiple peaks, 5H), 7.22-7.12 (multiple 
peaks, 3H), 6.97-6.93 (m, 2H), 1.77 (s, 3H). 13C{1H} NMR (d6-acetone): δ 162.60 (d, 
1JCF = 243 Hz), 160.15, 147.34, 140.76, 140.35, 138.29 (d, 4JCF = 3.0 Hz), 138.12, 
131.99, 131.82 (d, 3JCF = 7.6 Hz), 130.79, 130.30, 129.07, 128.16, 123.10, 115.35 (d, 2JCF 
= 21 Hz), 18.91.  Anal. Calcd for C18H14FN: C, 82.11, H, 5.36, N, 5.32; Found: C, 81.86, 




Substrate 27 (150 mg, 0.89 mmol, 1 equiv), [Mes–I–p-MeOC6H5]BF4 (449 mg, 1.02 
mmol, 1.1 equiv) and Pd(OAc)2 (10 mg, 0.044 mmol, 5 mol %) were combined in acetic 
acid (8 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the reaction 
was stirred at 120°C for 12 hours.  The reaction mixture was filtered through a plug of 
glass wool and concentrated under vacuum. The resulting oil was dissolved in CH2Cl2 
and extracted with saturated aqueous NaHCO3 (1 x 30 mL). The organic layer was dried 
over MgSO4, filtered, and concentrated to afford an orange oil, which was purified by 
chromatography on silica gel (Rf = 0.20 in 80% hexanes/20% ethyl acetate). The product 
65 was obtained as a clear oil (197 mg, 81% yield); 1H NMR (d6-acetone): δ 8.42 (d, J = 
4.4 Hz, 1H), 7.46-7.28 (multiple peaks, 5H), 7.14-7.11 (m, 1H), 7.02 (d, J = 8.4 Hz, 2H), 
6.70 (d, J = 8.4 Hz, 2H), 3.68 (s, 3H), 1.70 (s, 3H). 13C{1H} NMR (d6-acetone): δ 159.73, 
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158.68, 146.42, 140.22, 139.73, 137.18, 133.40, 131.17, 130.17, 129.94, 129.33, 128.13, 
126.68, 122.12, 113.22, 54.49, 18.09. HRMS (electrospray) [M+] calcd for C19H19NO, 




Substrate 27 (150 mg, 0.89 mmol, 1 equiv), [Mes–I–p-CH3C6H5]BF4 (432 mg, 1.02 
mmol, 1.15 equiv) and Pd(OAc)2 (10 mg, 0.044 mmol, 5 mol %) were combined in acetic 
acid (8 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the reaction 
was stirred at 100°C for 12 hours.  The reaction mixture was filtered through a plug of 
glass wool and concentrated under vacuum. The resulting oil was dissolved in CH2Cl2 
and extracted with saturated aqueous NaHCO3 (1 x 30 mL). The organic layer was dried 
over MgSO4, filtered, and concentrated to afford an orange oil, which was purified by 
chromatography on silica gel (Rf = 0.25 in 80% hexanes/20% ethyl acetate). The product 
66 was obtained as a yellow solid (193 mg, 84% yield); mp 59-62 ºC.  1H NMR (d6-
acetone): δ 8.45 (d, J = 4.4 Hz, 1H), 7.50-7.43 (multiple peaks, 3H), 7.39-7.33 (multiple 
peaks, 2H), 7.15 (t, J = 7.6 Hz, 1H), 7.04-6.98 (multiple peaks, 4H), 2.23 (s, 3H), 1.74 (s, 
3H). 13C{1H} NMR (d6-acetone): δ 159.68, 146.39, 140.49, 139.81, 138.29, 137.15, 
136.14, 131.16, 129.95, 129.43, 128.98, 128.46, 128.13, 126.91, 122.12.  Anal. Calcd for 





Substrate 27 (150 mg, 0.89 mmol, 1 equiv), [Mes–I–p-ClC6H5]BF4 (453 mg, 1.02 mmol, 
1.15 equiv) and Pd(OAc)2 (10 mg, 0.044 mmol, 5 mol %) were combined in acetic acid 
(8 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the reaction was 
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stirred at 100°C for 12 hours.  The reaction mixture was filtered through a plug of glass 
wool and concentrated under vacuum. The resulting oil was dissolved in CH2Cl2 and 
extracted with saturated aqueous NaHCO3 (1 x 30 mL). The organic layer was dried over 
MgSO4, filtered, and concentrated to afford an orange oil, which was purified by 
chromatography on silica gel (Rf = 0.25 in 75% hexanes/25% ethyl acetate). The product 
67 was obtained as a yellow solid (205 mg, 83% yield); mp 106-107 ºC.  1H NMR (d6-
acetone): δ 8.42 (dd, J = 4.8, 1.2 Hz, 1H), 7.55-7.46 (multiple peaks, 3H), 7.43 (dt, J = 
7.5, 0.8 Hz, 1H), 7.38-7.36 (m, 1H), 7.21-7.12 (multiple peaks, 5H), 1.79 (s, 3H). 
13C{1H} NMR (d6-acetone): δ 160.11, 147.48, 140.84, 140.82, 140.25, 138.31, 133.25, 
132.12, 131.71, 130.95, 130.39, 129.25, 128.81, 128.53, 123.27, 19.07. Anal. Calcd for 





Substrate 27 (150 mg, 0.89 mmol, 1 equiv), [Mes–I–p-CF3C6H5]BF4 (466 mg, 0.98 
mmol, 1.1 equiv) and Pd(OAc)2 (10 mg, 0.044 mmol, 5 mol %) were combined in acetic 
acid (8 mL) in a 20 mL vial. The vial was sealed with a Teflon lined cap, and the reaction 
was stirred at 100°C for 12 hours.  The reaction mixture was filtered through a plug of 
glass wool and concentrated under vacuum. The resulting oil was dissolved in CH2Cl2 
and extracted with saturated aqueous NaHCO3 (1 x 30 mL). The organic layer was dried 
over MgSO4, filtered, and concentrated to afford an orange oil, which was purified by 
chromatography on silica gel (Rf = 0.25 in 75% hexanes/25% ethyl acetate). The product 
68 was obtained as a yellow oil (242 mg, 87% yield). 1H NMR (d6-acetone): δ 8.42 (d, J 
= 4.2 Hz, 1H), 7.57-7.53 (multiple peaks, 5H), 7.46-7.40 (multiple peaks, 2H), 7.35 (d, J 
= 8.4 Hz, 2H), 7.18 (dd, J = 8.0 Hz, 7.6 Hz, 1H). 13C{1H} NMR (d6-acetone): δ159.83, 
147.84, 146.27, 140.87, 140.13, 138.42, 132.21, 131.06, 130.76, 130.59, 129.34, 129.08 
(d, J = 32 Hz), 128.99, 125.59 (q, J = 4 Hz), 124.43 (q, 270 Hz), 123.39, 19.08.  Anal. 
Calcd for C18H14FN: C, 72.83, H, 4.50, N, 4.47; Found: C, 72.53, H, 4.60, N, 4.36.  
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Reaction of 27 with Ph–I. Substrate 27 (15.0 mg, 0.09 mmol, 1 equiv), Ph–I (21.7 mg, 
0.11 mmol, 1.20 equiv), and Pd(OAc)2 (1.00 mg, 0.004 mmol, 5 mol %) were combined 
in AcOH (1.04 mL) in a 2 mL vial equipped with a small magnetic stir bar. The vial was 
sealed with a Teflon-lined cap and heated at 100ºC for 12 hr.  The reaction was cooled to 
room temperature and analyzed by gas chromatography, which showed only starting 
material and Ph–I with <1% of product 33. 
 
Reaction of 27 with Ph–OTf. Substrate 27 (15.0 mg, 0.09 mmol, 1 equiv), Ph–OTf (24.1 
mg, 0.11 mmol, 1.20 equiv), and Pd(OAc)2 (1.00 mg, 0.0044 mmol, 5 mol%) were 
combined in AcOH (1.04 mL) in a 2 mL vial equipped with a small magnetic stir bar. 
The vial was sealed with a Teflon-lined cap and heated at 100ºC for 12 hr.  The reaction 
was cooled to room temperature and analyzed by gas chromatography, which showed 
only starting material (27) and Ph–OTf with <1% of product 33. 
 
Reaction of 27 with [Ph2I]BF4 in the Presence of Hg.  Substrate 27 (10.0 mg, 0.059 
mmol, 1 equiv), [Ph2I]BF4 (26.1 mg, 0.071 mmol, 1.20 equiv), and Pd(OAc)2 (0.700 mg, 
0.0031 mmol, 5 mol%) were combined in AcOH (0.50 mL) in a 2 mL vial equipped with 
a small magnetic stir bar. Metallic Hg (>500 equiv) was added to the reaction mixture, 
and the vial was sealed with a Teflon-lined cap and heated at 100ºC for 12 hr.  The 
reaction was cooled to room temperature and analyzed by gas chromatography, which 
revealed quantitative conversion to product 33. SAFETY NOTE: These reactions 
should be handled with extreme caution, as the reaction of excess [Ph2I]BF4 is 
known to generate highly toxic phenyl mercury compounds!41  
 
Reaction of 27 with [Ph2I]BF4 in the Presence of MEHQ.  Substrate 27 (10.0 mg, 
0.059 mmol, 1 equiv), [Ph2I]BF4 (26.1 mg, 0.071 mmol, 1.20 equiv), and Pd(OAc)2 
(0.700 mg, 0.0031 mmol, 5 mol%) were combined in AcOH (0.50 mL) in a 2 mL vial 
equipped with a small magnetic stir bar. MEHQ (1.83 mg, 0.015 mmol, 25 mol%) was 
added to the reaction mixture, and the vial was sealed with a Teflon-lined cap and heated 
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at 100ºC for 12 hr. The reaction was cooled to room temperature and analyzed by gas 
chromatography, which revealed quantitative conversion to product 33. 
 
Reaction of 27 with [Ph2I]BF4 in the Presence of Galvinoxyl. Substrate 27 (10.0mg, 
0.059 mmol, 1 equiv), [Ph2I]BF4 (26.1 mg, 0.071 mmol, 1.20 equiv), and Pd(OAc)2 
(0.700 mg, 0.0031 mmol, 5 mol %) were combined in AcOH (0.50 mL) in a 2 mL vial 
equipped with a small magnetic stir bar. Galvinoxyl (6.23 mg, 0.015 mmol, 25 mol%) 
was added to the reaction mixture, and the vial was sealed with a Teflon-lined cap and 
heated at 100ºC for 12 hr. The reaction was cooled to room temperature and analyzed by 








Synthesis of Palladacycle 72. Substrate 1 (1.07 g, 6.30 mmol, 1.4 equiv), and Pd(OAc)2 
(1.01 g, 4.50 mmol, 1 equiv) were combined in MeOH (63 mL) in a 200 mL flask 
equipped with a magnetic stir bar and stirred at room temperature for 12 hr. The reaction 
mixture was then filtered, and the precipitate was washed with diethyl ether (100 mL), 
collected and dried. The product was obtained as a yellow solid (918 mg, 61% yield). 1H 
NMR (d6-acetone): δ  7.92 (d, J = 5.2 Hz, 2H), 7.42 (d, J = 7.5 Hz, 2H), 7.26 (d, J = 7.5 
Hz, 2H), 6.94 (d, J = 7.4 Hz, 2H), 6.88-6.78 (multiple peaks, 4H), 6.53 (dd, J = 7.6, 2.0 
Hz, 2H), 2.44 (s, 6H), 2.09 (s, 6H).  Anal. Calcd for C28H26N2O4Pd2: C, 50.39, H, 3.93, 
N, 4.20; Found: C, 50.27, H, 3.98, N, 4.10. 
 
Stoichiometric Reaction of 72 with [Ph2I]BF4. Complex 72 (15.0 mg, 0.02 mmol, 1 
equiv), [Ph2I]BF4 (61.1 mg, 0.17 mmol, 3.2 equiv per Pd), and 18 (19.0 mg, 0.11 mmol, 
2.5 equiv per Pd)  were combined in AcOH (0.37 mL) in a 2 mL vial equipped with a 
small magnetic stir bar. The vial was sealed with a Teflon-lined cap and heated at 100ºC 
for 12 hr.  The reaction was cooled to room temperature and analyzed by gas 
chromatography, which showed 90 % yield of 33 (determined relative to an internal 
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standard). Significant quantities of phenylated 18 (product 20) were also observed by GC 
(as expected since an excess of oxidant was utilized). Importantly, when [Ph2I]BF4 was 
replaced with Ph–I or Ph–OTf under otherwise identical conditions <1% of product 33 
was observed by GC. 
 
When the stoichiometric reaction between 72 and [Ph2I]BF4 reaction was conducted in 
the absence of added substrate 18 (under the following conditions: complex 72 (1 equiv, 
0.02 mmol), [Ph2I]BF4 (1.2 equiv per Pd, 0.05 mmol), AcOH (0.37 mL), 12 hr, 100ºC) 
product 33 was obtained in 20% yield (determined relative to an internal standard) as the 
major product detectable by GC analysis. 1H NMR spectroscopy and electrospray mass 
spectrometry revealed a complex mixture of additional high molecular weight organic 
products, and the MS data is consistent with the formation of a mixture of polyphenylated 
momomers and dimers of 27. While the origin of these products and the details of this 
reactivity remains under investigation, we hypothesize that added 18 may act to trap 
reactive cationic palladium species (generated after initial C–C bond forming reductive 
elimination) that may be responsible for producing these polyphenylated products. 
Notably, under catalytic conditions, a large excess of substrate is present relative to 





II. Reactions with Mixed Iodonium Reagents [Ph–I–Ar]BF4 
 
Reaction of 27 with [Ph–I–Ar]BF4. Substrate 27 (10.0 mg, 0.059 mmol, 1 equiv), [Ph–
I–Ar]BF4 (0.071 mmol, 1.20 equiv), and Pd(OAc)2 (0.700 mg, 0.0031 mmol, 5 mol %) 
were combined in AcOH (0.49 mL) in a 2 mL vial equipped with a small magnetic stir 
bar. The vial was sealed with a Teflon-lined cap and heated at 100ºC for 12 hr.  The 
reaction was cooled to room temperature and analyzed by gas chromatography. The 
yields of the products were determined by integration relative to a GC standard (2-
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Palladium-Catalyzed Ligand-Directed Halogenation of Arenes 
 
 
4.1 Background and Significance 
 
Halogenated arenes are widely prevalent in a variety of biologically active 
molecules and pharmaceutical agents (Scheme 1).1 Aryl halides also serve as important 
precursors to organolithium2 and Grignard reagents.3 Furthermore, aryl halides have been 
employed as substrates for nucleophilic aromatic substitution4 and for benzyne 
generation. 5 Additionally, aryl halides have found widespread utility as reactants for a 
variety of cross coupling reactions. As a result of the diverse potential applications of 
aromatic halides, the development of new site selective, chemoselective, and functional 
group tolerant approaches to the synthesis of these molecules remains an important 
challenge. 
 






























Current methods for the synthesis of aryl halides include electrophilic aromatic 
substitution (EAS)6, 7 and directed ortho-lithiation.8 While these transformations have 
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been widely used, they have several disadvantages. First, these reactions in general 
require the use of strong acids (EAS) and bases (directed ortho-lithiation) that might not 
be compatible with many commonly used functional groups. Second, they often lead to a 
mixture of isomeric halogenated products that might be difficult and tedious to separate. 
Additionally, benzylic halogenation and overhalogenation are a very common 
consequence of these methods. Finally, there are significant limitations in the substrate 
scope of these transformations. For example, EAS most commonly requires electron rich 
arenes. Due to the clear limitations of the current methods, the development of new, 
simple and complementary methodologies for the synthesis of halogenated arenes is 
highly desirable. 
Our group has recently developed several palladium-catalyzed methods for the 
chelate-directed oxidative functionalization of C–H bonds using hypervalent iodine(III) 
reagents as terminal oxidants. For example, the reaction of diverse organic substrates 
with PhI(OAc)29-12 or [Ph2I]BF413,14 in conjunction with a PdII catalyst leads to the ligand-
directed conversion of sp2 and sp3 C–H bonds to C–O and C–C bonds, respectively. 
These results suggested the possibility of an analogous Pd-catalyzed transformation for 
the direct conversion of C–H bonds to C–X (X = Cl, Br, I) bonds using electrophilic 
halogenating reagents such as PhICl2 (Scheme 2). We envisioned that such a reaction 
would provide the desired products with complete site selectivity and without the 
requirement for electron rich substrates or strong acids/bases.  
 





CL H+ CL X
C-H Activation Halogenation
(4) (X = Cl, Br, I)  
 
A key step in the proposed palladium-catalyzed directed C–H 
activation/halogenation reactions would require the conversion of the C–Pd bond in 4 to a 
C–X bond in the product (Scheme 1). This transformation is well known to be 
challenging from PdII (and most other metal complexes) because its microscopic reverse 
– the oxidative addition of aryl/vinyl/alkyl halides to Pd0 – is highly thermodynamically 
and kinetically favored relative to the desired reductive elimination reaction. For 
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example, Roy and Hartwig have shown that the Keq for direct reductive elimination of 
haloarenes from PdII ranges from ~10–5 (for Ar–I) to ~10–2 (for Ar–Cl) (Scheme 3).14 
Additionally, the rate constant for the reductive elimination from 5 to form 8 ranges from 
10-4 to10-5 s-1 at 65 °C (Scheme 4). As a result, the desired reaction is not amenable to 
catalysis via a traditional PdII/0 catalytic cycle.15  
 



















(X = Cl; 5)
(X = Br; 6)
(X = I; 7)
(X = Cl; 8)
(X = Br; 9)













(5) (8)  
 
However, recent work from our group has shown that reductive elimination 
reactions from PdIV have very different electronic requirements than those from PdII, 16 
indicating that the desired carbon–halogen coupling could be facile from this oxidation 
state. A number of literature reports further supported the potential viability of this 
approach. For example, van Koten and Elsevier have directly observed transient PdIV 
intermediates in the oxidation of PdII complexes with molecular halogens or PhICl2.17, 18 
As shown in Scheme 5, the reaction of cyclopalladated complex 11 with Cl2 affords the 
PdIV intermediate 12 (Scheme 5), which was moderately stable and could be 
characterized by 1H NMR spectroscopy at room temperature. However, it decomposed 
over time to afford halogenated product 13. While the mechanism of formation of 13 was 
not studied in detail, it presumably involves C–Cl bond forming reductive elimination at 
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PdIV. Elsevier and coworkers reported a similar reaction between the cationic complex 14 
and PhICl2 (Scheme 6). 
 











































van Koten’s research group has also demonstrated that the halogenation of  
cyclopalladated PdII complexes can be achieved using a combination of a non-
halogenating oxidant and a chloride ion source.19 For example, the reaction of complex 
17 with MoO(O2)2•HMPT•H2O leads to the halogenated organic product 18. Notably the 
yield of 18 increases in the presence of (triethyl)(benzyl)ammonium chloride ([TEBA]Cl) 
as the chloride ion source (Scheme 7).  
 



















The mechanism of this reaction is proposed to involve oxidation of 17 to a PdIV 
aryl intermediate 19.  Subsequent attack of the chloride ions on this PdIV-aryl species 






























There have also been reports of stoichiometric iodinations of cyclopalladated 
compounds using I2 as the oxidant. For example, the reaction of 20 with I2 leads to the 
formation of 21 (Scheme 9). The treatment of 21 with 1,10-phenanthroline monohydrate 
releases the organic product.20 
 
























Very recently, our group has demonstrated that N-chlorosuccinimide (NCS) can 
oxidize PdII to PdIV.21 Specifically, we have shown that the reaction of the 
biscyclometallated PdII complex 23 with NCS affords an isolable PdIV complex 24. 
Furthermore, thermolysis of 24 in a variety of solvents cleanly affords the chlorinated 
product 25 via C–Cl bond forming reductive elimination (Scheme 10). 
 
Scheme 10: Stoichiometric Chlorination with NCS 
N N
Pd












(23) (24) (25)  
 
In addition, several groups have reported that intermediates generated upon 
aminopalladation (Scheme 11), oxypalladation (Scheme 12), and halopalladation 
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(Scheme 13) of alkenes at PdII can undergo C–X (X = Cl, Br) bond formation with 
oxidants such as Br2, CuCl2, mixtures of peroxides and halide salts, or PhICl2.22-25 
 





10 mol % Pd(OCOCF3)
CuBr2, K2CO3, THF






 upon aminopalladation  
 










 upon oxypalladation  
 














 upon halopalladation  
 
Based on this precedent, we felt that Pd-catalyzed C–H bond halogenation could 
proceed by a catalytic cycle involving: (i) ligand-directed C–H activation at a PdII 
center,26-29 (ii) oxidation of the resulting palladacycle to PdIV, and (iii) carbon–halogen 
bond-forming reductive elimination to form the desired product and regenerate the 
catalyst (Scheme 14). Importantly, based on the stoichiometric examples described 
above, a variety of electrophilic halogenating reagents such as Cl2, PhICl2, I2, and NCS 
could potentially be used for these reactions. 
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There were a few early reports of palladium-catalyzed chelate-directed 
halogenation of arenes proceeding via the mechanism depicted in Scheme 11 prior to our 
work. Fahey demonstrated that the PdCl2-catalyzed reaction of azobenzene with Cl2 
affords the ortho-chlorinated azobenzene 26-Cl in 8% isolated yield (Scheme 15).30 The 
low yield of 26-Cl in this reaction is partly due to the formation of di-, tri-, and 
tetrachlorinated products 26-Cl2, Iso-26-Cl2, 26-Cl3, and 26-Cl4, respectively. While this 
transformation demonstrated the feasibility of palladium-catalyzed chelate-directed 
halogenation of arenes, it was not applied to the chlorination of other substrates or toward 
the incorporation of other halogens into the products. Additionally, the formation of 
mixtures of products and the use of Cl2 as the oxidant severely limits the practical 
applicability of this reaction.  
 





Cl20 mol % PdCl2 
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Dioxane, 


























In 2001, Kodama and coworkers reported the palladium-catalyzed ortho-
iodination of benzoic acid derivatives using Pd(OAc)2 as the catalyst and N-
iodosuccinimide (NIS) as the terminal oxidant. This methodology was limited to C–I 
bond formation and carboxylic acids as the directing group (Scheme 16).31 
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Scheme 16: Palladium-Catalyzed Iodination of Benzoic Acid Derivatives 
10 mol % Pd(OAc)2 
1 equiv NIS
DMF







(27) (28)  
 
While all the aforementioned examples of palladium-catalyzed ligand-directed 
halogenation of C–H bonds represent a remarkable advancement in the field of site 
selective halogenation of arenes, they are limited with respect to the scope of directing 
groups and substrates. Additionally, none of these methods represent a general method 
for the incorporation of a variety of halogens (Cl, Br, and I) under a similar set of 
reaction conditions.  
More recently Allison Dick, a former member of our group, showed that the 
Pd(OAc)2-catalyzed reaction of benzo[h]quinoline (29) and N-chlorosuccinimide (NCS) 
affords 29-Cl in 95% yield via chelate-directed halogenation of the C–H10 bond (Scheme 
17). In addition, the corresponding brominated product 29-Br could be obtained in 
excellent yield (93%) using NBS as the stoichiometric oxidant. Importantly, these 
reactions showed exclusive selectivity for halogenation of the C–H10 bond proximal to 
the chelating group.12  
 
Scheme 17: Palladium-Catalyzed Halogenation of Benzo[h]quinoline 
N N
NXS
1-2 mol % Pd(OAc)2
XH10
(29)
X = Cl, 29-Cl (95%) 




With these preliminary results from our group, we desired to undertake a 
comprehensive exploration of the palladium-catalyzed ligand-directed C–H 
activation/halogenation reactions. Specifically, we wanted to develop reaction conditions 
that are general with respect to directing groups and arenes and would allow the 
incorporation of diverse (Cl, Br ,and I) halogens into the final products.32, 33  
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4.2 Initial Results 
 
Our initial experimentation revealed that there was no universal set of reaction 
conditions for these transformations, and that varying the solvent (typically between 
MeCN and AcOH), temperature (ranging from 100 – 120 ºC), and oxidant (between NXS 
and CuX2) was necessary in order to obtain the optimal conditions for each substrate. 
Additionally, substrates with different substitution patterns on the aryl ring and with 
different directing groups showed dramatically different reactivities. In general, the 
substrates could be divided into four types (Scheme 18) based on their reactivity in the 
presence and absence of palladium as follows: (i) substrates for which the Pd-catalyzed 
reaction results in chelate-directed halogenation, while the control (without Pd catalyst) 
affords no halogenated products (Type 1), (ii) substrates for which the Pd-catalyzed and 
control reactions afford different halogenated products (Type 2), (iii) substrates for which 
the catalyzed and the uncatalyzed reactions afford the same product or mixtures of 
products (Type 3), and (iv) substrates for which the similarity/difference in reactivity 
between the Pd-catalyzed and control reactions is dictated by the nature of the oxidant 



































































4.3 Type 1 Substrates 
 
Type 1 substrates generally contain electron withdrawing directing groups such as 
pyridines, oxime ethers, isoxazolines, quinolines, and tetrazoles; furthermore, the arene 
ring that undergoes halogenation is typically electron-neutral or electron-deficient 
(containing substituents such as halides, oxime ethers, ketones and aldehydes) and hence 
not activated towards EAS. Substrates containing such structural motifs possess a wide 
range of potential applications. For example, isoxazolines serve as useful precursors to β-
amino acids,34 while pyridines and tetrazoles are important components of diverse drug 
molecules.35 Tetrazole derivatives can also be used as trigger explosives and serve as 
components of mixed propellants.35  
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3-Methyl-2-phenylpyridine (31) represents a prototypical Type 1 substrate. Thus 
palladium-catalyzed halogenation of 31 was studied using a variety of electrophilic 
halogenating reagents in AcOH and MeCN. Under all of the conditions examined, 31 
afforded <5% halogenated products in the absence of the palladium catalyst. In contrast, 
in the presence of Pd(OAc)2, most of the reagents screened afforded significant quantities 
of the ortho-halogenated products 31-Cl, 31-Br, or 31-I. In general, the N-
halosuccinimides proved to be superior oxidants, providing the highest isolated yields of 
31-Cl (65 %), 31-Br (56 %) and 31-I (79 %) (Scheme 19).  
 




1.2 equiv NCS, NBS or NIS
5 mol % Pd(OAc)2
AcOH or MeCN




X = Cl; (31-Cl); 65%
X = Br; (31-Br); 56%
X = I; (31-I); 79%
(31)  
 
Among the other oxidants examined (Table 4.1), a number of notable 
observations were made. Consistent with the C–H activation/acetoxylation reactions 
using PhI(OAc)2 as the terminal oxidant, the use of the analogous iodine(III) reagent 
PhICl2 afforded the desired product 31-Cl, albeit in only 32% yield (Table 4.1, entry 5). 
The low yield of this transformation can most likely be attributed to the instability of 
PhICl2 at the elevated temperatures (100 ºC) utilized for these transformations36 (at room 
temperature no product formed and only unreacted substrate was seen by crude GC). 
Interestingly, neither Br2 nor I2 afforded substantial quantities of halogenated products 
(Table 4.1, entries 11 and 17, respectively), despite the fact that these reagents are highly 
effective for the stoichiometric halogenation of PdII alkyl,37 aryl,30, 38 and vinyl39 species. 
This may be due to the decreased reactivity and/or solubility of PdX2 (presumably formed 
in situ from the reaction of Pd(OAc)2 with halide ions) in these reactions.40 In contrast, 
CuCl2 was an effective reagent for transforming 31 to 31-Cl in 30% GC yield under 
standard conditions (Table 4.1, entry 6). This result is particularly remarkable because 
CuCl2 could potentially be utilized in catalytic quantities with readily available and 
inexpensive dioxygen as the ultimate terminal oxidant.41-44  
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a 2.4 equiv halogenating reagent; b Isolated yields from reactions  
carried out at 120 ºC; c 2 equiv LiX. 
 
A number of other Type 1 substrates were identified, and the results of their Pd-
catalyzed reactions with N-halosuccinimides are summarized in Tables 4.2, 4.3, and 4.4. 
As discussed above, all these substrates afforded <5% of halogenated products in the 
absence of palladium. However, in the presence of the palladium catalyst, the ligand-
directed ortho-halogenated products were obtained in modest to good yields. All of these 
transformations (and those described throughout this chapter) are completely tolerant of 
ambient air and moisture and were typically conducted on the bench-top using 
commercial solvents and reagents. Furthermore, the safe and inexpensive nature of these 
transformations makes them easily scalable, and relatively large-scale reactions (11 to 82 
mmol) typically afforded comparable yields to those carried out with 0.5-1.5 mmol of 
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material. This is exemplified by substrate 33 (Table 4.3), for which Allison Dick has 
shown that reactions performed at 17 mmol and 1.4 mmol scales afforded product 33-Br 
in nearly identical 51% isolated yield. In addition, the use of 1 mol % catalyst afforded 
comparable yields in similar reaction times to 5 mol % Pd(OAc)2; for example, 31-Cl, 
31-Br and 31-I were obtained in 71%, 54%, and 90% GC yields, respectively, after 12 h 
with 1 mol % Pd. Further reduction of the catalyst load (to 0.5 mol %) typically resulted 
in some (~20%) diminishment in yield. The easy and practical scale up along with the 
low catalyst loadings should make these halogenation reactions very attractive for diverse 
applications. 
 
Table 4.2. Palladium-Catalyzed Chlorination of Type 1 Substratesa 































































 Conditions: 5 mol % Pd(OAc)2, 1.2-2.0 equiv NBS, 100-120 ºC, 12 h, MeCN or AcOH. 
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 Conditions: 5 mol % Pd(OAc)2, 1.05-2.1 equiv NIS, 100-120 ºC, 12 h, MeCN or AcOH;  
b3.0 equiv NIS. 
 
 
In reactions of meta-substituted arene substrates 41, which bear two chemically 
inequivalent ortho C–H bonds, the less hindered position was usually halogenated with 
high selectivity (Scheme 20).45 Further, the site selectivity of these reactions was general 
for different directing groups. For example, the reactions of pyridine and oxime ether 

























In naphthyl substituted substrates 43 and 44, Waseem Anani, a former 
undergraduate in our group, demonstrated that the less sterically congested 3’ ortho-C–H 
bond was selectively halogenated, despite the fact that the 1’ position is more 
nucleophilic (Scheme 21). This sensitivity to the steric environment of the arene ring is 
analogous to the Pd-catalyzed C–H activation/functionalization reactions described in 
Chapters 2 and 3.9, 13, 45  
 





1.1 equiv NCS, CH3CN
5 mol % Pd(OAc)2






1.1 equiv NCS, CH3CN
5 mol % Pd(OAc)2






3.0 equiv NIS, CH3CN
5 mol % Pd(OAc)2
100 ºC, 12 h
(60%) (44-I)  
 
C–H activation/halogenation reactions of Type 1 substrates containing two 
readily accessible, chemically equivalent C–H bonds generally led to modest yields of the 
monohalogenated products due to competitive formation of the corresponding 
difunctionalized compounds. Tuning the stoichiometry of the oxidant in these systems 
allowed for the formation of dihalogenated products in good yields. For example, the 
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palladium-catalyzed chlorination of 45 afforded the monochlorinated product 45-Cl in 
57% yield. However, the use of excess oxidant in this reaction afforded the dichlorinated 
product 45-Cl2 in 72% yield (Scheme 22). 
 
Scheme 22: Palladium-Catalyzed Halogenation of 46 
 
(45)
2.5 equiv NCS, CH3CN
5 mol % Pd(OAc)2




1.2 equiv NCS, CH3CN
5 mol % Pd(OAc)2
















Several approaches can be taken to attenuate the extent of dihalogenation in these 
systems if it is not desired. For example, as discussed above, the incorporation of a meta-
substituent generally decreased the formation of dihalogenated side-products, presumably 
by reducing the rate of a second C–H activation at the more sterically hindered site 
(Scheme 20). Additionally, dihalogenation could be minimized in phenylpyridine 
derivatives by placing a substituent at the 3-position of the pyridine moiety (for example, 
substrate 31 in Scheme 19). As shown in Scheme 23, the extent of dihalogenation in 
these systems decreases with increasing size of the halogen on the arene counterpart. This 
is illustrated by the fact that ~35% of the difunctionalized products were formed when 
31-Cl and 31-Br were subjected to forcing reaction conditions (5 mol % Pd(OAc)2, 2 
equiv NXS, AcOH, 120 °C), while only traces (<5%) of the diiodinated product was 
observed in the analogous reaction of 31-I with NIS (Scheme 23). In these systems, the 
unfavorable steric interactions between the ortho-halogen of the mono-functionalized 
arene and the 3-substituent on the pyridine ring make it difficult to achieve coplanarity 
between the aryl rings, which is necessary for the second C–H 
activation/functionalization to occur.46, 47 
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Scheme 23: Effect of the Halogen Size on Dihalogenation 
N
2.0 equiv NXS
5 mol % Pd(OAc)2
AcOH, 120 ºC, 12 h
X
X = Cl; (31-Cl2); ~35%
X = Br; (31-Br2); ~35%




X = Cl; (31-Cl)
X = Br; (31-Br)




4.4 Type II Substrates 
 
Type 2 substrates are generally activated towards EAS and hence undergo 
halogenation in the absence of the Pd catalyst. However, in these cases there is a 
difference in the products favored by the catalyzed reaction versus by electrophilic 
aromatic substitution; therefore, the products obtained with Pd are complementary to 
those obtained in the control reactions. Oxime ether substrate 46 exemplifies this class of 
substrates (Scheme 24).  
 

















Major Product Major Product  
 
The arene ring of 46 is activated at the 3-position toward EAS due to the electron-
donating methoxy substituent. Hence, the major product (Iso-46-X) in these reactions 
without palladium resulted from halogenation ortho to the activated methoxy substituent. 
As shown in Table 5, the reaction of 46 afforded significant quantities of the halogenated 
products with a variety of halogenating reagents both in the presence and absence of the 
palladium catalyst. While the control reactions with NXS in AcOH cleanly afforded the 
3-substituted products Iso-46-X (Table 4.5, entry 1), other oxidants such as PhICl2, 










































































In the presence of 5 mol % Pd(OAc)2, the catalyzed reaction in general out-
competed EAS affording ortho-halogenated compounds 46-Cl, 46-Br, and 46-I as the 
predominant products in most cases. Interestingly, however, the use of the highly reactive 
iodine(III) reagent PhICl2 as the oxidant led solely to the EAS product Iso-46-Cl even in 
the presence of the palladium catalyst. Other oxidants such as Br2 and Chloramine-T 
afforded mixtures of products favoring the desired ligand-directed ortho-halogenated 
isomer with only modest selectivity. Gratifyingly, the palladium-catalyzed reaction of 46 
with N-halosuccinimides (NXS) as the terminal oxidants led to the exclusive formation of 
the desired chelate-directed products in GC yields ranging from 48-87%. Under these 
optimal conditions, the products 46-Cl, 46-Br and 46-I were isolated in 58%, 72% and 
46% yields respectively. 
Similar results were observed in analogous Type 2 substrates with different 
directing groups. For example, 3-methyl-2-(4-methoxyphenyl)pyridine (47) afforded 47-
Cl in 76% isolated yield in the Pd-catalyzed reaction, while only Iso-47-Cl was obtained 
in the control (Scheme 25).  
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Scheme 25: Catalyzed versus Uncatalyzed Chlorination of 47 
1.1 equiv NCS
CH3CN, 100 °C















Substrate 48, which contains a methoxy substituent on the ring of the pyridine 
directing group, showed comparable behavior (Scheme 26). In the absence of Pd, a 
mixture of regioisomeric products was obtained with Cl incorporated ortho (Iso-48-Cl-
ortho) and para (Iso-48-Cl-para) to the methoxy substituent on the electron rich pyridine 
ring. However, in the presence of 20 mol % Pd(OAc)2, the directed chlorination product 
48-Cl was obtained cleanly in 71% yield (Scheme 26). 
 


























Other substrates that fall into Type 2 are those containing the heterocyclic 
directing groups isoquinoline (49) and pyrazole (50) (Scheme 27). Without added 
palladium, these substrates underwent chlorination on the heterocyclic ring; however, in 
the presence of 5 mol % Pd(OAc)2, Pd-catalyzed directed C–H activation/chlorination 
out-competed EAS, and the ortho-chlorinated products 49-Cl and 50-Cl were obtained in 




Scheme 27: Chlorination of Substrates 49 and 50 
2.0 equiv NCS
AcOH, 100 °C





























Another Type 2 substrate is the oxime ether 51 (Scheme 28). The 2º benzylic 
position of 51 is highly activated towards benzylic halogenation with NCS or NBS, and, 
in the absence of Pd-catalyst, the benzylic halides Iso-51-Cl and Iso-51-Br were obtained 
as the major products (albeit in modest yields – Scheme 28). However, in the Pd-
catalyzed process, chelate-directed halogenation was fast relative to benzylic oxidation, 
and haloarenes 51-Cl and 51-Br were obtained in 88% and 62% isolated yields, 
respectively.  
 
Scheme 28: Chelate-Directed versus Benzylic Halogenation  
1.05 equiv NCS
CH3CN, 100 °C


































A final Type 2 compound is the meta-substituted oxime ether 52 which possesses 
three potential sites for directed C–H activation (Scheme 29). In contrast to the substrates 
discussed in section 4.3 above, 52 underwent Pd-catalyzed chlorination with high (>20:1) 
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selectivity for the more hindered 2-position of the arene. This may be the result of the 
cooperative coordination of both the amide and the oxime directing groups to the Pd-
center during the C–H activation step of this reaction.9 However, the reaction of 52 with 
NCS in the absence of palladium afforded a complex mixture of isomeric chlorinated 
products.  
 




















4.5 Type 3 Substrates 
Type 3 substrates are activated towards EAS at the same position (in the 
molecule) as the palladium-catalyzed ligand-directed halogenation reactions. As such, 
these compounds favor the same product or mixtures of products both in the presence and 
absence of palladium. Hence, unless otherwise noted, the use of a palladium catalyst 
offers no significant advantage in terms of the yield, purity or selectivity of reactions with 
these substrates. For example, 53, containing a highly electron donating arene substituent 
(e.g., OMe) at the position meta- to the directing group, is a representative member of 
this type. In this compound, both the catalyzed and the uncatalyzed processes afforded 
halogenation para to the substituent. Thus, the use of a palladium catalyst was not 
necessary to obtain the “chelate-directed” ortho-halogenated product 53-Cl in high yields 
(Scheme 30).  
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Azobenzene 54 also falls under Type 3, as both the catalyzed and the uncatalyzed 
reactions afford the ortho-iodinated product 54-I as the major product (Scheme 31). 
However, in this case the use of palladium affords the desired chelate directed product in 
higher yields because the reaction in the absence of palladium affords a 4:1 mixture of 
isomeric iodinated products. Similarly, the reaction of pivalamide 55 with NCS afforded 
significant quantities of the ortho-chlorinated product 55-Cl with or without palladium 
(Scheme 31). However, in this case, the catalyzed reaction provided 55-Cl in higher yield 
and selectivity, as it suppressed formation of dichlorinated side-products, which were 
produced in ~50% yield in the control reaction. Thus for substrates 54 and 55, the 
addition of Pd could be advantageous for applications where high material throughput 
and facile isolation/purification steps are necessary. 
 
Scheme 31: Halogenation of Substrates 54 and 55 
1.01 equiv NCS
CH3CN, 100 °C






































Type 3 substrates are not limited to those undergoing arene C–H 
functionalization. For example, Waseem Anani demonstrated that 8-methylquinoline (56) 
reacts with NCS to afford the benzylic chloride 56-Cl with or without palladium (Scheme 
32). However, interestingly, with CuCl2 as the oxidant, this product is formed only in the 
Pd-catalyzed transformation, and not in the control. Hence, 56 represents a Type 3 
substrate with NCS while it is a Type 1 substrate with CuCl2. 
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4.6 Type 4 Substrates 
Type 4 substrates are those in which there is a delicate balance between the 
catalyzed and uncatalyzed processes, such that the nature of the oxidant dictates which 
product predominates. In general, the chlorination of Type 4 substrates with NCS was 
most amenable to palladium catalysis, and they typically reacted to form different major 
mono-chlorinated products in Pd-catalyzed versus control reactions. In contrast, 
halogenating reagents such as NIS generally afforded identical results with and without 
Pd.  
This Type 4 behavior is clearly illustrated by the reactivity profile of 
pyrrolidinone substrate 57 (Table 4.6). As shown in Table 4.6, the control reaction with 
NCS afforded an approximately 1:1 mixture of ortho and para-chlorinated products (57-
Cl and Iso-57-Cl, respectively), while the ortho-chlorinated product 57-Cl predominated 
in the Pd-catalyzed reaction. In contrast, the reaction of 57 with NBS provided a mixture 
of ortho and para brominated products 57-Br and Iso-57-Br both in the presence and 
absence of palladium. Finally, the reaction of 57 with NIS afforded exclusively the para 




















































































 1.5-1.8 equiv NXS, 100 ºC, 12 h, AcOH; bUncorrected yields as determined by GC and GCMS. 
 
Similarly, control reactions of pyrrolidinones 58, 59 and 60 (Table 4.7) as well as 
the acetanilide 61 with NCS afforded a mixture of chlorinated products, while the 
analogous Pd-catalyzed reactions afforded 58-Cl, 59-Cl, 60-Cl and 61-Cl in 58%, 77%, 
81%, and 70% isolated yields respectively, along with only traces of the undesired 
isomeric products. Again, the corresponding bromination reactions of 58 and 59 afforded 
approximately 3:1-4:1 mixture of regioisomeric brominated products both in the presence 


















































































(Iso-58-Cl, <5%) (58-Cl, 45%)b (Iso-58-Cl, 41%)b
N
OBr



















































The reactivity of Type 4 substrates represents a competition between the 
palladium-catalyzed reaction and electrophilic aromatic substitution. The results in 
Tables 4.6 and 4.7 suggest that changing the oxidants alters the relative rates of the 
catalyzed and the uncatalyzed processes. Current efforts in our group are directed 
towards delineating the effect of the oxidants on the relative contributions of the 
catalyzed and the noncatalyzed reaction pathways.  
 
 
4.7 Subsequent Examples 
 
Subsequent to the preliminary communication from our group, Yu and coworkers 
demonstrated that oxazolines can serve as efficient directing groups for the Pd-catalyzed 
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C–H activation/iodination of sp3 C–H bonds using I2 as the electrophilic iodinating 
reagent in conjunction with stoichiometric amounts of PhI(OAc)2 (Scheme 33).48-50 The 
authors believe that PhI(OAc)2 serves as the source of the acetate to regenerate the 
Pd(OAc)2 catalyst in these reactions. In general, these reactions were selective for the 
iodination of primary over secondary C–H bonds. Additionally the efficiency of these 
transformations was very sensitive to the size of the substituent at the 4-position of the 
oxazoline moiety. The yields of the iodinated products decreased when the t-butyl group 
was replaced with relatively smaller Ph, i-Pr or Me groups.  
 











H 10 mol % Pd(OAc)2 






Concurrent with our work, Shi and coworkers reported the palladium-catalyzed 
chelate-directed halogenation of acetanilide derivatives using CuX2 (X= Cl, Br) as the 
oxidant in conjunction with stoichiometric quantities of Cu(OAc)2 (Scheme 34). This 
methodology was very sensitive to the nature of the nitrogen protecting group. The 
desired halogenated product was only obtained with N-acetyl, N-pivolyl and N-(3’-
phenylpropionyl) amides. Substrates bearing formyl, benzoyl, tosyl, and trifluoroacetyl 
protecting groups exhibited low reactivity. Furthermore, the yield of the chlorinated 
product diminished significantly with decreasing electron density on the arene.  
 






10 mol % Pd(OAc)2
2 equiv Cu(OAc)2
2 equiv CuCl2
 DCE, 80 °C








In summary, we have conducted the first detailed exploration of palladium-
catalyzed chelate-directed chlorination, bromination, and iodination of arenes using N-
halosuccinimides as terminal oxidants. Preliminary results demonstrate that the 
halogenation of benzylic sp3 C–H bonds can also be achieved using this methodology. 
These reactions were generally tolerant of a variety of functional groups and showed 
wide scope with respect to directing groups. Furthermore, the reactivity trends of the 
various compounds greatly depended on the substitution pattern/electronics of the 
substrate as well as the ligand abilities of the directing group. Hence, the products 
obtained from these reactions are often different from and highly complementary to those 
obtained via traditional methods, such as electrophilic aromatic substitution and benzylic 
halogenation. The broad scope and often orthogonal nature of these Pd-catalyzed 
halogenation reactions should make them a valuable synthetic tool for accessing a more 
diverse array of halogenated organic molecules.  
 
4.9 Experimental Procedure 
 
General: NMR spectra were obtained on a Varian Inova 500 (499.90 MHz for 
1H; 125.70 MHz for 13C), a Varian Inova 400 (399.96 MHz for 1H; 100.57 MHz for 13C; 
376.34 MHz for 19F), or a Varian Mercury 300 (300.07 MHz for 1H NMR, 75.45 MHz 
for 13C; 282.35 MHz for 19F) spectrometer. 1H and 13C NMR chemical shifts are reported 
in parts per million (ppm) relative to TMS, with the residual solvent peak used as an 
internal reference. Multiplicities are reported as follows: singlet (s), doublet (d), doublet 
of doublets (dd), doublet of doublets of doublets (ddd), doublet of triplets (dt), triplet (t), 
triplet of doublets (td), triplet of triplets (tt), quartet (q), quintet (quin), multiplet (m), and 
broad resonance (br). IR spectra were obtained on a Perkin-Elmer Spectrum BX FT-IR 
spectrometer. Melting points were determined with a Mel-Temp 3.0, a Laboratory 
Devices Inc, USA instrument and are uncorrected. HRMS data were obtained on a 
Micromass AutoSpec Ultima Magnetic Sector mass spectrometer. Gas Chromatography 
was performed on a Shimadzu GC-17A equipped with a Restek Rtx©-5 column (15m, 
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0.25 mm 1D, 0.25 µm df) and a FID detector. GC yields are reported as corrected GC 
yields based on a calibration curve against naphthalene as an internal standard. Typical 
errors associated with GC yields is approximately +/- 5%. GCMS analysis was performed 
on a Shimadzu GCMS QP-5000 equipped with a Restek Rtx©-5 column (30m, 0.25 mm 
1D, 0.25 µm df). Reactions with CuCl2 were not conducive to GC analysis directly from 
the crude reaction mixture because a large amount of the desired product remained 
coordinated to the copper. To correct for this, pyridine was added to each crude reaction 
mixture (1/2 the total volume of the reaction for small scale screenings) to liberate the 
product prior to GC analysis. 
Materials and Methods: All reactions were performed with magnetic stirring in 
scintillation vials or thick-walled glass pressure-resistant vessels sealed with a Teflon 
bushing. Reaction product solutions and chromatography fractions were concentrated by 
rotary evaporation and then at ca. 10 mtorr (vacuum pump). Flash chromatography was 
performed on EM Science silica gel 60 (0.040–0.063 mm particle size, 230–400 mesh) 
and thin layer chromatography was performed on Merck TLC plates pre-coated with 
silica gel 60 F254.Pyridine substrates 31, 36, 37, 43, 44, 47, 48, 49 and 52 were prepared 
by Suzuki coupling of the corresponding arylboronic acid with 2-bromo-3-picoline, 2-
bromopyridine, or 1-chloroisoquinoline.51 Substrates 33, 34 and 35 were prepared by 
Stille coupling of 2-tributylpyridyltin with the corresponding aryl bromides.52 Oxime 
substrates 39, 46, 51, and 52 were prepared as previously reported,11 and tetrazole53 and 
azobenzene54 substrates 38 and 54 were prepared according to literature procedures. 
Amide substrates 57-60 was synthesized via arylation of the corresponding lactams.55, 
56 The remainder of the substrates were obtained from commercial sources (typically 
Acros Organics, Aldrich, or Lancaster) and were used without further purification. 
Pd(OAc)2 was obtained from Pressure Chemical and used as received. NCS and NBS 
were obtained from Acros, while NIS was obtained from Oakwood Products, and all 
were used without further purification. Solvents were obtained from Fisher Chemical and 
used as received.  
 
General Procedure for Palladium-Catalyzed Halogenationn of C–H bonds: 
Procedure A. Substrate, oxidant, and Pd(OAc)2 were combined in a 20 mL vial or a 
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larger pressure vessel. Solvent was added, the vial was sealed with a Teflon lined cap, 
and the mixture was heated at 100 ºC (unless otherwise noted) for 12 h. The solvent was 
removed under vacuum, and the resulting residues were purified by chromatography on 
silica gel. 
 
Procedure B. Substrate, oxidant, and Pd(OAc)2 were combined in a 20 mL vial. Solvent 
was added, the vial was sealed with a Teflon lined cap, and the mixture was heated at 100 
ºC (unless otherwise noted) for 12 h. The reaction mixture was then diluted with CH2Cl2 
(10 mL). An aqueous solution of Na2CO3 (10 mL) was then added dropwise to this 
mixture until the effervescence ceased. The organic and aqueous layers were separated. 
The aqueous layer was washed with CH2Cl2 (3 x 15 mL). The combined organic layers 
were dried over MgSO4, filtered and concentrated. The crude product was then purified 
by chromatography on silica gel. 
 
Procedure C. Substrate, oxidant, and Pd(OAc)2 were combined in a 20 mL vial. Solvent 
was added, the vial was sealed with a Teflon lined cap, and the mixture was heated at 100 
ºC (unless otherwise noted) for 12 h. The solvent was removed under vacuum. The crude 
residue was dissolved in CH2Cl2 (15 mL) and washed with NaHCO3 (1 x 15mL). The 
aqueous layer was washed with CH2Cl2 (2 x 15 mL). The combined organic layers were 
dried over MgSO4, filtered, and then concentrated. The resulting oil was purified by 
chromatography on silica gel. 
 
Procedure D. A solution of the oxidant in the reaction solvent was added slowly with 
stirring to a solution of the substrate in the same solvent. The resulting mixture was 
stirred at room temperature for 1 h, then the solvent was evaporated. The crude residue 
was extracted between CH2Cl2 and H2O to remove the succinimide byproduct. The 
organic layer was washed with brine, filtered, and concentrated to afford the product. 
 
Procedure E. The substrate and CuX2 were dissolved in MeCN and heated to 120 oC for 
12 h. After evaporation of the solvent, the resulting material was taken up in CH2Cl2 and 
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washed several times with an equal volume of a solution of 5% pyridine in water, until 
the aqueous layer was no longer a bright blue color. The organic layer was then washed 
with brine, dried with MgSO4, filtered and condensed to give the crude product, liberated 
from most of the copper oxidant. 
Procedure F. Substrate, oxidant, and Pd(OAc)2 were combined in a 20 mL vial. Solvent 
was added, the vial was sealed with a Teflon lined cap, and the mixture was heated at 100 
ºC for 12 h. The solvent was removed under vacuum. The crude residue was dissolved in 
CH2Cl2 (15 mL) and washed with a solution of 5% pyridine in water (3 x 15mL) 
followed by washing with brine (1 x 15 mL). The combined organic layers were dried 
over MgSO4, filtered, and then concentrated. The resulting oil was purified by 
chromatography on silica gel. 
N
Cl  
Substrate 31 (100 mg, 0.591 mmol, 1 equiv), NCS (86.8 mg, 0.650 mmol, 1.10 equiv), 
and Pd(OAc)2 (6.6 mg, 0.029 mmol, 5 mol %) were combined in a 20 mL vial. AcOH 
(4.9 mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was 
heated at 120 ºC for 12 h. The solvent was removed under vacuum. The crude product 
was dissolved in CH2Cl2, filtered through a pad of silica and washed with a 50/50 mixture 
of hexanes/ethyl acetate (300 mL). The filtrate was concentrated and the resulting oil was 
purified by chromatography on silica gel (Rf = 0.3 in 5% EtOAc/95% CH2Cl2). Product 
31-Cl was isolated as a clear oil (78 mg, 65% yield). 1H NMR (400 MHz, CDCl3): δ 8.53 
(d, J = 4.8 Hz, 1H), 7.60 (d, J = 7.7 Hz, 1H), 7.48-7.46 (m, 1H), 7.36-7.30 (multiple 
peaks, 3H), 7.26-7.23 (m, 1H), 2.17 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 157.03, 
146.61, 139.35, 137.85, 132.75, 132.23, 130.38, 129.47, 129.39, 126.90, 122.90, 18.77. 





Substrate 31 (100 mg, 0.591 mmol, 1 equiv), NBS (126 mg, 0.709 mmol, 1.20 equiv), 
and Pd(OAc)2 (6.6 mg, 0.029 mmol, 5 mol%) were combined in a 20 mL vial. AcOH (4.9 
mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was heated 
at 120 ºC for 12 h. The solvent was removed under vacuum. The crude product was 
dissolved in CH2Cl2, filtered through a pad of silica and washed with a 50/50 mixture of 
hexanes/ethyl acetate (300 mL). The filtrate was concentrated and the resulting oil was 
purified by chromatography on silica gel (Rf = 0.3 in 5% EtOAc/95% CH2Cl2). Product 
31-Br was isolated as a clear oil (82 mg, 56% yield). 1H NMR (500 MHz, CDCl3): δ 8.53 
(d, J = 4.8 Hz, 1H), 7.66 (d, J = 8.0 Hz, 1H), 7.60 (d, J = 7.7 Hz, 1H), 7.40 (td, J = 7.5, 
1.2 Hz, 1H), 7.31-7.24 (multiple peaks, 3H), 2.15 (s, 3H). 13C NMR (100 MHz, CDCl3): 
δ 158.47, 146.58, 141.41, 137.79, 132.59, 131.83, 130.20, 129.46, 127.46, 122.91, 
122.51, 18.88. Anal. Calcd for C12H10BrN: C, 58.09, H, 4.06, N, 5.65; Found: C, 58.29, 




Substrate 31 (50.0 mg, 0.295 mmol, 1 equiv), NIS (79.8 mg, 0.354 mmol, 1.20 equiv), 
and Pd(OAc)2 (3.3 mg, 0.015 mmol, 5 mol %) were combined in a 20 mL vial. CH3CN 
(2.5 mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was 
heated at 100 ºC for 12 h. The solvent was removed under vacuum. The crude product 
was dissolved in CH2Cl2, filtered through a pad of silica and washed with a 50/50 mixture 
of hexanes/ethyl acetate (150 mL). The filtrate was concentrated and the resulting oil was 
purified by chromatography on silica gel (Rf = 0.3 in 5% EtOAc/95% CH2Cl2). Product 
31-I was isolated as a clear oil (69 mg, 79% yield). 1H NMR (500 MHz, CDCl3): δ 8.54-
8.52 (m, 1H), 7.93 (ddd, J = 8.0, 1.2, 0.38 Hz, 1H), 7.60 (ddd, J = 7.7, 1.6, 0.71 Hz, 1H), 
7.43 (td, J = 7.5, 1.2 Hz, 1H), 7.27-7.24 (multiple peaks, 2H), 7.09 (td, J = 7.7, 1.7 Hz, 
1H), 2.13 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 160.90, 146.59, 145.25, 138.93, 
137.93, 131.29, 129.39, 129.17, 128.22, 122.99, 97.63, 19.09. Anal. Calcd for C12H10IN: 





Substrate 32 (206 mg, 1.33 mmol, 1 equiv), NCS (213 mg, 1.59 mmol, 1.20 equiv), and 
Pd(OAc)2 (14.9 mg, 0.066 mmol, 5 mol %) were combined in a 20 mL vial. CH3CN (8.6 
mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was heated 
at 100 ºC for 12 h. The solvent was removed under vacuum. The crude product was 
dissolved in CH2Cl2, filtered through a pad of celite and washed with copius CH2Cl2. The 
filtrate was concentrated and the resulting oil was purified by chromatography on silica 
gel (Rf = 0.32 in 10% EtOAc/90% hexanes). Product 32-Cl was isolated as a clear oil 
(138 mg, 55% yield). 1H NMR (400 MHz, CDCl3): δ 8.69 (d, J = 5.6 Hz, 1H), 7.73 (td, J 
= 7.6, 2.0 Hz, 1H), 7.61 (d, J = 8.0 Hz, 1H), 7.56 (dd, J = 7.2, 2.0 Hz, 1H), 7.44 (dd, J = 




Substrate 33 (204 mg, 1.20 mmol, 1 equiv), NCS (193 mg, 1.40 mmol, 1.20 equiv), and 
Pd(OAc)2 (13.5 mg, 0.060 mmol, 5 mol %) were combined in a 20 mL vial. CH3CN (7.8 
mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was heated 
at 120 ºC for 12 h. The solvent was removed under vacuum and the resulting oil was 
purified by chromatography on silica gel (Rf = 0.2 in 10% EtOAc/90% hexanes). Product 
33-Cl was isolated as a clear oil (154 mg, 63% yield). 1H NMR (400 MHz, CDCl3): δ 
8.72 (ddd, J = 4.8, 1.6, 0.8 Hz, 1H), 7.75 (td, J = 7.6, 1.6 Hz, 1H), 7.65 (dt, J = 8.0, 0.8 
Hz, 1H), 7.42 (d, J = 2.0 Hz, 1H), 7.35 (d, J = 8.0 Hz, 1H), 7.28 (ddd, J = 7.6, 4.8, 1.2 
Hz, 1H), 7.14 (dd, J = 8.4, 2.4 Hz, 1H), 2.37 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 
156.91, 149.46, 138.68, 136.87, 135.72, 132.05, 130.30, 129.78, 128.94, 124.88, 122.26, 








Substrate 34 (202 mg, 1.00 mmol, 1 equiv), NCS (247 mg, 1.80 mmol, 1.80 equiv), and 
Pd(OAc)2 (11.5 mg, 0.051 mmol, 5 mol %) were combined in a 20 mL vial. CH3CN (6.6 
mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was heated 
at 120 ºC for 12 h. The solvent was removed under vacuum and the resulting oil was 
purified by chromatography on silica gel (Rf = 0.12 in 20% EtOAc/80% hexanes). 
Product 34-Cl was isolated as a clear oil (78 mg, 30% yield). 1H NMR (400 MHz, 
CDCl3): δ 8.74 (ddd, J = 5.2, 2.0, 1.2 Hz, 1H), 8.16 (d, J = 1.2 Hz, 1H), 7.92 (dd, J = 8.4, 
2.0 Hz, 1H), 7.78 (td, J = 7.6, 2.0 Hz, 1H), 7.65 (dt, J = 8.0, 0.8 Hz, 1H), 7.56 (d, J = 8.8 
Hz, 1H), 7.32 (ddd, J = 7.6, 5.2, 1.6 Hz, 1H),  2.61 (s, 3H). 13C NMR (100 MHz, CDCl3): 
δ 196.99, 156.09, 149.91, 139.60, 137.49, 136.29, 136.06, 131.96, 130.75, 129.16, 






Substrate 35 (199 mg, 0.890 mmol, 1 equiv), NCS (239 mg, 1.70 mmol, 2.0 equiv), and 
Pd(OAc)2 (10.0 mg, 0.044 mmol, 5 mol %) were combined in a 20 mL vial. AcOH (5.8 
mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was stirred 
at 120 ºC for 12 h. The solvent was removed under vacuum, and the resulting crude 
material was purified by chromatography on silica gel (Rf = 0.28 in 8% EtOAc/92% 
hexanes). Product 35-Cl was isolated as a tan oil (94 mg, 41% yield). 1H NMR (400 
MHz, acetone-d6): δ 8.49 (ddd, J = 4.8, 1.6, 0.8 Hz, 1H), 7.97 (br s, 1H), 7.23 (dt, J = 7.6, 
0.8 Hz, 1H), 7.05 (td, J = 8.0, 2.0 Hz, 1H), 6.99-6.97 (multiple peaks, 2H), 6.62 (ddd, J = 







Substrate 35 (150 mg, 0.672 mmol, 1 equiv), NBS (239 mg, 1.344 mmol, 2.0 equiv), and 
Pd(OAc)2 (7.5 mg, 0.034 mmol, 5 mol %) were combined in a 20 mL vial. AcOH (5.6 
mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was stirred 
at 120 ºC for 12 h. The solvent was removed under vacuum, and the resulting crude 
material was purified by chromatography on silica gel (Rf = 0.23 in 5% EtOAc/95% 
hexanes). Product 35-Br was isolated as a tan oil (128 mg, 63% yield). 1H NMR (500 
MHz, acetone-d6): δ 8.73 (ddd, J = 4.5, 1.5, 1.0 Hz, 1H), 8.00 (d, J = 8.5 Hz, 1H), 7.95 
(td, J = 8.0, 1.5 Hz, 1H), 7.88 (d, J = 2.0 Hz, 1H), 7.76 (dt, J = 8.0, 1.0 Hz, 1H), 7.71 
(ddd, J = 8.0, 2.5, 0.5 Hz, 1H), 7.47 (ddd, J = 7.5, 5.0, 1.0 Hz, 1H). 13C NMR (75 MHz, 
CDCl3): δ 156.68, 149.48, 141.73, 136.18, 133.94, 130.00 (q, 2JC-F = 33 Hz), 128.32 (q, 
3JC-F = 4 Hz), 126.19 (q, 3JC-F = 4 Hz), 125.68 (q, 4JC-F = 1 Hz), 124.68, 123.68 (q, 1JC-F = 
273 Hz), 123.02. 19F NMR (376 MHz, CDCl3): δ –62.67. Anal. Calcd for C12H7BrF3N: 




Procedure A was followed at 120 °C, utilizing substrate 33 (201 mg, 1.20 mmol, 1 
equiv), NBS (254 mg, 1.40 mmol, 1.2 equiv), Pd(OAc)2 (13.3 mg, 0.06 mmol, 5 mol %), 
and CH3CN (7.7 mL). Product 33-Br was isolated as a clear oil (151 mg, 51% yield, Rf = 
0.10 in 95% hexanes/5% EtOAc). 1H NMR (400 MHz, CDCl3): δ 8.71 (d, J = 4.9 Hz, 
1H), 7.75 (td, J = 7.6, 1.8 Hz, 1H), 7.61 (d, J = 7.9 Hz, 1H), 7.54 (d, J = 8.1 Hz, 1H), 
7.36 (d, J = 2.3 Hz, 1H), 7.29 (ddd, J = 7.5, 4.9, 1.2 Hz, 1H), 7.07 (dd, J = 8.1, 2.3 Hz, 
1H), 2.35 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 158.3, 149.3, 140.8, 137.5, 135.7, 
132.9, 132.1, 130.5, 124.8, 122.3, 118.3, 20.8. Anal. Calcd for C12H10BrN: C, 58.09, H, 





Procedure A was followed at 120 °C, utilizing substrate 32 (2.17 g, 14.0 mmol, 1 equiv), 
NBS (2.99 g, 16.8 mmol, 1.2 equiv), Pd(OAc)2 (156 mg, 0.70 mmol),  and CH3CN (200 
mL). Product 32-Br was isolated as a yellow oil (2.07 g, 63% yield, Rf = 0.05 in 95% 
hexanes/5% EtOAc). 1H NMR (500 MHz, CDCl3): δ 8.72 (ddd, J = 5.0, 1.5, 1.0 Hz, 1H), 
7.77 (td, J = 8.0, 2.0 Hz, 1H), 7.68 (dd, J = 8.0, 1.5 Hz, 1H), 7.61 (dt, J = 8.0, 1.0 Hz, 
1H), 7.54 (dd, J = 7.5, 1.5 Hz, 1H), 7.41 (dt, J = 7.5, 1.5 Hz, 1H), 7.30 (ddd, J = 7.5, 5.0, 
1.0 Hz, 1H), 7.27-7.24 (m (obscured by solvent), 1H). 13C NMR (75 MHz, CDCl3): δ 
158.4, 149.5, 141.3, 135.9, 133.3, 131.5, 129.8, 127.6, 124.8, 122.5, 121.8. HRMS EI 





Substrate 36 (150 mg, 0.801 mmol, 1 equiv), NIS (216 mg, 0.961 mmol, 1.20 equiv), and 
Pd(OAc)2 (9.0 mg, 0.040 mmol, 5 mol %) were combined in a 20 mL vial. AcOH (6.7 
mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was heated 
at 100 ºC for 12 h. The solvent was removed under vacuum. The crude product was 
dissolved in CH2Cl2, filtered through a pad of silica and washed with a 50/50 mixture of 
hexanes/ethyl acetate (300 mL). The filtrate was concentrated and the resulting solid was 
purified by chromatography on silica gel (Rf = 0.3 in 5% EtOAc/95% CH2Cl2). Product 
36-I was isolated as a clear oil (175 mg, 70% yield). 1H NMR (500 MHz, CDCl3): δ 8.52 
(d, J = 4.8 Hz, 1H), 7.66 (dd, J = 8.1, 2.5 Hz, 1H), 7.60 (d, J = 7.7 Hz, 1H), 7.27-7.21 
(multiple peaks, 2H), 7.16 (td, J = 8.2, 2.5 Hz, 1H), 2.12 (s, 3H). 13C NMR (100 MHz, 
CDCl3): δ 161.47 (d, 1JC-F = 251 Hz), 159.98, 146.62, 141.47, 138.11, 131.63, 130.03 (d, 
3JC-F = 7.4 Hz), 125.89 (d, 2JC-F = 24 Hz), 123.21, 115.45 (d, 2JC-F = 21 Hz), 97.15 (d, 3JC-
F = 8.0 Hz), 19.10. 19F NMR (376 MHz, CDCl3): d  –112.77. Anal. Calcd for C12H9FIN: 






Procedure B was followed, utilizing substrate 37 (150 mg, 0.633 mmol, 1 equiv), NIS 
(171 mg, 0.759 mmol, 1.2 equiv), Pd(OAc)2 (7.1 mg, 0.032 mmol, 5 mol %) and CH3CN 
(5.3 mL). Product 37-I was isolated as a light yellow viscous oil with gradient elution 
from 100% CH2Cl2 to 95% CH2Cl2/5% EtOAc (179 mg, 78% yield, Rf = 0.22 in 
CH2Cl2). 1H NMR (400 MHz, CDCl3): δ 8.55 (d, J = 3.6 Hz, 1H), 8.19 (s, 1H), 7.71 (d, J 
= 6.0 Hz, 1H), 7.64 (d, J = 6.4 Hz, 1H), 7.38 (d, J = 6.4 Hz, 1H), 7.30 (dd, J = 6.2, 3.8 
Hz, 1H), 2.13 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 159.7, 148.9, 146.8, 138.1, 135.8 
(q, JCF = 4.4 Hz), 131.4 (q, JCF = 33 Hz), 131.1, 129.5, 125.2 (q, JCF = 3.6 Hz), 123.5, 
122.8 (q, JCF = 272 Hz), 97.5, 18.9. 19F NMR (376 MHz, CDCl3): δ –62.7 (s). Anal. 





Procedure A was followed, utilizing substrate 32 (150 mg, 0.966 mmol, 1 equiv), NIS 
(457 mg, 2.03 mmol, 2.1 equiv), Pd(OAc)2 (10.8 mg, 0.048 mmol, 5 mol %), and AcOH 
(8.1 mL). Product 32-I2 was isolated as a light brown solid (162 mg, 41% yield, mp = 
122.7-124.2 ºC, Rf = 0.29 in 90% hexanes/10% EtOAc). 1H NMR (500 MHz, CDCl3): δ 
8.76 (d, J = 4.5 Hz, 1H), 7.93 (d, J = 8 Hz, 2H), 7.83 (t, J = 8 Hz, 1H), 7.36 (m, 1H), 7.26 
(d, J = 8 Hz, 1H), 6.75 (t, J = 8 Hz, 1H). 13C NMR (100 MHz): δ 164.2, 149.2, 148.2, 
139.0, 136.6, 131.1, 124.1, 123.2, 96.9. Anal. Calcd for C11H7I2N: C, 32.46, H, 1.73, N, 







Procedure A was followed, utilizing substrate 38 (150 mg, 0.936 mmol, 1 equiv), NIS 
(442 mg, 1.97 mmol, 2.1 equiv), Pd(OAc)2 (20.9 mg, 0.094 mmol, 10 mol %), and AcOH 
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(7.8 mL). Product 38-I was isolated as a viscous milky white oil (111 mg, 41% yield, Rf 
= 0.23 in 98.5% toluene/1.5% MeCN). The calibrated GC yield (against naphthalene as 
the internal standard) of the reaction was 41%. Note: the sample obtained from column 
chromatography was contaminated with approximately 50% of the starting material. 
Samples for HRMS, NMR analysis and calibrated GC yields were obtained after further 
purification by HPLC (95% hexanes/5% EtOAc, 20 mL/min, Waters µ-porasil 19.1 mm). 
mp = 71.8-72.7 °C. 1H NMR (400 MHz, CDCl3): δ 8.03 (dd, J = 7.8, 1.0 Hz, 1H), 7.73 
(dd, J = 7.8, 1.4 Hz, 1H), 7.46 (td, J = 7.8, 1.6 Hz, 1H), 7.16 (td, J = 7.8, 1.5 Hz, 1H), 
4.45 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 165.6, 140.7, 132.4, 131.2, 131.1, 128.2, 







Substrate 39 (150 mg, 0.657 mmol, 1 equiv), NIS (177 mg, 0.789 mmol, 1.20 equiv), and 
Pd(OAc)2 (7.4 mg, 0.033 mmol, 5 mol %) were combined in a 20 mL vial. AcOH (5.5 
mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was heated 
at 100 ºC for 12 h. The solvent was removed under vacuum, and the resulting brown 
solids were purified by chromatography on silica gel (Rf = 0.2 in 25% CH2Cl2/75% 
hexanes). Product 39-I was isolated as a white solid as a 4:1 mixture of E:Z oxime 
isomers (133 mg, 57% yield); mp = 67.0-68.0 °C. Major oxime isomer: 1H NMR (500 
MHz, CDCl3): δ 7.69 (d, J = 8.4 Hz, 1H), 7.38 (d, J = 2.4 Hz, 1H), 7.17 (dd, J = 8.4, 2.4 
Hz, 1H), 3.99 (s, 3H), 2.17 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 157.32, 144.37, 
140.79, 132.98, 132.46, 122.50, 93.93, 62.07, 16.51. Minor oxime isomer: 1H NMR (500 
MHz, CDCl3): δ 7.68 (d, J = 8.8 Hz, 1H), 7.16-7.14 (multiple peaks, 2H), 3.83 (s, 3H), 
2.14 (s, 3H). Anal. Calcd for C9H9BrNO: C, 30.54, H, 2.56, N, 3.96; Found: C, 30.51, H, 







Substrate 40 (121 mg, 0.519 mmol, 1 equiv), NIS (140 mg, 0.623 mmol, 1.20 equiv), and 
Pd(OAc)2 (5.8 mg, 0.025 mmol, 5 mol %) were combined in a 20 mL vial. AcOH (4.3 
mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was heated 
at 100 ºC for 12 h. The solvent was removed under vacuum, and the resulting brown 
solids were purified by chromatography on silica gel (Rf = 0.26 in 2% EtOAc/98% 
CH2Cl2). Product 40-I was isolated as a clear viscous oil (101 mg, 54% yield). 1H NMR 
(500 MHz, CDCl3): δ 7.86 (dd, J = 7.9, 1.2 Hz, 1H), 7.32 (td, J = 7.4, 1.2 Hz, 1H), 7.28 
(dd, J = 7.6, 1.9 Hz, 1H), 6.97 (td, J = 7.9, 1.9 Hz, 1H), 4.81-4.76 (m, 1H), 4.13 (dd, J = 
11.8, 4.1 Hz, 1H), 4.06 (dd, J = 11.8, 5.8 Hz, 1H), 3.89 (d, J = 15.4 Hz, 1H), 3.85 (d, J = 
15.4 Hz, 1H), 3.00 (dd, J = 17.3, 10.9 Hz, 1H), 2.67 (dd, J = 17.3, 7.1 Hz, 1H), 2.09 (s, 
3H). 13C NMR (100 MHz, CDCl3): 170.72, 156.62, 139.81, 138.78, 129.97, 129.03, 
128.78, 100.59, 77.46, 65.03, 38.92, 38.79, 20.74. IR (thin film): 1741, 1233 cm-1. 
HRMS electrospray (m/z): [M+] calcd for C13H14INO3, 359.0018; found, 359.0000. GC 




Substrate 43 (100 mg, 0.487 mmol, 1 equiv), NCS (71.5 mg, 0.536 mmol, 1.1 equiv), and 
Pd(OAc)2 (8.4 mg, 0.024 mmol, 5 mol %) were combined in a 20 mL vial. CH3CN (4.0 
mL) was added, the vial was sealed with a Teflon-lined cap, and the mixture was heated 
at 100 ºC for 12 h. The solvent was removed under vacuum, and the resulting 
yellow/brown solid was purified by chromatography on silica gel (Rf = 0.18 in 25% 
EtOAc/75% toluene). Product 43-Cl was isolated as a light yellow solid (96 mg, 82% 
yield); mp = 78.2-79.2 °C. 1H NMR (400 MHz, CDCl3): δ 8.79-8.77 (m, 1H), 8.09 (s, 
1H), 7.99 (s, 1H), 7.88 (d, J = 7.9 Hz, 1H), 7.81-7.79 (multiple peaks, 2H), 7.74-7.71 (m, 
1H), 7.56-7.48 (multiple peaks, 2H), 7.36-7.32 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 
156.75, 149.31, 136.11, 133.67, 131.85, 131.16, 129.67, 128.40, 128.25, 127.39, 126.70, 
126.58, 125.21, 122.51. Two carbon resonances appear to be coincidently overlapping. 
HRMS electrospray (m/z): [M+] calcd for C15H10ClN, 239.0502; found, 239.0499. GC 





Procedure A was followed, utilizing substrate 44 (100 mg, 0.487 mmol, 1 equiv), NCS 
(72 mg, 0.536 mmol, 1.1 equiv), Pd(OAc)2 (5.5 mg, 0.024 mmol, 5 mol %), and CH3CN 
(4.0 mL). Product 44-Cl was isolated as a yellow solid (81 mg, 70% yield, mp = 85.7-
86.4 ºC, Rf = 0.11 in 95% toluene/5% EtOAc). 1H NMR (400 MHz, CDCl3): δ 8.80-8.79 
(m, 1H), 8.03-7.97 (multiple peaks, 3H), 7.77 (d, J = 8.9 Hz, 1H), 7.58-7.49 (multiple 
peaks, 3H), 7.43 (d, J = 7.9 Hz, 1H), 7.26 (d, J = 8.5 Hz, 1H). 13C NMR (100 MHz): δ 
157.4, 150.6, 137.6, 137.3, 134.2, 133.1, 131.0, 130.7, 129.0, 128.1, 127.8, 127.1, 126.7, 





Procedure A was followed, utilizing substrate 44 (100 mg, 0.487 mmol, 1 equiv), NIS 
(329 mg, 1.46 mmol, 3.0 equiv), Pd(OAc)2 (5.5 mg, 0.024 mmol, 5 mol %), and CH3CN 
(4.0 mL). Product 44-I was isolated as a yellow solid (97 mg, 60% yield, mp = 85.9-87.0 
ºC, Rf = 0.19 in 97.5% Toluene/2.5% EtOAc). 1H NMR (400 MHz, acetone-d6): δ 8.78 
(ddd, J = 4.9, 1.8, 1.0 Hz, 1H), 8.03-7.97 (multiple peaks, 3H), 7.77 (d, J = 8.9 Hz, 1H), 
7.58-7.49 (multiple peaks, 2H), 7.44-7.42 (multiple peaks, 2H), 7.26 (d, J = 8.5 Hz, 1H). 
13C NMR (100 MHz, acetone-d6): δ 161.8, 150.5, 144.4, 137.5, 136.3, 133.9, 131.1, 
130.6, 129.0, 127.9, 127.4, 127.1, 126.3, 123.9, 97.1. HRMS EI (m/z): [M+] Calcd for 






Substrate 45 (100 mg, 0.546 mmol, 1 equiv), NCS (87.5 mg, 0.655 mmol, 1.20 equiv), 
and Pd(OAc)2 (6.1 mg, 0.027 mmol, 5 mol %) were combined in a 20 mL vial. CH3CN 
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(4.5 mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was 
heated at 120 ºC for 12 h. The solvent was removed under vacuum. The crude product 
was dissolved in CH2Cl2, filtered through a pad of silica and washed with a 50/50 mixture 
of hexanes/ethyl acetate (300 mL). The filtrate was concentrated and the resulting solid 
was purified by chromatography on silica gel (Rf = 0.2 in 5% EtOAc/95% CH2Cl2). 
Product 45-Cl was isolated as a white solid (67 mg, 57% yield); mp = 67.2-67.7 °C. 1H 
NMR (400 MHz, CDCl3): δ 10.0 (s, 1H), 8.77-8.75 (m, 1H), 8.00 (d, J = 1.6 Hz, 1H), 
7.88 (dd, J = 7.9, 1.6 Hz, 1H), 7.82 (td, J = 7.6, 1.8 Hz, 1H), 7.80 (d, J = 7.8 Hz, 1H), 
7.71 (dt, J = 7.9, 0.9 Hz, 1H), 7.36 (ddd, J = 7.6, 4.9, 1.6 Hz, 1H). 13C NMR (100 MHz, 
CDCl3): δ 190.57, 155.52, 149.78, 144.45, 137.08, 136.05, 133.29, 132.39, 131.11, 
127.91, 124.82, 123.09. IR (KBr): 2922, 1697 cm-1. HRMS electrospray (m/z): [M+] 
calcd for C12H8ClNO, 217.0294; found, 217.0289. GC analysis (Restek Rtx@-5, FID 







Substrate 45 (100 mg, 0.546 mmol, 1 equiv), NCS (182 mg, 1.364 mmol, 2.5 equiv), and 
Pd(OAc)2 (6.1 mg, 0.027 mmol, 5 mol %) were combined in a 20 mL vial. CH3CN (4.5 
mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was heated 
at 120 ºC for 12 h. The solvent was removed under vacuum. The crude product was 
dissolved in CH2Cl2, filtered through a pad of silica and washed with a 50/50 mixture of 
hexanes/ethyl acetate (300 mL). The filtrate was concentrated and the resulting solid was 
purified by chromatography on silica gel (Rf = 0.3 in 5% EtOAc/95% CH2Cl2). Product 
45-Cl2 was isolated as a white solid (99 mg, 72% yield); mp = 106.6-107 °C. 1H NMR 
(400 MHz, CDCl3): δ 9.98 (s, 1H), 8.78 (d, J = 4.9 Hz, 1H), 7.91 (s, 2H), 7.86 (td, J = 
7.7, 1.8 Hz, 1H), 7.41-7.38 (m, 1H), 7.35 (d, J = 7.8 Hz, 1H). 13C NMR (100 MHz, 
CDCl3): δ 189.22, 154.45, 149.82, 143.48, 137.28, 136.61, 135.94, 128.88, 124.60, 
123.44. IR (KBr): 2852, 1692, 1546 cm-1. Anal. Calcd for C12H7Cl2NO: C, 57.17, H, 






Procedure A was followed, utilizing substrate 46 (100 mg, 0.558 mmol, 1 equiv), NCS 
(81.9 mg, 0.614 mmol, 1.1 equiv), Pd(OAc)2 (6.2 mg, 0.028 mmol, 5 mol %), and AcOH 
(4.6 mL). Product 46-Cl was isolated as a clear oil as a 3:1 mixture of oxime E/Z isomers 
(69 mg, 58% yield, Rf = 0.20 in 55% hexanes/45% CH2Cl2). Major oxime isomer: 1H 
NMR (400 MHz, CDCl3): δ 7.27 (d, J = 8.8 Hz, 1H), 6.94 (d, J = 2.5 Hz, 1H), 6.81 (dd, J 
= 8.8, 2.5 Hz, 1H), 3.99 (s, 3H), 3.82 (s, 3H), 2.20 (s, 3H). 13C NMR (100 MHz, CDCl3): 
δ 160.4, 155.8, 133.4, 130.9, 129.3, 115.3, 112.8, 61.8, 55.6, 16.5. Minor oxime isomer: 
1H NMR (400 MHz, CDCl3): δ 7.05 (d, J = 8.5 Hz, 1H), 6.96 (d, J = 2.5 Hz, 1H), 6.84 
(dd, J = 8.5, 2.5 Hz, 1H), 3.99 (s, 3H), 3.83 (s, 3H), 2.20 (s, 3H). HRMS EI (m/z): [M+] 







Procedure A was followed, utilizing substrate 46 (100 mg, 0.558 mmol, 1 equiv), NCS 
(89.4 mg, 0.669 mmol, 1.2 equiv), and AcOH (4.6 mL). Product Iso-46-Cl was isolated 
as a white solid as a single oxime isomer (62 mg, 53% yield, mp = 60.2-61.6 ºC, Rf = 
0.25 in 60% hexanes/40% CH2Cl2). 1H NMR (400 MHz, CDCl3): δ 7.71 (d, J = 2.0 Hz, 
1H), 7.50 (dd, J = 8.8, 2.4 Hz, 1H), 6.90 (d, J = 8.4 Hz, 1H), 3.98 (s, 3H), 3.92 (s, 3H), 
2.18 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 155.6, 152.9, 130.0, 127.8, 125.4, 114.0, 






Procedure A was followed, utilizing substrate 46 (100 mg, 0.558 mmol, 1 equiv), NBS 
(109 mg, 0.614 mmol, 1.1 equiv), Pd(OAc)2 (6.2 mg, 0.028 mmol, 5 mol %), and AcOH 
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(4.6 mL). Product 46-Br was isolated as a clear oil as a 3:1 mixture of oxime E/Z isomers 
(105 mg, 72% yield, Rf = 0.30 in 55% hexanes/45% CH2Cl2). Major oxime isomer: 1H 
NMR (400 MHz, CDCl3): δ 7.23 (d, J = 8.8 Hz, 1H), 7.12 (d, J = 2.8 Hz, 1H), 6.85 (dd, J 
= 8.4, 2.8 Hz, 1H), 3.97 (s, 3H), 3.80 (s, 3H), 2.19 (s, 3H). 13C NMR (100 MHz, CDCl3): 
δ 160.2, 156.7, 131.3, 130.9, 122.2, 118.3, 113.3, 61.8, 55.6, 16.7. HRMS EI (m/z): [M+] 
Calcd for C10H12BrNO2, 257.0051; Found, 257.0056.   Minor oxime isomer: 1H NMR 
(400 MHz, CDCl3): δ 7.13 (d, J = 2.3 Hz, 1H), 7.00 (d, J = 8.6 Hz, 1H), 6.87 (dd, J = 8.6, 
2.3 Hz, 1H), 3.82 (s, 3H), 3.80 (s, 3H), 2.15 (s, 3H). HRMS EI (m/z): [M+] Calcd for 







Procedure A was followed, utilizing substrate 46 (100 mg, 0.558 mmol, 1 equiv), NBS 
(119 mg, 0.669 mmol, 1.2 equiv), and AcOH (4.6 mL). Product Iso-46-Br was isolated 
as a white solid as a single oxime isomer (99 mg, 69% yield, mp = 70.2-71.1 ºC, Rf = 
0.30 in 55% hexanes/45% CH2Cl2). 1H NMR (400 MHz, CDCl3): δ 7.88 (d, J = 2.4 Hz, 
1H), 7.55 (dd, J = 8.4, 2.4 Hz, 1H), 6.87 (d, J = 8.8 Hz, 1H), 3.98 (s, 3H), 3.91 (s, 3H), 
2.17 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 156.4, 152.9, 130.9, 130.4, 126.2, 111.7, 






Procedure A was followed, utilizing substrate 46 (100 mg, 0.558 mmol, 1 equiv), NIS 
(151 mg, 0.669 mmol, 1.2 equiv), Pd(OAc)2 (6.2 mg, 0.028 mmol, 5 mol %), and AcOH 
(4.6 mL). Product 46-I was isolated as a clear oil as a 3:1 mixture of oxime E/Z isomers 
(78 mg, 46% yield, Rf = 0.29 in 55% hexanes/45% CH2Cl2). Major oxime isomer: 1H 
NMR (400 MHz, CDCl3): δ 7.38 (d, J = 2.4 Hz, 1H), 7.15 (d, J = 8.4 Hz, 1H), 6.89 (dd, J 
= 8.8, 2.8 Hz, 1H), 3.98 (s, 3H), 3.79 (s, 3H), 2.17 (s, 3H). 13C NMR (100 MHz, CDCl3): 
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δ 159.7, 158.2, 135.2, 129.9, 124.7, 114.1, 96.0, 61.8, 55.6, 16.9. Minor oxime isomer: 
1H NMR (400 MHz, CDCl3): δ 7.38 (d, J = 2.2 Hz, 1H), 6.94 (d, J = 8.4 Hz, 1H), 6.92 
(dd, J = 8.4, 2.1 Hz, 1H), 3.82 (s, 3H), 3.78 (s, 3H), 2.14 (s, 3H). HRMS EI (m/z): [M+] 







Procedure A was followed, utilizing substrate 46 (100 mg, 0.558 mmol, 1 equiv), NIS 
(151 mg, 0.669 mmol, 1.2 equiv), and AcOH (4.6 mL). Product Iso-46-I was isolated as a 
light yellow solid as a single oxime isomer (81 mg, 47% yield, mp = 65.0-66.4 ºC, Rf = 
0.29 in 55% hexanes/45% CH2Cl2). 1H NMR (400 MHz, CDCl3): δ 8.10 (d, J = 2.4 Hz, 
1H), 7.59 (dd, J = 8.4, 2.4 Hz, 1H), 6.79 (d, J = 8.8 Hz, 1H), 3.98 (s, 3H), 3.89 (s, 3H), 
2.17 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 158.7, 152.8, 137.0, 131.0, 127.3, 110.3, 






Substrate 47 (150 mg, 0.753 mmol, 1 equiv) and NCS (111 mg, 0.828 mmol, 1.1 equiv) 
were combined in a 20 mL vial. CH3CN (7 mL) was added, the vial was sealed with a 
Teflon-lined cap, and the mixture was heated at 100 ºC for 12 h. The solvent was 
removed under vacuum, and the resulting yellow/brown solid was purified by 
chromatography on silica gel (Rf = 0.40 in 90% CH2Cl2/10% EtOAc). Product Iso-47-Cl 
was isolated as a clear oil (167 mg, 95% yield). 1H NMR (400 MHz, acetone-d6): δ 8.45 
(d, J = 4.8 Hz, 1H), multiple peaks (7.65-7.63, 2H), 7.52 (dd, J = 8.4, 2.0 Hz, 1H), 7.21 
(dd, J = 7.6, 4.8 Hz, 1H), 7.16 (d, J = 8.4 Hz, 1H), 3.94 (s, 3H), 2.37 (s, 3H).  13C NMR 
(100 MHz, acetone-d6): δ 157.34, 155.57, 147.78, 139.38, 135.00, 131.59, 131.34, 
129.73, 122.92, 122.19, 112.47, 56.48, 20.29. Anal. Calcd for C13H12ClNO: C, 66.81, H, 






Substrate 47 (150 mg, 0.753 mmol, 1 equiv), NCS (105 mg, 0.791 mmol, 1.05 equiv), 
and Pd(OAc)2 (8.4 mg, 0.038 mmol, 5 mol %) were combined in a 20 mL vial. AcOH (7 
mL) was added, the vial was sealed with a Teflon-lined cap, and the mixture was heated 
at 100 ºC for 12 h. The solvent was removed under vacuum, and the resulting 
yellow/brown solid was purified by chromatography on silica gel (Rf = 0.40 in 85% 
CH2Cl2/15% EtOAc). Product 47-Cl was isolated as a clear oil (133 mg, 76% yield). 1H 
NMR (400 MHz, acetone-d6): d 8.45 (d, J = 4.8 Hz, 1H), 7.67 (d, J = 7.6 Hz, 1H), 7.27 
(dd, J = 8.0, 4.8 Hz, 1H), 7.24 (d, J = 8.4 Hz, 1H), 7.07 (d, J = 2.4 Hz, 1H), 6.99 (dd, J = 
8.4, 2.4 Hz, 1H), 3.87 (s, 3H), 2.13 (s, 3H). 13C NMR (125 MHz, acetone-d6): d 160.88, 
157.82, 147.39, 138.26, 133.74, 133.09, 132.95, 132.14, 123.56, 115.05, 113.87, 55.97, 







Procedure B was followed, utilizing substrate 48 (100 mg, 0.395 mmol, 1 equiv), NCS 
(58 mg, 0.434 mmol, 1.1 equiv), Pd(OAc)2 (17.7 mg, 0.079 mmol, 20 mol %), and AcOH 
(3.3 mL). Product 48-Cl was isolated as a clear oil (81 mg, 71% yield, Rf = 0.35 in 98% 
hexanes/2% EtOAc). 1H NMR (400 MHz, acetone-d6): δ 8.01-7.98 (m, 1H), 7.83 (dd, J = 
8.1, 7.2 Hz, 1H), 7.82-7.75 (multiple peaks, 2H), 7.37 (dd, J = 10.0, 0.8 Hz, 1H), 6.86 
(dd, J = 11.0, 1.2 Hz, 1H), 3.94 (s, 3H). 13C NMR (100 MHz, acetone-d6): δ 164.8, 153.4, 
140.8, 140.1, 137.1, 132.3, 129.9 (q, JCF = 32.2 Hz), 129.3 (q, JCF = 4.05 Hz), 127.2 (q, 
JCF = 3.7 Hz), 124.9 (q, JCF = 272 Hz), 118.5, 111.4, 53.8. 19F NMR (282 MHz, acetone-
d6): δ –63.1 (s) Anal. Calcd for C13H9ClF3NO: C, 54.28, H, 3.15, N, 4.87; Found: C, 












Procedure B was followed, utilizing substrate 48 (100 mg, 0.395 mmol, 1 equiv), NCS 
(58 mg, 0.434 mmol, 1.1 equiv), and AcOH (3.3 mL). GC analysis of the crude reaction 
mixture showed 3:1 mixture of regioisomeric mono-chlorinated products. Isomer Iso-48-
Cl-ortho was isolated as a clear oil (36 mg, 32% yield, Rf = 0.18 in 98% hexanes/2% 
toluene). 1H NMR (400 MHz, acetone-d6): δ 8.44 (s, 1H), 8.40 (d, J = 7.7 Hz, 1H), 7.90 
(d, J = 7.9 Hz, 1H), 7.79-7.73 (multiple peaks, 2H), 7.68 (d, J = 8.0 Hz, 1H), 4.12 (s, 3H). 
13C NMR (100 MHz, acetone-d6): δ 159.74, 151.80, 140.43, 139.86, 131.55 (q, JCF = 32 
Hz), 131.17, 130.70, 125.37 (q, JCF = 271 Hz), 126.57 (q, JCF = 3.8 Hz), 124.03 (q, JCF = 
3.8 Hz), 118.28, 115.13, 54.59. 19F NMR (376 MHz, CDCl3): δ –62.72 (s). HRMS EI 
(m/z): [M+] Calcd for C13H9ClF3NO, 287.0325; Found, 287.0318. Isomer Iso-48-Cl-para 
was isolated as a clear oil (57 mg, 50% yield, Rf = 0.13 in 98% hexanes/2% toluene). 1H 
NMR (400 MHz, CDCl3): δ 8.12-8.09 (multiple peaks, 2H), 7.73-7.64 (multiple peaks, 
2H), 7.59 (t, J = 7.7 Hz, 1H), 6.85 (d, J = 8.7 Hz, 1H), 3.94 (s, 3H). 13C NMR (100 MHz, 
CDCl3): δ 163.30, 151.8, 142.2, 140.1, 134.2, 130.8 (q, JCF = 32 Hz), 129.1, 126.9 (q, JCF 
= 3.7 Hz), 126.3 (q, JCF = 3.6 Hz), 125.3 (q, JCF = 271 Hz), 122.3, 112.8, 54.2. 19F NMR 
(376 MHz, CDCl3):δ –62.6 (s). HRMS EI (m/z): [M+] Calcd for C13H9ClF3NO, 





Substrate 49 (150 mg, 0.731 mmol, 1 equiv), NCS (146 mg, 1.096 mmol, 1.5 equiv), and 
Pd(OAc)2 (8.2 mg, 0.036 mmol, 5 mol %) were combined in a 20 mL vial. AcOH (6.1 
mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was stirred 
at 100 ºC for 12 h. The solvent was removed under vacuum, and the resulting crude 
material was purified by chromatography on silica gel (Rf = 0.33 in 5% EtOAc/95% 
hexanes). Product 49-Cl was isolated as a light yellow semisolid (93 mg, 53% yield). 1H 
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NMR (300 MHz, acetone-d6): δ 8.60 (dd, J = 5.7, 2.7, 1H), 8.05 (d, J = 8.3 Hz, 1H), 7.87 
(dd, J = 5.7, 2.5 Hz, 1H), 7.81-7.75 (m, 1H), 7.65-6.49 (multiple peaks, 6H). 13C NMR 
(75 MHz, acetone-d6): δ 159.34, 143.02, 139.54, 137.07, 133.66, 132.27, 131.06, 130.81, 
130.23, 128.37, 127.89, 127.82, 127.49, 121.34. Two carbon resonances appear to be 
coincidently overlapping. HRMS electrospray (m/z): [M+] calcd for C15H10ClN, 






Procedure A was followed, utilizing substrate 49 (100 mg, 0.487 mmol, 1 equiv), NCS 
(130 mg, 0.974 mmol, 2.0 equiv), and AcOH (4.0 mL). Product Iso-49-Cl was isolated as 
a white solid (66 mg, 56% yield, mp = 129.7-130.3 ºC, Rf = 0.29 in 90% hexanes/10% 
CH2Cl2). 1H NMR (400 MHz, acetone-d6): δ 8.65 (s, 1H), 8.28 (d, J = 8.4 Hz, 1H), 8.13 
(d, J = 8.4 Hz, 1H), 7.94 (dt, J = 6.8, 1.2 Hz, 1H), 7.74 (dt, J = 6.8, 1.2 Hz, 1H), 7.70-
7.68 (multiple peaks, 2H), 7.58-7.53 (multiple peaks, 3H). 13C NMR (100 MHz, acetone-
d6): δ 160.5, 141.7, 139.9, 134.7, 132.3, 130.8, 129.6, 129.3, 129.1, 128.7, 128.2, 127.6, 






Procedure B was followed, utilizing substrate 50 (150 mg, 1.04 mmol, 1 equiv), NCS 
(146 mg, 1.09 mmol, 1.05 equiv), Pd(OAc)2 (23.3 mg, 0.104 mmol, 10 mol %), and 
AcOH (8.7 mL). Product 50-Cl was isolated as a clear oil (108 mg, 58% yield, Rf = 0.12 
in 60% hexanes/40% CH2Cl2). The calibrated GC yield (against naphthalene as the 
internal standard) of the reaction was 72%. Note: the sample obtained from column 
chromatography was contaminated with approximately 13% of the starting material. 
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Samples for microanalysis were obtained after further purification by HPLC (98% 
hexanes/2% EtOAc, 20 mL/min, Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, 
CDCl3): δ 7.88 (d, J = 3.2 Hz, 1H), 7.75 (s, 1H), 7.58 (dd, J = 10.4, 2.0 Hz, 1H), 7.52 (dd, 
J = 10.2, 2.6 Hz, 1H), 7.42-7.30 (multiple peaks, 2H), 6.48 (t, J = 2.6 Hz, 1H). 13C NMR 
(100 MHz, CDCl3): δ 140.9, 131.3, 130.6, 128.9, 128.3, 127.8, 127.6, 106.6. Two carbon 
resonances are coincidently overlapping. HRMS EI (m/z): [M+] Calcd for C9H7ClN2, 






Procedure B was followed, utilizing substrate 50 (150 mg, 1.04 mmol, 1 equiv), NCS 
(146 mg, 1.09 mmol, 1.05 equiv), and AcOH (8.7 mL). Product Iso-50-Cl was isolated as 
a clear oil (154 mg, 83% yield, mp = 72.5-74.3 ºC, Rf = 0.26 in 70% hexanes/30% 
CH2Cl2). 1H NMR (400 MHz, CDCl3): δ 7.89 (s, 1H), 7.64-7.62 (multiple peaks, 3H), 
7.45 (t, J = 7.4 Hz, 2H), 7.31(tt, J = 7.4, 1.1 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 
139.7, 139.4, 129.5, 126.9, 124.8, 118.9, 112.3. HRMS EI (m/z): [M+] Calcd for 






Procedure A was followed, utilizing substrate 51 (150 mg, 0.856 mmol, 1 equiv), NCS 
(120 mg, 0.899 mmol, 1.05 equiv), Pd(OAc)2 (9.6 mg, 0.043 mmol, 5 mol %), and AcOH 
(7 mL). Product 51-Cl was isolated as a clear oil (179 mg, 88% yield, Rf = 0.3 in 75% 
hexanes/25% CH2Cl2). 1H NMR (300 MHz, acetone-d6): δ 7.32 (dd, J = 7.8, 1.5 Hz, 1H), 
7.23-7.13 (multiple peaks, 2H), 3.96 (s, 3H), 2.72 (t, J = 6.6 Hz, 2H), 2.65 (t, J = 6.0 Hz, 
2H), 1.76-1.67 (m, 2H). 13C NMR (75 MHz, acetone-d6): δ 152.9, 144.8, 132.3, 130.3, 
129.8, 129.7, 127.4, 62.3, 31.3, 25.3, 21.7. Anal. Calcd for C11H12ClNO: C, 63.01, H, 






Procedure A was followed, utilizing substrate 51 (150 mg, 0.856 mmol, 1 equiv), NCS 
(120 mg, 0.899 mmol, 1.05 equiv), and CH3CN (7 mL). Product Iso-51-Cl was isolated 
as a clear oil (70 mg, 39% yield, Rf = 0.3 in 75% hexanes/25% CH2Cl2). Note: product 
Iso-51-Cl was isolated in higher yield (66%) from the analogous reaction in AcOH; 
however, the isolated product from this reaction was contaminated with traces of 
isomeric chlorinated impurities. 1H NMR (400 MHz, acetone-d6): δ 7.98 (d, J = 7.6 Hz, 
1H), 7.33 (t, J = 6.4 Hz, 1H), 7.25-7.22 (m, 2H), 5.63 (t, J = 2.8 Hz, 1H), 4.02 (s, 3H), 
3.26-3.17 (m, 1H), 2.80-2.76 (m, 1H), 2.30-2.15 (multiple peaks, 2H). 13C NMR (100 
MHz, acetone-d6): δ 151.7, 138.3, 130.4, 129.8, 128.6, 127.3, 125.0, 62.8, 47.9, 30.7, 







Substrate 51 (150 mg, 0.856 mmol, 1 equiv), NBS (160 mg, 0.899 mmol, 1.05 equiv), 
and Pd(OAc)2 (9.6 mg, 0.043 mmol, 5 mol %) were combined in a 20 mL vial. AcOH (7 
mL) was added, the vial was sealed with a Teflon lined cap, and mixture was heated at 
100 ºC for 12 h. The solvent was removed under vacuum, and the resulting brown solids 
were purified by chromatography on silica gel (Rf = 0.3 in 75% hexanes/25% CH2Cl2). 
Product 51-Br was isolated as a clear oil (135 mg, 62% yield). 1H NMR (500 MHz, 
CDCl3): δ 7.53 (d, J = 8.2 Hz, 1H), 7.09 (d, J = 7.5 Hz, 1H), 7.04 (t, J = 7.7 Hz, 1H), 4.04 
(s, 3H), 2.76 (t, J = 6.9 Hz, 2H), 2.62 (t, J = 6.1 Hz, 2H), 1.75 (quin, J = 6.0 Hz, 2H). 13C 
NMR (100 MHz, CDCl3): δ 153.03, 143.84, 133.20, 130.79, 128.98, 126.94, 120.33, 
62.19, 30.93, 24.79, 21.01. Anal. Calcd for C11H12BrNO: C, 51.99, H, 4.94, N, 5.51; 






Procedure A was followed, utilizing substrate 51 (150 mg, 0.856 mmol, 1 equiv), NBS 
(160 mg, 0.899 mmol, 1.05 equiv), and AcOH (7.1 mL). Product Iso-51-Br was isolated 
as a clear oil (64 mg, 29% yield, Rf = 0.3 in 80% hexanes/20% EtOAc). 1H NMR (400 
MHz, CDCl3): δ 8.01 (d, J = 7.8 Hz, 1H), 7.30-7.14 (multiple peaks, 3H), 5.63 (t, J = 2.7 
Hz, 1H), 4.06 (s, 3H), 3.34-3.27 (m, 1H), 2.76 (app d, J = 16 Hz, 1H), 2.32-2.24 (m, 1H), 
2.19-2.08 (m, 1H). 13C NMR (75 MHz, CDCl3): δ 151.5, 137.1, 129.5, 128.9, 127.7, 
126.5, 124.5, 62.7, 37.9, 30.6, 25.3. HRMS EI (m/z): [M+] Calcd for C11H12BrNO, 







Procedure C was followed, utilizing substrate 52 (150 mg, 0.727 mmol, 1 equiv), NCS 
(116 mg, 0.872 mmol, 1.2 equiv), Pd(OAc)2 (16.3 mg, 0.072 mmol, 10 mol %), and 
AcOH (6.1 mL) Product 52-Cl was isolated as a light yellow solid as a 4:1 mixture of 
oxime isomers (105 mg, 60% yield, mp = 123.9-125.3 ºC, Rf = 0.20 in 70% hexanes/30% 
EtOAc). Major oxime isomer:1H NMR (400 MHz, CDCl3): δ 8.33 (d, J = 8.1 Hz, 1H), 
7.64 (br s, 1H), 7.24 (t, J = 7.8 Hz, 1H), 7.02 (d, J = 7.5 Hz, 1H), 3.94 (s, 3H), 2.21 (s, 
3H), 2.14 (s, 3H). 13C NMR (100 MHz): δ 168.2, 155.4, 137.2, 135.0, 128.4, 127.5, 
125.0, 121.7, 61.9, 24.9, 16.3. Minor oxime isomer:1H NMR (400 MHz, CDCl3): δ 8.35 
(d, J = 7.9 Hz, 1H), 7.67 (br s, 1H), 7.31 (t, J = 7.7 Hz, 1H), 6.85 (d, J = 7.7 Hz, 1H), 
3.80 (s, 3H), 2.24 (s, 3H), 2.15 (s, 3H). IR (KBr): 1654 cm-1. HRMS EI (m/z): [M+] 
Calcd for C11H13ClN2O2, 240.0666; Found, 240.0662.The reaction in the absence of 






Procedure with Pd Catalyst: Substrate 53 (150 mg, 0.753 mmol, 1 equiv), NCS (102 mg, 
0.760 mmol, 1.01 equiv), and Pd(OAc)2 (8.4 mg, 0.038 mmol, 5 mol%) were combined 
in a 20 mL vial. CH3CN (7 mL) was added, the vial was sealed with a Teflon-lined cap, 
and the mixture was heated at 100 ºC for 12 h. The solvent was removed under vacuum, 
and the resulting yellow/brown solid was purified by chromatography on silica gel (Rf = 
0.31 in 90% CH2Cl2/10% EtOAc). Product 53-Cl was isolated as a light yellow solid 
(120 mg, 68% yield). 
Procedure without Pd Catalyst: Substrate 53 (150 mg, 0.753 mmol, 1 equiv) and NCS 
(102 mg, 0.760 mmol, 1.01 equiv), were combined in a 20 mL vial. CH3CN (7 mL) was 
added, the vial was sealed with a Teflon-lined cap, and the mixture was heated at 100 ºC 
for 12 h. The solvent was removed under vacuum, and the resulting yellow/brown solid 
was purified by chromatography on silica gel (Rf = 0.31 in 90% CH2Cl2/10% EtOAc). 
Product 53-Cl was isolated as a light yellow solid (144 mg, 82% yield). The products 
with and without Pd were identical by GC and 1H NMR analysis. 
Mp = 77.9-79.0 ºC. 1H NMR (300 MHz, acetone-d6): δ 8.45 (d, J = 4.5 Hz, 1H), 7.67 (d, 
J = 7.8 Hz, 1H), 7.43 (d, J = 8.7 Hz, 1H), 7.32-7.27 (m, 1H), 7.00 (dd, J = 8.7, 3.0 Hz, 
1H), 6.88 (d, J =  2.7 Hz, 1H), 3.82 (s, 3H), 2.14 (s, 3H). 13C NMR (125 MHz, acetone-
d6): δ 158.61, 157.13, 146.62, 140.83, 137.46, 131.70, 129.98, 123.51, 122.95, 115.69, 
115.23, 55.14, 17.92. Anal. Calcd for C13H12ClNO: C, 66.81, H, 5.18, N, 5.99; Found: C, 







Procedure A was followed, utilizing substrate 54 (100 mg, 0.475 mmol, 1 equiv), NIS 
(160 mg, 0.713 mmol, 1.5 equiv), Pd(OAc)2 (5.3 mg, 0.024 mmol, 5 mol %), and AcOH 
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(4.0 mL). Product 54-I was isolated as an orange solid (65 mg, 41% yield, mp = 64.6-
66.0 ºC, Rf = 0.20 in 98% hexanes/2% CH2Cl2). 1H NMR (400 MHz, CDCl3): δ 7.88 (d, J 
= 8.0 Hz, 1H), 7.81-7.79 (multiple peaks, 2H), 7.45-7.39 (multiple peaks, 2H), 7.32 (d, J 
= 7.2 Hz, 1H), 7.01 (dd, J = 8.0, 2.4 Hz, 1H), 2.48 (s, 3H), 2.38 (s, 3H). 13C NMR (100 
MHz, CDCl3): δ 152.4, 151.1, 139.4, 139.1, 139.0, 133.1, 132.3, 128.9, 123.9, 120.8, 
117.8, 98.4, 21.4, 20.9. HRMS EI (m/z): [M+] Calcd for C14H13IN2, 336.0123; Found, 







Procedure A was followed, utilizing substrate 55 (150 mg, 0.784 mmol, 1 equiv), NCS 
(126 mg, 0.941 mmol, 1.2 equiv), Pd(OAc)2 (8.8 mg, 0.039 mmol, 5 mol %) and AcOH 
(6.5 mL). Product 55-Cl was isolated as a white solid (118 mg, 67% yield, mp = 158.4-
160.0 ºC, Rf = 0.20 in 80% hexanes/20% EtOAc). 1H NMR (400 MHz, acetone-d6): δ 
8.31 (br s, 1H), 7.28 (dd, J = 7.4, 2.4 Hz, 1H), 7.21-7.14 (multiple peaks, 2H), 2.22 (s, 
3H), 1.34 (s, 9H). 13C NMR (100 MHz, acetone-d6): δ 176.9, 139.9, 135.4, 133.5, 129.7, 
128.6, 127.7, 39.9, 27.9, 18.8. IR (KBr): 1654 cm-1. Anal. Calcd for C12H16ClNO: C, 




Procedure F was followed, utilizing substrate 56 (110 mg, 0.768 mmol, 1 equiv), CuCl2 
(413 mg, 3.07 mmol, 4.0 equiv), Pd(OAc)2 (8.6 mg, 0.038 mmol, 5 mol %), and CH2Cl2 
(6.4 mL). Product 56-Cl was isolated as a yellow solid (118 mg, 86% yield, Rf = 0.21 in 
95% hexanes/5% EtOAc). 1H NMR (300 MHz, CDCl3): δ 8.98 (dd, J = 4.2, 1.8 Hz, 1H), 
8.16 (dd, J = 8.3, 1.8 Hz, 1H), 7.79-7.87 (multiple peaks, 2H), 7.53 (t, J = 7.1 Hz, 1H), 
7.44 (dd, J = 8.3, 4.2 Hz, 1H), 5.34 (s, 2H). 13C NMR (75 MHz, CDCl3): δ 150.3, 146.1, 
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136.6, 135.8, 130.3, 128.9, 128.5, 126.5, 121.7, 42.6. Anal. Calcd for C10H8ClN: C, 






Procedure C was followed, utilizing substrate 57 (209 mg, 1.29 mmol, 1 equiv), NCS 
(208 mg, 1.55 mmol, 1.2 equiv), Pd(OAc)2 (14.5 mg, 0.064 mmol, 5 mol %), and AcOH 
(8.4 mL). Product 57-Cl was isolated as an off-white solid (197 mg, 77% yield, mp = 
40.9-42.4 ºC, Rf = 0.30 in 60% hexanes/40% EtOAc). 1H NMR (400 MHz, acetone-d6): δ 
7.51 (d, J = 7.3 Hz, 1H), 7.39-7.32 (multiple peaks, 3H), 3.77 (t, J = 6.92 Hz, 2H), 2.43 
(t, J = 7.2Hz, 2H), 2.22 (q, J = 6.9 Hz, 2H). 13C NMR (100 MHz, acetone-d6): δ 174.7, 
138.2, 132.9, 130.9, 130.8, 129.8, 128.7, 50.5, 31.4, 19.9. IR (KBr): 1698 cm-1. HRMS EI 






Procedure C was followed, utilizing substrate 57 (203 mg, 1.26 mmol, 1 equiv), NCS 
(202 mg, 1.51 mmol, 1.5 equiv), and AcOH (8.1 mL).) Product Iso-57-Cl was isolated as 
a white solid (142 mg, 58% yield, mp = 95.5-96.6 ºC, Rf = 0.44 in 60% hexanes/40% 
EtOAc). 1H NMR (400 MHz, CDCl3): δ 7.58 (d, J = 9.2 Hz, 2H), 7.32 (d, J = 8.8 Hz, 
2H), 3.84 (t, J = 7.2 Hz, 2H), 2.62 (t, J = 8 Hz, 2H), 2.17 (m, 2H). 13C NMR (100 MHz, 
CDCl3): δ 174.2, 137.9, 129.4, 128.7, 120.8, 48.6, 32.6, 17.8. IR(KBr): 1679 cm-1. 






Procedure A was followed, utilizing substrate 57 (150 mg, 0.930 mmol, 1 equiv), NBS 
(199 mg, 1.12 mmol, 1.2 equiv), Pd(OAc)2 (10.4 mg, 0.046 mmol, 5 mol %), and AcOH 
(7.7 mL). Product Iso-57-Br was isolated as a white solid (156 mg, 70% yield, Rf = 0.30 
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in 60% hexanes/40% EtOAc). The NMR data was identical to that reported previously 






Procedure with palladium catalyst: Procedure A was followed, utilizing substrate 57 
(100 mg, 0.620 mmol, 1 equiv), NIS (209 mg, 0.930 mmol, 1.5 equiv), Pd(OAc)2 (6.9 
mg, 0.031 mmol, 5 mol %), and AcOH (5.2 mL). Product Iso-57-I was isolated as a light 
yellow solid (141 mg, 80% yield, mp = 140.0-141.6 ºC, Rf = 0.28 in 60% hexanes/40% 
EtOAc). Procedure without palladium catalyst: Procedure A was followed, utilizing 
substrate 59 (100 mg, 0.620 mmol, 1 equiv), NIS (209 mg, 0.930 mmol, 1.5 equiv), and 
AcOH (5.2 mL). Product Iso-57-I was isolated as a light yellow solid (141 mg, 80% 
yield, mp = 140.0-141.6 ºC, Rf = 0.28 in 60% hexanes/40% EtOAc). The products with 
and without Pd were identical by GC and 1H NMR analysis. 1H NMR (400 MHz, 
CDCl3): δ 7.60 (d, J = 8.4 Hz, 2H), 7.39 (d, J = 8.4 Hz, 2H), 3.81 (t, J = 7.2 Hz, 2H), 2.59 
(t, J = 8.1 Hz, 2H), 2.19-2.11 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 174.3, 139.1, 
137.7, 121.5, 87.9, 48.4, 32.7, 17.8. IR (KBr): 1684 cm-1. Anal. Calcd for C10H10INO: C, 






Procedure C was followed, utilizing substrate 58 (100 mg, 0.571 mmol, 1 equiv), NCS 
(114 mg, 0.856 mmol, 1.5 equiv), Pd(OAc)2 (6.39 mg, 0.028 mmol, 0.05 mol equiv), and 
AcOH (8.4 mL). Product 58-Cl was isolated as an off-white solid (68.0 mg, 57% yield, 
mp = 55.9-56.9 ºC, Rf = 0.18 in 90% CH2Cl2/10% EtOAc). 1H NMR (500 MHz, CDCl3): 
δ 7.48 (dd, J = 7.6, 1.3 Hz, 1H), 7.32 (td, J = 7.5, 1.5 Hz, 1H), 7.29-7.25 (multiple peaks, 
2H), 3.60 (m, 1H), 3.49 (m, 1H), 2.64-2.52 (multiple peaks, 2H), 2.02-1.93 (multiple 
peaks, 4H). 13C NMR (100 MHz, CDCl3): δ 169.8, 140.6, 132.2, 130.4, 129.4, 128.9, 
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127.9, 50.9, 32.5, 23.4, 21.4. IR (KBr): 2921, 1652 cm-1. HRMS EI (m/z): [M+Na+] 





Substrate 59 (100 mg, 0.528 mmol, 1 equiv), NCS (106 mg, 0.793 mmol, 1.50 equiv), 
and Pd(OAc)2 (5.92 mg, 0.026 mmol, 5 mol %) were combined in a 20 mL vial. AcOH 
(4.4 mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was 
heated at 100 ºC for 12 h. The solvent was removed under vacuum. The crude was 
dissolved in CH2Cl2 (15mL) and washed with NaHCO3 (1 x 15mL). The aqueous layer 
was washed with CH2CL2 (2 x 15mL). The combined organic layers were dried over 
MgSO4, filtered and the concentrated. The resulting oil was purified by chromatography 
on silica gel (Rf = 0.21 in 40% EtOAc/60% hexanes). Product 59-Cl was isolated as a 
milky white viscous oil (91.0 mg, 77 % yield). 1H NMR (400 MHz, acetone-d6): δ 7.46 
(dd, J = 7.7, 1.7 Hz, 1H), 7.31-7.27 (m, 1H), 7.26-7.21 (multiple peaks, 2H), 3.77 (dd, J = 
14.4, 8.3 Hz, 1H), 3.56 (dd, J = 14.0, 7.6 Hz, 1H), 2.78-2.67 (m, 2H), 1.98-1.74 (multiple 
peaks, 6H). 13C NMR (100 MHz, acetone-d6): δ 175.61, 142.22, 132.06, 130.34, 129.36, 
128.45, 127.79, 52.77, 37.49, 30.13, 28.68, 23.37. IR (thin film): 2927, 1662, 1478 cm-1. 
HRMS electrospray (m/z): [M+Na]+] calcd for C12H14ClNO, 246.0662; found, 246.0658. 





Substrate 60 (201 mg, 1.147 mmol, 1 equiv), NCS (230 mg, 1.721 mmol, 1.50 equiv), 
and Pd(OAc)2 (12.8 mg, 0.057 mmol, 5 mol %) were combined in a 20 mL vial. AcOH 
(13 mL) was added, the vial was sealed with a Teflon lined cap, and the mixture was 
heated at 100 ºC for 12 h. The solvent was removed under vacuum, and the resulting 
brown solids were purified by chromatography on silica gel (Rf = 0.14 in 40% 
EtOAc/60% hexanes). Product 60-Cl was isolated as a light brown oil (194 mg, 81% 
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yield). 1H NMR (400 MHz, acetone-d6): δ 7.37 (d, J = 8.2 Hz, 1H), 7.19 (d, J = 2.1 Hz, 
1H), 7.15 (dd, J = 8.2, 2.1 Hz, 1H), 3.74 (t, J = 6.7 Hz, 2H), 2.42 (t, J = 8.1 Hz, 2H), 2.32 
(s, 3H), 2.21 (quin, J = 7.2 Hz, 2H). 13C NMR (100 MHz, acetone-d6): δ 174.86, 139.18, 
138.19, 131.53, 130.88, 130.81, 130.05, 50.79, 31.74, 21.05, 20.26. IR (KBr): 2951, 
1700, 1487 cm-1. Anal. Calcd for C11H12ClNO: C, 63.01, H, 5.77, N, 6.68; Found: C, 
62.86, H, 5.64, N, 6.57. The control reaction with substrate 2 (in the absence of Pd 
catalyst) showed multiple mono-chlorinated products, indicative of unselective 






Procedure A was followed, utilizing substrate 61 (150 mg, 0.884 mmol, 1 equiv), NCS 
(212 mg, 1.59 mmol, 1.8 equiv), Pd(OAc)2 (9.90 mg, 0.044 mmol, 5 mol %), and AcOH 
(7.4 mL). Product 61-Cl was isolated as a white solid (126 mg, 70% yield, mp = 133.4-
133.9 ºC, Rf = 0.28 in 80% hexanes/20% EtOAc). 1H NMR (400 MHz, acetone-d6): δ 
8.74 (br s, 1H), 8.35 (d, J = 2.4 Hz, 1H), 7.44 (d, J = 8.4 Hz, 1H), 7.14 (dd, J = 8.4, 2.4 
Hz, 1H), 2.22 (s, 3H). 13C NMR (100 MHz, acetone-d6): δ 169.7, 137.6, 133.3, 131.3, 
125.3, 123.l, 122.8, 24.3. IR (KBr): 1666 cm-1. HRMS EI (m/z): [M+] Calcd for 







Procedure A was followed, utilizing substrate 61 (150 mg, 0.884 mmol, 1 equiv), NCS 
(142 mg, 1.06 mmol, 1.2 equiv), and AcOH (7.4 mL). Product 61-Cl was isolated as a 
white solid (77 mg, 43% yield, mp = 133.4-133.9 ºC, Rf = 0.28 in 80% hexanes/20% 
EtOAc). The NMR data was identical to that reported above for the reaction with 
palladium. The Product Iso-61-Cl was isolated as a white solid (70 mg, 39% yield, mp = 
121.9-123.3 ºC, Rf = 0.24 in 60% hexanes/40% EtOAc).1H NMR (400 MHz, acetone-d6): 
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δ 7.78 (br s, 1H), 7.73 (d, J = 1.8 Hz, 1H), 7.35-7.29 (multiple peaks, 2H), 2.17 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 168.7, 137.3, 132.7, 130.4, 127.5, 121.6, 119.1, 24.5. IR 
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Palladium-Catalyzed Arylhalogenation of Alkenes 
 
 
5.1 Background and Significance 
 
Palladium-catalyzed cascade reactions are widely used for the assembly of 
complex organic molecules.1 These transformations frequently involve σ-alkyl-PdII 
complexes that are formed by olefin insertion into a Pd-aryl bond (2 in Scheme 1).1 The 
Pd-aryl species 1 in these transformations can be generated by oxidative addition of Pd0 
into aryl halides or through transmetallation of aryl metal reagents (Ar-[M]) onto PdII.  
 






















(M = B, Si, Sn)
 
 
Intermediates such as 2 have been shown to undergo a variety of reactions to 
afford valuable functionalized products. For example, 2 is known to undergo β-hydride 
elimination to afford alkene products 3.2 The olefin insertion/β-hydride elimination 
sequence depicted in Scheme 2 is the well-known Mizoroki-Heck Reaction. 
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Alternatively, 2 can be intercepted by olefin/alkyne insertion or by CO insertion to afford 
4 and 5, respectively.3  
 




























In contrast, selective and high yielding approaches to the oxidative 
functionalization of σ-alkyl-PdII intermediates such as 2 remain rare (Scheme 3). These 
reactions would lead to the formation of a C–C bond and a C–X bond (X = Cl, Br, I, F, 
O, N) with concomitant generation of a stereocenter in a single transformation. 
Additionally, the direct conversion of the Pd–C bond of 2 into a variety of C–X bonds 
would make these transformations very valuable for the diverse functionalization of 
easily accessible α-olefins. 
 




















An early report by Heck described the oxidative halogenation of intermediates of 
general structure 2 to form 1,2-arylhalogenated compounds.4,5 For example, the 
palladium-catalyzed reaction of 8 with 9 as the arylating reagent and CuCl2 as the 
terminal oxidant afforded product 10 in 80% yield (Scheme 4). However, competing 
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formation of alkene product 11 (via β-hydride elimination) along with the requirement of 
toxic aryl mercury reagent 9 severely limited the scope, yields, and overall synthetic 
utility of these transformations. 
 
Scheme 4: 1,2-Arylchlorination of 8 
O LiCl, CuCl2 AcOH, 
H2O, 25 °C









(8) (9)  
 
In order to develop general, high yielding and selective methods for the diverse 
oxidative functionalization of intermediates like 2, several challenges need to be 
addressed (Scheme 5). First, the Pd-aryl intermediate 1 has the potential to undergo 
oxidative cleavage prior to olefin insertion, affording substituted arenes 14 rather than the 
desired functionalized product 15.  Secondly, Heck-type chemistry could occur, in which 
the σ-alkyl-Pd species formed upon olefin insertion into the Pd-C bond of 2 undergoes β-
hydride elimination/olefin dissociation to yield alkene products 16. Finally, complex 12, 
generated upon β-hydride elimination might undergo olefin insertion into the Pd-H bond 
to form either of the two isomeric σ-alkyl-Pd intermediates 2 or 13. Subsequent oxidative 
cleavage of the Pd-C bonds of 2 and 12 would afford mixtures of the vicinal and geminal 
difunctionalized products 15 (1,2-isomer) and 17 (1,1-isomer), respectively. Hence, 
reaction conditions must be rationally designed to obtain either the 1,2-product 15 or the 
1,1-product 17. Importantly, the selective formation of either the 1,1- or the 1,2-isomers 
from the same α-olefin reactant would significantly enhance the synthetic applicability of 




























































With these considerations in mind, we initiated investigations towards oxidative 
functionalization of Heck intermediates using electrophilic halogenating reagents 
(halogen = Cl, Br) as the terminal oxidants to obtain the arylhalogenated products 15 and 
17. We anticipated that the wide variety of readily accessible halogenating oxidants6 with 
different reactivities would enable us to have the versatility to design reaction conditions 
to obtain either the 1,1- or the 1,2-arylhalogenated products selectively. In order to obtain 
the 1,2-products selectively, careful control of the relative rate of olefin insertion versus 
oxidation of 2 as well as the relative rate of oxidation of 2 versus β-hydride elimination 
would be essential. We reasoned that the use of solvents that are not employed in Heck 
reactions might assist in preventing β-hydride elimination processes. Heck reactions are 
most commonly conducted in polar solvents such as DMF and DMA. Hence, we thought 
that the use of non-polar solvents such as Et2O or CH2Cl2 might limit β-hydride 
elimination/dissociation processes. More importantly, we hypothesized that selectivity 
could be achieved by using an oxidant that is sufficiently reactive to out-compete β-
hydride elimination from 2, yet attenuated to allow olefin insertion prior to oxidation of 
1.  
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Recent work has demonstrated that σ-Pd-alkyl species generated through C–H 
activation can undergo oxidative halogenation using hypervalent iodine(III) reagents.6-9 
For example, Yu and coworkers have shown that the palladium-catalyzed reaction of 18 
with a combination of I2 and PhI(OAc)2 leads to the iodinated product 19 (Scheme 6).8 
These transformations are proposed to involve C–I reductive elimination from transient 
PdIV intermediates at the key product-forming step. The high reactivity of iodine(III) 
oxidants allows for a faster rate of oxidation of σ-Pd-alkyl intermediate 20 to the 
corresponding PdIV species 20, versus β-hydride elimination.10-13 The resistance of these 
PdIV complexes toward β-hydride elimination allows for the functionalization of 21 in the 
subsequent step with little to no formation of alkene byproducts.  
 






H 10 mol % Pd(OAc)2 

















































(20) (21)  
 
Based on this work, we reasoned that the iodine(III) oxidant PhICl2 might have 
the potential to outcompete β-hydride elimination from palladium alkyl intermediates, 
and allow the formation of the 1,2-arylchlorinated product 22 (Scheme 8).14 Importantly, 
van Koten has demonstrated that high oxidation state PdIV intermediates are accessible 











































Conversely, we envisioned that the use of less reactive oxidants could allow 
access to both the σ-Pd-alkyl and the Pd-benzyl intermediates 2 and 13, respectively, via 
β-hydride elimination/reinsertion processes from 2. In these systems, mixtures of 1,1- and 
1,2-products would be expected if there were no preference for oxidative 
functionalization of 2 versus 13. However, sporadic literature reports have suggested 
selectivity for the reaction of Pd-benzyl intermediates in the presence of other 
equilibrating isomeric σ-Pd-alkyl species.16-20 For example, Tamaru and coworkers 
demonstrated the palladium-catalyzed 1,1-phenylchlorination of 1-octene (Scheme 9).17 
However, the yield for this transformation was not reported and 1-octene was the only 
substrate examined. More recently, a similar 1,1-phenylchlorination reaction was 
demonstrated for substrate 26 with CuCl2 as the oxidant (Scheme 10).16 Based on these 
reports, we speculated that the use of less reactive oxidants such as CuCl26, 21-25 and NCS 
under reaction conditions that favor the oxidative cleavage of 13 versus 2, could 
potentially afford the 1,1-products selectively.  
 




5 mol % PdCl2(PhCN)2
CuCl2, Et2O
(24) (25) (24b-Cl)No yield reported  
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5.2 Synthetic Scope of Arylchlorinations 
 
Our studies began by investigating the Pd-catalyzed reaction of 1-octene with 
PhSnBu3 in the presence of PhICl2 as the terminal oxidant. As discussed above, we 
envisioned that the use of PhICl2 would limit β-hydride elimination from 2 and allow for 
the selective formation of the 1,2-product 22 (Scheme 8). We chose PhSnBu3 as the 
arylating reagent because it is known to transmetallate to PdII to generate phenyl 
palladium species under relatively mild reaction conditions.  
As shown in Table 5.1, we were pleased to find that the desired 1,2-product was 
formed in a number of different solvents at room temperature. Although the 1,1-isomer 
was the major product in most solvents, the 1,2-product was indeed favored in the 
reaction in CH2Cl2, albeit with low selectivity (entry 10). Gratifyingly, lowering the 
reaction temperature to –78 °C afforded the 1,2-product in good selectivity. However, the 























Solvent NMR yieldEntry 1,2:1,1
25%CH2Cl2 2:1




































Gas chromatographic analysis of the crude reaction mixture revealed the 
formation of chlorobenzene as a side product. Based on the proposed mechanism in 
Scheme 5, we theorized that the formation of chlorobenzene might be a result of 
oxidative cleavage of the Pd-aryl complex 1 (generated upon transmetallation) by PhICl2 
prior to olefin insertion. Interestingly, a control experiment showed that this side product 
actually results from the direct reaction of PhICl2 with PhSnBu3 in the absence of the 
palladium catalyst (Scheme 11). 
 





CH2Cl2, -78 to 25 °C
with or without cat. PdII
(25) (28) (29)  
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 This side reaction could then be responsible for the low yield of the desired 1,2-
product, since only a small excess (1.3 equiv) of PhSnBu3 was being used. Consistent 
with this hypothesis, the yield of the 1,2-product increased significantly when an 
additional 1.3 equiv of PhSnBu3 was added one hour after the start of the reaction (to 
make up for the loss due to the side reaction). Hence, under the optimal conditions (10 
mol % PdCl2(PhCN)2, 4 equiv PhICl2, 2.6 equiv of PhSnBu3, CH2Cl2 –78 °C to 25 °C), 
the palladium-catalyzed phenylchlorination of 1-octene (24) afforded the 1,2-product 
24a-Cl in 72% yield and the corresponding 1,1-isomer 24b-Cl in 6% yield (as 
determined by 1H NMR spectroscopy) (Scheme 12). Additionally, very small amounts of 
2,1-phenylchlorinated product 24c-Cl (5%) and dichlorinated product 24-Cl2 (4%) were 
also formed in this reaction. Gratifyingly, only trace (<2%) of the alkene product 30 
generated via β-hydride elimination was observed in the crude reaction mixture.  
 
Scheme 12: Palladium-Catalyzed 1,2-Arylchlorination of 1-Octene 
C6H13
10 mol % PdCl2(PhCN)2
Ph–SnBu3
+ 4 equiv PhICl2
























As shown in Table 5.2, these conditions for the formation of the 1,2-
phenylchlorinated products could be applied to a number of different α-olefins. These 
reactions were tolerant of a wide variety of common functional groups such as esters, 
aromatic and alkyl halides, benzylic hydrogens, amides, silyl ethers, and both electron 
rich and electron poor aryl groups. In all cases, the products were obtained in good to 






Table 5.2: Substrate Scope for 1,2-Phenylchlorination 
Ph
R
10 mol % PdCl2(PhCN)2 
2-4 equiv PhICl2











1,2 Product 1,1 Product
(35a-Cl) (35b-Cl)
(36a-Cl) (36b-Cl)
            Yield 1,2:1,1
(37a-Cl) (37b-Cl)
(38a-Cl) (38b-Cl)
72%     8:1
84%   13:1
96%     9:1
92%   11:1
85%     6:1
86%     8:1
68%     6:1



















































































These reactions were also general with respect to the tin reagent. As shown in 
Table 5.3, electron rich and electron poor substituents, as well as oxidizable 
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functionalities such as benzylic hydrogens and aromatic halides could be well tolerated 
on the arylating component. Furthermore, the sterically hindered o-tolyl tin reagent could 
be effectively used in these transformations. However, in these cases significant 
quantities (12%-14%) of the 2,1-isomer also formed. Interestingly, selectivity for the 1,2-
product was much higher (>20:1) with styrene substrates (Table 5.4) than with those 



























Table 5.3: Substrate Scope for 1,2-Arylchlorination 
Ar
R
10 mol % PdCl2(PhCN)2 
2-4 equiv PhICl2












84%     11:1

























3 96%   10:1




















6 86%   11:1
CH3 CH3
a total yield of the 1,2-, 1,1- and the 2,1-isomers. bRatio is 1,2 : (1,1+1,4). cYield is the sum of 1,2-,

































































81%a   >20:1
81%b   >20:1
80%b   >20:1
63%b   >20:1
(43a-Cl)













a Crude H NMR yields. b Isolated yields  
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Having optimal parameters for the formation of the 1,2-product, we next sought to 
design reaction conditions to obtain selectivity for the 1,1-arylchlorinated product. As 
discussed above in Section 5.1, we reasoned that by switching from the highly reactive 
oxidant PhICl2 to less reactive oxidants such as CuCl2 or N-chlorosuccinimide (NCS), we 
could promote the formation of the 1,1-isomer. We were pleased to discover that under 
otherwise identical conditions to the PhICl2 reaction, the use of NCS or CuCl2 in the 
palladium-catalyzed arylchlorination of 1-octene led to exclusive formation of the 1,1-
product 24b-Cl, albeit in low (<5% and 13%) yields (Table 5.5, entries 1 and 4).  
Gratifyingly, with CuCl2 as the oxidant, ethereal solvents like Et2O and THF resulted in 
the 1,1-product in 59% and 60% yield respectively (Table 5.5, entries 5 and 6). As shown 
in Table 5.6 below, the 1,1-arylchlorination reactions show a substrate scope analogous 
to the 1,2-reactions discussed above. Notably in all cases, only trace amounts of the β-
hydride elimination product are observed, and the 1,1-isomer is obtained in >20:1 
selectivity. 
 
Table 5.5: Optimization for 1,1-Phenylchlorination of 1-Octene 
Ph
R
10 mol % PdCl2(PhCN)2 
Oxidant-Cl























a Yield determined by 1H NMR spectroscopy of crude 






Table 5.6: Substrate Scope for 1,1-Phenylchlorination 
Ph
R
10 mol % PdCl2(PhCN)2 
4 equiv CuCl2










            Yield 1,1:1,2
(37b-Cl)
(38b-Cl)
53%     >20:1
54%   >20:1
71%     >20:1
66%   >20:1
71%     >20:1
45%     >20:1
55%
    
>20:1








































45%     >20:1
70%
dr=1:1
    
>20:1
























Like the 1,2-arylchlorinations, these reactions were also effective with a wide 
array of different arylating reagents. The 1,1-isomer was obtained in excellent selectivity 
with electronically and sterically different aryltributyl tin derivatives (Table 5.7).  
 
Table 5.7: Substrate Scope for 1,1-Arylchlorination 
Ar
R
10 mol % PdCl2(PhCN)2 
4 equiv CuCl2




1,1 Product             Yield 1,1:1,2
(38-p-Brb-Cl)
67%     >20:1
59%   >20:1

















































5.3 Synthetic Scope of Arylbrominations 
 
Having investigated the scope and selectivity of the arylchlorination reactions we 
next turned our efforts towards the development of analogous palladium-catalyzed 
arylbrominations. We reasoned that the use of electrophilic brominating reagents as 
terminal oxidants in place of PhICl2 or CuCl2 should lead to arylbrominated products 
under otherwise identical conditions. However, we did not know how closely the trends 
in site selectivity would compare between the arylchlorinations and arylbrominations. As 
shown in Table 5.8 below, the use of CuBr2 and NBS as oxidants in the palladium-
catalyzed reaction of 1-octene with PhSnBu3 afforded significant quantities of the 
arylbrominated products in a variety of solvents, and the yields were generally higher 
with CuBr2. Furthermore, analogous to the arylchlorination reactions, the use of CuBr2 in 
Et2O led to the corresponding 1,1-arylbrominated product in good yield (54%) and with 
excellent selectivity (>20:1).  
 













Et2O >20:1 0.128 M
16%
3
THF 1:15 0.032 M







CH2Cl2CuBr24 trace product 0.032 M
Solvent NMR yieldEntry 1,1:1,2 [octene]Oxidant
C6H13
10 mol % PdCl2(CH3CN)2 
Oxidant-Br











Interestingly, the use of CuBr2 in THF instead of Et2O led to a complete reversal 
of site selectivity and afforded the 1,2-arylbrominated isomer as the major product (24a-
Br : 24b-Br = 15:1), albeit in low (16%) yield (Table 5.8, entry 6). Notably, this is in 
contrast to the trend observed in the arylchlorinaton reactions, in which the use of CuCl2 
in THF favors the formation of the 1,1-arylhalogenated products. Subsequent 
optimization revealed that that the desired 1,2-phenylbrominated product could be 
obtained in 53% yield simply by increasing the concentration of the reaction mixture to 
0.128 M (Table 5.8, entry 7).  
The major side product formed (~15% yield as determined by 1H NMR 
spectroscopy) in the 1,2-arylbromination of 1-octene in THF was product 52 resulting 
from solvent incorporation in the product. Three possible mechanisms depicted in 
Scheme 13, could account for the formation of 52.26 Further studies need to be conducted 






















































































As shown in Tables 5.9-5.11, the optimal reaction conditions for formation of the 
1,1- and 1,2-arylbrominated products are general for a variety of α-olefins. These 
transformations exhibit a scope and functional group tolerance similar to the 
arylchlorination reactions. Analogous to the 1,2-arylchlorinations with PhICl2, the 1,2-
arylbrominations with CuBr2/THF also afford the 1,2-products with much greater 
selectivity (>20:1) with styrene substrates (Table 5.10) than with those shown in Table 
5.9. The low yields of the arylbrominated products with styrene substrates are partly due 
to the formation of significant quantities (34%–65%) of stilbene derivatives via β-hydride 
elimination. Additionally, 15%–41% of the unreacted substrate also remained at the end 
of the reaction.  
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Table 5.9: Substrate Scope for 1,2-Arylbromination 
Ar
R
10 mol % PdCl2(CH3CN)2 
4 equiv CuBr2










1,2 Product 1,1 Product
(35a-Br) (35b-Br)
            Yield 1,2:1,1
(38a-Br) (38b-Br)
49%a     11:1
55%   15:1
50%     17:1
55%     11:1












































































Table 5.10: 1,2-Arylbromination of Styrene Substrates 
Substrate 1,2 Product 1,2:1,1bEntry
(42a-Br)








































52%   >20:1
30%   >20:1
19%   >20:1
(43a-Br)












aReaction conditions: 10 mol% PdCl2(CH3CN)2, 4 equiv CuBr2, 2 equiv p-XPhSnBu3 added 
at the start of the reaction and another 1 equiv added 4 h after the start of the reaction, THF, 
0.096 M in substrate, -78 °C - 25 °C. b Determined by 1HNMR spectroscopy analysis of the








Table 5.11: Substrate Scope for 1,1-Arylbromination 
Ar
R
10 mol % PdCl2(CH3CN)2 
4 equiv CuBr2










            Yield 1,1:1,2
(37b-Br)
(38b-Br)
57%     >20:1
71%   >20:1
68%     >20:1
61%   >20:1
70%     >20:1
41%     >20:1
37%
    
>20:1

























































5.4 Mechanistic Investigations of 1,2-Arylhalogenations 
 
We next turned our efforts toward obtaining insight into the mechanism of these 
arylhalogenation reactions. In particular, we desired to (i) gain evidence for the proposed 
mechanistic pathway via deuterium labeling studies, (ii) understand the role of the 
oxidants in imparting the 1,2 versus 1,1 selectivity, (iii) investigate the reasons for the 
high selectivity for benzylic functionalization with CuCl2 and CuBr2 in Et2O, and (iv) 
gain insight into the stereochemical course of these transformations.  
Deuterium Labeling Studies: The key steps of the proposed mechanism for the 
formation of the 1,2-arylhalogenated product 15 are as follows: (i) transmetallation 
between ArSnBu3 and the PdII catalyst to form aryl palladium intermediate 1, (ii) 
insertion of alkene into the Pd–C bond of 1 to afford 2, and (iii) oxidative halogenation of 
the Pd–C bond in 2 to release the product and regenerate the catalyst (Scheme 14).  
 




































(X = Cl, Br)
 
 
The observed formation of 24-d2a-Cl and 24-d2a-Br in the reaction of 1-octene–
(1,1-d2) under the standard conditions with PhICl2 and CuBr2/THF, respectively strongly 
supports our mechanistic proposal for the formation of the 1,2-products in these reactions 




Scheme 15: Proposed Pathway for the 1,2-Arylhalogenation of 1-Octene-(1,1-d2) 
10 mol % PdCl2(PhCN)2
4 equiv PhICl2






10 mol % PdCl2(CH3CN)2
4 equiv CuBr2









































(X = Cl, Br)
 
 
 The formation of the 1,1-arylhalogenated products can also be explained based on 
the mechanistic manifold depicted in Scheme 14. β-Hydride elimination from 2, followed 
by fast reinsertion into the Pd–H bond with the opposite regiochemistry, would result in a 
new Pd-alkyl intermediate 13. Oxidative halogenation of 13 would lead to the 1,1-
product 17 (Eq. 3). Consistent with this mechanistic proposal, the reaction of 1-octene-
(1,1-d2) under the 1,1-arylchlorination and 1,1-phenylbromination conditions affords 
products 24-d2b-Cl and 24-d2b-Br, respectively, with clean incorporation of deuterium at 
the 1 and the 2-positions (Schemes 17 and 18).  
 
Scheme 17: Proposed Pathway for the 1,1-Arylhalogenation of 1-Octene-(1,1-d2) 
10 mol % PdCl2(PhCN)2
4 equiv CuCl2






10 mol % PdCl2(CH3CN)2
4 equiv CuBr2






































(53) (54) (55) (24-d2b-X)(24-d2)
Et2O




 Role of Oxidant in 1,2 versus 1,1 Selectivity: As discussed in Sections 5.2 and 
5.3 above, selectivity for the formation of the 1,2- and the 1,1-products is highly 
dependent on the oxidant and the reaction conditions. The use of PhICl2 or CuBr2/THF 
leads to the formation of the 1,2-arylchlorinated or 1,2-arylbrominated isomer as the 
major product. However, the use of CuCl2 and CuBr2/Et2O affords the 1,1-products with 
high selectivity. 
 In order to explain this selectivity, we hypothesized that, with the highly reactive 
oxidant PhICl2, the oxidative chlorination of intermediate 2 is significantly faster that β-
hydride elimination (Scheme 14). Thus, formation of the 1,2-isomer is favored, and is 
observed as the predominant product. Conversely, oxidative chlorination of 2 with the 
less reactive oxidant CuCl2 is slower. This permits equilibration between 2 and 13. In this 
scenario, when both intermediates 2 and 12 are accessible, it appears that halogenation of 
the Pd-benzyl intermediate 13 is more favorable than the halogenation of the Pd-alkyl 
species 2. We propose that this accounts for the observed selectivity for the 1,1-
arylchlorinated product under these conditions.  
 The formation of the 1,2-arylbrominated products with CuBr2 in THF is intriguing 
because the analogous CuCl2 oxidant selectively affords 1,1-arylchlorinated isomers 
under otherwise identical reaction conditions. Very early reports on CuII-mediated 
halogenation reactions suggest that the reactivity of CuBr2 can be altered significantly in 
the presence of donor solvents or coordinating additives.27 For example, the halogenation 
of carbonyl compounds and polynuclear aromatics by CuBr2 require refluxing methanolic 
solutions for long reaction times (3-100 h) to afford the products in low (8-10%) yields. 
In contrast, similar brominations of diolefins could be performed at room temperature 
over 5 – 10 minutes (Scheme 19). This difference in reactivity of CuBr2 toward olefins is 
attributed to the coordination of the diolefin to the CuBr byproduct of the reaction. The 
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consumption of CuBr is proposed to be the driving force for these reactions. Notably, 
however, similar reactions with CuCl2 could only be achieved with strongly coordinating 
additives like acetonitrile.  Based on this precedent we wondered if this reversal of 
selectivity in THF versus Et2O with CuBr2 as the oxidant was a result of the different 
coordinating abilities of the two solvents.  
 
Scheme 19: CuBr2 Mediated Bromination of Diolefins 
CuBr2





Y = Br (10%)
Y = OCH3 (32%)
Y = Br (17%)
Y = OCH3 (41%)  
 
To probe this hypothesis, we subjected 1-octene to the standard reaction 
conditions with CuBr2 as the oxidant using a series of methyl-substituted 
tetrahydrofurans as the solvent.28 Importantly, THF, 2-methyl-THF and 2,5-dimethyl-
THF would be expected to differ significantly in their coordinating abilities, but not in 
their dielectric constants. As shown in Table 5.12, both the yield and the selectivity for 
the 1,2-product decreased as the steric bulk of the solvent increased. These data imply 
that solvent coordination (or lack thereof) to CuBr2 is playing a role in imparting the 
observed site selectivity in the arylbrominations. Thus, although CuBr2 in Et2O may 
behave analogously to CuCl2, we propose that solvent (THF) coordination to CuBr2 
appears to increase its reactivity, resulting in faster oxidative halogenation. This could 
























10 mol % PdCl2(CH3CN)2 
4 equiv CuBr2









Benzylic Functionalization with CuCl2 and CuBr2 in Et2O: As discussed above, 
the arylhalogenation reactions with CuCl2 or CuBr2/Et2O afford the 1,1-arylhalogenated 
products with high selectivity, presumably via preferential functionalization of the Pd-
benzyl intermediate over the equilibrating Pd-alkyl intermediate. Further confirmation of 
this preference for benzylic functionalization was obtained when we examined the Pd-
catalyzed phenylchlorination and phenylbromination of 4-(4-chlorophenyl)-1-butene 
(40). In this homoallyl benzene system, initial olefin insertion of 40 would afford the Pd-
alkyl complex 57. However, subsequent β-hydride elimination/reinsertion processes 
could lead to isomeric Pd-alkyl complexes 56–59, and hence products 40a-X–40d-X 
(Scheme 20). As shown in Scheme 21, these reactions afforded two isomeric 
phenylhalogenated products – 1,1-functionalized 40b-Cl and 40b-Br and 1,4-
functionalized 40d-Cl and 40d-Br – in a 4:1 and a 6:1 ratio respectively. The formation 
of 40d-Cl and 40d-Br (which requires the Pd in 58 to migrate 2 carbons down the alkyl 
chain) confirms that there are equilibrating β-hydride elimination/reinsertion steps prior 
to oxidative cleavage. In addition, the sole formation of 40b-Cl, 40b-Br, 40d-Cl, and 
40d-Br (as opposed to isomers resulting from halogenation at other positions along the 
alkyl chain) supports the proposed selectivity for benzylic functionalization with CuX2 in 
Et2O (Scheme 20). 
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X = Cl or Br
CuCl2 or CuBr2




Scheme 21: Arylhalogenation of 4-(4-chlorophenyl)-1-butene 










10 mol % PdCl2(PhCN)2
4 equiv CuCl2
(68%)























Based on these results, we postulated that CuX2 in Et2O should afford 1,2 
products for substrates such as styrene for which the Pd-alkyl intermediate formed upon 

















(X = Cl, Br)
 
 
 To probe this hypothesis, we subjected styrene to our 1,1-arylhalogenation 
conditions with a number of electronically different tributylaryltin derivatives. As 
predicted, the 1,2-product was the major product of this transformation regardless of the 
electronic nature of the transmetallating reagent or the alkene substrate (Tables 5.13 and 
5.14). Similar preference for the 1,2-products was observed when substituted styrenes 43, 
45, amd 46 were subjected to the 1,1-arylhalogenation conditions with PhSnBu3 as the 
arylating reagent (Tables 5.13 and 5.14). The yields of the products in these cases are 
modest due to formation of significant amounts of the β-hydride products (30%–50%) 
and/or the low reactivity of the substrate (20%–75% of the unreacted substrate was 
















Table 5.13: Arylchlorination of Styrene Substrates with CuCl2 
aYields and selectivities determined by 1H NMR Spectroscopy. bIsolated yields










































49%   7.6:1
50%   2.2:1
38%   2.4:1
(43a-Cl)






















32%b   >20:1















Table 5.14: Arylbromination of Styrene Substrates with CuBr2 in Et2O 










































4%   >20:1
25%   20:1
36%   >20:1
(43a-Br)












aYields and selectivities determined by 1H NMR Spectroscopy. bReaction 
conditions: 10 mol % PdCl2(CH3CN)2, 4 equiv CuBr2, 1.3 equiv PhSnBu3, Et2O, 
0 °C - 25 °C, 0.032 M in substrate  
 
In addition to providing further evidence to support the preference for benzylic 
functionalization with CuX2 in Et2O, the styrene results also help to discount an 
alternative mechanism for the 1,1-arylhalogenations that would involve a standard Heck-
type reaction followed by hydrohalogenation of the resulting olefin 62 (Schemes 23 and 
24). If this sequential Heck/hydrohalogenation mechanism were operating, an identical 
distribution of 42-p-Ra-X and 42-p-Rb-X would be expected for the reactions depicted in 
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Schemes 22 and 23. However, these transformations afforded very different ratios of 42-
p-Ra-X : 42-p-Rb-X (Tables 5.13 and 5.14). 
 















































With the styrene and homoallyl benzene results in hand, we next sought to 
understand the reasons for preferential benzylic functionalization with CuX2 in Et2O. We 
hypothesized that the selectivity for benzylic halogenation might arise from equilibration 
of σ-benzyl Pd intermediate 64 with a corresponding π-benzyl Pd species (65) (Scheme 
25).10 A π-benzyl interaction could lead to increased amounts of the 1,1-product by (i) 
shifting the equilibrium between σ-alkyl complex 63 and 64/65 to the right and/or (ii) 




























To probe this hypothesis, the Pd-catalyzed reactions of 2-vinylnapthalene (67) 
with a number of electronically different aryltributyltin derivatives and CuCl2 or CuBr2 in 
Et2O (Table 5.15) were compared under identical conditions to the styrene reactions in 
Tables 5.13 and 5.14. In both cases, initial alkene insertion would directly generate a Pd-
benzyl or Pd-naphthyl intermediate; therefore, significant quantities of 1,2-
arylhalogenated products were expected in both reactions. Indeed, as shown in Tables 
5.13-5.15, the expected products were observed. The ratio of 1,2- to 1,1-products with 
styrene using CuCl2 as the oxidant ranged from 1:1 to 7.6:1 (Table 5.13), while the 
corresponding reactions with vinylnaphthalene provided a >50:1 ratio of 67-p-Ra-X : 67-
p-Rb-X (Table 5.15, entries 1-4). Similarly, the selectivity for the 1,2-product increased 
from 20:1 (Table 5.14, entry 6) to >50:1 (Table 5.15, entry 5) in going from styrene to 
vinylnaphthalene with CuBr2 as the oxidant and p-fluorophenyltributyl tin as the 
arylating reagent. Literature reports have shown that π-naphthyl complexes are both more 
thermodynamically stable and more kinetically reactive than the corresponding π-benzyl 
species.19,20,29 As such, this large increase in selectivity between styrene and 
vinylnaphthalene provides strong support for π-aryl stabilization as a key factor dictating 







































49%b   >50:1
77%a   >50:1











aYield determined by 1H NMR spectroscopy; bIsolated yield; cSelectivities determined by





69%a   >50:14 CuCl2
 
 
Stereochemistry: Having gained an understanding of the mechanism and 
selectivities in the arylhalogenation reactions, we next desired to investigate the 
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stereochemical course of the C–X (X = Cl, Br) bond forming step. The first step of the 
arylhalogenations described herein is well documented to proceed with syn 
stereochemistry to afford σ-Pd-alkyl intermediates 68 (Scheme 26). In contrast, the 
subsequent oxidative halogenation of the Pd–C bond in 68 could potentially occur with 
retention, inversion, or racemization of stereochemistry at the carbon, depending on the 
substrate, oxidant, and reaction conditions.30-32 In order, to develop enantioselective  
arylhalogenation reactions, it would be essential that the oxidative cleavage occurs with 
either inversion or retention but not racemization. Hence, we wanted to undertake 
stereochemical studies to gain insight into the product forming oxidative halogenation 
step in our arylhalogenation reactions.  
 































We began our studies by subjecting the stereochemically pure internal cis and 
trans olefin substrates cis-72 and trans-72 to our arylhalogenation conditions with 
different oxidants. As shown in Tables 5.16 and 5.17, these reactions proceeded to afford 
significant quantities of the arylhalogenated products under all conditions examined. The 
reactions with CuX2 proceed with modest diastereoselectivities. Diastereomer 72a-X was 
formed as the major product in the reactions with the olefin cis-72, and the opposite 
diastereomer 72b-X was predominant in reactions with the olefin trans-72 which 
illustrates that these transformations proceed stereoselectively. Similarly, with PhICl2, the 
same trend in diastereomer formation was observed with respect to substrate olefin 
geometry. Interestingly however, in contrast to the reactions with CuX2, the 
arylhalogenations of cis-72 and trans-72 with PhICl2 proceeded with excellent levels of 
diastereoselectivity to afford products 72a-X and 72b-X respectively with >20:1 
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selectivity. Importantly, the relative stereochemistry of product 72a-Cl was confirmed by 
X-ray crystallography. The structural assignment for the analogous phenylbrominated 
product 72a-Br was made based on the coupling constant analogy between 72a-Cl and 
72a-Br. However, in order to absolutely confirm the stereochemistry of the products via 
X-ray crystallography, with CuBr2 as the oxidant the arylbrominations of cis-73 and 
trans-73 were examined. The stereochemistry of the major diastereomer from the 
reaction of cis-73 was confirmed using X-ray crystallography analysis. 
 











10 mol % PdII 
Oxidant-X












50%   10:11
Solvent
10%   10:1













































10 mol % PdII 
Oxidant-X












(X = Cl, Br)
Ph
Major:MinorEntry
13%   3:11
Solvent
13%   2:1




















The formation of the major diastereomers in the reactions of cis-72, cis-73, trans-
73 and trans-72 could be explained by the mechanism depicted in Scheme 27. This 
mechanism involves transmetallation between PhSnBu3 and the PdII catalyst to generate 
the PdII-phenyl species. Syn olefin insertion of the cis or the trans alkenes into the Pd–C 
bond would then afford intermediates 74 and 75 respectively. The formation of 72a-X (or 
73a-X for R = acetate) and 72b-X (or 73b-X for R = acetate) as the major diastereomers 
from the reaction of substrates cis-72 (or cis-73) and trans-72 (or trans-73), respectively, 
under our reaction conditions necessitates that the oxidative halogenation of the benzyl 
Pd-alkyl intermediates 74 and 75 proceeds predominantly with retention of 



























































 In order to probe whether the carboxylate groups at the terminus of the substrates 
cis-72, cis-73, trans-73 and trans-72 were playing a role in imparting the observed 
stereoselectivity, we examined the reactions of substrates cis-76 and trans-76. However, 
as shown in Tables 5.18 and 5.19, the major diastereomers from the reaction of these 
substrates also resulted from retention of stereochemistry at oxidative cleavage with all 
oxidants. 
 






10 mol % PdII 
Oxidant-X









55%   9:11
Solvent
30%   7:1





















10 mol % PdII 
Oxidant-X









37%   1.3:11
Solvent
15%   2:1
















 Finally, we desired to assess whether these stereochemical results were unique to 
substrates (such as cis-72, cis-73, cis-76, trans-72, trans-73 and trans-76) for which 
oxidative cleavage occurs at a benzylic position. Hence we studied the arylchlorination of  
substrate 77 with PhICl2 as the oxidant. As shown in Scheme 28 the reaction of 77 
afforded product 77-Cl in 39% NMR yield as the only diastereomer.  X-ray 
crystallography analysis of the product confirmed that this reaction proceeds with 
retention of stereochemistry at the carbon at oxidative cleavage. 
 
Scheme 28: Arylchlorination of Olefin 77 
SnBu3
+
10 mol % PdCl2(PhCN)2
 2 equiv PhICl2

























In summary, we have developed Pd-catalyzed reactions for the arylchlorination 
and the arybromination of α-olefins by oxidatively intercepting Heck intermediates. 
Depending on the nature of the oxidant and the reaction conditions, both 1,1- and 1,2-
arylhalogenated products can be obtained in good yield and with good to excellent 
selectivity. The selectivity of these reactions can be tuned rationally (i) by controlling the 
relative rates of oxidative functionalization versus β-hydride elimination from 
equilibrating PdII-alkyl species and (ii) by π-benzyl stabilization of Pd intermediates. 
Importantly, these reactions form the mechanistic basis for the future development of 
more synthetically useful aryloxygenated, arylaminated and arylfluorinated products 
using a broad scope of oxidants and transmetalating reagents. Additionally, the insights 
gained from the arylhalogenation reactions will be applied toward the development of 
enantioselective versions of these reactions and for the synthesis of complex biologically 
active molecules such as 78 and 79 (Scheme 29). 
 




















5.6 Experimental Procedure 
 
General Procedures: NMR spectra were obtained on a Varian Inova 500 (499.90 MHz 
for 1H; 125.70 MHz for 13C), a Varian Inova 400 (399.96 MHz for 1H; 100.57 MHz for 
13C; 376.34 MHz for 19F), or a Varian Mercury 300 (300.07 MHz for 1H NMR, 75.45 
MHz for 13C) spectrometer. 1H and 13C NMR chemical shifts are reported in parts per 
million (ppm) relative to TMS, with the residual solvent peak used as an internal 
reference. Multiplicities are reported as follows: singlet (s), doublet (d), doublet of 
 202 
doublets (dd), doublet of doublets of doublets (ddd), doublet of triplets (dt), triplet (t), 
quartet (q), quintet (quin), multiplet (m), and broad resonance (br). IR spectra were 
obtained on a Perkin-Elmer Spectrum BX FT-IR spectrometer. 
 
Materials and Methods: Substrates 31,1 33,2 34,3 354 and 365 were prepared using 
literature procedures.1 Substrate 38 was synthesized by reaction of 5-hexen-1-ol with 
Ac2O in pyridine. Substrates 24, 32, 37, 39, 40, 42, 43, 44, 45, 46, 24-d2 and 67 were 
obtained from commercial sources and used as received. PhSnBu3,6 p-XPhSnBu3 (X = 
Cl, F, H, CF3, CH3 and OMe),6 2-naphthylSnBu3,6 PdCl2(CH3CN)2 and PdCl2(PhCN)27 
were prepared using literature procedures. PhICl2 was prepared via a modification of a 
literature procedure,8 was stored at –30 ºC under inert atmosphere, and was prepared 
fresh every three weeks. NCS and CuCl2 were obtained from Acros Organics and Strem 
Chemicals and used without further purification. CH2Cl2 was obtained from Fisher 
Chemical and used without further purification. Diethyl ether was purified using an 
Innovative Technology (IT) solvent purification system composed of activated alumina, 
copper catalyst, and molecular sieves. Flash chromatography was performed on EM 
Science silica gel 60 (0.040–0.063 mm particle size, 230–400 mesh) and thin layer 
chromatography was performed on Merck TLC plates pre-coated with silica gel 60 F254. 
HPLC was performed on a Varian ProStar 210 HPLC using Waters µ-Porasil 10µm silica 
(19 x 300 mm) columns. Melting points were determined with a Mel-Temp 3.0, a 
Laboratory Devices Inc, USA instrument and are uncorrected. Control reactions (in the 
absence of Pd catalyst) were run with 1-octene and styrene, with both PhICl2 and CuCl2 
and showed none of the desired products. In addition, reactions of 30, cis-stilbene and 









A solution of iodobenzene (4 mL) in CH2Cl2 (80 mL) was cooled to 0 ºC. Chlorine gas 
was bubbled through this solution for 10 min, and the resulting reaction mixture was 
stirred at 0 ºC for an additional 0.5 h. The yellow solid that precipitated during the 
reaction was collected on a frit and washed with copious hexane. PhICl2 was obtained as 




PdCl2(PhCN)2 (34.2 mg, 0.089 mmol, 10 mol %) was weighed into a 50 mL Schlenk 
flask. PhICl2 (980 mg, 3.56 mmol, 4.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and a solution of substrate  (100 mg, 0.891 mmol, 1.00 equiv) in 
CH2Cl2 (28 mL) was added. PhSnBu3 (425 mg, 1.159 mmol, 1.30 equiv) was added, and 
the resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 (425 mg, 
1.158 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h.  The reaction mixture was 
gravity filtered through a pad of silica pre-wetted with a 1% solution of Et3N in Et2O, and 
the pad was washed with 1% Et3N in Et2O (2 x 100 mL). The filtrate was dried over 
MgSO4, filtered, and concentrated. The 1H NMR spectrum of this crude reaction mixture 
showed a 10 : 1 ratio of 24a-Cl : 24b-Cl. The product was purified by chromatography 
on silica gel using 0.5% Et3N in hexanes. The product was isolated as a clear oil (140 mg, 
71% yield, Rf = 0.43 in hexanes). Note: The isolated product contained 88% of 24a-Cl 
and 7% of 24b-Cl (13 : 1 ratio of 24a-Cl : 24b-Cl) as well as  traces of the 2,1 isomer 
(4%) and the 1,3 isomer (1%). Samples of 24a-Cl for HRMS and NMR analysis were 
obtained after further purification by HPLC (100% hexanes, 20 mL/min, Waters µ-
porasil 19.1 mm). 1H NMR (500 MHz, CDCl3): δ 7.34 (t, J = 7.50 Hz, 2H), 7.29-7.23 
(multiple peaks, 3H), 4.15-4.10 (m, 1H), 3.07 (d, J = 7.00 Hz, 2H), 1.83-1.77 (m, 1H), 
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1.75-1.67 (m, 1H), 1.64-1.57 (m, 1H), 1.48-1.40 (m, 1H), 1.37-1.26 (multiple peaks, 6H), 
0.91 (t, J = 7.00 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 138.11, 129.34, 128.36, 
126.69, 64.06, 45.03, 37.68, 31.68, 28.74, 26.41, 22.56, 14.04. HRMS EI (m/z): [M+] 





PdCl2(PhCN)2 (12.1 mg, 0.032 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (348 mg, 1.27 mmol, 4.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and a solution of substrate 31 (100 mg, 0.316 mmol, 1.00 equiv) in 
CH2Cl2 (10 mL) was added. PhSnBu3 (150.9 mg, 0.411 mmol, 1.30 equiv) was added, 
and the resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 (150.9 
mg, 0.411 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room 
temperature over 5 h and stirred for an additional 7 h. The reaction mixture was gravity 
filtered through a pad of silica pre-wetted with a 1% solution of Et3N in Et2O, and the pad 
was washed with 1% Et3N in Et2O (2 x 100 mL). The filtrate was dried over MgSO4, 
filtered, and concentrated. The 1H NMR spectrum of this crude reaction mixture showed 
a 10 : 1 ratio of 31a-Cl : 31b-Cl. The product was purified by chromatography on silica 
gel using 1.5% ethyl acetate/98.5% hexanes. The product was isolated as a clear oil (96.5 
mg, 72% yield, Rf = 0.13 in 2% ethyl acetate/98% hexanes). Note: The isolated product 
contained 80% of 31a-Cl and 10% of 31b-Cl (8 : 1 ratio of 31a-Cl : 31b-Cl) as well as  
traces of the 2,1 isomer (6%) and the 1,3 isomer (4%). Samples of 31a-Cl for HRMS and 
NMR analysis were obtained after further purification by HPLC (1.5% ethyl 
acetate/98.5% hexanes, 20 mL/min, Waters µ-porasil 19.1 mm). 1H NMR (500 MHz, 
CDCl3): δ 7.66 (d, J = 8.50 Hz, 2H), 7.31 (t, J = 7.49 Hz, 2H), 7.26-7.23 (m, 1H), 7.20 
(d, J = 7.75 Hz, 2H), 7.07 (d, J = 8.00 Hz, 2H), 4.42 (s, 2H), 4.12-4.06 (m, 1H), 3.44 (t, J 
= 6.25 Hz, 2H), 3.05 (dd, J = 14.24, 7.24 Hz, 1H), 3.01 (dd, J = 14.00, 6.50 Hz, 1H), 
1.82-1.75 (m, 1H), 1.73-1.47 (multiple peaks, 5H). 13C NMR (100 MHz, CDCl3): δ 
138.31, 137.98, 137.46, 129.46, 129.34, 128.41, 126.75, 92.88, 72.22, 70.22, 63.76, 
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PdCl2(PhCN)2 (23.5 mg, 0.061 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (675 mg, 2.45 mmol, 4.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and a solution of substrate 32 (100 mg, 0.613 mmol, 1.00 equiv) in 
CH2Cl2 (9.6 mL) was added. PhSnBu3 (293 mg, 0.797 mmol, 1.3 equiv) was added, and 
the resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 (293 mg, 
0.797 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room 
temperature over 5 h and stirred for an additional 7 h. The reaction mixture was gravity 
filtered through a pad of silica pre-wetted with a 1% solution of Et3N in Et2O, and the pad 
was washed with 1% Et3N in Et2O (2 x 100 mL). The filtrate was dried over MgSO4, 
filtered, and concentrated. The 1H NMR spectrum of this crude reaction mixture showed 
a 12 : 1 ratio of 32a-Cl : 32b-Cl. The product was purified by chromatography on silica 
gel using 0.5% Et3N/99.5% hexanes. The product was isolated as a clear oil (140 mg, 
84% yield, Rf = 0.18 in hexanes). Note: The isolated product contained 80% of 32a-Cl 
and 6% of 32b-Cl (13 : 1 ratio of 32a-Cl : 32b-Cl) as well as  traces of the 2,1 isomer 
(6%) and the 1,3 isomer (8%). Samples of 32a-Cl for HRMS and NMR analysis were 
obtained after further purification by HPLC (100% hexanes, 20 mL/min, Waters µ-
porasil 19.1 mm). 1H NMR (500 MHz, CDCl3): δ 7.32 (t, J = 7.74 Hz, 2H), 7.25 (t, J = 
7.74 Hz, 1H), 7.21 (t, J = 8.00 Hz, 2H), 4.12-4.07 (m, 1H), 3.39 (t, J = 6.75 Hz, 2H), 3.07 
(dd, J = 14.24, 7.74 Hz, 1H, approximate values due to second order effects), 3.03 (dd, J 
= 14.50, 6.99 Hz, 1H, approximate values due to second order effects), 1.92-1.67 
(multiple peaks, 5H), 1.60-1.55 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 137.78, 129.33, 
128.45, 126.83, 63.43, 44.97, 36.62, 33.34, 32.19, 25.14. HRMS EI (m/z): [M+] Calcd for 







PdCl2(PhCN)2 (15.0 mg, 0.039 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (432 mg, 1.57 mmol, 4.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and a solution of substrate 33 (100 mg, 0.393 mmol, 1.00 equiv) in 
CH2Cl2 (6.1 mL) was added. PhSnBu3 (188 mg, 0.511 mmol, 1.30 equiv) was added, and 
the resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 (188 mg, 
0.511 mmol, 1.3 equiv) was added, and the reaction was allowed to warm to room 
temperature over 5 h and stirred for an additional 7 h. The reaction mixture was gravity 
filtered through a pad of silica pre-wetted with a 1% solution of Et3N in Et2O, and the pad 
was washed with 1% Et3N in Et2O (2 x 100 mL). The filtrate was dried over MgSO4, 
filtered, and concentrated. The 1H NMR spectrum of this crude reaction mixture showed 
a >20 : 1 ratio of 33a-Cl : 33b-Cl. The product was purified by chromatography on silica 
gel using 8% ethyl acetate/92% hexanes. The product was isolated as a clear viscous oil 
(137 mg, 96% yield, Rf = 0.20 in 8% ethyl acetate/92% hexanes). Note: The isolated 
product contained 84% of 33a-Cl and 9% of 33b-Cl (9 : 1 ratio of 33a-Cl : 33b-Cl) as 
well as  traces of the 2,1 isomer (7%). Samples of 33a-Cl for HRMS and NMR analysis 
were obtained after further purification by HPLC (3% ethyl acetate/97% hexanes, 20 
mL/min, Waters µ-porasil 19.1 mm).  1H NMR (500 MHz, CDCl3): δ 7.78 (d, J = 8.00 
Hz, 2H), 7.35-7.30 (muliple peaks, 4H), 7.27-7.23 (m, 1H), 7.18 (d, J = 8.50 Hz, 2H), 
4.05-4.00 (multiple peaks, 3H), 3.02 (dd, J = 14.24, 7.24 Hz, 1H), 2.97 (dd, J = 14.00, 
6.49 Hz, 1H), 2.45 (s, 3H), 1.76-1.56 (multiple peaks, 5H), 1.46-1.39 (m, 1H). 13C NMR 
(100 MHz, CDCl3): δ 144.74, 137.73, 133.11, 129.84, 129.29, 128.45, 127.89, 126.83, 
70.20, 63.35, 44.95, 36.82, 28.33, 22.48, 21.64. IR (thin film): 2952, 1358, 1176 cm-1. 





PdCl2(PhCN)2 (11.3 mg, 0.029 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (325 mg, 1.18 mmol, 4.00 equiv) was added to this flask in the glove box. 
 207 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and a solution of substrate 34 (100 mg, 0.295 mmol, 1.00 equiv) in 
CH2Cl2 (9.2 mL) was added. PhSnBu3 (141 mg, 0.384 mmol, 1.30 equiv) was added, and 
the resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 (141 mg, 
0.384 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room 
temperature over 5 h and stirred for an additional 7 h. The reaction mixture was gravity 
filtered through a pad of silica pre-wetted with a 1% solution of Et3N in Et2O, and the pad 
was washed with 1% Et3N in Et2O (2 x 100 mL). The filtrate was dried over MgSO4, 
filtered, and concentrated. The 1H NMR spectrum of this crude reaction mixture showed 
a 10 : 1 ratio of 34a-Cl : 34b-Cl. The product was purified by chromatography on silica 
gel using 1% ethyl acetate/99% hexanes. The product was isolated as a clear oil (122 mg, 
92% yield, Rf = 0.15 in 1% ethyl acetate/99% hexanes). Note: The isolated product 
contained 89% of 34a-Cl and 8% of 34b-Cl (11 : 1 ratio of 34a-Cl : 34b-Cl) as well as  
traces of the 2,1 isomer (3%). Samples of 34a-Cl for HRMS and NMR analysis were 
obtained after further purification by HPLC (0.4% ethyl acetate/99.6% hexanes, 20 
mL/min, Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, CDCl3): δ 7.63 (dd, J = 7.80, 
1.40 Hz, 4H), 7.42-7.32 (multiple peaks, 6H), 7.28 (dd, J = 7.20, 1.40 Hz, 2H), 7.22 (dd, 
J = 6.00, 1.40 Hz, 1H), 7.17 (d, J = 7.20 Hz, 2H), 4.08-4.01 (m, 1H), 3.62 (t, J = 6.20 Hz, 
2H), 2.99 (d, J = 6.80 Hz, 2H), 1.75-1.44 (multiple peaks, 6H), 1.02 (s, 9H). 13C NMR 
(100 MHz, CDCl3): δ 138.04, 135.58, 134.03, 129.54, 129.36, 128.38, 127.60, 126.71, 
63.87, 63.61, 44.96, 37.35, 31.96, 26.89, 22.79, 19.22. HRMS EI (m/z): [M+Na]+ Calcd 







PdCl2(PhCN)2 (8.36 mg, 0.022 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (120 mg, 0.436 mmol, 2.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and a solution of substrate 35 (50.0 mg, 0.218 mmol, 1.00 equiv) 
in CH2Cl2 (3.4 mL) was added. PhSnBu3 (104 mg, 0.284 mmol, 1.30 equiv) was added, 
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and the resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 (104 mg, 
0.284 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room 
temperature over 5 h and stirred for an additional 7 h. The reaction mixture was gravity 
filtered through a pad of silica pre-wetted with a 1% solution of Et3N in Et2O, and the pad 
was washed with 1% Et3N in Et2O (2 x 100 mL). The filtrate was dried over MgSO4, 
filtered, and concentrated. The 1H NMR spectrum of this crude reaction mixture showed 
a 6 : 1 ratio of 35a-Cl : 35b-Cl. The product was purified by chromatography on silica 
gel using 1% ethyl acetate/99% hexanes. The product was isolated as a clear viscous oil 
(62.4 mg, 85% yield, Rf = 0.14 in 8% ethyl acetate/92% hexanes). Note: The isolated 
product contained 80% of 35a-Cl and 13% of 35b-Cl (6 : 1 ratio of 35a-Cl : 35b-Cl) as 
well as  traces of the 2,1 isomer (2%) and the 1,3 isomer (5%). Samples of 35a-Cl for 
HRMS and NMR analysis were obtained after further purification by HPLC (2% ethyl 
acetate/98% hexanes, 20 mL/min, Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, 
CDCl3): δ 7.80 (dd, J = 6.00, 3.20 Hz, 2H), 7.86 (dd, J = 6.00, 3.60 Hz, 2H), 7.31-7.11 
(multiple peaks, 5H), 4.07-4.00 (m, 1H), 3.64 (t, J = 6.80 Hz, 2H), 3.01 (dd, J = 14.00, 
7.60 Hz, 1H), 2.97 (dd, J = 14.00, 6.80 Hz, 1H), 1.83-1.75 (m, 1H), 1.72-1.56 (multiple 
peaks, 4H), 1.50-1.38 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 168.39, 137.88, 133.90, 
132.12, 129.32, 128.41, 126.77, 123.21, 63.51, 45.04, 37.73, 37.07, 28.04, 23.76. IR (thin 
film): 2928, 1716, 1371 cm-1. HRMS EI (m/z): [M+Na]+ Calcd for C20H20ClNO2, 





PdCl2(PhCN)2 (16.4 mg, 0.043 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (469 mg, 1.71 mmol, 4.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and a solution of substrate 36 (100 mg, 0.427 mmol, 1.00 equiv) in 
CH2Cl2 (13 mL) was added. PhSnBu3 (204 mg, 0.555 mmol, 1.30 equiv) was added, and 
the resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 (204 mg, 
0.555 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room 
 209 
temperature over 5 h and stirred for an additional 7 h. The reaction mixture was gravity 
filtered through a pad of silica pre-wetted with a 1% solution of Et3N in Et2O, and the pad 
was washed with 1% Et3N in Et2O (2 x 100 mL). The filtrate was dried over MgSO4, 
filtered, and concentrated. The 1H NMR spectrum of this crude reaction mixture showed 
a 8 : 1 ratio of 36a-Cl : 36b-Cl. The product was purified by chromatography on silica 
gel using 8% ethyl acetate/92% hexanes. The product was isolated as a clear viscous oil 
(126 mg, 86% yield, Rf = 0.19 in 8% ethyl acetate/92% hexanes). Note: The isolated 
product contained 85% of 36a-Cl and 10% of 36b-Cl (8 : 1 ratio of 36a-Cl : 36b-Cl) as 
well as  traces of the 2,1 isomer (5%). Samples of 36a-Cl for HRMS and NMR analysis 
were obtained after further purification by HPLC (3% ethyl acetate/97% hexanes, 20 
mL/min, Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, CDCl3): δ 7.78 (dd, J = 7.79, 
1.80 Hz, 1H), 7.46 (m, 1H), 7.30 (t, J = 7.20 Hz, 2H), 7.26-7.20 (multiple peaks, 3H), 
6.98 (ddd, J = 8.00, 4.40, 1.19 Hz, 2H), 4.29 (t, J = 6.19 Hz, 2H), 4.15-4.08 (m, 1H), 3.90 
(s, 3H), 3.07 (dd, J = 14.00, 7.20 Hz, 1H), 3.03 (dd, J = 14.00, 6.40 Hz, 1H), 1.88-1.69 
(multiple peaks, 5H), 1.64-1.56 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 166.30, 159.12, 
137.87, 133.41, 131.54, 129.33, 128.42, 126.78, 120.31, 120.10, 112.00, 64.53, 63.69, 
55.95, 45.03, 37.17, 28.20, 23.09. IR (thin film): 2922, 1723, 1249 cm-1. HRMS EI (m/z): 




PdCl2(PhCN)2 (32.4 mg, 0.085 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (931 mg, 3.38 mmol, 4.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and a solution of substrate 37 (100 mg, 0.846 mmol, 1.00 equiv) in 
CH2Cl2 (13 mL) was added. PhSnBu3 (404 mg, 1.10 mmol, 1.30 equiv) was added, and 
the resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 (404 mg, 
1.10 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room 
temperature over 5 h and stirred for an additional 7 h. The reaction mixture was gravity 
filtered through a pad of silica pre-wetted with a 1% solution of Et3N in Et2O, and the pad 
was washed with 1% Et3N in Et2O (2 x 100 mL). The filtrate was dried over MgSO4, 
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filtered, and concentrated. The 1H NMR spectrum of this crude reaction mixture showed 
a 5 : 1 ratio of 37a-Cl : 37b-Cl. The product was purified by chromatography on silica 
gel using 0.5% Et3N/99.5% hexanes. The product was isolated as a clear oil (131 mg, 
68% yield, Rf = 0.25 in hexanes). Note: The isolated product contained 80% of 37a-Cl 
and 14% of 37b-Cl (6 : 1 ratio of 37a-Cl : 37b-Cl) as well as  traces of the 2,1 isomer 
(6%). Samples of 37a-Cl for HRMS and NMR analysis were obtained upon further 
purification of the isolated product by chromatography on silica gel using 0.5% 
Et3N/99.5% hexanes. 1H NMR (400 MHz, CDCl3): δ 7.32-7.19 (multiple peaks, 10H), 
4.33-4.26 (m, 1H), 3.10 (dd, J = 14.40, 5.60 Hz, 2H), 3.00 (dd, J = 14.00, 8.00 Hz, 2H). 
13C NMR (100 MHz, CDCl3): δ 137.84, 129.33, 128.42, 126.80, 63.95, 44.29. HRMS EI 





PdCl2(PhCN)2 (26.9 mg, 0.070 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (387 mg, 1.41 mmol, 2.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and a solution of substrate 38 (100 mg, 0.704 mmol, 1.00 equiv) in 
CH2Cl2 (11 mL) was added. PhSnBu3 (336 mg, 0.915 mmol, 1.30 equiv) was added, and 
the resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 (336 mg, 
0.915 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room 
temperature over 5 h and stirred for an additional 7 h. The reaction mixture was gravity 
filtered through a pad of silica pre-wetted with a 1% solution of Et3N in Et2O, and the pad 
was washed with 1% Et3N in Et2O (2 x 100 mL). The filtrate was dried over MgSO4, 
filtered, and concentrated. The 1H NMR spectrum of this crude reaction mixture showed 
a 10 : 1 ratio of 38a-Cl : 38b-Cl. The product was purified by chromatography on silica 
gel using 3% ethyl acetate/97% hexanes. The product was isolated as a clear oil (152 mg, 
86% yield, Rf = 0.13 in 3% ethyl acetate/97% hexanes). Note: The isolated product 
contained 85% of 38a-Cl and 9% of 38b-Cl (10 : 1 ratio of 38a-Cl : 38b-Cl) as well as  
traces of the 2,1 isomer (6%). Samples of 38a-Cl for HRMS and NMR analysis were 
obtained after further purification by HPLC (1.5% ethyl acetate/98.5% hexanes, 20 
 211 
mL/min, Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, CDCl3): δ 7.28 (t, J = 7.40 Hz, 
2H), 7.23-7.21 (m, 1H), 7.17 (d, J = 7.20 Hz, 2H), 4.08-4.00 (m, 1H), 4.01 (t, J = 6.20 
Hz, 2H), 3.03 (dd, J = 13.79, 7.00 Hz, 1H, approximate values due to second order 
effects), 2.98 (dd, J = 14.20, 6.59 Hz, 1H, approximate values due to second order 
effects), 2.00 (s, 3H), 1.80-1.42 (multiple peaks, 6H). 13C NMR (100 MHz, CDCl3): δ 
171.14, 137.84, 129.31, 128.42, 126.80, 64.21, 63.58, 45.04, 37.11, 28.05, 22.98, 20.97. 
IR (thin film): 2923, 1741, 1238 cm-1. HRMS EI (m/z): [M+Na]+ Calcd for C14H19ClO2, 




PdCl2(PhCN)2 (29.0 mg, 0.076 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (832 mg, 3.02 mmol, 4.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and a solution of substrate 39 (100 mg, 0.756 mmol, 1.00 equiv) in 
CH2Cl2 (12 mL) was added. PhSnBu3 (361 mg, 0.983 mmol, 1.30 equiv) was added, and 
the resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 (361 mg, 
0.983 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h.  The reaction mixture was 
filtered through a pad of celite  and washed with copius Et2O (150 mL). The filtrate was 
concentrated. The 1H NMR spectrum of this crude reaction mixture showed a 11 : 1 ratio 
of 39a-Cl : 39b-Cl. The product was purified by chromatography on silica gel using 
0.5% Et3N in hexanes. The product was isolated as a clear oil (137 mg, 75% yield, Rf = 
0.23 in hexanes). Note: The isolated product contained 86% of 39a-Cl and 6% of 39b-Cl 
(14 : 1 ratio of 39a-Cl : 39b-Cl) as well as  traces of the 2,1 isomer (6%) and the 1,2-
dichloro product (1%). Samples of 39a-Cl for HRMS and NMR analysis were obtained 
after further purification by HPLC (100% hexanes, 20 mL/min, Waters µ-porasil 19.1 
mm). 1H NMR (500 MHz, CDCl3): δ 7.31-7.14 (multiple peaks, 10H), 4.11-4.03 (m, 1H), 
3.09-3.00 (multiple peaks, 2H), 2.95-2.89 (m, 1H), 2.76-2.69 (m, 1H), 2.11-1.92 
 212 
(multiple peaks, 2H). 13C NMR (100 MHz, CDCl3): δ 140.96, 137.74, 129.34, 128.50, 





PdCl2(PhCN)2 (23.0 mg, 0.060 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (660 mg, 2.40 mmol, 4.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and substrate 40 (100 mg, 0.600 mmol, 1.00 equiv) and CH2Cl2 
(9.4 mL) were added. PhSnBu3 (286 mg, 0.780 mmol, 1.30 equiv) was added, and the 
resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 (286 mg, 0.780 
mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room temperature 
over 5 h and then stirred for an additional 7 h.  The reaction mixture was filtered through 
a pad of celite and washed with copius Et2O (150 mL). The filtrate was concentrated. The 
1H NMR spectrum of this crude reaction mixture showed a 3 : 1 ratio of 40a-Cl : 40b-Cl. 
The product was purified by chromatography on silica gel using 1% Et3N/99% hexanes. 
The product was isolated as a clear oil (147 mg, 89% yield, Rf = 0.33 in  hexanes). Note: 
The isolated product contained 71% of 40a-Cl and 22% of 40b-Cl (3 : 1 ratio of 40a-Cl : 
40b-Cl) as well as  traces of the 2,1 isomer (7%). Samples of 40a-Cl for HRMS and 
NMR analysis were obtained after further purification by HPLC (100% hexanes, 20 
mL/min, Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, CDCl3): δ 7.28-7.18 (multiple 
peaks, 5H), 7.14 (d, J = 8.8 Hz, 4H), 7.04 (d, J = 8.8 Hz, 4H), 4.03-3.96 (m, 1H), 3.05 
(dd, J = 14.0, 7.2 Hz, 1H), 2.99 (dd, J = 14.0, 6.4 Hz, 1H), 2.89-2.82 (m, 1H), 2.71-2.64 
(m, 1H), 2.05-1.86 (multiple peaks, 2H). 13C NMR (100 MHz, CDCl3): δ 139.37, 137.61, 
131.82, 129.85, 129.32, 128.56, 128.44, 126.85, 62.66, 45.01, 38.99, 31.97. HRMS EI 






PdCl2(PhCN)2 (20.1 mg, 0.052 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (289 mg, 1.05 mmol, 2.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and substrate 41 (100 mg, 0.525 mmol, 1.00 equiv) and CH2Cl2 
(8.2 mL) were added. PhSnBu3 (251 mg, 0.766 mmol, 1.30 equiv) was added, and the 
resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 (251 mg, 0.766 
mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room temperature 
over 5 h and then stirred for an additional 7 h.  The reaction mixture was filtered through 
a pad of celite and washed with copius Et2O (150 mL). The filtrate was concentrated. The 
1H NMR spectrum of this crude reaction mixture showed a 7:1 ratio of 41a-Cl : 41b-Cl. 
The product was purified by chromatography on silica gel using 2% EtOAc/1% 
Et3N/97% hexanes. The product was isolated as a clear oil (131 mg, 83% yield, Rf = 0.14 
in 2% EtOAc/98% hexanes). Note: The isolated product contained 88% of 41a-Cl and 
7% of 41b-Cl (12 : 1 ratio of 41a-Cl : 41b-Cl) as well as  traces of the 2,1 isomer (5%). 
Samples of 41a-Cl for HRMS and NMR analysis were obtained after further purification 
by HPLC (0.2% EtOAc/99.8% hexanes, 20 mL/min, Waters µ-porasil 19.1 mm). 1H 
NMR (400 MHz, CDCl3): δ 7.33-7.19 (multiple peaks, 8H), 7.17 (d, J = 7.2 Hz, 2H), 
4.45 (s, 2H), 4.10-4.02 (m, 1H), 3.43 (t, J = 6.4 Hz, 2H), 3.00 (d, J = 6.8 Hz, 2H), 1.80-
1.44 (multiple peaks, 6H). 13C NMR (100 MHz, CDCl3): δ 138.52, 137.98, 129.32, 






PdCl2(PhCN)2 (11.3 mg, 0.030 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (162 mg, 1.182 mmol, 2.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and a solution of substrate 34 (100 mg, 0.295 mmol, 1.00 equiv) in 
CH2Cl2 (4.6 mL) was added. p-FPhSnBu3 (148 mg, 0.384 mmol, 1.30 equiv) was added, 
and the resulting mixture stirred at –78 °C for 1 h. A second aliquot of p-FPhSnBu3 (148 
mg, 0.384 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h.  The reaction mixture was 
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filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate was 
concentrated. The 1H NMR spectrum of this crude reaction mixture showed a 10:1 ratio 
of 34-p-F-a-Cl : 34-p-F-b-Cl. The product was purified by chromatography on silica gel 
using 0.5% EtOAc/0.5% Et3N/99% hexanes. The product was isolated as a clear oil (116 
mg, 84% yield, Rf = 0.37 in 1% EtOAc/99% hexanes). Note: The isolated product 
contained 81% of 34-p-F-a-Cl and 7% of 34-p-F-b-Cl (11 : 1 ratio of 34-p-F-a-Cl and 
34-p-F-b-Cl) as well as the 2,1 isomer (7%) and the 1,2-dichloro product (5%). Samples 
of 34-p-F-a-Cl for HRMS and NMR analysis were obtained after further purification by 
HPLC (0.2 % EtOAc/99.8% hexanes, 20 mL/min, Waters µ-porasil 19.1 mm). 1H NMR 
(400 MHz, CDCl3): δ 7.67-7.64 (multiple peaks, 4H), 7.44-7.35 (multiple peaks, 6H), 
7.18-7.14 (multiple peaks, 2H), 6.98 (tt, J = 8.40, 3.2 Hz, 2H), 4.05-3.99 (m, 1H), 3.65 (t, 
J = 6.40 Hz, 2H), 3.02-2.93 (multiple peaks, 2H), 1.75-1.49 (multiple peaks, 6H), 1.04 (s, 
9H). 13C NMR (100 MHz, CDCl3): δ 161.75 (1JC-F = 243 Hz), 135.56, 133.98, 133.65 
(4JC-F = 3.0 Hz), 130.81 (3JC-F = 8.5 Hz) 129.55, 127.60, 115.17 (2JC-F = 21Hz) 63.83, 
63.55, 43.99, 37.31, 31.90, 26.86, 22.78, 19.20. 19F NMR (376 MHz, CDCl3): δ  -116.05 









PdCl2(PhCN)2 (16.7 mg, 0.044 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (240 mg, 0.872 mmol, 2.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and a solution of substrate 35 (100 mg, 0.436 mmol, 1.00 equiv) in 
CH2Cl2 (6.8 mL) was added. p-BrPhSnBu3 (252 mg, 0.567 mmol, 1.30 equiv) was added, 
and the resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 (252 mg, 
0.567 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h.  The reaction mixture was 
filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate was 
concentrated. The 1H NMR spectrum of this crude reaction mixture showed a 8 : 1 ratio 
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of 35-p-Br-a-Cl : 35-p-Br-b-Cl. The product was purified by chromatography on silica 
gel using 7% EtOAc/1% Et3N/92% hexanes. The product was isolated as a clear viscous 
oil (178 mg, 96% yield, Rf = 0.12 in 8% EtOAc/92% hexanes). Note: The isolated 
product contained 75% of 35-p-Br-a-Cl and 11% of 35-p-Br-b-Cl (7 : 1 ratio of 35-p-
Br-a-Cl and 35-p-Br-b-Cl) as well as  traces of the 2,1 isomer (5%) and the 1,2-dichloro 
product (9%). Samples of 35-p-Br-a-Cl for HRMS and NMR analysis were obtained 
after further purification by HPLC (5% EtOAc/95% hexanes, 20 mL/min, Waters µ-
porasil 19.1 mm). 1H NMR (500 MHz, CDCl3): δ 7.81 (br s, 2H), 7.70 (br s, 2H), 7.40 (d, 
J = 8.40 Hz, 2H), 7.06 (d, J = 7.60 Hz, 2H), 4.06-3.96 (m, 1H), 3.66 (t, J = 6.80 Hz, 2H), 
3.01-2.91 (multiple peaks, 2H), 1.81-1.60 (multiple peaks, 5H), 1.50-1.40 (m, 1H). 13C 
NMR (100 MHz, CDCl3): δ 168.39, 136.78, 133.92, 132.09, 131.49, 131.05, 123.21, 
120.71, 63.07, 44.28, 37.65, 37.13, 27.96, 23.70. HRMS Electrospray: [M+Na]+ Calcd 






PdCl2(PhCN)2 (9.05 mg, 0.024 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (130 mg, 0.472 mmol, 2.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and a solution of substrate 36 (55.3 mg, 0.236 mmol, 1.00 equiv) 
in CH2Cl2 (3.7 mL) was added. o-CH3PhSnBu3 (117mg, 0.307 mmol, 1.30 equiv) was 
added, and the resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 
(117mg, 0.307 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to 
room temperature over 5 h and then stirred for an additional 7 h.  The reaction mixture 
was filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate 
was concentrated. The 1H NMR spectrum of this crude reaction mixture showed a 10:1 
ratio of 36-o-CH3a-Cl : 35-o-CH3b-Cl. The product was purified by chromatography on 
silica gel using 7% EtOAc/1% Et3N/92% hexanes. The product was isolated as a clear 
viscous oil (60.3 mg, 96% yield, Rf = 0.12 in 8% EtOAc/92% hexanes). Note: The 
isolated product contained 80% of 36-o-CH3a-Cl and 8% of 36-o-CH3b-Cl (10 : 1 ratio 
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of 36-o-CH3a-Cl : 36-o-CH3b-Cl) as well as the 2,1 isomer (12%) and the 1,2-dichloro 
product (0.3%). Samples of 36-o-CH3a-Cl for HRMS and NMR analysis were obtained 
after further purification by HPLC (5% EtOAc/95% hexanes, 20 mL/min, Waters µ-
porasil 19.1 mm). 1H NMR (400 MHz, CDCl3): δ 7.76 (dd, J = 7.80, 1.60 Hz, 1H), 7.47-
7.42 (m, 1H), 7.15-7.12 (multiple peaks, 4H), 6.98-6.94 (multiple peaks, 2H), 4.28 (t, J = 
6.80 Hz, 2H), 4.12-4.05 (m, 1H), 3.88 (s, 3H), 3.10 (dd, J = 14.00, 7.60 Hz, 1H), 3.02 
(dd, J = 14.00, 6.80 Hz, 1H), 2.31 (s, 3H), 1.90-1.60 (multiple peaks, 6H). No further 
characterization was obtained because the 1,2-product was contaminated with significant 





PdCl2(PhCN)2 (7.50 mg, 0.019 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (108 mg, 0.393 mmol, 2.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and a solution of substrate 33 (50.0 mg, 0.196 mmol, 1.00 equiv) 
in CH2Cl2 (3.1 mL) was added. o-CH3PhSnBu3 (97.4 mg, 0.256 mmol, 1.30 equiv) was 
added, and the resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 
(97.4 mg, 0.256 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to 
room temperature over 5 h and then stirred for an additional 7 h.  The reaction mixture 
was filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate 
was concentrated. The 1H NMR spectrum of this crude reaction mixture showed a 7 : 1 
ratio of 33-o-CH3a-Cl : 33-o-CH3b-Cl. The product was purified by chromatography on 
silica gel using 8% EtOAc/1% Et3N/91% hexanes. The product was isolated as a clear 
viscous oil (64.9 mg, 86% yield, Rf = 0.24 in 8% EtOAc/92% hexanes). Note: The 
isolated product contained 79% of 33-o-CH3a-Cl and 7% of 33-o-CH3b-Cl (11 : 1 ratio 
of 33-o-CH3a-Cl : 33-o-CH3b-Cl) as well as  significant quantities of the 2,1 isomer 
(14%). Samples of 33-o-CH3a-Cl for HRMS and NMR analysis were obtained after 
further purification by HPLC (3% EtOAc/97% hexanes, 20 mL/min, Waters µ-porasil 
19.1 mm). 1H NMR (500 MHz, CDCl3): δ 7.79 (d, J = 8.00 Hz, 2H), 7.35 (d, J = 7.50 Hz, 
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2H), 7.20-7.19 (multiple peaks, 4H), 4.05-4.00 (m, 1H), 3.08 (dd, J = 14.00, 7.50 Hz, 
2H), 2.99 (dd, J = 14.50, 6.50 Hz, 1H), 2.46 (s, 3H), 2.33 (s, 3H), 1.78-1.60 (multiple 
peaks, 5H), 1.50-1.40 (m, 1H). Carbon was not obtained because the 1,2-product was 





PdCl2(PhCN)2 (26.9 mg, 0.070 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (387 mg, 1.41 mmol, 2.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and a solution of substrate 38 (100 mg, 0.703 mmol, 1.00 equiv) in 
CH2Cl2 (11 mL) was added. p-CH3PhSnBu3 (349 mg, 0.914 mmol, 1.30 equiv) was 
added, and the resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 
(349 mg, 0.914 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to 
room temperature over 5 h and then stirred for an additional 7 h.  The reaction mixture 
was filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate 
was concentrated. The 1H NMR spectrum of this crude reaction mixture showed a 5 : 1 
ratio of 38-p-CH3a-Cl : 38-p-CH3b-Cl. The product was purified by chromatography on 
silica gel using 1.5% EtOAc/1% Et3N/98% hexanes. The product was isolated as a clear 
viscous oil (121 mg, 66% yield, Rf = 0.11 in 2.5% EtOAc/97.5% hexanes). Note: The 
isolated product contained 73% of 38-p-CH3a-Cl and 15% of 38-p-CH3b-Cl (5 : 1 ratio 
of 38-p-CH3a-Cl : 38-p-CH3b-Cl) as well as  traces of the 2,1 isomer (10%) and the β-
hydride product (3%). Samples of 38-p-CH3a-Cl for HRMS and NMR analysis were 
obtained after further purification by HPLC (1% EtOAc/99% hexanes, 20 mL/min, 
Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, CDCl3): δ 7.12-7.06 (multiple peaks, 
4H), 4.08-4.01 (multiple peaks, 3H), 3.04-2.93 (multiple peaks, 2H), 2.31 (s, 3H), 2.02 (s, 
3H), 1.80-1.43 (multiple peaks, 6H). 13C NMR (100 MHz, CDCl3): δ 171.15, 136.37, 
134.77, 129.18, 129.12, 64.25, 63.78, 44.63, 37.06, 28.07, 22.99, 21.06, 20.97. HRMS EI 






PdCl2(PhCN)2 (29.0 mg, 0.060 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (832 mg, 3.02 mmol, 4.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and substrate 39 (100 mg, 0.980 mmol, 1.00 equiv) and CH2Cl2 
(12 mL) were added. p-ClPhSnBu3 (395 mg, 0.980 mmol, 1.30 equiv) was added, and the 
resulting mixture stirred at –78 °C for 1 h. A second aliquot of p-ClPhSnBu3 (395 mg, 
0.980 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h.  The reaction mixture was 
filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate was 
concentrated. The 1H NMR spectrum of this crude reaction mixture showed a 2 : 1 ratio 
of 39-p-Cla-Cl: (39-p-Clb-Cl + 39-p-Cld-Cl). The product was purified by 
chromatography on silica gel using 1% Et3N/99% hexanes. The product was isolated as a 
clear oil (137 mg, 66% yield, Rf = 0.33 in hexanes). Note: The isolated product contained 
68% of 39-p-Cla-Cl and 29% of 39-p-Clb-Cl + 39-p-Cld-Cl (2 : 1 ratio of 39-p-Cla-Cl: 
(39-p-Clb-Cl + 39-p-Cld-Cl) as well as  traces of the 2,1 isomer (3%). Samples of 39-p-
Cla-Cl for HRMS and NMR analysis were obtained after further purification by HPLC 
(100% hexanes, 20 mL/min, Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, CDCl3): δ 
7.28-7.18 (multiple peaks, 5H), 7.14 (d, J = 8.8 Hz, 4H), 7.04 (d, J = 8.8 Hz, 4H), 4.03-
3.96 (m, 1H), 3.05 (dd, J = 14.0, 7.2 Hz, 1H), 2.99 (dd, J = 14.0, 6.4 Hz, 1H), 2.89-2.82 
(m, 1H), 2.71-2.64 (m, 1H), 2.05-1.86 (multiple peaks, 2H). 13C NMR (100 MHz, 
CDCl3): δ 139.37, 137.61, 131.82, 129.85, 129.32, 128.56, 128.44, 126.85, 62.66, 45.01, 




PdCl2(PhCN)2 (18.4 mg, 0.050 mmol, 5 mol %) was weighed into a 25 mL Schlenk flask. 
CuCl2 (516 mg, 3.84 mmol, 4.00 equiv) was added to this flask in the glove box. The 
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flask was sealed with a rubber septum. The flask was cooled to 0 °C, and substrate 42 
(100 mg, 0.960 mmol, 1.00 equiv) and Et2O (30 mL) was added. PhSnBu3 (458 mg, 1.25 
mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room temperature 
over 5 h and then stirred for an additional 7 h.  The reaction mixture was filtered through 
a pad of celite and washed with copius Et2O (150 mL). The filtrate was extracted with 1 
M aqueous KF solution. The organic layers were extracted once with brine, dried over 
MgSO4 and filtered. The filtrate was concentrated and purified by chromatography on 
silica gel using hexanes. The product 42a-Cl was isolated as a clear oil (126 mg, 60% 
yield, Rf = 0.16 in hexanes). 1H NMR (400 MHz, CDCl3): δ 7.34-7.18 (multiple peaks, 
8H), 7.08 (dd, J = 8.4, 2.0 Hz, 2H), 5.02 (t, J = 7.6 Hz, 1H), 3.37 (dd, J = 14.0, 8.0 Hz, 
1H), 3.32 (dd, J = 14.0, 7.2 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 141.11, 137.43, 
129.39, 128.53, 128.30, 127.11, 126.80, 64.12, 46.47. One of the carbons is 





PdCl2(PhCN)2 (22.2 mg, 0.058 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (319 mg, 1.16 mmol, 2.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and substrate 43 (100 mg, 0.581 mmol, 1.00 equiv) and Et2O (18 
mL) was added. PhSnBu3 (277 mg, 0.755 mmol, 1.30 equiv) was added, and the reaction 
was allowed to warm to room temperature over 5 h and then stirred for an additional 7 h.  
The reaction mixture was filtered through a pad of celite and washed with copius Et2O 
(150 mL). The filtrate was concentrated and purified by chromatography on silica gel 
using 0.5% Et3N/99.5% hexanes. The product 43a-Cl was isolated as a clear oil (127 mg, 
78% yield, Rf = 0.21 in hexanes). 1H NMR (400 MHz, acetone d6): δ 7.57 (d, J = 8.0 Hz, 
2H), 7.43 (d, J = 8.4 Hz, 2H), 7.28-7.20 (multiple peaks, 3H), 7.08 (d, J = 7.2 Hz, 2H), 
5.07 (t, J = 7.2 Hz, 1H), 3.40 (dd, J = 14.0, 7.6 Hz, 1H), 3.30 (dd, J = 14.0, 7.2 Hz, 1H). 
13C NMR (100 MHz, CDCl3): δ 144.90, 136.71, 130.39 (2JC-F = 32 Hz), 129.37, 128.44, 
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127.58, 127.07, 125.50 (3JC-F = 3.7 Hz), 123.91 (1JC-F = 270 Hz), 62.86, 46.40. HRMS EI 





PdCl2(PhCN)2 (27.7 mg, 0.072 mmol, 10 mol %) and PhICl2 (397 mg, 1.44 mmol, 2.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (20 mL) was added in the 
glove box, and the flask was cooled to 0 °C. Substrate 44 (100 mg, 0.721 mmol, 1.00 
equiv) and PhSnBu3 (344 mg, 0.938 mmol, 1.30 equiv) in dry Et2O (2 mL) were added, 
and the reaction was allowed to warm to room temperature over 5 h and then stirred for 
an additional 7 h. The reaction mixture was gravity filtered through a pad of silica pre-
wetted with a 1% solution of Et3N in Et2O, and the pad was washed with 1% Et3N in 
Et2O (2 x 100 mL). The filtrate was dried over MgSO4, filtered, concentrated, and 
purified by chromatography on silica gel using 1% Et3N/99% hexanes. Product 44a-Cl 
was isolated as a clear oil (121 mg, 67% yield, Rf = 0.20 in hexanes). 1H NMR (400 
MHz, CDCl3): δ 7.27-7.29 (multiple peaks, 7H), 7.04 (d, J = 7.34 Hz, 2H), 4.98 (t, J = 
7.39 Hz, 1H), 3.35 (dd, J = 13.79, 7.39 Hz, 1H), 3.25 (dd, J = 14.00, 7.20 Hz, 1H). 13C 
NMR (100 MHz, CDCl3): δ 139.56, 136.97, 134.03, 129.38, 128.69, 128.55, 128.40, 





PdCl2(PhCN)2 (31.4 mg, 0.082 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (450 mg, 1.64 mmol, 2.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and substrate 45 (100 mg, 0.819 mmol, 1.00 equiv) and Et2O (25 
mL) was added. PhSnBu3 (391 mg, 1.064 mmol, 1.30 equiv) was added, and the reaction 
was allowed to warm to room temperature over 5 h and then stirred for an additional 7 h.  
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The reaction mixture was filtered through a pad of celite and washed with copius Et2O 
(150 mL). The filtrate was concentrated and purified by chromatography on silica gel 
using 0.5% Et3N/99.5% hexanes. The product 45a-Cl was isolated as a clear oil (98 mg, 
51% yield, Rf = 0.20 in hexanes). 1H NMR (500 MHz, acetone d6): δ 7.51-7.48 (multiple 
peaks, 2H), 7.25-7.16 (multiple peaks, 5H), 7.12-7.08 (multiple peaks, 2H), 5.31 (t, J = 
6.4 Hz, 1H), 3.42 (dd, J = 14.0, 8.0 Hz, 1H approximate values due to second order 
effects), 3.38 (dd, J = 14.0, 7.5 Hz, 1H approximate values due to second order effects). 
13C NMR (100 MHz, acetone d6): δ 163.28 (1JC-F = 244 Hz), 138.62 (4JC-F = 3.0 Hz), 
138.56, 130.37 (3JC-F = 8 Hz), 130.28, 129.13, 127.59, 116.08 (2JC-F = 22 Hz), 64.02, 




PdCl2(PhCN)2 (32.4 mg, 0.085 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (465 mg, 1.69 mmol, 2.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and substrate 46 (100 mg, 0.846 mmol, 1.00 equiv) and Et2O (36 
mL) was added. PhSnBu3 (404 mg, 1.100 mmol, 1.30 equiv) was added, and the reaction 
was allowed to warm to room temperature over 5 h and then stirred for an additional 7 h.  
The reaction mixture was filtered through a pad of celite and washed with copius Et2O 
(150 mL). The crude NMR showed a 83% yield of 46a-Cl and a >20:1 ratio of 46a-Cl : 
46b-Cl. The filtrate was concentrated and purified by chromatography on silica gel using 
1% pyridine/99% hexanes. A second column was done with 0.5% pyridine/99.5% 
hexanes. The product 46a-Cl was isolated as a clear oil (97 mg, 51% yield, Rf = 0.24 in 
hexanes). 1H NMR (400 MHz, CDCl3): δ 7.29-7.21 (multiple peaks, 5H), 7.16-7.12 
(multiple peaks, 4H), 5.05 (t, J = 7.2 Hz, 1H), 3.40 (dd, J = 14.0, 8.0 Hz, 1H), 3.35 (dd, J 
= 13.6, 6.6 Hz, 1H), 2.35 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 138.22, 138.14, 
137.60, 129.38, 129.20, 128.28, 127.01, 126.75, 64.12, 46.38, 21.15. HRMS EI (m/z): 






PdCl2(PhCN)2 (18.4 mg, 0.048 mmol, 5 mol %) was weighed into a 25 mL Schlenk flask. 
CuCl2 (516 mg, 3.84 mmol, 4.00 equiv) was added to this flask in the glove box. The 
flask was sealed with a rubber septum. The flask was cooled to 0 °C, and substrate 42 
(100 mg, 0.960 mmol, 1.00 equiv) and Et2O (19 mL) was added. p-CF3PhSnBu3 (543 mg, 
1.248 mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h.  The reaction mixture was 
filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate was 
extracted with 1 M aqueous KF solution (2 x 100 mL) and once with brine (1 x 100 mL). 
The combined organic layers were dried over MgSO4 and filtered. The filtrate was 
concentrated and purified by chromatography on silica gel using hexanes. The product 
was isolated as a clear oil (197 mg, 73% yield, Rf = 0.24 in hexanes) as a mixture of 1,1 
ans 1,2-isomers. Samples of 42-p-CF3a-Cl for HRMS and NMR analysis were obtained 
after further purification by HPLC (100% hexanes, 20 mL/min, Waters µ-porasil 19.1 
mm).  1H NMR (400 MHz, CDCl3): δ 7.50 (d, J = 8.0 Hz, 2H), 7.34-7.29 (multiple peaks, 
5H), 7.21 (d, J = 8.0 Hz, 2H), 5.03 (t, J = 6.8 Hz, 1H), 3.42 (dd, J = 14.0, 8.0 Hz, 1H), 
3.37 (dd, J = 14.0, 6.8 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 141.37, 140.59, 129.78, 
129.14 (2JC-F = 32 Hz), 128.67, 128.57, 127.03, 125.24 (3JC-F = 3.6 Hz), 124.14 (1JC-F = 






PdCl2(PhCN)2 (18.4 mg, 0.048 mmol, 5 mol %) and CuCl2 (258 mg, 1.92 mmol, 4.00 
equiv) were weighed into a 50 mL Schlenk flask. Dry Et2O (15 mL) was added in the 
glove box, and the flask was cooled to 0 °C. Substrate 42 (50.0 mg, 0.480 mmol, 1.00 
equiv) and p-ClPhSnBu3 (251 mg, 0.624 mmol, 1.30 equiv) were added, and the reaction 
was allowed to warm to room temperature over 5 h and then stirred for an additional 7 h. 
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The reaction mixture was gravity filtered through a pad of silica pre-wetted with a 1% 
solution of Et3N in Et2O, and the pad was washed with 1% Et3N in Et2O (2 x 100 mL). 
The filtrate was dried over MgSO4, filtered, and concentrated. The 1H NMR spectrum of 
this crude reaction mixture showed a 3 : 1 ratio of 42-p-Cla-Cl : 42-p-Clb-Cl. The crude 
product was purified by chromatography on silica gel using 0.5% Et3N/99.5% hexanes. 
The product was isolated as a clear oil as a 2 : 1 mixture of 42-p-Cla-Cl and 42-p-Clb-Cl 
(52 mg, 44% yield, Rf = 0.20 in hexanes). Since 42-p-Cla-Cl and 42-p-Clb-Cl were 
inseparable, samples of 42-p-Cla-Cl and 42-p-Clb-Cl for HRMS and NMR analysis were 
obtained from the reactions of styrene and p-chlorostyrene, respectively, with PhICl2. 





PdCl2(PhCN)2 (36.8 mg, 0.096 mmol, 10 mol %) and PhICl2 (528 mg, 1.92 mmol, 2.00 
equiv) were weighed into a 50 mL Schlenk flask. Dry Et2O (28 mL) was added in the 
glove box, and the flask was cooled to 0 °C. Substrate 42 (100 mg, 0.960 mmol, 1.00 
equiv) and p-ClPhSnBu3 (501 mg, 1.25 mmol, 1.30 equiv) in dry Et2O (2 mL) were 
added, and the reaction was allowed to warm to room temperature over 5 h and then 
stirred for an additional 7 h. The reaction mixture was gravity filtered through a pad of 
silica pre-wetted with a 1% solution of Et3N in Et2O, and the pad was washed with 1% 
Et3N in Et2O (2 x 100 mL). The filtrate was dried over MgSO4, filtered, concentrated, 
and purified by chromatography on silica gel using 1% Et3N/99% hexanes. Product 42-p-
Cla-Cl was isolated as a white solid (195 mg, 81% yield, Rf = 0.26 in hexanes, mp = 
76.0-76.7 ºC). 1H NMR (500 MHz, CDCl3): δ 7.35-7.29 (multiple peaks, 5H), 7.23 (d, J 
= 8.00 Hz, 2H), 7.03 (d, J = 8.50, 2H), 5.00 (t, J = 7.24 Hz, 1H), 3.37 (dd, J = 14.00, 8.00 
Hz, 1H), 3.30 (dd, J = 13.75, 6.74 Hz, 1H). 13C NMR (100 MHz, Acetone-d6): δ 142.06, 
137.61, 132.84, 132.05, 129.32, 129.15, 128.98, 128.11, 64.51, 45.75. HRMS EI (m/z): 






PdCl2(PhCN)2 (36.8 mg, 0.096 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (528 mg, 1.92 mmol, 2.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and substrate 42 (100 mg, 0.96 mmol, 1.00 equiv) and Et2O (30 
mL) was added. p-FPhSnBu3 (481 mg, 1.06 mmol, 1.30 equiv) was added, and the 
reaction was allowed to warm to room temperature over 5 h and then stirred for an 
additional 7 h.  The reaction mixture was filtered through a pad of celite and washed with 
copius Et2O (150 mL). The filtrate was concentrated and purified by chromatography on 
silica gel using 0.5% Et3N/99.5% hexanes. The product 42-p-Fa-Cl was isolated as a 
clear oil (177 mg, 80% yield, Rf = 0.24 in hexanes). 1H NMR (500 MHz, acetone d6): δ 
7.45 (d, J = 8.0 Hz, 2H), 7.37-7.22 (multiple peaks, 5H), 7.00 (d, J = 8.8 Hz, 2H), 5.25 (t, 
J = 7.6 Hz, 1H), 3.40 (dd, J = 14.0, 8.0 Hz, 1H), 3.37 (dd, J = 14.0, 7.2 Hz, 1H). 13C 
NMR (100 MHz, acetone d6): δ 162.60 (1JC-F = 242 Hz), 142.19, 134.78 (4JC-F = 2.9 Hz), 
132.16 (3JC-F = 8 Hz), 129.38, 129.18, 128.17, 115.67 (2JC-F = 21 Hz), 64.88, 45.77. 19F 
NMR (376 MHz, acetone-d6): δ -117.58 – -117.66. HRMS EI (m/z): [M]+ Calcd for 




PdCl2(PhCN)2 (36.8 mg, 0.096 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (528 mg, 1.92 mmol, 2.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire and cooled 
to -78 °C. Et2O (28 mL) was added. A solution of substrate 42 (100 mg, 0.96 mmol, 1.00 
equiv) in dry Et2O (1 mL) and p-CH3PhSnBu3 (475 mg, 1.25 mmol, 1.30 equiv) in dry 
Et2O (1 mL) were added, and the reaction was allowed to warm to room temperature over 
5 h and then stirred for an additional 7 h. The reaction mixture was filtered through a pad 
of celite and washed with copius Et2O (150 mL). The filtrate was concentrated and 
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purified by chromatography on silica gel using 1% Et3N/99% hexanes. Product 42-p-
CH3a-Cl was isolated as a clear oil (137 mg, 63% yield, Rf = 0.24 in hexanes). 1H NMR 
(400 MHz, CDCl3): δ 7.39-7.29 (multiple peaks, 5H), 7.08 (d, J = 7.6 Hz,1H), 7.02 (d, J 
= 8.0 Hz, 1H), 5.04 (t, J = 7.6 Hz, 1H), 3.41-3.30 (multiple peaks, 2H) 2.32 (s, 3H). 13C 
NMR (100 MHz, CDCl3): δ 141.24, 136.35, 134.39, 129.25, 129.00, 128.50, 128.25, 





PdCl2(PhCN)2 (18.4 mg, 0.050 mmol, 5 mol %) and CuCl2 (516 mg, 3.84 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to 0 °C. Et2O (30 mL) was added at 
0 °C. Substrate 42 (100 mg, 0.960 mmol, 1.00 equiv) in Et2O (1 mL) and o-CH3PhSnBu3 
(476 mg, 1.25 mmol, 1.30 equiv) were added, and the reaction was allowed to warm to 
room temperature over 5 h and then stirred for an additional 7 h. The reaction mixture 
was filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate 
was extracted with 1 M aqueous KF solution (2 x 100 mL) and once with brine (1 x 100 
mL). The combined organic layers were dried over MgSO4 and filtered. The filtrate was 
concentrated. The crude 1H NMR spectrum of this reaction mixture showed a 6:1 ratio 
6:1. The crude product was purified by chromatography on silica gel using hexanes. 
Product 42-o-CH3a-Cl was isolated as an oil (95 mg, 43% yield, Rf = 0.13 in hexanes) as 
a mixture of 42-o-CH3a-Cl and 42-o-CH3b-Cl. Samples of 42-o-CH3a-Cl for HRMS 
and NMR analysis were obtained after further purification by HPLC (100% hexanes, 20 
mL/min, Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, CDCl3): δ 7.33-7.24 (multiple 
peaks, 5H), 7.11-7.00 (multiple peaks, 4H), 5.02 (t, J = 8.0 Hz, 1H), 3.40 (dd, J = 14.4, 






PdCl2(PhCN)2 (18.4 mg, 0.050 mmol, 5 mol %) and CuCl2 (516 mg, 3.84 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to 0 °C. Et2O (30 mL) was added at 
0 °C. Substrate 42 (100 mg, 0.960 mmol, 1.00 equiv) in Et2O (1 mL) and p-
OMePhSnBu3 (496 mg, 1.25 mmol, 1.30 equiv) were added, and the reaction was 
allowed to warm to room temperature over 5 h and then stirred for an additional 7 h. The 
reaction mixture was filtered through a pad of celite and washed with copius Et2O (150 
mL). The filtrate was concentrated. The filtrate was extracted with 1 M aqueous KF 
solution (2 x 100 mL) and once with brine (1 x 100 mL). The combined organic layers 
were dried over MgSO4 and filtered. The crude product was purified by chromatography 
on silica gel using  a gradient of hexanes to 1% EtOAc/99 % hexanes to 2% EtOAc/98% 
hexanes. Product 42-p-OMea-Cl was isolated as an oil (75 mg, 32% yield, Rf = 0.20 in 
2% EtOAc/98% hexanes). Samples of 42-p-OMea-Cl for HRMS and NMR analysis 
were obtained after further purification by HPLC (2% EtOAc/98% hexanes, 20 mL/min, 
Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, CDCl3): δ 7.33-7.26 (multiple peaks, 
5H), 6.99 (d, J = 7.6 Hz, 2H), 6.78 (d, J = 7.2 Hz, 2H), 4.98 (t, J = 7.2 Hz, 1H), 3.74 (s, 
3H), 3.32 (dd, J = 14.4, 8.0 Hz, 1H), 3.26 (dd, J = 14.4, 7.2 Hz, 1H). 
 
Cl  
PdCl2(PhCN)2 (34.2 mg, 0.089 mmol, 10 mol %) and CuCl2 (479 mg, 3.565 mmol, 4.00 
equiv) were weighed into a 50 mL Schlenk flask. Dry Et2O was added in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire and cooled 
to –78 °C. Substrate 24 (100 mg, 0.891 mmol, 1.00 equiv) and PhSnBu3 (425 mg, 1.158 
mmol, 1.30 equiv) were added, and the reaction was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h. The reaction mixture was 
gravity filtered through a pad of silica pre-wetted with a 1% solution of Et3N in Et2O, and 
 227 
the pad was washed with 1% Et3N in Et2O (2 x 100 mL). The filtrate was dried over 
MgSO4, filtered, concentrated, and purified by chromatography on silica gel that was pre-
wetted with 0.5% Et3N in hexanes. Product 24b-Cl was isolated as a clear oil (98.0 mg, 
50% yield, Rf = 0.53 in hexanes). 1H NMR (400 MHz, CDCl3): δ 7.39-7.24 (multiple 
peaks, 5H), 4.85 (dd, J = 8.00, 6.79 Hz, 1H), 2.17-1.98 (multiple peaks, 2H), 1.51-1.41 
(m, 1H), 1.37-1.20 (multiple peaks, 9H), 0.87 (t, J = 6.40 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): δ 142.01, 128.56, 128.15, 126.92, 63.89, 39.99, 31.73, 29.08, 28.97, 27.08, 






PdCl2(PhCN)2 (12.1 mg, 0.032 mmol, 10 mol %) and CuCl2 (170 mg, 1.27 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (8 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. A solution of substrate 31 (100 mg, 0.316 mmol, 1.00 equiv) in dry 
Et2O (2 mL) and PhSnBu3 (150.9 mg, 0.411 mmol, 1.30 equiv) were added, and the 
reaction was allowed to warm to room temperature over 5 h and then stirred for an 
additional 7 h. The reaction mixture was gravity filtered through a pad of silica pre-
wetted with a 1% solution of Et3N in Et2O, and the pad was washed with 1% Et3N in 
Et2O (2 x 100 mL). The filtrate was dried over MgSO4, filtered, concentrated, and 
purified by chromatography on silica gel. Product 31b-Cl was isolated as a clear oil (70.9 
mg, 53% yield, Rf = 0.13 in 1.5% ethyl acetate/98.5% hexanes). 1H NMR (500 MHz, 
CDCl3): δ 7.66 (d, J = 8.00 Hz, 2H), 7.37-7.28 (multiple peaks, 5H), 7.07 (d, J = 7.50 Hz, 
2H), 4.84 (t, J = 7.00 Hz, 1H), 4.42 (s, 2H), 3.43 (t, J = 6.00 Hz, 2H), 2.17-2.09 (m, 1H), 
2.06-1.99 (m, 1H), 1.59 (quin, J = 6.87 Hz, 2H), 1.53-1.46 (m, 1H), 1.44-1.28 (multiple 
peaks, 3H). 13C NMR (100 MHz, CDCl3): δ 141.87, 138.33, 137.39, 129.40, 128.56, 
128.16, 126.88, 92.83, 72.13, 70.27, 63.68, 39.90, 29.46, 26.83, 25.60. HRMS EI (m/z): 





PdCl2(PhCN)2 (23.5 mg, 0.061 mmol, 10 mol %) and CuCl2 (330 mg, 2.45 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (17 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. A solution of substrate 32 (100 mg, 0.613 mmol, 1.00 equiv) in dry 
Et2O (2 mL), and PhSnBu3 (292.7 mg, 0.797 mmol, 1.3 equiv) were added, and the 
reaction was allowed to warm to room temperature over 5 h and then stirred for an 
additional 7 h. The reaction mixture was gravity filtered through a pad of silica pre-
wetted with a 1% solution of Et3N in Et2O, and the pad was washed with 1% Et3N in 
Et2O (2 x 100 mL). The filtrate was dried over MgSO4, filtered, concentrated, and 
purified by chromatography on silica gel using 0.5% triethylamine/99.5% hexanes. 
Product 32b-Cl was isolated as a clear oil (100 mg, 60% yield, Rf = 0.21 in hexanes). 
Note: The isolated product also contained 11% of the 1,6 isomer. Samples of 32b-Cl for 
HRMS and NMR analysis were obtained after further purification by HPLC (100% 
hexanes, 20 mL/min, Waters µ-porasil 19.1 mm).  1H NMR (400 MHz, CDCl3): δ 7.40-
7.28 (multiple peaks, 5H), 4.86 (dd, J = 8.00, 6.40 Hz, 1H), 3.39 (t, J = 6.60 Hz, 2H), 
2.20-2.00 (multiple peaks, 2H), 1.86 (quin, J = 7.00 Hz, 2H), 1.58-1.45 (multiple peaks, 
3H), 1.41-1.31 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 141.74, 128.63, 128.25, 126.88, 
63.55, 39.77, 33.61, 32.47, 27.50, 26.22. HRMS EI (m/z): [M+] Calcd for C12H16ClBr, 




PdCl2(PhCN)2 (13.7 mg, 0.036 mmol, 10 mol %) and CuCl2 (192 mg, 1.43 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (9 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. A solution of substrate 33 (90.7 mg, 0.357 mmol, 1.00 equiv) in 
dry Et2O (2 mL) and PhSnBu3 (188 mg, 0.511 mmol, 1.30 equiv) were added, and the 
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reaction was allowed to warm to room temperature over 5 h and then stirred for an 
additional 7 h. The reaction mixture was gravity filtered through a pad of silica pre-
wetted with a 1% solution of Et3N in Et2O, and the pad was washed with 1% Et3N in 
Et2O (2 x 100 mL). The filtrate was dried over MgSO4, filtered, concentrated, and 
purified by chromatography on silica gel using 8% ethyl acetate/92% hexanes. Product 
33b-Cl was isolated as a viscous clear oil (91.5 mg, 71% yield, Rf = 0.18 in 8% ethyl 
acetate/92% hexanes). 1H NMR (500 MHz, CDCl3): δ 7.78 (d, J = 8.49 Hz, 2H), 7.37-
7.28 (multiple peaks, 7H), 4.79 (dd, J = 8.24, 6.24 Hz, 1H), 4.01(t, J = 6.24 Hz, 2H), 2.44 
(s, 3H), 2.10-2.03 (m, 1H), 2.00-1.93 (m, 1H), 1.63 (quin, J = 6.87 Hz, 2H), 1.48-1.22 
(multiple peaks, 4H). 13C NMR (100 MHz, CDCl3): δ 144.69, 141.69, 133.15, 129.82, 
128.64, 128.28, 127.87, 126.85, 70.29, 63.49, 39.70, 28.62, 26.40, 24.81, 21.63. IR (thin 
film): 2940, 1358, 1175 cm-1. HRMS EI (m/z): [M+Na]+ Calcd for C19H23ClO3S, 




PdCl2(PhCN)2 (11.3 mg, 0.029 mmol, 10 mol %) and CuCl2 (159 mg, 1.18 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (7 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. A solution of substrate 34 (100 mg, 0.295 mmol, 1.00 equiv) in dry 
Et2O (2 mL) and PhSnBu3 (141 mg, 0.384 mmol, 1.30 equiv) were added, and the 
reaction was allowed to warm to room temperature over 5 h and then stirred for an 
additional 7 h. The reaction mixture was gravity filtered through a pad of silica pre-
wetted with a 1% solution of Et3N in Et2O, and the pad was washed with 1% Et3N in 
Et2O (2 x 100 mL). The filtrate was dried over MgSO4, filtered, concentrated, and 
purified by chromatography on silica gel using 1% ethyl acetate/99% hexanes. Product 
34b-Cl was isolated as a clear oil (86.7 mg, 66% yield, Rf = 0.18 in 1% ethyl acetate/99% 
hexanes). 1H NMR (400 MHz, CDCl3): δ 7.67 (dd, J = 7.80, 1.40 Hz, 4H), 7.45-7.28 
(multiple peaks, 11H), 4.83 (dd, J = 8.00, 6.40 Hz, 1H), 3.65 (t, J = 6.40 Hz, 2H), 2.17-
1.98 (multiple peaks, 2H), 1.59-1.26 (multiple peaks, 6H), 1.05 (s, 9H). 13C NMR (100 
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MHz, CDCl3): δ 141.92, 135.55, 134.03, 129.51, 128.58, 128.17, 127.58, 126.91, 63.77, 
63.67, 39.96, 32.27, 26.86, 26.82, 25.21, 19.20. HRMS EI (m/z): [M+Na]+ Calcd for 







PdCl2(PhCN)2 (16.7 mg, 0.044 mmol, 10 mol %) and CuCl2 (235 mg, 1.74 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (12 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. A solution of substrate 35 (100 mg, 0.436 mmol, 1.00 equiv) in dry 
Et2O (2 mL) and PhSnBu3 (208 mg, 0.567 mmol, 1.30 equiv) were added, and the 
reaction was allowed to warm to room temperature over 5 h and then stirred for an 
additional 7 h. The reaction mixture was gravity filtered through a pad of silica pre-
wetted with a 1% solution of Et3N in Et2O, and the pad was washed with 1% Et3N in 
Et2O (2 x 100 mL). The filtrate was dried over MgSO4, filtered, concentrated, and 
purified by chromatography on silica gel using 8% ethyl acetate/92% hexanes. Product 
35b-Cl was isolated as a clear viscous oil (106 mg, 71% yield, Rf = 0.20 in 8% ethyl 
acetate/92%hexanes). 1H NMR (400 MHz, CDCl3): δ 7.83 (dd, J = 5.40, 3.00 Hz, 2H), 
7.70 (dd, J = 5.60, 2.80 Hz, 2H), 7.37-7.25 (multiple peaks, 5H), 4.83 (dd, J = 8.00, 6.40 
Hz, 1H), 3.66 (t, J = 7.20 Hz, 2H), 2.19-1.98 (multiple peaks, 2H), 1.67 (quin, J = 7.40 
Hz, 2H), 1.58-1.49 (m, 1H), 1.43-1.31 (multiple peaks, 3H). 13C NMR (100 MHz, 
CDCl3): δ 168.42, 141.77, 133.88, 132.10, 128.59, 128.20, 126.89, 123.17, 63.59, 39.78, 
37.83, 28.39, 26.64, 26.27. IR (thin film): 2938, 1709, 1395 cm-1. HRMS EI (m/z): 






PdCl2(PhCN)2 (16.4 mg, 0.043 mmol, 10 mol %) and CuCl2 (229 mg, 1.71 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (11 mL) was added in the 
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glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. A solution of substrate 36 (100 mg, 0.427 mmol, 1.00 equiv) in dry 
Et2O (2 mL) and PhSnBu3 (204 mg, 0.555 mmol, 1.30 equiv) were added, and the 
reaction was allowed to warm to room temperature over 5 h and then stirred for an 
additional 7 h. The reaction mixture was gravity filtered through a pad of silica pre-
wetted with a 1% solution of Et3N in Et2O, and the pad was washed with 1% Et3N in 
Et2O (2 x 100 mL). The filtrate was dried over MgSO4, filtered, concentrated, and 
purified by chromatography on silica gel using 8% ethyl acetate/92% hexanes. Product 
36b-Cl was isolated as a clear viscous oil (98.0 mg, 67% yield, Rf = 0.20 in 8% ethyl 
acetate/92% hexanes). Note: The isolated product also contained 4% of the 1,6 isomer. 
1H NMR (500 MHz, CDCl3): δ 7.78 (dd, J = 7.74, 1.74 Hz, 1H), 7.46 (td, J = 7.49 1.50 
Hz, 1H), 7.38-7.28 (multiple peaks, 5H), 6.99-6.96 (multiple peaks, 2H), 4.85 (dd, J = 
8.00, 6.49 Hz, 1H), 4.28 (t, J = 6.50 Hz, 2H), 3.89 (s, 3H), 2.20-2.12 (m, 1H), 2.09-2.02 
(m, 1H), 1.75 (quin, J = 6.99 Hz, 2H), 1.58-1.54 (m, 1H), 1.53-1.46 (multiple peaks, 2H), 
1.43-1.35 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 166.26, 159.10, 141.81, 133.38, 
131.48, 128.61, 128.23, 126.89, 120.33, 120.09, 112.00, 64.64, 63.64, 55.93, 39.90, 
28.51, 26.74, 25.51. IR (thin film): 2938, 1723, 1490 cm-1. HRMS EI (m/z): [M+Na]+ 
Calcd for C20H23ClO3, 369.1233; Found, 369.1241.  
 
Cl  
PdCl2(PhCN)2 (2.90 mg, 0.008 mmol, 10 mol %) and CuCl2 (40.6 mg, 0.302 mmol, 4.00 
equiv) were weighed into a 4 mL scintillation vial. Et2O (1.2 mL) and CH3NO2 (1.2 mL) 
was added, and the vial was cooled to 0 °C. Substrate 37 (8.92 mg, 0.075 mmol, 1.00 
equiv) and PhSnBu3 (36.0 mg, 0.098 mmol, 1.30 equiv) were added, and the vial was 
sealed with a Teflon lined cap. The reaction was allowed to warm to room temperature 
over 5 h and then stirred for an additional 7 h. Ten identical reactions were set up and 
then combined for purification. The reaction mixture was gravity filtered through a pad of 
silica pre-wetted with a 1% solution of Et3N in Et2O, and the pad was washed with 1% 
Et3N in Et2O (2 x 100 mL). The filtrate was dried over MgSO4, filtered, concentrated, 
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and purified by chromatography on silica gel using 0.5% Et3N/99.5% hexanes. Product 
37b-Cl was isolated as a clear oil (94.4 mg, 55% yield, Rf = 0.21 in hexanes). 1H NMR 
(400 MHz, acetone d6): δ 7.45 (d, J = 8.00 Hz, 2H), 7.38 (t, J = 7.40 Hz, 2H), 7.32 (dt, J 
= 7.20, 2.00 Hz, 1H), 7.28 (t, J = 7.40 Hz, 2H), 7.22-7.17 (multiple peaks, 3H), 4.99 (dd, 
J = 8.20, 6.20 Hz, 1H), 2.84-2.77 (m, 1H), 2.70-2.63 (m, 1H), 2.48-2.31 (multiple peaks, 
2H). 13C NMR (100 MHz, acetone-d6): δ 142.68, 141.73, 129.48, 129.29, 129.24, 129.14, 
127.92, 126.89, 63.86, 42.24, 33.82. HRMS EI (m/z): [M+] Calcd for C15H15Cl, 





PdCl2(PhCN)2 (26.9 mg, 0.070 mmol, 10 mol %) and CuCl2 (378 mg, 2.81 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (20 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. A solution of substrate 38 (100 mg, 0.704 mmol, 1.00 equiv) in dry 
Et2O (2 mL) and PhSnBu3 (336 mg, 0.915 mmol, 1.30 equiv) were added, and the 
reaction was allowed to warm to room temperature over 5 h and then stirred for an 
additional 7 h. The reaction mixture was gravity filtered through a pad of silica pre-
wetted with a 1% solution of Et3N in Et2O, and the pad was washed with 1% Et3N in 
Et2O (2 x 100 mL). The filtrate was dried over MgSO4, filtered, concentrated, and 
purified by chromatography on silica gel using 2.5% ethyl acetate/0.5% Et3N/97% 
hexanes. Product 38b-Cl was isolated as a clear oil (126 mg, 71% yield, Rf = 0.13 in 3% 
ethyl acetate/97% hexanes). 1H NMR (400 MHz, CDCl3): δ 7.39-7.28 (multiple peaks, 
5H), 4.84 (dd, J = 8.19, 6.59 Hz, 1H), 4.04 (t, J = 6.80 Hz, 2H), 2.19-1.98 (multiple 
peaks, 2H), 2.04 (s, 3H), 1.62 (quin, J = 7.00 Hz, 2H), 1.55-1.48 (m, 1H), 1.44-1.31 
(multiple peaks, 3H). 13C NMR (100 MHz, CDCl3): δ 171.14, 141.78, 128.60, 128.22, 
126.86, 64.31, 63.60, 39.85, 28.37, 26.69, 25.38, 20.96. IR (thin film): 2939, 1737, 1240 





PdCl2(PhCN)2 (14.5 mg, 0.038 mmol, 10 mol %) and CuCl2 (203 mg, 1.51 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (10 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. A solution of substrate 39 (50.0 mg, 0.378 mmol, 1.00 equiv) in 
dry Et2O (2 mL) and PhSnBu3 (181 mg, 0.492 mmol, 1.30 equiv) were added, and the 
reaction was allowed to warm to room temperature over 5 h and then stirred for an 
additional 7 h. The reaction mixture was filtered through a pad of celite, and the pad was 
washed with Et2O (2 x 100 mL). The filtrate was concentrated and purified by 
chromatography on silica gel using 0.5% Et3N/99.5% hexanes. Product 39b-Cl was 
isolated as a clear oil (76 mg, 84% yield, Rf = 0.23 in hexanes). 1H NMR (400 MHz, 
CDCl3): δ 7.36-7.24 (multiple peaks, 7H), 7.20-7.14 (multiple peaks, 3H), 4.87 (t, J = 
7.20 Hz, 1H), 2.65 (t, J = 7.60 Hz, 2H), 2.22-2.02 (multiple peaks, 2H), 1.90-1.79 (m, 
1H), 1.71-1.60 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 141.74, 141.70, 128.60, 128.35, 
128.22, 126.90, 125.88, 63.59, 39.43, 35.19, 28.73. HRMS EI (m/z): [M+] Calcd for 




1H NMR (500 MHz, CDCl3): δ 7.41-7.30 (multiple peaks, 5H), 4.89 (t, J = 6.5 Hz, 1H), 
4.14-4.06 (multiple peaks, 2H), 2.24-2.08 (multiple peaks, 2H), 2.06 (s, 3H), 1.93-1.83 





1H NMR (500 MHz, CDCl3) (mixture of diastereomers): δ 7.36-7.30 (multiple peaks, 
10H), 5.80-5.75 (m, 1H), 4.87-4.82 (m, 1H), 2.21-1.82 (multiple peaks, 7H). 13C NMR 
(100 MHz, CDCl3) (mixture of diastereomers): δ 171.81, 41.31, 141.30, 140.03, 140.00, 
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128.66, 128.65, 128.52, 128.36, 128.34, 128.04, 126.82, 126.37, 75.28, 74.99, 63.27, 





1H NMR (400 MHz, CDCl3) (mixture of diastereomers): δ 7.32-7.23 (multiple peaks, 
8H), 7.17-7.15 (multiple peaks, 2H), 6.82-6.74 (multiple peaks, 4H), 4.70 (t, J = 8.0 Hz, 
1H), 4.58 (t, J = 7.2 Hz, 1H), 4.37-4.19 (multiple peaks, 4H), 3.76 (quin, J = 7.6 Hz, 1H), 
3.40 (quin, J = 8.0 Hz, 1H), 2.70-2.57 (multiple peaks, 2H), 2.52 (t, J = 6.8 Hz, 2H), 2.35 




PdCl2(PhCN)2 (7.54 mg, 0.020 mmol, 10 mol %) and CuCl2 (106 mg, 0.786 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (4.1 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. A solution of substrate 33 (50.0 mg, 0.197 mmol, 1.00 equiv) in 
dry Et2O (1 mL) and o-CH3PhSnBu3 (97.4 mg, 0.256 mmol, 1.30 equiv) in dry Et2O (1 
mL) were added, and the reaction was allowed to warm to room temperature over 5 h and 
then stirred for an additional 7 h. The reaction mixture was filtered through a pad of celite 
and washed with copius Et2O (150 mL). The filtrate was concentrated and purified by 
chromatography on silica gel using 7% ethyl acetate/1% Et3N/92% hexanes. Product 33-
o-CH3b-Cl was isolated as a viscous clear oil (50.0 mg, 67% yield, Rf = 0.15 in 8% ethyl 
acetate/92% hexanes). 1H NMR (400 MHz, CDCl3): δ 7.77 (d, J = 8.00 Hz, 2H), 7.42 (d, 
J = 7.20 Hz, 1H), 7.43 (d, J = 8.00 Hz, 2H), 7.23-7.12 (multiple peaks, 3H), 5.05 (dd, J = 
8.80, 6.00 Hz, 1H), 4.00 (t, J = 6.40 Hz, 2H), 2.43 (s, 3H), 2.35 (s, 3H), 2.14-2.04 (m, 
1H), 2.01-1.93 (m, 1H), 1.63 (quin, J = 6.87 Hz, 2H), 1.52-1.25 (multiple peaks, 4H). 13C 
NMR (100 MHz, CDCl3): δ 144.70, 139.55, 133.14, 133.14, 130.55, 129.82, 128.07, 
127.86, 126.56, 126.33, 70.28, 59.55, 38.50, 28.63, 26.54, 24.90, 21.62, 19.01. HRMS EI 








PdCl2(PhCN)2 (13.5 mg, 0.035 mmol, 10 mol %) and CuCl2 (189 mg, 1.41 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (9 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. A solution of substrate 38 (50.0 mg, 0.352 mmol, 1.00 equiv) in 
dry Et2O (1 mL) and p-BrPhSnBu3 (203 mg, 0.457 mmol, 1.30 equiv) in dry Et2O (1 mL) 
were added, and the reaction was allowed to warm to room temperature over 5 h and then 
stirred for an additional 7 h. The reaction mixture was filtered through a pad of celite and 
washed with copius Et2O (150 mL). The filtrate was concentrated and purified by 
chromatography on silica gel using 1.5% ethyl acetate/1% Et3N/97.5% hexanes. Product 
38-p-Brb-Cl was isolated as a viscous clear oil (63.0 mg, 54% yield, Rf = 0.11 in 2.5% 
ethyl acetate/97.5% hexanes). 1H NMR (500 MHz, CDCl3): δ 7.46 (d, J = 6.80 Hz, 2H), 
7.23 (d, J = 6.40 Hz, 2H), 4.77 (t, J = 7.6 Hz, 1H), 4.02 (t, J = 6.80 Hz, 2H), 2.13-1.90 
(multiple peaks, 2H), 1.63-1.56 (m, 1H), 1.52-1.27 (multiple peaks, 5H). 13C NMR (100 
MHz, CDCl3): δ 171.13, 140.81, 131.75, 128.59, 122.08, 64.25, 62.61, 39.76, 28.35, 







PdCl2(PhCN)2 (6.11 mg, 0.016 mmol, 10 mol %) and CuCl2 (85.6 mg, 0.637 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (3.0 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. A solution of substrate 34 (53.9 mg, 0.159 mmol, 1.00 equiv) in 
dry Et2O (1 mL) and p-FPhSnBu3 (79.7 mg, 0.207 mmol, 1.30 equiv) in dry Et2O (1 mL) 
were added, and the reaction was allowed to warm to room temperature over 5 h and then 
stirred for an additional 7 h. The reaction mixture was filtered through a pad of celite and 
washed with copius Et2O (150 mL). The filtrate was concentrated and purified by 
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chromatography on silica gel using 0.5% ethyl acetate/0.5% Et3N/99% hexanes. Product 
34-p-Fb-Cl was isolated as a viscous clear oil (43.0 mg, 59% yield, Rf = 0.33 in 1% ethyl 
acetate/99% hexanes). 1H NMR (400 MHz, CDCl3): δ 7.67-7.65 (multiple peaks, 4H), 
7.45-7.32 (multiple peaks, 8H), 7.03 (tt, J =  8.8, 2.0 Hz, 2H), 4.81 (t, J = 8.00 Hz, 1H), 
3.65 (t, J = 6.00 Hz, 2H), 2.15-1.93 (multiple peaks, 2H), 1.58-1.20 (multiple peaks, 6H), 
1.05 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 162.36 (JC-F = 246.75 Hz), 137.80 (JC-F = 
3.12 Hz), 135.55, 134.03, 129.52, 128.65 (JC-F = 8.56 Hz), 127.58, 115.48 (JC-F = 21.75 
Hz), 63.63, 62.88, 40.04, 32.24, 26.86, 26.77, 25.18, 19.20. 19F NMR (376.34 MHz, 






PdCl2(PhCN)2 (13.5 mg, 0.035 mmol, 10 mol %) and CuCl2 (189 mg, 1.41 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (9 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. A solution of substrate 38 (50.0 mg, 0.352 mmol, 1.00 equiv) in 
dry Et2O (1 mL) and p-CH3PhSnBu3 (174 mg, 0.457 mmol, 1.30 equiv) in dry Et2O (1 
mL) were added, and the reaction was allowed to warm to room temperature over 5 h and 
then stirred for an additional 7 h. The reaction mixture was filtered through a pad of celite 
and washed with copius Et2O (150 mL). The filtrate was concentrated and purified by 
chromatography on silica gel using 1.5% ethyl acetate/1% Et3N/97.5% hexanes. Product 
38-p-CH3b-Cl was isolated as a viscous clear oil (68.0 mg, 73% yield, Rf = 0.11 in 2.5% 
ethyl acetate/97.5% hexanes). 1H NMR (400 MHz, CDCl3): δ 7.26 (d, J = 8.4, 2H), 7.15 
(d, J = 7.6, 2H), 4.82 (t, J = 7.20 Hz, 1H), 4.04 (t, J = 6.40 Hz, 2H), 2.34 (s, 3H), 2.19-
1.98 (multiple peaks, 2H), 2.02 (s, 3H), 1.61 (quin, J = 6.80 Hz, 2H), 1.54-1.46 (m, 1H), 
1.42-1.30 (multiple peaks, 3H). 13C NMR (100 MHz, CDCl3): δ 171.18, 138.87, 138.10, 






PdCl2(PhCN)2 (7.54 mg, 0.020 mmol, 10 mol %) and CuCl2 (106 mg, 0.786 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (4.1 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. A solution of substrate 33 (50.0 mg, 0.197 mmol, 1.00 equiv) in 
dry Et2O (1 mL) and 2-naphthylPhSnBu3 (107 mg, 0.256 mmol, 1.30 equiv) in dry Et2O 
(1 mL) were added, and the reaction was allowed to warm to room temperature over 5 h 
and then stirred for an additional 7 h. The reaction mixture was filtered through a pad of 
celite and washed with copius Et2O (150 mL). The filtrate was concentrated and purified 
by chromatography on silica gel using 8% ethyl acetate/1% Et3N/91% hexanes. Product 
33-2-naphthylb-Cl was isolated as a viscous clear oil (34.4 mg, 42% yield, Rf = 0.19 in 
8% ethyl acetate/92% hexanes). 1H NMR (400 MHz, CDCl3): δ 7.84-7.74 (multiple 
peaks, 6H), 7.49-7.45 (multiple peaks, 3H), 7.30 (d, J = 8.0, 2H), 4.95 (t, J = 6.40 Hz, 
1H), 3.99 (td, J = 8.40, 2.00 Hz, 2H), 2.42 (s, 3H), 2.20-2.01 (multiple peaks, 2H), 1.61 
(quin, J = 6.40 Hz, 2H), 1.46-1.29 (multiple peaks, 4H). 13C NMR (100 MHz, CDCl3): δ 
144.69, 138.85, 133.15, 133.0, 129.81, 128.72, 128.02, 127.85, 127.68, 126.45, 126.40, 
125.88, 124.46, 70.28, 63.73, 39.57, 28.62, 26.45, 24.85, 21.62. Two carbons are 








PdCl2(PhCN)2 (8.40 mg, 0.022 mmol, 10 mol %) and CuCl2 (117 mg, 0.872 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (4.8 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. A solution of substrate 35 (50.0 mg, 0.218 mmol, 1.00 equiv) in 
dry Et2O (1 mL) and p-BrPhSnBu3 (126 mg, 0.284 mmol, 1.30 equiv) in dry Et2O (1 mL) 
were added, and the reaction was allowed to warm to room temperature over 5 h and then 
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stirred for an additional 7 h. The reaction mixture was filtered through a pad of celite and 
washed with copius Et2O (150 mL). The filtrate was concentrated and purified by 
chromatography on silica gel using 8% ethyl acetate/1% Et3N/91% hexanes. Product 35-
p-Brb-Cl was isolated as a viscous clear oil (43 mg, 47% yield, Rf = 0.20 in 8% ethyl 
acetate/92% hexanes). However, the yield is approximate because the 1H NMR of the 
isolated product contained some aromatic impurity. 1H NMR (400 MHz, CDCl3): δ 7.84-
7.74 (multiple peaks, 6H), 7.49-7.45 (multiple peaks, 3H), 7.30 (d, J = 8.0, 2H), 4.95 (t, J 
= 6.40 Hz, 1H), 3.99 (td, J = 8.40, 2.00 Hz, 2H), 2.42 (s, 3H), 2.20-2.01 (multiple peaks, 
2H), 1.61 (quin, J = 6.40 Hz, 2H), 1.46-1.29 (multiple peaks, 4H). 13C NMR (100 MHz, 
CDCl3): δ 168.40, 140.79, 133.88, 132.08, 131.74, 128.60, 123.17, 122.06, 62.58, 39.66, 





PdCl2(CH3CN)2 (23.1 mg, 0.089 mmol, 10 mol %) and CuBr2 (796 mg, 3.56 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (7 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. Substrate 24 (100 mg, 0.891 mmol, 1.00 equiv) PhSnBu3 (425 mg, 
1.159 mmol, 1.30 equiv) and CuBr (128 mg, 0.891 mmol, 1.00 equiv) in THF were 
added, and the reaction was allowed to warm to room temperature over 5 h and then 
stirred for an additional 7 h. The reaction mixture was filtered through a pad of celite and 
washed with copius Et2O (150 mL). The filtrate was concentrated  and the crude product 
was purified by chromatography on silica gel using 0.5% Et3N/99.5% hexanes. Product 
was isolated as a viscous clear oil (124.0 mg, 53% yield, Rf = 0.80 in hexanes) as a 10:1 
mixture of 24a-Br:24b-Br. Samples of 24a-Br for HRMS and NMR analysis were 
obtained after further purification by HPLC (100% hexanes, 20 mL/min, Waters µ-
porasil 19.1 mm). 1H NMR (400 MHz, CDCl3): δ 7.32-7.18 (multiple peaks, 5H), 4.19 
(m, 1H), 3.16 (multiple peaks, 2H), 1.87-1.74 (multiple peaks, 2H), 1.59 (m, 1H), 1.40 
(m, 1H), 1.32-1.26 (multiple peaks, 5H), 0.87 (t, J = 6.4 Hz, 3H). 13C NMR (100 MHz, 
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CDCl3): δ 138.66, 129.20, 128.38, 126.72, 57.83, 45.72, 38.18, 31.63, 28.60, 27.51, 





52 was the major side product isolated from the 1,2-phenylbromination of 1-octene. After 
the desired product from the 1,2-arylbromination of 1-octene was isolated, the column 
was eluted with 100 % EtOAc and the eluent collected and concentrated and then 
chromatographed using 2% EtOAc/98% hexanes to obtain product 52 (Rf = 0.54 in 5% 
EtOAc/95% hexanes). 1H NMR (400 MHz, CDCl3): δ 7.28-7.16 (multiple peaks, 5H), 
3.44-3.30 (multiple peaks, 5H), 2.76 (dd, J = 13.60, 6.80 Hz, 1H), 2.69 (dd, J = 13.20, 
5.60 Hz, 1H), 1.83 (quin, J = 7.2 Hz, 2H), 1.60 (quin, J = 5.6 Hz, 2H), 1.45-1.14 
(multiple peaks, 10H), 0.86 (t, J = 6.80 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 139.39, 
129.43, 128.16, 125.98, 81.14, 68.29, 40.95, 34.18, 33.83, 31.85, 29.63, 29.41, 28.66, 






PdCl2(CH3CN)2 (5.10 mg, 0.020 mmol, 10 mol %) and CuBr2 (175 mg, 0.786 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. THF (1 mL) was added 
at -78 °C. A solution of substrate 33 (50.0 mg, 0.197 mmol, 1.00 equiv) in THF (0.53 
mL) and PhSnBu3 (93.8 mg, 0.256 mmol, 1.30 equiv) were added sequentially, and the 
reaction was allowed to warm to room temperature over 5 h and then stirred for an 
additional 7 h. The reaction mixture was filtered through a pad of celite and washed with 
copius Et2O (150 mL). The filtrate was concentrated and the crude product was purified 
by chromatography on silica gel using 8% EtOAc/1% Et3N/91% hexanes. Product was 
isolated as a viscous clear oil (40.0 mg, 50% yield, Rf = 0.18 in 8% EtOAc/92% hexanes) 
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as a 17:1 mixture of 33a-Br and 33b-Br. Samples of 33a-Br for HRMS and NMR 
analysis were obtained after further purification by HPLC (3% EtOAc/97% hexanes, 20 
mL/min, Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, CDCl3): δ 7.78 (d, J = 8.4 Hz, 
2H), 7.35-7.23 (multiple peaks, 5H), 7.17 (d, J = 8.8 Hz, 2H), 4.12 (m, 1H), 4.01 (t, J = 
6.0 Hz, 2H), 3.17 (dd, J = 14.40, 7.60 Hz, 1H), 3.09 (dd, J = 14.00, 6.8 Hz, 1H) 2.44 (s. 
3H), 1.83-1.57 (multiple peaks, 5H), 1.44 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 
144.74, 138.29, 133.09, 129.85, 129.15, 128.47, 127.89, 126.87, 70.16, 56.80, 45.65, 








PdCl2(CH3CN)2 (11.3 mg, 0.044 mmol, 10 mol %) and CuBr2 (390 mg, 1.74 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. THF (2.4 mL) was 
added at -78 °C.  A solution of substrate 35 (100 mg, 0.436 mmol, 1.00 equiv) in THF (1 
mL) and PhSnBu3 (208 mg, 0.567 mmol, 1.30 equiv) were added sequentially, and the 
reaction was allowed to warm to room temperature over 5 h and then stirred for an 
additional 7 h. The reaction mixture was filtered through a pad of celite and washed with 
copius Et2O (150 mL). The filtrate was concentrated and the 1H NMR spectrum of this 
crude reaction mixture showed a 9 : 1 ratio of 35a-Br : 35b-Br. The crude product was 
purified by chromatography on silica gel using 8% EtOAc/1% Et3N/91% hexanes. 
Product was isolated as a viscous clear oil (91 mg, 55% yield, Rf = 0.16 in 8% 
EtOAc/92% hexanes) as a 11:1 mixture of 35a-Br:35b-Br. Samples of 35a-Br for 
HRMS and NMR analysis were obtained after further purification by HPLC (3.5% 
EtOAc/96.5% hexanes, 20 mL/min, Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, 
CDCl3): δ 7.84 (dd, J = 5.2, 3.2 Hz, 2H), 7.71 (dd, J = 5.2, 2.8 Hz, 2H), 7.32-7.18 
(multiple peaks, 5H), 4.18 (m, 1H), 3.67 (t, J = 7.2 Hz, 2H), 3.19 (dd, J = 14.40, 8.00 Hz, 
1H), 3.12 (dd, J = 14.00, 6.4 Hz, 1H), 1.91-1.60 (multiple peaks, 5H), 1.47 (m, 1H). 13C 
NMR (100 MHz, CDCl3): δ 168.38, 138.43, 133.90, 132.11, 129.17, 128.44, 126.80, 
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123.21, 57.02, 45.75, 37.69, 37.55, 27.88, 24.89. HRMS EI (m/z): [M+Na]+ Calcd for 





PdCl2(CH3CN)2 (18.2 mg, 0.070 mmol, 10 mol %) and CuBr2 (628 mg, 2.81 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. THF (4.5 mL) was 
added at -78 °C.  A solution of substrate 38 (100 mg, 0.703 mmol, 1.00 equiv) in THF (1 
mL) and PhSnBu3 (336 mg, 0.914 mmol, 1.30 equiv) were added sequentially, and the 
reaction was allowed to warm to room temperature over 5 h and then stirred for an 
additional 7 h. The reaction mixture was filtered through a pad of celite and washed with 
copius Et2O (150 mL). The filtrate was concentrated and the 1H NMR spectrum of this 
crude reaction mixture showed a 9 : 1 ratio of 38a-Br : 38b-Br. The crude product was 
purified by chromatography on silica gel using 2.5% EtOAc/1% Et3N/96.5% hexanes. 
Product was isolated as a viscous clear oil (128 mg, 62% yield, Rf = 0.11 in 2.5% 
EtOAc/97.5% hexanes) as a 15:1 mixture of 38a-Br : 38b-Br. Samples of 38a-Br for 
HRMS and NMR analysis were obtained after further purification by HPLC (1.5% 
EtOAc/98.5% hexanes, 20 mL/min, Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, 
CDCl3): δ 7.32-7.22 (multiple peaks, 3H), 7.18 (d, J = 8.0 Hz, 2H), 4.17 (m, 1H), 4.03 (t, 
J = 6.0 Hz, 2H), 3.20 (dd, J = 14.40, 7.60 Hz, 1H), 3.12 (dd, J = 14.40, 7.2 Hz, 1H), 2.02 
(s, 3H), 1.87-1.55 (multiple peaks, 5H), 1.48 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 
171.13, 138.43, 129.18, 128.47, 126.85, 64.19, 57.11, 45.76, 37.62, 27.94, 24.13, 20.97. 




PdCl2(CH3CN)2 (15.5 mg, 0.060 mmol, 10 mol %) and CuBr2 (536 mg, 2.40 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. THF (4.7 mL) was 
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added at -78 °C. Substrate 40 (100 mg, 0.600 mmol, 1.00 equiv) and PhSnBu3 (286 mg, 
0.780 mmol, 1.30 equiv) were added sequentially, and the reaction was allowed to warm 
to room temperature over 5 h and then stirred for an additional 7 h. The reaction mixture 
was filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate 
was concentrated and the 1H NMR spectrum of this crude reaction mixture showed a 14 : 
1 ratio of 40a-Br : 40b-Br. The crude product was purified by chromatography on silica 
gel using 1% pyridine/99% hexanes. Product was isolated as a viscous clear oil (130 mg, 
68% yield, Rf = 0.26 in hexanes) as a 18:1 mixture of 40a-Br:40b-Br. Note: The isolated 
product also contained approximately 4.5% of the 2,1 phenylhalogenated (Cl or Br) 
product. Samples of 40a-Br for HRMS and NMR analysis were obtained after further 
purification by HPLC (100% hexanes, 20 mL/min, Waters µ-porasil 19.1 mm). 1H NMR 
(400 MHz, CDCl3): δ 7.25-7.15 (multiple peaks, 5H), 7.09 (d, J = 7.2 Hz, 2H), 7.00 (d, J 
= 8.4 Hz, 2H), 4.06 (m, 1H), 3.16 (dd, J = 14.00, 7.20 Hz, 1H), 3.08 (dd, J = 14.40, 6.8 
Hz, 1H), 2.84 (m, 1H), 2.65 (m, 1H), 2.07-1.92 (multiple peaks, 2H). 13C NMR (100 
MHz, CDCl3): δ 139.19, 138.17, 131.84, 129.85, 129.17, 128.56, 128.46, 126.89, 56.18, 






PdCl2(CH3CN)2 (7.70 mg, 0.029 mmol, 10 mol %) and CuBr2 (264 mg, 1.18 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. THF (1.3 mL) was 
added at -78 °C. A solution of substrate 34 (100 mg, 0.295 mmol, 1.00 equiv) in THF (1 
mL) and PhSnBu3 (141 mg, 0.384 mmol, 1.30 equiv) were added sequentially, and the 
reaction was allowed to warm to room temperature over 5 h and then stirred for an 
additional 7 h. The reaction mixture was filtered through a pad of celite and washed with 
copius Et2O (150 mL). The filtrate was concentrated and the 1H NMR spectrum of this 
crude reaction mixture showed a 14 : 1 ratio of 34a-Br : 34b-Br. The crude product was 
purified by chromatography on silica gel using 0.5% EtOAc/0.5% Et3N/99% hexanes. 
Product was isolated as a clear oil (92.2 mg, 64% yield, Rf = 0.22 in 1% EtOAc/99% 
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hexanes) as a 22:1 mixture of 34a-Br : 34b-Br. Samples of 34a-Br for HRMS and NMR 
analysis were obtained after further purification by HPLC (0.2% EtOAc/99.8% hexanes, 
20 mL/min, Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, CDCl3): δ 7.66-7.63 
(multiple peaks, 4H), 7.43-7.34 (multiple peaks, 6H), 7.32-7.23 (multiple peaks, 3H), 
7.19-7.17 (multiple peaks, 2H), 4.20-4.13 (m, 1H), 3.63 (t, J = 6.40 Hz, 2H), 3.19-3.09 
(multiple peaks, 2H), 1.84-1.45 (multiple peaks, 6H), 1.03 (s, 9H). 13C NMR (100 MHz, 
CDCl3): δ 138.58, 135.57, 134.00, 129.53, 129.20, 128.40, 127.60, 126.75, 63.56, 57.60, 
45.70, 45.64, 37.84, 31.82, 26.87, 23.93, 19.20. HRMS EI (m/z): [M+H]+ Calcd for 





PdCl2(CH3CN)2 (15.9 mg, 0.061 mmol, 10 mol %) and CuBr2 (548 mg, 2.45 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. THF (4.8 mL) was 
added at -78 °C. Substrate 32 (100 mg, 0.613 mmol, 1.00 equiv) and PhSnBu3 (293 mg, 
0.797 mmol, 1.30 equiv) were added sequentially, and the reaction was allowed to warm 
to room temperature over 5 h and then stirred for an additional 7 h. The reaction mixture 
was filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate 
was concentrated and the 1H NMR spectrum of this crude reaction mixture showed a 17 : 
1 ratio of 32a-Br : 32b-Br. The crude product was purified by chromatography on silica 
gel using 1% Et3N/99% hexanes. Product was isolated as a clear oil (107 mg, 55% yield, 
Rf = 0.23 in hexanes) as a 15:1 mixture of 32a-Br : 32b-Br. Samples of 32a-Br for 
HRMS and NMR analysis were obtained after further purification by HPLC (100% 
hexanes, 20 mL/min, Waters µ-porasil 19.1 mm). 1H NMR (500 MHz, CDCl3): δ 7.33 (t, 
J = 8.00 Hz, 2H), 7.29-7.21 (multiple peaks, 3H), 4.23-4.18 (m, 1H), 3.40 (t, J = 6.50 Hz, 
2H), 3.23 (dd, J = 14.0, 7.50 Hz, 2H), 3.16 (dd, J = 14.0, 6.80 Hz, 2H), 1.93-1.75 
(multiple peaks, 5H), 1.64-1.57 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 138.35, 129.18, 
128.47, 126.87, 56.87, 45.68, 37.11, 33.28, 32.05, 26.26. HRMS EI (m/z): [M+] Calcd 






PdCl2(CH3CN)2 (18.2 mg, 0.070 mmol, 10 mol %) and CuBr2 (628 mg, 2.81 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. THF (3.5 mL) was 
added at -78 °C.  A solution of substrate 38 (100 mg, 0.703 mmol, 1.00 equiv) in THF (1 
mL) and a solution of o-CH3PhSnBu3 (348 mg, 0.914 mmol, 1.30 equiv) were added 
sequentially, and the reaction was allowed to warm to room temperature over 5 h and 
then stirred for an additional 7 h. The reaction mixture was filtered through a pad of celite 
and washed with copius Et2O (150 mL). The filtrate was concentrated and the 1H NMR 
spectrum of this crude reaction mixture showed a 12 : 1 ratio of 38-o-CH3a-Br : 38-o-
CH3b-Br. The crude product was purified by chromatography on silica gel using 2.5% 
EtOAc/ 1%Et3N/96.5% hexanes. Product was isolated as a clear oil (93.1 mg, 43% yield, 
Rf = 0.17 in 2.5% EtOAc/97.5% hexanes) as a 9:1 mixture of 38-o-CH3a-Br : 38-o-
CH3b-Br. Samples of 38-o-CH3a-Br for HRMS and NMR analysis were obtained after 
further purification by HPLC (2% EtOAc/98% hexanes, 20 mL/min, Waters µ-porasil 
19.1 mm). 1H NMR (400 MHz, CDCl3): δ 7.15-7.12 (multiple peaks, 4H), 4.20-4.13 (m, 
1H), 4.03 (t, J = 6.00 Hz, 2H), 3.26 (dd, J = 14.40, 7.20 Hz, 1H), 3.12 (dd, J = 14.40, 
7.20 Hz, 1H), 2.32 (s, 3H), 2.03 (s, 3H), 1.87-1.42 (multiple peaks, 6H). 13C NMR (100 
MHz, CDCl3): δ 171.13, 136.81, 136.20, 130.52, 129.96, 126.97, 125.95, 64.20, 56.35, 
43.19, 37.81, 27.95, 24.32, 20.97, 19.57. HRMS CI with ammonia (m/z): [M+NH4]+ 
Calcd for C15H21BrO2, 330.1068; Found, 330.1069. 
 
Br  
PdCl2(CH3CN)2 (11.5 mg, 0.045 mmol, 10 mol %) and CuBr2 (398 mg, 1.78 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (14 mL) was added 
at -78 °C. Substrate 24 (50.0 mg, 0.445 mmol, 1.00 equiv) and PhSnBu3 (213 mg, 0.579 
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mmol, 1.30 equiv) were added, and the reaction was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h. The reaction mixture was 
filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate was 
concentrated and purified by chromatography on silica gel using 0.5% pyridine/99.5% 
hexanes. Product 24b-Br was isolated as a clear oil (54 mg, 46% yield, Rf = 0.57 in 
hexanes). 1H NMR (400 MHz, CDCl3): δ 7.39-7.24 (multiple peaks, 5H), 4.94 (t, J = 7.2 
Hz, 1H), 2.31-2.23 (m, 1H), 2.16-2.08 (m, 1H), 1.49-1.40 (m, 1H), 1.39-1.15 (multiple 
peaks, 9H), 0.85 (t, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 142.33, 128.64, 
128.23, 127.24, 55.83, 39.99, 31.72, 29.04, 28.86, 28.24, 22.59, 14.05. HRMS EI (m/z): 





PdCl2(CH3CN)2 (4.10 mg, 0.016 mmol, 10 mol %) and CuBr2 (141 mg, 0.633 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (3.9 mL) was 
added at -78 °C. Substrate 31 (50.0 mg, 0.158 mmol, 1.00 equiv) in Et2O (1 mL) and 
PhSnBu3 (75.5 mg, 0.206 mmol, 1.30 equiv) were added, and the reaction was allowed to 
warm to room temperature over 5 h and then stirred for an additional 7 h. The reaction 
mixture was filtered through a pad of celite and washed with copius Et2O (150 mL). The 
filtrate was concentrated and purified by chromatography on silica gel using 1% 
EtOAc/1% Et3N/98% hexanes. Product 31b-Br was isolated as a viscous clear oil (42.0 
mg, 57% yield, Rf = 0.13 in 2% ethyl acetate/99% hexanes). 1H NMR (400 MHz, 
CDCl3): δ 7.65 (dd, J = 8.8, 2.8 Hz, 2H), 7.38-7.24 (multiple peaks, 5H), 7.05 (d, J = 8.0 
Hz, 2H), 4.93 (t, J = 8.0 Hz, 1H), 4.40 (s, 2H), 3.41 (t, J = 6.0 Hz, 2H), 2.32-2.23 (m, 
1H), 2.17-2.08 (m, 1H), 1.58 (quin, J = 6.8 Hz, 2H), 1.54-1.24 (multiple peaks, 4H). 13C 
NMR (100 MHz, CDCl3): δ 142.19, 138.30, 137.41, 129.43, 128.66, 128.28, 127.21, 
92.87, 72.16, 70.25, 55.57, 39.90, 29.45, 28.01, 25.51. HRMS CI with ammonia (m/z): 





PdCl2(CH3CN)2 (7.95 mg, 0.031 mmol, 10 mol %) and CuBr2 (274 mg, 1.23 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (9.6 mL) was 
added at -78 °C. Substrate 32 (50.0 mg, 0.307 mmol, 1.00 equiv) and PhSnBu3 (146 mg, 
0.399 mmol, 1.30 equiv) were added, and the reaction was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h. The reaction mixture was 
filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate was 
concentrated and purified by chromatography on silica gel using 1% Et3N/99% hexanes. 
Product 32b-Br was isolated as a viscous clear oil (68.5 mg, 71% yield, Rf = 0.23 in  
hexanes). Note: The isolated product also contained 7% of the product where the terminal 
bromine was replaced with a phenyl group. Samples of 32b-Br for HRMS and NMR 
analysis were obtained after further purification by HPLC (100% hexanes, 20 mL/min, 
Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, CDCl3): δ 7.39-7.25 (multiple peaks, 
5H), 4.93 (t, J = 7.2 Hz, 1H), 3.37 (t, J = 6.4 Hz, 1H), 2.33-2.23 (m, 1H), 2.17-2.10 (m, 
1H), 1.83 (quin, J = 6.8 Hz, 2H), 1.54-1.43 (multiple peaks, 5H), 1.37-1.24 (m, 1H). 13C 
NMR (100 MHz, acetone-d6): δ 143.33, 129.45, 129.10, 128.19, 56.52, 40.43, 34.53, 





PdCl2(CH3CN)2 (5.1 mg, 0.020 mmol, 10 mol %) and CuBr2 (175 mg, 0.786 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (5.1 mL) was 
added at -78 °C. A solution of substrate 33 (50.0 mg, 0.197 mmol, 1.00 equiv) in Et2O (1 
mL) and PhSnBu3 (93.8 mg, 0.256 mmol, 1.30 equiv) were added, and the reaction was 
allowed to warm to room temperature over 5 h and then stirred for an additional 7 h. The 
reaction mixture was filtered through a pad of celite and washed with copius Et2O (150 
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mL). The filtrate was concentrated and purified by chromatography on silica gel using 
7% ethyl acetate/1% Et3N/92% hexanes. Product 33b-Br was isolated as a viscous clear 
oil (54.3 mg, 68% yield, Rf = 0.18 in 8% ethyl acetate/92% hexanes). 1H NMR (400 
MHz, CDCl3): δ 7.77 (dd, J = 8.4, 2.0 Hz, 2H), 7.36-7.24 (multiple peaks, 7H), 4.87 (t, J 
= 7.2 Hz, 1H), 3.99 (t, J = 6.0 Hz, 2H), 2.43 (s, 3H), 1.61 (quin, J = 6.8 Hz, 2H), 1.48-
1.20 (multiple peaks, 5H). 13C NMR (100 MHz, CDCl3): δ 144.74, 138.29, 133.09, 
129.85, 129.15, 128.47, 127.89, 126.87, 70.16, 56.80, 45.65, 37.31, 28.21, 23.62, 21.64. 




PdCl2(CH3CN)2 (3.83 mg, 0.015 mmol, 10 mol %) and CuBr2 (132 mg, 0.591 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (3.6 mL) was 
added at -78 °C. A solution of substrate 34 (50.0 mg, 0.148 mmol, 1.00 equiv) in Et2O (1 
mL) and PhSnBu3 (70.5 mg, 0.192 mmol, 1.30 equiv) were added, and the reaction was 
allowed to warm to room temperature over 5 h and then stirred for an additional 7 h. The 
reaction mixture was filtered through a pad of celite and washed with copius Et2O (150 
mL). The filtrate was concentrated and purified by chromatography on silica gel using 
0.5% ethyl acetate/1% Et3N/98.5% hexanes. Product 34b-Br was isolated as a viscous 
clear oil (43.6 mg, 61% yield, Rf = 0.30 in 1% ethyl acetate/99% hexanes). 1H NMR (400 
MHz, CDCl3): δ 7.64 (d, J = 8.0 Hz, 4H), 7.42-7.24 (multiple peaks, 11H), 4.91 (t, J = 
8.4 Hz, 1H), 3.62 (td, J = 6.4, 1.2 Hz, 2H), 2.29-2.06 (multiple peaks, 2H), 1.56-1.18 
(multiple peaks, 6H), 1.02 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 142.25, 135.56, 
134.05, 129.52, 128.65, 128.26, 127.58, 127.24, 120.30, 120.09, 111.99, 63.65, 55.65, 
39.97, 32.25, 27.97, 26.86, 25.12, 19.21. HRMS EI (m/z): [M+NH4]+ Calcd for 








PdCl2(CH3CN)2 (5.65 mg, 0.022 mmol, 10 mol %) and CuBr2 (194 mg, 0.872 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (5.8 mL) was 
added at -78 °C. A solution of substrate 35 (50.0 mg, 0.218 mmol, 1.00 equiv) in Et2O (1 
mL) and PhSnBu3 (104 mg, 0.284 mmol, 1.30 equiv) were added, and the reaction was 
allowed to warm to room temperature over 5 h and then stirred for an additional 7 h. The 
reaction mixture was filtered through a pad of celite and washed with copius Et2O (150 
mL). The filtrate was concentrated and purified by chromatography on silica gel using 
7% ethyl acetate/1% Et3N/92% hexanes. Product 35b-Br was isolated as a viscous clear 
oil (58.5 mg, 70% yield, Rf = 0.17 in 10% ethyl acetate/90% hexanes). 1H NMR (400 
MHz, CDCl3): δ 7.84-7.79 (multiple peaks, 2H), 7.71-7.67 (multiple peaks, 2H), 7.37-
7.22 (multiple peaks, 5H), 4.91 (t, J = 7.2 Hz, 1H), 3.64 (t, J = 6.8 Hz, 2H), 2.30-2.21 (m, 
1H), 2.15-2.07 (m, 1H), 1.65 (quin, J = 7.2 Hz, 2H), 1.58-1.46 (m, 1H), 1.40-1.31 
(multiple peaks, 3H). 13C NMR (100 MHz, CDCl3): δ 168.40, 142.09, 133.87, 132.09, 
128.65, 128.28, 127.20, 123.16, 55.40, 39.77, 37.80, 28.35, 27.79, 26.16. HRMS EI 






PdCl2(CH3CN)2 (5.54 mg, 0.021 mmol, 10 mol %) and CuBr2 (191 mg, 0.854 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (5.7 mL) was 
added at -78 °C. A solution of substrate 36 (50.0 mg, 0.213 mmol, 1.00 equiv) in Et2O (1 
mL) and PhSnBu3 (102 mg, 0.277 mmol, 1.30 equiv) were added, and the reaction was 
allowed to warm to room temperature over 5 h and then stirred for an additional 7 h. The 
reaction mixture was filtered through a pad of celite and washed with copius Et2O (150 
mL). The filtrate was concentrated and purified by chromatography on silica gel using 
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8% ethyl acetate/1% Et3N/91% hexanes. Product 36b-Br was isolated as a viscous clear 
oil (34 mg, 41% yield, Rf = 0.20 in 8% ethyl acetate/92% hexanes). 1H NMR (400 MHz, 
CDCl3): δ 7.76 (dt, J = 8.0, 2.8 Hz, 1H), 7.49-7.25 (multiple peaks, 6H), 6.99-6.95 
(multiple peaks, 2H), 4.95 (td, J = 8.0, 2.0 Hz, 1H), 4.27 (td, J = 6.8, 2.8 Hz, 2H), 3.89 (s, 
3H), 2.33-2.26 (m, 1H), 2.20-2.11 (m, 1H), 1.74 (quin, J = 6.0 Hz, 2H), 1.58-1.30 
(multiple peaks, 4H). 13C NMR (100 MHz, CDCl3): δ 166.25, 159.11, 142.13, 133.40, 
131.49, 128.68, 128.32, 127.21, 120.30, 120.09, 111.99, 64.61, 55.94, 55.46, 39.89, 




PdCl2(CH3CN)2 (10.9 mg, 0.042 mmol, 10 mol %) and CuBr2 (132 mg, 0.591 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (13 mL) was added 
at -78 °C. Substrate 37 (50.0 mg, 0.423 mmol, 1.00 equiv) and PhSnBu3 (202 mg, 0.55 
mmol, 1.30 equiv) were added, and the reaction was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h. The reaction mixture was 
filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate was 
concentrated and purified by chromatography on silica gel using 1% Et3N/99% hexanes. 
Product 37b-Br was isolated as a clear oil (42 mg, 37% yield, Rf = 0.13 in hexanes). 1H 
NMR (400 MHz, CDCl3): δ 7.41-7.13 (multiple peaks, 10H), 4.90 (td, J = 8.0, 1.2 Hz, 
1H), 2.84-2.57 (multiple peaks, 3H), 2.48-2.38 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 





PdCl2(CH3CN)2 (9.12 mg, 0.035 mmol, 10 mol %) and CuBr2 (314 mg, 1.41 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (10 mL) was added 
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at -78 °C. A solution of substrate 38 (50.0 mg, 0.352 mmol, 1.00 equiv) in Et2O (1 mL) 
and PhSnBu3 (167 mg, 0.457 mmol, 1.30 equiv) were added, and the reaction was 
allowed to warm to room temperature over 5 h and then stirred for an additional 7 h. The 
reaction mixture was filtered through a pad of celite and washed with copius Et2O (150 
mL). The filtrate was concentrated and purified by chromatography on silica gel using 
1.5% ethyl acetate/1% Et3N/97.5% hexanes. Product 38b-Br was isolated as a viscous 
clear oil (71.0 mg, 68% yield, Rf = 0.11 in 2% ethyl acetate/98% hexanes). 1H NMR (400 
MHz, CDCl3): δ 7.39-7.26 (multiple peaks, 5H), 4.94 (t, J = 7.2 Hz, 1H), 4.03 (td, J = 
6.8, 0.8 Hz, 2H), 2.34-2.24 (m, 1H), 2.18-2.11 (m, 1H), 2.03 (s, 3H), 1.65-1.29 (multiple 
peaks, 6H). 13C NMR (100 MHz, CDCl3): δ 171.13, 142.10, 128.66, 128.30, 127.17, 
64.28, 55.39, 39.83, 28.34, 27.86, 25.26, 20.97. HRMS EI (m/z): [M+NH4]+ Calcd for 







PdCl2(CH3CN)2 (9.12 mg, 0.035 mmol, 10 mol %) and CuBr2 (314 mg, 1.41 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (10 mL) was added 
at -78 °C. A solution of substrate 38 (50.0 mg, 0.352 mmol, 1.00 equiv) in Et2O (1 mL) 
and p-FPhSnBu3 (176 mg, 0.457 mmol, 1.30 equiv) were added, and the reaction was 
allowed to warm to room temperature over 5 h and then stirred for an additional 7 h. The 
reaction mixture was filtered through a pad of celite and washed with copius Et2O (150 
mL). The filtrate was concentrated and purified by chromatography on silica gel using 
1.5% ethyl acetate/1% Et3N/97.5% hexanes. Product 38-p-Fb-Br was isolated as a 
viscous clear oil (52.5 mg, 49% yield, Rf = 12 in 2% ethyl acetate/98% hexanes) as a 10:1 
ratio of 1,1:1,2 isomers. 1H NMR (400 MHz, CDCl3): δ 7.37-7.31 (multiple peaks, 2H), 
7.00 (t, J = 8.8 Hz, 2H), 4.90 (t, J = 7.2 Hz, 1H), 4.02 (t, J = 6.8 Hz, 1H), 2.29-2.20 (m, 
1H), 2.13-2.03 (m, 1H), 2.01 (s, 3H), 1.60 (quin, J = 6.8 Hz, 2H), 1.53-1.44 (m, 1H), 
1.41-1.23 (multiple peaks, 3H). 13C NMR (100 MHz, CDCl3): δ 171.13, 162.32 (JC-F = 
247.65 Hz), 138.07 (JC-F = 3.12 Hz), 128.97, 115.59 (JC-F = 21.75 Hz), 64.24, 54.34, 
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39.99, 28.35, 27.84, 25.23, 20.95. HRMS EI (m/z): [M+NH4]+ Calcd for C14H18BrFO2, 








PdCl2(CH3CN)2 (11.3 mg, 0.044 mmol, 10 mol %) and CuBr2 (390 mg, 1.745 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (1.8 mL) was 
added at -78 °C. A solution of substrate 35 (100 mg, 0.436 mmol, 1.00 equiv) in Et2O (1 
mL) and a solution of p-CH3PhSnBu3 (216 mg, 0.567 mmol, 1.30 equiv) in Et2O (1 mL) 
were added, and the reaction was allowed to warm to room temperature over 5 h and then 
stirred for an additional 7 h. The reaction mixture was filtered through a pad of celite and 
washed with copius Et2O (150 mL). The filtrate was concentrated and purified by 
chromatography on silica gel using 8% ethyl acetate/1% Et3N/91% hexanes. Product 35-
p-CH3b-Br was isolated as a viscous clear oil (60 mg, 35% yield, Rf = 0.24 in 8% ethyl 
acetate/92% hexanes). 1H NMR (400 MHz, CDCl3): δ 7.84-7.80 (multiple peaks, 2H), 
7.71-7.67 (multiple peaks, 2H), 7.25 (d, J = 8.0 Hz, 2H), 7.11 (d, J = 7.6 Hz, 2H), 4.91 (t, 
J = 7.6 Hz, 1H), 3.64 (t, J = 7.2 Hz, 2H), 2.31 (s, 3H), 2.30-2.20 (m, 1H), 2.15-2.02 (m, 
1H), 1.65 (quin, J = 7.2 Hz, 2H), 1.52-1.25 (multiple peaks, 4H). 13C NMR (100 MHz, 
CDCl3): δ 168.41, 139.18, 138.20, 133.88, 132.12, 129.35, 127.10, 123.18, 55.61, 39.78, 
37.83, 28.37, 27.84, 26.18, 21.16.  
 
Cl
D D  
PdCl2(PhCN)2 (24.0 mg, 0.063 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (689 mg, 2.51 mmol, 4.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and substrate 24-d2 (71.5 mg, 0.626 mmol, 1.00 equiv) and CH2Cl2 
(19 mL) were added. PhSnBu3 (299 mg, 0.814 mmol, 1.30 equiv) was added, and the 
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resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 (299 mg, 0.814 
mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room temperature 
over 5 h and then stirred for an additional 7 h.  The reaction mixture was filtered through 
a pad of celite and washed with copius Et2O (150 mL). The filtrate was concentrated. The 
1H NMR spectrum of this crude reaction mixture showed a >20 : 1 ratio of 24-d2a-Cl : 
24-d2b-Cl. The product was purified by chromatography on silica gel using 0.5% 
Et3N/99.5% hexanes. The product was isolated as a clear oil (113 mg, 80% yield, Rf = 
0.33 in  hexanes). Note: The isolated product contained 91% of 24-d2a-Cl and 4% of 24-
d2b-Cl (23 : 1 ratio of 24-d2a-Cl : 24-d2b-Cl) as well as  traces of the 2,1 isomer (5%). 1H 
NMR (500 MHz, CDCl3): δ 7.38-7.21 (multiple peaks, 10H), 4.10 (dd, J = 9.0, 4.0 Hz, 
1H), 1.81-1.55 (multiple peaks, 3H), 1.45-1.38 (m, 1H), 1.32-1.27 (multiple peaks, 6H), 
0.89 (t, J = 7.0 Hz, 3H). 
 
Br
D D  
PdCl2(CH3CN)2 (11.4 mg, 0.044 mmol, 10 mol %) and CuBr2 (391 mg, 1.75 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. THF (3.4 mL) was 
added at -78 °C. Substrate (50.0 mg, 0.438 mmol, 1.00 equiv) and PhSnBu3 (209 mg, 
0.570 mmol, 1.30 equiv) were added sequentially, and the reaction was allowed to warm 
to room temperature over 5 h and then stirred for an additional 7 h. The reaction mixture 
was filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate 
was concentrated and the 1H NMR spectrum of this crude reaction mixture showed a 20 : 
1 ratio of 24-d2a-Br : of 24-d2b-Br. The crude product was purified by chromatography 
on silica gel using 1% Et3N/99% hexanes. Product was isolated as a viscous clear oil 
(83.7 mg, 72% yield, Rf = 0.80 in hexanes) as a >20:1 mixture of 24-d2a-Br: 24-d2a-Br. 
1H NMR (400 MHz, CDCl3): δ 7.35-7.21 (multiple peaks, 5H), 4.22-4.19 (m, 1H), 1.87-
1.75 (multiple peaks, 2H), 1.65-1.56 (m, 1H), 2.33-2.24 (m, 1H), 1.47-1.38 (m, 1H), 
1.38-1.28 (multiple peaks, 6H), 0.91-0.88 (multiple peaks, 3H). 13C NMR (100 MHz, 
CDCl3): δ 138.57, 129.18, 128.37, 126.73, 57.67, 38.09, 31.64, 28.60, 27.51, 22.55, 






PdCl2(CH3CN)2 (11.4 mg, 0.044 mmol, 10 mol %) and CuBr2 (391 mg, 1.75 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (14 mL) was added 
at -78 °C. Substrate 24-d2 (50.0 mg, 0.438 mmol, 1.00 equiv) and PhSnBu3 (209 mg, 0.57 
mmol, 1.30 equiv) were added, and the reaction was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h. The reaction mixture was 
filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate was 
concentrated and purified by chromatography on silica gel using 1% Et3N/99% hexanes. 
Product 24-d2b-Br was isolated as a clear oil (49 mg, 42% yield, Rf = 0.74 in hexanes). 
1H NMR (400 MHz, CDCl3): δ 7.40-7.25 (multiple peaks, 5H), 2.24-2.10 (m, 1H), 1.50-
1.40 (m, 1H), 1.65-1.56 (m, 1H), 2.33-2.24 (m, 1H), 1.47-1.38 (m, 1H), 1.36-1.20 
(multiple peaks, 9H), 0.87 (t, J =5.6 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 142.27, 





PdCl2(PhCN)2 (23.0 mg, 0.060 mmol, 10 mol %) and CuCl2 (322 mg, 2.40 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (17 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to –78 °C. A solution of substrate 40 (100 mg, 0.600 mmol, 1.00 equiv) in dry 
Et2O (2 mL) and PhSnBu3 (286 mg, 0.780 mmol, 1.30 equiv) were added, and the 
reaction was allowed to warm to room temperature over 5 h and then stirred for an 
additional 7 h. The reaction mixture was gravity filtered through a pad of silica pre-
wetted with a 1% solution of Et3N in Et2O, and the pad was washed with 1% Et3N in 
Et2O (2 x 100 mL). The filtrate was dried over MgSO4, filtered, and concentrated. The 1H 
NMR spectrum of this crude reaction mixture showed a 5 : 1 ratio of 40a-Cl : 40d-Cl. 
The crude product was purified by chromatography on silica gel using 0.5% Et3N/99.5% 
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hexanes. The product was isolated as a clear oil as a 4: 1 mixture of 40a-Cl and 40d-Cl 
(113 mg, 68% yield, Rf = 0.34 in hexanes). Samples of 40a-Cl and 40d-Cl for HRMS 
and NMR analysis were obtained after further purification by HPLC (100% hexanes, 20 
mL/min, Waters µ-porasil 19.1 mm). 1H NMR (500 MHz, CDCl3): δ 7.35-7.28 (multiple 
peaks, 5H), 7.26-7.22 (multiple peaks, 2H), 7.07 (dd, J = 8.49, 2.00 Hz, 2H), 4.84 (td, J = 
7.24, 2.00 Hz, 1H), 2.61 (t, J = 7.50 Hz, 2H), 2.18-2.10 (m, 1H), 2.07-2.00 (m, 1H), 1.86-
1.77 (m, 1H), 1.67-1.58 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 141.64, 140.10, 131.62, 
129.70, 128.65, 128.46, 128.30, 126.88, 63.49, 39.33, 34.52, 28.64. HRMS EI (m/z): 





1H NMR (400 MHz, CDCl3): δ 7.34-7.27 (multiple peaks, 6H), 7.20 (t, J = 7.50 Hz, 1H), 
7.16 (d, J = 7.00 Hz, 2H), 4.83 (dd, J = 8.00, 6.50 Hz, 1H), 2.66 (t, J = 7.50 Hz, 2H), 
2.19-2.11 (m, 1H), 2.08-2.00 (m, 1H), 1.88-1.79 (m, 1H), 1.69-1.60 (m, 1H). 13C NMR 
(100 MHz, CDCl3): δ 141.56, 140.28, 133.99, 128.81, 128.42, 128.36, 128.32, 125.98, 






PdCl2(CH3CN)2 (15.5 mg, 0.060 mmol, 10 mol %) and CuBr2 (536 mg, 2.40 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (19 mL) was added 
at -78 °C. Substrate 40 (100 mg, 0.600 mmol, 1.00 equiv) and PhSnBu3 (286 mg, 0.78 
mmol, 1.30 equiv) were added, and the reaction was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h. The reaction mixture was 
filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate was 
concentrated and purified by chromatography on silica gel using 0.5% pyridine/99.5% 
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hexanes. The 1H NMR spectrum pf this crude reaction mixture showed a 7:1 ratio of 40a-
Br : 40d-Br. Product was isolated as a clear oil (150 mg, 91% yield, Rf = 28 in hexanes) 
as a 7:1 mixture of 40a-Br : 40d-Br. The clean product was rechromatographed to obtain 
a sample of pure 40a-Br by collecting individual fractions. 1H NMR (400 MHz, CDCl3): 
δ 7.36-7.24 (multiple peaks, 5H), 7.22 (d, J = 8.4 Hz, 2H), 7.05 (d, J = 8.0 Hz, 2H), 4.93 
(t, J = 7.2 Hz, 1H), 2.60 (t, J = 8.0 Hz, 2H), 2.32-2.23 (m, 1H), 2.17-2.08 (m, 1H), 1.85-
1.74 (m, 1H), 1.64-1.55 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 141.95, 140.02, 131.64, 
129.69, 128.71, 128.47, 128.37, 127.19, 55.19, 39.31, 34.41, 29.79. HRMS EI (m/z) for 





PdCl2(CH3CN)2 (19.6 mg, 0.076 mmol, 10 mol %) and CuBr2 (676 mg, 3.02 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (24 mL) was added 
at -78 °C. Substrate 39 (100 mg, 0.756 mmol, 1.00 equiv) and p-ClPhSnBu3 (395 mg, 
0.98 mmol, 1.30 equiv) were added, and the reaction was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h. The reaction mixture was 
filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate was 
concentrated and the 1H NMR spectrum of this crude reaction mixture showed a 3:1 ratio 
of 40d-Br : 40a-Br. The crude product purified by chromatography on silica gel using 
0.5% pyridine/99.5% hexanes. Product was isolated as a clear oil (93 mg, 45% yield, Rf = 
26 in hexanes) as a 3:1 mixture of 40d-Br : 40a-Br. The clean product was 
rechromatographed to obtain a sample of pure 40d-Br by collecting individual fractions. 
1H NMR (400 MHz, CDCl3): δ 7.30-7.13 (multiple peaks, 9H), 4.91 (t, J = 8.0 Hz, 1H), 
2.65 (t, J = 7.6 Hz, 2H), 2.34-2.24 (m, 1H), 2.18-2.09 (m, 1H), 1.87-1.76 (m, 1H), 1.67-
1.57 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 141.48, 140.59, 133.98, 128.87, 128.60, 
128.41, 128.34, 125.98, 53.99, 39.35, 35.04, 29.82. HRMS EI (m/z) for loss of Br: Calcd 






PdCl2(PhCN)2 (24.9 mg, 0.065 mmol, 10 mol %) and CuCl2 (579 mg, 2.59 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (18 mL) was added in the 
glove box. The flask was sealed with a rubber septum that was secured with copper wire 
and cooled to 0 °C. A solution of substrate 67 (100 mg, 0.649 mmol, 1.00 equiv) in dry 
Et2O (1 mL) and p-CH3PhSnBu3 (321 mg, 0.843 mmol, 1.30 equiv) in dry Et2O (1 mL) 
were added, and the reaction was allowed to warm to room temperature over 5 h and then 
stirred for an additional 7 h. The reaction mixture was filtered through a pad of celite and 
washed with copius Et2O (150 mL). The filtrate was concentrated and purified by 
chromatography on silica gel using 1% Et3N/99% hexanes. Product 67-p-CH3a-Cl was 
isolated as a white solid (65.0 mg, 36% yield, Rf = 0.15 in hexanes). 1H NMR (400 MHz, 
CDCl3): δ 7.84-7.76 (multiple peaks, 3H), 7.71 (br s, 1H), 7.54 (dd, J = 8.8, 2.0 Hz, 1H), 
7.48-7.45 (multiple peaks, 2H), 7.04-7.00 (multiple peaks, 4H), 5.19 (t, J = 7.2 Hz, 1H), 
3.47-3.37 (multiple peaks, 2H) 2.27 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 138.46, 
136.41, 134.35, 133.16, 132.98, 129.25, 129.07, 128.56, 128.07, 127.68, 126.35, 126.34, 
126.28, 124.76, 64.58, 45.86, 21.04. HRMS EI (m/z): [M]+ Calcd for C19H17Cl, 





PdCl2(PhCN)2 (24.8 mg, 0.065 mmol, 10 mol %) and CuCl2 (349 mg, 2.59 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to 0 °C. Et2O (18 mL) was added at 
0 °C. Substrate 67 (100 mg, 0.649 mmol, 1.00 equiv) in Et2O (2 mL) and p-CF3PhSnBu3 
(367 mg, 0.843 mmol, 1.30 equiv) were added, and the reaction was allowed to warm to 
room temperature over 5 h and then stirred for an additional 7 h. The reaction mixture 
was filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate 
was concentrated and the crude product was purified by chromatography on silica gel 
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using a 1% Et3N/99% hexanes. Product 67-p-CF3a-Cl was isolated as a white solid (105 
mg, 49% yield, Rf = 0.15 in hexanes). 1H NMR (500 MHz, CDCl3): δ 7.86-7.81 (multiple 
peaks, 2H), 7.79-7.77 (m, 1H), 7.71 (br s, 1H), 7.54-7.47 (multiple peaks, 5H), 7.23 (d, J 
= 8.8 Hz, 2H), 5.21 (t, J = 7.6 Hz, 1H), 3.52 (dd, J = 14.0, 7.6 Hz, 1H approximate values 
due to second order effects), 3.47 (dd, J = 14.5, 7.6 Hz, 1H approximate values due to 
second order effects). 13C NMR (100 MHz, CDCl3): δ 141.35, 137.81, 133.22, 132.93, 
129.78, 129.18 (2JC-F = 32 Hz), 128.79, 128.06, 127.71, 126.59, 126.56, 126.23, 125.29 
(4JC-F = 3.0 Hz), 124.47, 124.16, (1JC-F = 270 Hz), 63.74, 45.96. 19F NMR (376 MHz, 





PdCl2(PhCN)2 (24.8 mg, 0.065 mmol, 10 mol %) and CuCl2 (349 mg, 2.59 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to 0 °C. Et2O (18 mL) was added at 
0 °C. Substrate 67 (100 mg, 0.649 mmol, 1.00 equiv) in Et2O (2 mL) and p-FPhSnBu3 
(325 mg, 0.843 mmol, 1.30 equiv) were added, and the reaction was allowed to warm to 
room temperature over 5 h and then stirred for an additional 7 h. The reaction mixture 
was filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate 
was concentrated and the crude product was purified by chromatography on silica gel 
using a 1% Et3N/99% hexanes. Product 67-p-Fa-Cl was isolated as a white solid (141 
mg, 77% yield, Rf = 0.15 in hexanes). 1H NMR (500 MHz, CDCl3): δ 7.92-7.89 (multiple 
peaks, 2H), 7.86-7.83 (m, 1H), 7.77 (br s, 1H), 7.60 (dd, J = 9.0, 2.0 Hz, 1H), 7.58-7.54 
(multiple peaks, 2H), 7.14-7.12 (multiple peaks, 2H), 6.99 (t, J = 9.5 Hz, 2H), 5.24 (t, J = 
7.5 Hz, 1H), 3.52 (dd, J = 14.0, 8.0 Hz, 1H), 3.46 (dd, J = 14.5, 7.5 Hz, 1H). 13C NMR 
(100 MHz, CDCl3): δ 161.77 (1JC-F = 243 Hz), 138.01, 133.13, 133.02 (4JC-F = 3.0 Hz), 
132.90, 130.89 (3JC-F = 8 Hz), 128.61, 128.02, 127.66, 126.44, 126.25, 124.58, 115.14 
(2JC-F = 21 Hz), 64.31, 45.42. One of the carbons is coincidentally overlapping. 19F NMR 






PdCl2(PhCN)2 (24.9 mg, 0.065 mmol, 10 mol %) and CuCl2 (349 mg, 2.59 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. Dry Et2O (16 mL) was added in the 
glove box, and the flask was cooled to 0 °C. A solution of substrate 67 (100 mg, 0.649 
mmol, 1.00 equiv) in dry Et2O (2 mL) and p-ClPhSnBu3 (338 mg, 0.843 mmol, 1.30 
equiv) in dry Et2O (2 mL) were added, and the reaction was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h. The reaction mixture was 
gravity filtered through a pad of silica pre-wetted with a 1% solution of Et3N in Et2O, and 
the pad was washed with 1% Et3N in Et2O (2 x 100 mL). The filtrate was dried over 
MgSO4, filtered, concentrated, and purified by chromatography on silica gel using 1% 
Et3N/99% hexanes. Product 67-p-Cla-Cl was isolated as a white solid (133 mg, 69% 
yield, Rf = 0.35 in hexanes, mp = 120.9-121.6 ºC). 1H NMR (500 MHz, CDCl3): δ 7.87-
7.83 (multiple peaks, 2H), 7.80-7.78 (m, 1H), 7.71 (s, 1H), 7.55-7.48 (multiple peaks, 
3H), 7.21 (d, J = 8.50 Hz, 2H), 7.06 (d, J = 8.99 Hz, 2H), 5.18 (t, J = 7.25 Hz, 1H), 3.46 
(dd, J = 14.00, 7.49 Hz, 1H), 3.41 (dd, J = 14.25, 7.25 Hz, 1H). 13C NMR (100 MHz, 
CDCl3): δ 137.91, 135.76, 133.15, 132.90, 132.73, 130.75, 128.67, 128.49, 128.04, 
127.68, 126.49, 126.47, 126.26, 124.54, 64.04, 45.59. HRMS EI (m/z): [M]+ Calcd for 





Product 67-p-ClbCl was isolated from the Pd-catalyzed reaction of p-chlorostyrene with 
2-naphthylSnBu3 and PhICl2, because the reaction with CuCl2 led to an inseparable 
mixture of 67-p-ClaCl and 67-p-ClbCl. PdCl2(PhCN)2 (27.9 mg, 0.072 mmol, 10 mol %) 
and PhICl2 (397 mg, 1.44 mmol, 2.00 equiv) were weighed into a 25 mL Schlenk flask. 
Dry Et2O (20 mL) was added in the glove box. The flask was sealed with a rubber septum 
that was secured with copper wire and the flask was cooled to –78 °C. p-chlorostyrene 
(100 mg, 0.721 mmol, 1.00 equiv) and 2-naphthylSnBu3 (391 mg, 0.938 mmol, 1.30 
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equiv) in dry Et2O (2 mL) were added, and the reaction was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h. The reaction mixture was 
gravity filtered through a pad of silica pre-wetted with a 1% solution of Et3N in Et2O, and 
the pad was washed with 1% Et3N in Et2O (2 x 100 mL). The filtrate was dried over 
MgSO4, filtered, concentrated, and purified by chromatography on silica gel using 1% 
Et3N/99% hexanes. Product 67-p-ClbCl was isolated as a white solid (121 mg, 56% 
yield, Rf = 0.35 in hexanes, mp = 130.9-132.3 ºC). 1H NMR (500 MHz, acetone-d6): δ 
7.83 (d, J = 8.99 Hz, 1H), 7.79 (d, J = 8.00 Hz, 2H), 7.73 (s, 1H), 7.51 (dt, J = 8.49, 2.24 
Hz, 2H), 7.48-7.42 (multiple peaks, 2H), 7.37 (td, J = 8.50, 2.00 Hz, 3H), 5.44 (t, J = 
7.50 Hz, 1H), 3.59 (dd, J = 14.24, 7.74 Hz, 1H), 3.55 (dd, J = 14.00, 7.49 Hz, 1H). 13C 
NMR (100 MHz, CDCl3): δ 139.56, 134.47, 134.08, 133.33, 132.37, 128.72, 128.56, 
128.20, 128.02, 127.62, 127.38, 126.11, 125.75, 62.99, 46.60. One of the carbon 
resonances is coincidently overlapping. HRMS EI (m/z): [M]+ Calcd for C18H14Cl2, 





Pd(acac) (14.6 mg, 0.048 mmol, 10 mol %) and CuBr2 (429 mg, 1.92 mmol, 4.00 equiv) 
were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber septum that 
was secured with copper wire and cooled to –78 °C. Et2O (5 mL) was added at -78 °C. 
Substrate 42 (50.0 mg, 0.480 mmol, 1.00 equiv) and p-FPhSnBu3 (240 mg, 0.57 mmol, 
1.30 equiv) were added, and the reaction was allowed to warm to room temperature over 
5 h and then stirred for an additional 7 h. The reaction mixture was filtered through a pad 
of celite and washed with copius Et2O (150 mL). The filtrate was concentrated and the 1H 
NMR of the crude reaction mixture showed a >20:1 ratio of 42-p-FaBr: 42-p-FbBr. The 
crude product was purified by chromatography on silica gel using 0.5% pyridine/99.5% 
hexanes. Product 42-p-FaBr was isolated as a clear oil (13 mg, 10% yield, Rf = 0.27 in 
hexanes). 1H NMR (400 MHz, CDCl3): δ 7.35-7.25 (multiple peaks, 5H), 7.05-7.01 
(multiple peaks, 2H), 6.91 (tt, J = 8.40, 3.20 Hz, 2H), 5.05 (t, J = 7.60 Hz, 1H), 3.51 (dd, 
J = 14.00, 7.20 Hz, 1H), 3.43 (dd, J = 14.40, 7.60 Hz, 1H). 13C NMR (100 MHz, CDCl3): 
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δ 161.77 (1JC-F = 243 Hz), 141.21, 133.76 (4JC-F = 3.1 Hz), 130.72 (3JC-F = 8.5 Hz), 
128.64, 128.47, 127.48, 115.20 (2JC-F = 21 Hz), 55.32, 45.62. HRMS EI (m/z) for loss of 





Pd(acac) (12.5 mg, 0.041 mmol, 10 mol %) and CuBr2 (429 mg, 1.92 mmol, 4.00 equiv) 
were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber septum that 
was secured with copper wire and cooled to –78 °C. Et2O (4.3 mL) was added at -78 °C. 
p-F-styrene (50.0 mg, 0.409 mmol, 1.00 equiv) and PhSnBu3 (195 mg, 0.532 mmol, 1.30 
equiv) were added, and the reaction was allowed to warm to room temperature over 5 h 
and then stirred for an additional 7 h. The reaction mixture was filtered through a pad of 
celite and washed with copius Et2O (150 mL). The filtrate was concentrated and the 1H 
NMR of the crude reaction mixture showed a >20:1 ratio of 45a-Br to 45b-Br. The crude 
product was purified by chromatography on silica gel using 0.5% pyridine/99.5% 
hexanes. Product 45a-Br was isolated as a clear oil (73 mg, 65% yield, Rf = 0.29 in 
hexanes). 1H NMR (400 MHz, CDCl3): δ 7.35-7.25 (multiple peaks, 5H), 7.05-7.01 
(multiple peaks, 2H), 6.91 (tt, J = 8.40, 3.20 Hz, 2H), 5.05 (t, J = 7.60 Hz, 1H), 3.51 (dd, 
J = 14.00, 7.20 Hz, 1H), 3.43 (dd, J = 14.40, 7.60 Hz, 1H). 13C NMR (100 MHz, CDCl3): 
δ 162.35 (1JC-F = 246 Hz), 137.80, 137.34 (4JC-F = 3.9 Hz), 129.27 (3JC-F = 8.5 Hz), 
129.18, 128.42, 126.93, 115.52 (2JC-F = 22 Hz), 54.28, 46.67. 19F NMR (376 MHz, 
CDCl3): δ -113.10 – -113.17. HRMS EI (m/z) for loss of Br: Calcd for C14H12BrF, 





Pd(acac) (9.9 mg, 0.032 mmol, 10 mol %) and CuBr2 (289 mg, 1.30 mmol, 4.00 equiv) 
were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber septum that 
was secured with copper wire and cooled to –78 °C. Et2O (2.4 mL) was added at -78 °C. 
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A solution of vinylnaphthalene (50.0 mg, 0.324 mmol, 1.00 equiv) in Et2O (1 mL) and p-
F-PhSnBu3 (162 mg, 0.422 mmol, 1.30 equiv) were added, and the reaction was allowed 
to warm to room temperature over 5 h and then stirred for an additional 7 h. The reaction 
mixture was filtered through a pad of celite and washed with copius Et2O (150 mL). The 
filtrate was concentrated and the 1H NMR of the crude reaction mixture showed a >20:1 
ratio of 67-p-Fa-Br to 67-p-Fb-Br. The crude product was purified by chromatography 
on silica gel using 1% pyridine/99% hexanes. Product 67-p-Fa-Br was isolated as a white 
solid (38 mg, 36% yield, Rf = 0.24 in hexanes). 1H NMR (400 MHz, CDCl3): δ 7.87 (d, J 
= 8.50 Hz, 1H), 7.85 (t, J = 6.00 Hz, 1H), 7.79  (t, J = 6.00 Hz, 1H), 7.72 (br s, 1H), 7.60 
(dd, J = 9.00, 2.00 Hz, 1H), 7.53-7.50 (multiple peaks, 2H), 7.11-7.09 (multiple peaks, 
2H), 6.93 (t, J = 8.50 Hz, 2H), 5.28 (t, J = 7.00 Hz, 1H), 3.64 (dd, J = 14.00, 7.50 Hz, 
1H), 3.58 (dd, J = 14.50, 7.50 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 161.77 (1JC-F = 
243 Hz), 138.38, 133.73 (4JC-F = 3.1 Hz), 133.17, 132.92, 130.72 (3JC-F = 8.5 Hz), 128.75, 
128.05, 127.69, 126.56, 126.50, 126.39, 125.12, 115.25 (2JC-F = 22 Hz), 55.72, 45.43. 19F 
NMR (376 MHz, CDCl3): δ -115.73 – -115.80. HRMS EI (m/z): [M]+ Calcd for 






PdCl2(CH3CN)2 (11.7 mg, 0.030 mmol, 10 mol %) and CuCl2 (164 mg, 1.218 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (8.5 mL) was 
added at -78 °C. A solution of substrate cis-72 (100 mg, 0.304 mmol, 1.00 equiv) in Et2O 
(1 mL) and PhSnBu3 (145 mg, 0.396 mmol, 1.30 equiv) were added, and the reaction was 
allowed to warm to room temperature over 5 h and then stirred for an additional 7 h. The 
reaction mixture was filtered through a pad of celite and washed with copius Et2O (150 
mL). The filtrate was concentrated. The crude 1H NMR spectrum of this reaction mixture 
showed a 10:1 ratio 72a-Cl : 72b-Cl. The crude product was purified by chromatography 
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on silica gel using 4% EtOAc/0.5% Et3N/95.5% hexanes. Product 72a-Cl was isolated as 
an oil (66 mg, 50% yield, Rf = 0.15 in 5% EtOAc/95% hexanes) as a mixture of 
diastereomers. Samples of 72a-Cl for HRMS and NMR analysis were obtained after 
further purification by HPLC (2%EtOAc/98% hexanes, 20 mL/min, Waters µ-porasil 
19.1 mm). 1H NMR (400 MHz, CDCl3) (major diastereomer): δ 8.00 (d, J = 8.4 Hz, 2H), 
7.64 (td, J = 7.2, 1.6 Hz, 2H), 7.48 (t, J = 8.0 Hz, 2H), 7.41 (t, J = 7.2 Hz, 1H), 7.19-7.10 
(multiple peaks, 8H), 7.04 (d, J = 7.6 Hz, 2H), 5.05 (d, J = 8.8 Hz, 1H), 4.29-4.23 (m, 
1H), 4.15-4.08 (m, 1H), 3.42 (td, J = 10.4, 3.2 Hz, 1H), 2.88-2.80 (m, 1H) 2.32-2.23 (m, 
1H). 13C NMR (100 MHz, CDCl3) (major diastereomer): δ 166.26, 145.59, 140.09, 
140.00, 139.50, 130.04, 128.92, 128.89, 128.49, 128.45, 128.13, 128.11, 127.91, 127.56, 
127.27, 127.08, 126.99, 68.17, 63.18, 51.64, 31.84. HRMS EI (m/z): [M+Na]+ Calcd for 
C29H25ClO2, 463.1441; Found, 463.1432. 
 
Structure Determination. 
 Colorless plates of 72a-Cl were grown by diffusion of pentane into a 
chlorobenzene solution at 25 deg. C.  A crystal of dimensions 0.18 x 0.16 x 0.08 mm was 
mounted on a Bruker SMART APEX CCD-based X-ray diffractometer equipped with a 
low temperature device and fine focus Mo-target X-ray tube (l = 0.71073 A) operated at 
1500 W power (50 kV, 30 mA).  The X-ray intensities were measured at 180(1) K; the 
detector was placed at a distance 5.055 cm from the crystal.  A total of 4095 frames were 
collected with a scan width of 0.5° in w and 0.45° in phi with an exposure time of 30 
s/frame.  The integration of the data yielded a total of 77825 reflections to a maximum 2q 
value of 54.74° of which 10525 were independent and 7708 were greater than 2s(I).  The 
final cell constants (Table 1) were based on the xyz centroids of 9856 reflections above 
10s(I).  Analysis of the data showed negligible decay during data collection; the data 
were processed with SADABS and corrected for absorption.  The structure was solved 
and refined with the Bruker SHELXTL (version 6.12) software package, using the space 
group P1bar with Z = 4 for the formula C29H25O2Cl.  There are two crystallographically 
independent molecules in the asymmetric unit.  All non-hydrogen atoms were refined 
anisotropically with the hydrogen atoms placed in idealized positions.  Full matrix least-
squares refinement based on F2 converged at R1 = 0.0417 and wR2 = 0.1013 [based on I 
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> 2sigma(I)], R1 = 0.0657 and wR2 = 0.1141 for all data.  Additional details are 
presented in Table 1 and are given as Supporting Information in a CIF file. 
 
Sheldrick, G.M. SHELXTL, v. 6.12; Bruker Analytical X-ray, Madison, WI, 2001. 
Sheldrick, G.M. SADABS, v. 2007/4.  Program for Empirical Absorption Correction of 
Area Detector Data, University of Gottingen: Gottingen, Germany, 2007.   








PdCl2(CH3CN)2 (14.0 mg, 0.037 mmol, 10 mol %) and CuCl2 (196 mg, 1.46 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. THF (10 mL) was added 
at 0 °C. A solution of substrate trans-72  (120 mg, 0.365 mmol, 1.00 equiv) in Et2O (1 
mL) and PhSnBu3 (174 mg, 0.475 mmol, 1.30 equiv) were added. The reaction was 
stirred at 0 °C for 1 hour after which another aliquot of PhSnBu3 (174 mg, 0.475 mmol, 
1.30 equiv) was added. The resulting reaction mixture was allowed to warm to room 
temperature over 5 h and then stirred for an additional 7 h. The reaction mixture was 
filtered through a pad of celite and washed with copius Et2O (150 mL). The filtrate was 
concentrated. The crude 1H NMR spectrum of this reaction mixture showed a 3:1 ratio 
diastereomers. The crude product was purified by chromatography on silica gel using 4% 
EtOAc/0.5% Et3N/95.5% hexanes. Product was isolated as an oil (69 mg, 43% yield, Rf = 
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0.15 in 5% EtOAc/95% hexanes) as a mixture of diastereomers. Samples of 72b-Cl for 
HRMS and NMR analysis were obtained after further purification by HPLC (2% 
EtOAc/98% hexanes, 20 mL/min, Waters µ-porasil 19.1 mm). 1H NMR (500 MHz, 
CDCl3) (minor diastereomer): δ 8.01 (dt, J = 8.5, 2.0 Hz, 8H), 7.21-7.18 (tt, J = 8.5, 1.5 
Hz, 4H), 7.50 (td, J = 7.0, 1.5 Hz, 2H), 7.43 (tt, J = 7.0, 1.0 Hz, 1H), 7.38-7.29 (multiple 
peaks, 8H), 7.25 (d, J = 7.5 Hz, 2H), 5.11 (d, J = 8.5 Hz, 1H), 4.18 (quin, J = 6.0 Hz, 
1H), 4.06-4.01 (m, 1H), 3.47 (td, J = 8.5, 3.5 Hz, 1H), 2.15-2.02 (multiple peaks, 2H). 
13C NMR (100 MHz, CDCl3) (minor diastereomer): δ 166.12, 145.64, 139.94, 139.87, 
130.00, 128.93, 128.80, 128.59, 128.55, 128.49, 128.16, 127.66, 127.37, 127.26, 127.00, 
67.64, 62.89, 51.23, 32.07. One of the carbons is coincidentally overlapping. HRMS EI 






PdCl2(CH3CN)2 (40.9 mg, 0.158 mmol, 20 mol %) and CuBr2 (705 mg, 3.15 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (5.2 mL) was 
added at -78 °C. A solution of substrate cis-73 (150 mg, 0.789 mmol, 1.00 equiv) in Et2O 
(1 mL) and PhSnBu3 (354 mg, 0.964 mmol, 1.30 equiv) were added, and the reaction was 
allowed to warm to room temperature over 5 h and then stirred for an additional 7 h. The 
reaction mixture was filtered through a pad of celite and washed with copius Et2O (150 
mL). The filtrate was concentrated. The crude 1H NMR spectrum of this reaction mixture 
showed a 5:1 ratio of diastereomers. The crude product was purified by chromatography 
on silica gel using 4% EtOAc/1% Et3N/95% hexanes. Product was isolated as an oil (94 
mg, 34% yield, Rf = 0.13 in 6% EtOAc/94% hexanes) as a mixture of diastereomers. 
Samples of 73a-Br and 73b-Br for HRMS and NMR analysis were obtained after further 
purification by HPLC (2% EtOAc/98% hexanes, 20 mL/min, Waters µ-porasil 19.1 mm). 
1H NMR (400 MHz, CDCl3) (major diastereomer): δ 7.19-7.05 (multiple peaks, 8H), 6.96 
(dd, J = 6.0, 1.2 Hz, 2H), 5.10 (d, J = 10.4 Hz, 1H), 3.99 (ddd, J = 11.0, 7.2, 5.0 Hz, 1H), 
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3.84-3.78 (m, 1H), 3.42 (td, J = 10, 3.6 Hz, 1H), 2.82-2.74 (m, 1H), 2.13-2.04 (m, 1H), 
1.99 (s, 3H). 13C NMR (100 MHz, CDCl3) (major diastereomer): δ 140.62, 139.38, 
128.40, 128.26, 128.13, 127.94, 127.87, 127.01, 62.57, 60.51, 51.08, 33.67, 20.86. 
HRMS EI (m/z): [M+Na]+ Calcd for C18H19BrO2, 369.0466; Found, 369.0459. 1H NMR 
(400 MHz, CDCl3) (minor diastereomer): δ 7.37-7.27 (multiple peaks, 8H), 7.21-7.18 
(multiple peaks, 2H), 5.09 (d, J = 9.6 Hz, 1H), 3.88-3.82 (m, 1H), 3.72-3.65 (m, 1H), 
3.43 (td, J = 9.6, 4.0 Hz, 1H), 1.94 (s, 3H) 1.92-1.76 (multiple peaks, 2H). 13C NMR (100 
MHz, CDCl3) (minor diastereomer): δ 140.82, 140.39, 128.67, 128.51, 128.26, 127.96, 
127.42, 62.44, 60.01, 50.97, 32.44, 20.80. One of the carbons is coincidentally 




 Colorless plates of 73a-Br were crystallized from a chlorobenzene/pentane 
solution at 23 deg. C.  A crystal of dimensions 0.40 x 0.24 x 0.085 mm was mounted on a 
standard Bruker SMART-APEX CCD-based X-ray diffractometer equipped with a low 
temperature device and fine focus Mo-target X-ray tube (l = 0.71073 A) operated at 1500 
W power (50 kV, 30 mA).  The X-ray intensities were measured at 200(2) K; the detector 
was placed at a distance 5.055 cm from the crystal.  A total of 2240 frames were 
collected with a scan width of 0.5° in w and 0.45° inf with an exposure time of 30 
s/frame.  The frames were integrated with the Bruker SAINT software package with a 
narrow frame algorithm.  The integration of the data yielded a total of 33141 reflections 
to a maximum 2q value of 56.72° of which 4073 were independent and 3316 were greater 
than 2s(I).  The final cell constants (Table 1) were based on the xyz centroids of 9972 
reflections above 10s(I).  Analysis of the data showed negligible decay during data 
collection; the data were processed with SADABS and corrected for absorption.  The 
structure was solved and refined with the Bruker SHELXTL (version 2008/3) software 
package, using the space group P2(1)/n with Z = 4 for the formula C18H19O2Br.  All 
non-hydrogen atoms were refined anisotropically with the hydrogen atoms placed in 
idealized positions.  Full-matrix least-squares refinement based on F2 converged at R1 = 
0.0300 and wR2 = 0.0726 [based on I > 2sigma(I)], R1 = 0.0405 and wR2 = 0.0784 for 
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all data.  Additional details are presented in Table 1 and are given as Supporting 
Information in a CIF file. 
 
Sheldrick, G.M. SHELXTL, v. 2008/3; Bruker Analytical X-ray, Madison, WI, 2008. 
 
Saint Plus, v. 7.53A, Bruker Analytical X-ray, Madison, WI, 2008. 
 
Sheldrick, G.M. SADABS, v. 2008/1.  Program for Empirical Absorption Correction of 





PdCl2(PhCN)2 (28.4 mg, 0.074 mmol, 10 mol %) and CuCl2 (399 mg, 2.96 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (22 mL) was added 
at -78 °C. A solution of substrate cis-76 (150 mg, 0.741 mmol, 1.00 equiv) in Et2O (1 
mL) and PhSnBu3 (353 mg, 0.964 mmol, 1.30 equiv) were added, and the reaction was 
allowed to warm to room temperature over 5 h and then stirred for an additional 7 h. The 
reaction mixture was filtered through a pad of celite and washed with copius Et2O (150 
mL). The filtrate was concentrated. The crude 1H NMR spectrum of this reaction mixture 
showed a 9:1 ratio of diastereomers. The crude product was purified by chromatography 
 267 
on silica gel using 0.5% Et3N/99.5% hexanes. Product was isolated as an oil (126 mg, 
55% yield, Rf = 0.21 in hexanes) as a mixture of diastereomers. However, one set of 
fractions was just the major diastereomer 76a-Cl and was used for characterization. 1H 
NMR (400 MHz, CDCl3): δ 7.20-7.08 (multiple peaks, 8H), 6.97 (d, J = 8.0 Hz, 2H), 
4.99 (d, J = 9.2 Hz, 1H), 3.16 (td, J = 12.0, 3.6 Hz, 1H), 2.31-2.23 (m, 1H), 1.83-1.73 (m, 
1H), 1.36-1.06 (multiple peaks, 10H), 0.86 (t, J = 6.0 Hz, 3H). 13C NMR (100 MHz, 
CDCl3) (major diastereomer): δ 140.75, 140.62, 128.63, 128.03, 127.92, 127.64, 127.62, 
126.53, 68.73, 54.41, 32.65, 31.78, 29.47, 29.09, 27.27, 22.59, 14.05. HRMS CI with 
ammonia: [M+NH4]+ Calcd for C21H27Cl, 332.2145; Found, 332.2149. 
 
Cl  
PdCl2(PhCN)2 (18.9 mg, 0.049 mmol, 10 mol %) and CuCl2 (266 mg, 1.98 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (14 mL) was added 
at -78 °C. A solution of substrate trans-76 (100 mg, 0.494 mmol, 1.00 equiv) in Et2O (1 
mL) and PhSnBu3 (236 mg, 0.642 mmol, 1.30 equiv) were added, and the reaction was 
allowed to warm to room temperature over 5 h and then stirred for an additional 7 h. The 
reaction mixture was filtered through a pad of celite and washed with copius Et2O (150 
mL). The filtrate was concentrated. The crude 1H NMR spectrum of this reaction mixture 
showed a 2:1 ratio of diastereomers. The crude product was purified by chromatography 
on silica gel using 0.5% Et3N/99.5% hexanes. Product was isolated as an oil (57 mg, 37% 
yield, Rf = 0.19 in hexanes) as a mixture of diastereomers. Samples of 76b-Cl for HRMS 
and NMR analysis were obtained after further purification by HPLC (100% hexanes, 20 
mL/min, Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, CDCl3) (minor diastereomer): 
δ 7.34-7.23 (multiple peaks, 8H), 7.16 (d, J = 6.8 Hz, 2H), 4.99 (d, J = 8.8 Hz, 1H), 3.14 
(td, J = 8.8, 4.8 Hz, 1H), 1.54-1.44 (multiple peaks, 2H), 1.22-0.96 (multiple peaks, 
10H), 0.80 (t, J = 7.6 Hz, 3H). 13C NMR (100 MHz, CDCl3) (minor diastereomer): δ 
141.36, 140.60, 128.62, 128.37, 128.16, 128.13, 127.65, 126.82, 68.25, 54.19, 32.98, 
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31.69, 29.26, 28.97, 27.31, 22.54, 14.02. HRMS CI with ammonia: [M+NH4]+ Calcd for 
C21H27Cl, 332.2145; Found, 332.2156. 
 
Br  
PdCl2(CH3CN)2 (38.5 mg, 0.099 mmol, 20 mol %) and CuBr2 (441 mg, 1.98 mmol, 4.00 
equiv) were weighed into a 25 mL Schlenk flask. The flask was sealed with a rubber 
septum that was secured with copper wire and cooled to –78 °C. Et2O (4.8 mL) was 
added at -78 °C. A solution of substrate cis-76 (100 mg, 0.494 mmol, 1.00 equiv) in Et2O 
(1 mL) and PhSnBu3 (236 mg, 0.642 mmol, 1.30 equiv) were added, and the reaction was 
allowed to warm to room temperature over 5 h and then stirred for an additional 7 h. The 
reaction mixture was filtered through a pad of celite and washed with copius Et2O (150 
mL). The filtrate was concentrated. The crude 1H NMR spectrum of this reaction mixture 
showed a 5:1 ratio of diastereomers. The crude product was purified by chromatography 
on silica gel using 1% Et3N/99.5% hexanes. Product was isolated as an oil (52 mg, 19% 
yield, Rf = 0.21 in hexanes) as a mixture of diastereomers. Samples of 76a-Br and 76b-
Br for HRMS and NMR analysis were obtained after further purification by HPLC 
(100% hexanes, 20 mL/min, Waters µ-porasil 19.1 mm). 1H NMR (400 MHz, CDCl3) 
(major diastereomer): δ 7.16-7.03 (multiple peaks, 8H), 6.94 (dd, J = 8.0, 1.2 Hz, 2H), 
5.09 (d, J = 10 Hz, 1H), 3.26 (td, J = 10.8, 3.2 Hz, 1H), 2.40-2.32 (m, 1H), 1.79-1.71 (m, 
1H), 1.36-1.00 (multiple peaks, 10H), 0.85 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, 
CDCl3) (major diastereomer): δ 141.17, 140.76, 128.45, 128.08, 128.00, 127.65, 126.49, 
61.52, 54.10, 34.70, 31.79, 29.43, 29.10, 27.32, 22.60, 14.06. One of the carbons is 
coincidentally overlapping. HRMS CI with ammonia: [M+NH4]+ Calcd for C21H27Br, 
376.1640; Found, 376.1641. 1H NMR (400 MHz, CDCl3) (minor diastereomer): δ 7.37-
7.24 (multiple peaks, 8H), 7.19 (d, J = 7.6 Hz, 2H), 5.05 (d, J = 10 Hz, 1H), 3.28-3.22 
(m, 1H), 1.48-1.41 (multiple peaks, 2H), 1.20-0.92 (multiple peaks, 10H), 0.79 (t, J = 7.2 
Hz, 3H). 13C NMR (100 MHz, CDCl3) (minor diastereomer): δ 142.39, 141.10, 128.54, 
128.33, 128.20, 127.93, 126.89, 61.02, 54.06, 33.59, 31.67, 29.21, 28.93, 27.48, 22.53, 
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14.01. One of the carbons is coincidentally overlapping. HRMS CI with ammonia: 








PdCl2(PhCN)2 (37.5 mg, 0.098 mmol, 10 mol %) was weighed into a 25 mL Schlenk 
flask. PhICl2 (537 mg, 1.95 mmol, 2.00 equiv) was added to this flask in the glove box. 
The flask was sealed with a rubber septum that was secured with copper wire. The flask 
was cooled to –78 °C, and substrate 77 (344 mg, 0.977 mmol, 1.00 equiv) and CH2Cl2 
(5.7 mL) were added. PhSnBu3 (466 mg, 1.27 mmol, 1.30 equiv) was added, and the 
resulting mixture stirred at –78 °C for 1 h. A second aliquot of PhSnBu3 (466 mg, 1.27 
mmol, 1.30 equiv) was added, and the reaction was allowed to warm to room temperature 
over 5 h and then stirred for an additional 7 h.  The reaction mixture was filtered through 
a pad of celite and washed with copius Et2O (150 mL). The filtrate was concentrated. The 
1H NMR spectrum of this crude reaction mixture showed a 39% yield of 77-Cl. The 
product was purified by chromatography on silica gel using 9% EtOAc/1% Et3N/90% 
hexanes. The product was isolated as a clear oil as a mixture with the corresponding 
dichloro product. Samples of 77-Cl for HRMS and NMR analysis were obtained after 
further purification by HPLC (6% EtOAc/94% hexanes, 20 mL/min, Waters µ-porasil 
19.1 mm). 1H NMR (400 MHz, CDCl3): δ 8.03-7.96 (multiple peaks, 4H), 7.57-7.53 
(multiple peaks, 2H), 7.45-7.40 (multiple peaks, 4H), 7.33-7.24 (multiple peaks, 5H), 
4.34-4.21 (multiple peaks, 5H), 3.03-2.98 (m, 1H), 2.07-1.99 (multiple peaks, 3H), 1.93-
1.82 (multiple peaks, 2H), 1.73-1.59 (multiple peaks, 3H). 13C NMR (100 MHz, CDCl3): 
δ 166.53, 166.48, 139.43, 132.89, 132.86, 130.26, 130.18, 129.49, 129.10, 128.32, 








 Colorless plates of 77-Cl were grown from a chlorobenzene/pentane solution at 
25 deg. C.  A crystal of dimensions 0.38 x 0.20 x 0.20 mm mounted on a Bruker SMART 
APEX CCD-based X-ray diffractometer equipped with a low temperature device and fine 
focus Mo-target X-ray tube (l = 0.71073 A) operated at 1500 W power (50 kV, 30 mA).  
The X-ray intensities were measured at 85(1) K; the detector was placed at a distance 
5.055 cm from the crystal.  A total of 4530 frames were collected with a scan width of 
0.5° in w and 0.45° in phi with an exposure time of 15 s/frame.  The integration of the 
data yielded a total of 93080 reflections to a maximum 2q value of 59.20° of which 6767 
were independent and 6209 were greater than 2s(I).  The final cell constants (Table 1) 
were based on the xyz centroids of 9843 reflections above 10s(I).  Analysis of the data 
showed negligible decay during data collection; the data were processed with SADABS 
and corrected for absorption.  The structure was solved and refined with the Bruker 
SHELXTL software package, using the space group P2(1)/c with Z = 4 for the formula 
C28H29O4Cl.  All non-hydrogen atoms were refined anisotropically with the hydrogen 
atoms placed in idealized positions.  Full matrix least-squares refinement based on F2 
converged at R1 = 0.0359 and wR2 = 0.0932 [based on I > 2sigma(I)], R1 = 0.0392 and 
wR2 = 0.0956 for all data.  Additional details are presented in Table 1 and are given as 
Supporting Information in a CIF file. 
 
Sheldrick, G.M. SHELXTL, v. 2008/3; Bruker Analytical X-ray, Madison, WI, 2008. 
Sheldrick, G.M. SADABS, v. 2008/1.  Program for Empirical Absorption Correction of 
Area Detector Data, University of Gottingen: Gottingen, Germany, 2008.   
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